Advanced Search

Amendments To The Cabinet Of Ministers On 19 December 2006, Regulations No. 1046 "health Care Organization And Financing Arrangements"

Original Language Title: Grozījumi Ministru kabineta 2006.gada 19.decembra noteikumos Nr.1046 "Veselības aprūpes organizēšanas un finansēšanas kārtība"

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
Cabinet of Ministers Regulations No. 1217 Riga 2010 December 28 (Mon. No 75 45) amendments to the Cabinet of Ministers on 19 December 2006, regulations No. 1046 "health care organization and financing arrangements" Issued in accordance with article 4 of the law on medical treatment, first subparagraph 1. make Cabinet on 19 December 2006, the provisions of no. 1046 "health care organization and financing arrangements" (Latvian journal, 2006, 208. No; 2007, 146.207. no; 2008, no. 118, 202; 2009, 25, 49, 104, 157, 183. 206. no; 2010, 16, 65, 89, 130, 161 no). the following amendments: 1. make paragraph 5 by the following: "5. the health settlement Center (hereinafter referred to as the Centre) this provision referred to in paragraph 2, the health service pay for State budget plans to redirect: 5.1 paid for outpatient health care services – not less than 45%;
5.2. payment for stationary health care services-up to 53%;
5.3. payment for the transnational settlement with European Union (EU) and European economic area (EEA) Member States and the Swiss Confederation (hereinafter Switzerland), with the medical authorities of the EU and EEA Member States and the Swiss population in the Republic of Latvia received health care services, as well as the requirements laid down in health care regulatory international contracts: not more than 2%. ";
1.2. the express section 14.14. as follows: "the psychotherapeutic and 14.14. psychological assistance, except in the following cases: If the assistance provided psychiatric 14.14.1. the hospitals or departments;
14.14.2. If required, besides providing outpatient psychiatric help children;
14.14.3. providing outpatient palliative care for children;
14.14.4. If assistance is provided to multiprofesionāl team rehabilitation programs, or alcohol and drug addiction in the medical rehabilitation program;
14.14.5. the psychological expertise of courts. ";
1.3. to replace the text "in paragraph 14.24. European Union and European economic area (hereinafter referred to as the EU, the EEA)" with the text "EU and EEA" and the words "of the Swiss Confederation (hereinafter Switzerland)" with the word "Switzerland";
1.4. the express section 14.36. the following wording: "for the surgical aid of 14.36. the exception provided outpatient health care services, day-hospital surgical assistance, provided emergency medical cases, surgical assistance for children, surgical treatment of inflammatory bowel disease, a hormonal endocrine glands surgical treatment, elective surgery a person with a disability under the expected health and integrity of the expertise of the National Commission of doctors certified persons with disabilities expected individual rehabilitation plan , and surgical assistance this provision of annex 2, paragraph 22, in health services (hereinafter referred to as the "Highlight services ');";
1.5. to supplement the rules by 14.37.9. section as follows: "14.37.9. systematic operations the person with disability according to the expected health and integrity of the expertise of the National Commission of doctors certified persons with disabilities expected individual rehabilitation plan;"
1.6. to delete in Word and 20.1 "and 240.1";
1.7. to supplement the provisions of the following paragraph 22.1: "22.1 At the register included only children up to 18 years of age.";
1.8. to supplement the rules with 31.1 points by the following: "excluded from the Pediatrics Centre 31.1 registered patient list of patients who reached 18 years of age. A pediatrician concerned shall inform the patient. ';
1.2. make and 33.2 33.1.. subparagraph by the following: 33.1. psychiatric hospital "patients continuously treated for longer than three months;
33.2. persons in custody; "
1.10. to supplement the provisions of this subparagraph with 43.4.: "sending material consideration 27.0. samples for laboratory examinations, referrals to patient compliance in poor status of the person recognised as such in accordance with the laws and regulations on the procedures for the family or single person to be recognized as living poor, or the person whose income per family member does not exceed 120 lats a month, or the status of a person whose income exceeds 120 lats but not exceeding 150 Lats per month. ";
1.11. to make 44.1 and 44.2. subparagraph such.: "44.1. family doctor patient acceptance time: not less than 20 44.1.1. hours per week if the number of patients registered with the practice is up to 2000;
44.1.2. not less than 25 hours a week, if the number of patients registered with the practice has more than 2000 patients;
44.2. the working time – not less than 40 hours a week, ensuring that this time the family doctor or nurse, or physician's Assistant (feldšer) availability of family physicians the basic practice; ";
1.12. Express 45 as follows: "45. Outside these rules referred to in paragraph 44 of the time family doctor provided health care services to the cities of the Republic – Riga, Jurmala, Ventspils, Liepaja, Jelgava, jekabpils, Valmiera, Rezekne and Daugavpils – can provide the duty doctor (doctor who accepts patients outside the family doctor work time). The duty doctor plan according to the number of the city's population by providing no less than the one the duty doctor to 40000 inhabitants. ";
1.13. supplement with 53.3 points as follows: "If the family doctor 53.3 years after the end of State-funded residency Center application submitted pursuant to this provision, paragraph 53, the center of this family doctor is registered on the waiting list. If that family doctors waiting list is over, record them in the order of submission of the application before the rest of the family doctor waiting list existing doctors. ";
1.14. delete paragraph number 2 55.1 "33.1";
1.15. supplement 57.2. subparagraph after the word "Ma" with the words "municipality of Mērsrags municipality";
1.16. supplement section 57.4. beyond words "jaunpiebalga municipality" with the words "kocēni municipality";
1.17. the deletion of the words in subparagraph 57.4. Lakewood municipality ";
1.18. replace 39.2 in the number "85" with the number "87";
1.19 replace 39.3 in the number "15" with the number "13";
1.20. supplement with 67.5. subparagraph by the following:

"67.5. registered number of patients primary health care physician list is not less than 600 (primary health care, the list included 300 children).";
1.21. delete paragraph 77 the number "76.3.";
1.22. supplement with 77.1 77.2 points and by the following: "sending material consideration 77.1 sample to laboratory studies, secondary ambulatory health care professional referral indicates patient compliance with the poor status of the person recognised as such in accordance with the laws and regulations on the procedures for the family or single person to be recognized as living poor, or the person whose income per family member does not exceed 120 Lats per month whether the status of a person whose income exceeds 120 lats, but not exceeding 150 Lats per month.
77.2 the material by sending a sample to the laboratory for the study of hospital patient days, secondary ambulatory health care professional referral indicates patient compliance with day hospital patient status. ";
1.23. supplement 88.2 point after the words ' rehabilitation medical doctor or by the words "rehabilitolog" or psychiatric help in the case of the psychiatrist or child psychiatrist ";
1.24. supplement 88.9 point after the words "or rehabilitolog" with the words "a psychiatric institution or Department profile of patients with mental and behavioural disorders, the psychiatrist, child psychiatrist;
1.25. supplement with 56.9 points as follows: "the payment for outpatient laboratory 56.9 services centre of the means made available to the family doctor and secondary ambulatory health-care specialists are controlled in accordance with the provisions of chapter V1 If outpatient laboratory service provider a month has provided services, which pay for about more than 20 000 lats, then by making outpatient laboratory services to pay for this service provider during that month, the Centre applies the following factors all relevant month payable amount: 56.9 1. If, in the course of services provided for the amount of 20 000 lats to 49999.99 litres, the coefficient of 0.95;
56.9 2. If, in the course of services provided for the amount of 50 000 lats, the coefficient 0.9. ";
1.26. the express section 60.5. the following wording: "97.3. payment for health care services provided to these regulations, paragraph 7.6 and section 10.17.10.18. persons referred to, as well as the EU Member States, EEA and the Swiss social security system insured persons and the requirements laid down in health care in regulating international agreements, according to the actual number of days this provision 22. Annex 3 days laid down in the tariff and the tariff manipulation that this provision in annex 18. marked with an asterisk (*). ";
1.27. supplement with V1 as follows: section "v. 1 outpatient laboratory services funded from the Centre for secondary 110.1 outpatient health care for State budget separately plans to annex 6 of these rules (except laboratory investigations in accordance with the provisions of annex 5) the specified outpatient laboratory services pay the resources intended for family doctors and secondary ambulatory health-care specialists. If next year, compared to the current year, funding for secondary ambulatory health care is increased or reduced, the Center proportionally reduced or increased planned outpatient laboratory services to pay for the resources.
Laboratory services in the settlement of 110.2 funds total about family doctors and secondary ambulatory health-care specialists for the following year shall be calculated as follows: 1. the family doctors 110.2-current year with family doctor dispatches the actual number of laboratory manipulation during the first half of the year is multiplied by this manipulation of the tariff and the results are multiplied by two, 110.2 2. secondary ambulatory health-care specialists-in the current year with the technician dispatches the actual number of laboratory manipulation during the first half of the year is multiplied by this manipulation of the tariff and the resulting Multiplies the result by two. Of all according to 110.3 this rule 110.2 points calculated for the resources centre creates a financial reserve of 5% that is used: 1. laboratory services 110.3 billed according to actual service, where provided: the 1.1 110.3 family doctor referrals, which receives a fixed payment according to paragraph 70 of these rules;
1.2. with a duty doctor 110.3 referrals;
110.3 1.3. in accordance with the provisions of annex 5;
2. laboratory services 110.3 billed under this rule 110.15 points.
110.4 per registered family physicians patient laboratory services for the resources provided for payment is calculated by dividing the provisions under this paragraph 110.1 and 110.2 1. section calculated means of which deprived 5%, with a total of all family physicians registered number of patients during the first half of the year.
110.5 each family doctor services pay for laboratory instruments provided for about year, calculated as follows: 1. in accordance with rule 110.5 of 110.4 points this calculated one at a family physician's patient laboratory services established to pay for the resources are multiplied by the corresponding factor: 110.5 1.1. patients to 1 year of age – 0.69;
110.5 1.2. patients from 1 to 6 years – 0.90;
110.5 1.3. patients from 7 to 17 years-0.59;
110.5 1.4. patients between 18 and 44 years – 0.56;
110.5 1.5. patients from 45 to 64 years: 1.33;
110.5 1.6. patients older than 65 years-1.84;
2. each according to 110.5 this rule 110.5 (a) 1 the resulting number multiplied with the family doctor, registered number of patients during the first half of the year given that rule 110.5) (1 in the appropriate age group;
3. amount according to 110.5 this rule 110.5 2. subparagraph figures obtained by winning a specific general practitioner services pay the common laboratory resources intended for the year you specify between the Centre and the medical establishment in the agreement concluded on the primary health care service delivery and payment.

110.6 secondary ambulatory health-care specialists on one episode of laboratory services for the resources provided for payment is calculated by dividing the total in accordance with the provisions of section 110.1 and 110.2 points, 2. calculated fee of laboratory services for the resources, from minus 5%, with last year's total of secondary ambulatory health-care specialists, the number of episodes during the first half of the year, multiply by two. In calculating the service laboratory 110.7 pay the resources for secondary ambulatory health-care specialists , the following factors: 1. the gynecologist to 110.7, birth, child-1.09 gynecologist;
110.7 endokrinolog, 2 children – 3.20 endokrinolog;
3. ģenētiķ – 40.17 110.7;
4. the oncologist to 110.7-2.99 ķīmijterapeit;
5. dermatovenerolog-110.7 1.18;
6. Paediatrics-1.71 110.7;
110.7 7. pneimonolog (ftiziopneimonolog), pneimonolog-0.57 of the child;
8. the oncologist – 1.68 110.7;
9. the ophthalmologist-110.7 0.02;
10. children's surgeon 110.7-0.09;
11. child psychiatrist, 110.7 psychiatrists-0.02;
12. narkolog-110.7 0.01;
13. other 110.7 secondary ambulatory health-care specialists – 0.63. Each of these provisions 110.8 110.7 referred to secondary ambulatory health-care specialists of laboratory services total pay the resources intended for the year calculated in accordance with this rule 110.6 points calculated on one episode of laboratory services for the resources pay multiplied by this provision in question under section 110.7 specialist ratio and specific specialist number of episodes during the first half of the year multiplied by two if the secondary 110.9. outpatient health care professional agreements with Center not from the beginning of the year, then calculate the fee of the laboratory service funds in about a year, multiplying 1/12 from average to one of the specialties of doctors calculated for payment of laboratory services for the resources for a year with the coming of the year full months.
110.10 calculated for a given secondary ambulatory health-care specialists for laboratory services pay the resources intended for the year indicates between the Centre and the medical establishment in the agreement concluded on the secondary ambulatory health care services and pay by adding together all the relevant medical authorities secondary ambulatory health-care specialists of laboratory services in the settlement of funds, calculated according to this provision the 110.9 110.8 and point.
110.11 family doctor and secondary ambulatory health-care specialists, sending patients to the outpatient laboratory services, is to control the calculated payment of laboratory services for the use of resources.
110.12 Center each month provides medical institutions with information on family physicians and secondary ambulatory health-care specialists of laboratory services to pay for the use of the resources.
every six months, up to 110.13 1 august (for the period from 1 January to 30 June) and up to 1 February (for the period from 1 July of the previous year to 31 December) – the Center compared the calculated and the contract with the hospital laboratory services specified in the settlement of the resources provided to the laboratory services used to pay for the resources.
If the family doctor or 110.14 medical establishment, providing outpatient health care services have spent more than 20% of its indicated in the contract for payment of laboratory services for the resources in the first half, the family physician or a medical authority in the second half of the year the laboratory calculated for service fee for the resources will be reduced by the amount that is 50% of the unused laboratory services to pay for the resources.
If the family doctor or 110.15 medical establishment, providing outpatient health care services in the first half of the year has brought to the Centre with a request for payment of laboratory services for the increase of the resources, the Center for the family doctor or the medical institution of the year increase in the second half of the calculated fee of laboratory services for the resources, if it is available and if: 1. the family doctor 110.15 the year's first half receives this provision 12.12 of the annex provided for in paragraph premium for chronic care patients in that is greater than 25% of the average for one family doctor estimated premium for chronic care patients;
2.110.15 medical institution where employed secondary ambulatory health-care specialists, the total number of episodes in the first half of the year increased by more than 25% of the projected number of episodes. "
1.28. deleted in paragraph 116 numbers "3.3", "3.6" and "3.12";
1.29. to supplement the provisions under paragraph 121.2.1.1 as follows: "121.2.1.1 with laboratories comply with the laws and regulations on medical institutions and their departments down the minimum requirements that are not tax or State social security payment debt;"
1.30. the deletion of 121.4. section;
1.31. deletion of 129.1 points;
1.32. Express 130.1.1. subparagraph as follows: "130.1.1. actual study, or the number of episodes of care through health care services during the nine months of the year, subject to the following conditions: 130.1.1.1. actual episodes of care and number of study children and pregnant women, within nine months of the current year;
130.1.1.2. the actual number of patients in the study who received services or haemofiltration haemodialysed and, during the nine months of the year;
130.1.1.3. in determining the scope of the contract, funding priority shifting this provision 24.1 of the annex referred to in medical institutions;
130.1.1.4. health care provider in the previous period provided the following health care services, contract, planned episodes of care or study number down not more than 50% of the average episode of care or study number one medical institution which provides a particular service;

130.1.1.5. health care provider in the previous period, the health care services provided by a part-time period into one of the types of services, contract, planned care episode or the number of study shall be determined in proportion to the amount of services provided in the period, if it is not less than three calendar months. If the service period is shorter, this provision shall apply 130.1.1.4. conditions referred to in paragraph; ";
1. Express 130.1.3. subparagraph as follows: "130.1.3." the health care provider, and the results of the selection procedure in accordance with the provisions of paragraph 128.1 Center agreed health services; ";
1.34. Express 130.2.1. subparagraph as follows: "130.2.1." the number of patients treated by the health care services, taking into account the data on the scope of the contract for planning the moment available for the current year full months: 130.2.1.1. actually treated children and pregnant women;
130.2.1.2. not less than 75% of the actual treatment of Oncology, tuberculosis and the number of psychiatric patients;
130.2.1.3. in determining the scope of the contract, funding priority for treatment, directs such institutions – limited liability company "liepājas regional hospital", a society with limited liability "Daugavpils regional hospital", the national society with limited liability "children clinical University Hospital", public company limited "Paul stradins clinical University Hospital", a society with limited liability "the Riga Eastern clinical University Hospital", a society with limited liability "Jelgava City Hospital", a society with limited liability "Jēkabpils district Central Hospital" , municipal limited liability company "Rezekne", public hospitals with limited liability "Ziemeļkurzem regional hospital" and the society with limited liability "Vidzeme hospital", as well as the national society with limited liability "the national rehabilitation center" the Vaivara ";"
1.35. the express 130.3 1.1. subparagraph by the following: "1. the calculation of 130.3 State budget projected average one study, care episodes cost of treating over health care services in a particular medical institution of the Centre's management information system data on the current year's nine months;"
1.36. Express 130.3 1.3. subparagraph by the following: "130.3 1.3. from the State budget for the planned average one study or care episodes multiplied by the cost of treating the planned study or the number of episodes;"
1.37. supplement with 130.3 2.4. subparagraph by the following: "this provision 22 2.4 130.3. the annex referred to in paragraph 4 of the Service Centre funding plan according to the amount paid in the previous year;"; "
1.38. the express 130.3 4. subparagraph by the following: "4. the patient contributions 130.3 per contract and treated patients, which fully or partially exempt from the patient's contributions, and the provision of coverage referred to in point 4.7 compensation that will cover the Center above a certain financial amount of the contract, according to the plan, the amount paid in the previous year, in proportion to the total number of planned hospitalization;";
1.39. supplement with 130.3 6. subparagraph by the following: "6. the planning of 130.3 fixed payment amount for the hospital's operation, are applied to the following criteria: 130.3 6.1. If the medical establishment to 130.3 this provision 2.1. (a) a fixed annual amount calculated for the hospital's action is more than 95% of the contract amount for the previous year, the fixed payment for stationary operation contract determines 95% from the previous year's amount (excluding public company limited" children clinical University Hospital " , a national society with limited liability "Paul stradins clinical University Hospital" and the society with limited liability "the Riga Eastern clinical University Hospital". Medical authorities referred to the fixed payment for stationary operation contract determines the 90% of the amount of the previous year, if the calculated annual amount fixed on the hospital's action is more than 90% of the contract amount for the previous year);
6.2. If the medical establishment 130.3 to 130.3 this provision 2.1. (a) a fixed annual amount calculated for the hospital's action is less than 85% of the contract amount for the previous year, the fixed payment for stationary operation contract determines 85% from the previous year's level. ';
make 130.8 points 1.40. the following wording: "the extent of the financial Contract 130.8 medical authority, created from a merger of several medical institutions or medical institutions, created by reorganizing one hospital, the Centre shall be determined taking into account the total of these rules or 130.1.130.2. the treatment referred to authorities.";
1.41. the express 130.9 2. subparagraph by the following: ' 2. where actual 130.9 patient contribution exceeds the planned compensation, additional financial resources directed to the compensation of patient contributions for this rule in paragraph 10 (except 10.17 and 10.18.) those persons provided health care services and the case referred to in paragraph 11 for those secondary ambulatory health care providers who receive a fixed monthly premium for Admissions Office action the planned financial resources, about the increasing of the amount corresponding to the difference between the period reviewed actual patient contribution the amount of the refund and the accounting period financial resources planned for patient contributions for compensation by applying a coefficient of patient contribution for re-scheduling calendar year; "
1.42. Express 130.9 4.1 and 4.2) (130.9 of the following: "4.1. If the actual 130.9 patient contribution exceeds the planned compensation, the Center calculated the funds required for patient contributions about compensation for paragraph 10 of these rules (except 10.17 and 10.18.) such persons provide health care services, as well as 11 and 11.1 cases in point, increasing the financial resources planned for the amount corresponding to the difference between the current period actual patient contribution the amount of the refund and the scheduled period of finance about the patient compensation of contribution, applying the relevant coefficient patient contributions for re-scheduling the calendar year;

4.2 according to 130.9 residual amount in proportion to the increase in the Centre's programme "highlighted services" and in the "other services" provided health services to pay the planned amount of all institutions in which the total number of hospitalization period is greater than 105% of the planned service program, in which the number of hospitalization more than 105% of the planned. If the calculation results in a medical institution services program funding must be increased by not more than 5% of the annual funding, the center of treatment in this programme to the authority the above amount of funding does not change ";
1.43. supplement with 130.9 4.3 and 130.9 5. subparagraph by the following: "the planned 4.3 130.9 funding paid for 22 of these rules referred to in paragraph 4 of annex Services Center rescheduled in proportion to the amount paid in the reporting period;
5. treatment of 130.9 institutions which calculate the additional funding, carry out restructuring of services calendar year corresponding to the period under review the volume of services provided services. ";
1. make the following paragraph in the 136.5:136.5. "service provider does not comply with the contract health care services: the current year 136.5.1. If in the first half of the financial agreement about hospital discharge is less than 80% of the planned amount of the financial half year, then the first planned for the second half of the financial amount is based on the first half of the financial amount of the actual execution of it;
136.5.2. If the current year's nine months of contract financial volume hospital discharge is less than 90% of the planned nine months of financial claims, the total amount of the contract is reduced to nine months according to the actual health care services. About funding for the rest of the calendar months is doomed by the hospital's receiving the explanation on the reason for the failure;
136.5.3. If the hospital services the number of hospitalization for the relevant period less than 80% of the planned, the Center can reduce the fixed payments on hospital activity; "
1.45.136.1 points to express the following: "If the medical establishment 136.1, which provide both outpatient and inpatient health care services have reached agreement for the health services and the financial settlement, scheduled stationary services three, six or nine months, the Center, on the basis of the hospital's written submissions, the Centre's management information system on hospital's actual volume of services provided is entitled to make changes to the financial agreement and redirect stationary health services financial resources provided outpatient health care services. ";
1.46. supplement with 136.3 and point following 136.4: "If according to this provision the 136.3 136.5. (a) are obtained financial resources for health care, Outpatient Center performs this reprogramming of funds in the following priority order: 1. the State compensated 136.3 patient contribution fee, if actually compensated patient contributions are larger than planned during the reporting period;
2. preventive examination 136.3 application fee, if the service actually provided more than planned during the reporting period;
3. provide service 136.3 territorial availability;
136.3 4. redirecting funding those services, planned volume of excess funding includes a greater number of patients for paid services;
136.3 5. medical authorities about the financial contracts of more than 105% of the overfishing, the Center directs funding pursuant to this provision, paragraph 4 136.3 application of the relevant factors and having regard to the available financial resources;
136.3 6. If the calculation determines that the medical authority funding must be increased or decreased by an amount not exceeding 100 lats, Centre for treatment a predefined amount of funding does not change.
the Center can perform feature 136.4 rescheduling other reporting periods, in coordination with the medical authority. ";
1.47. the supplement with 138.4 points as follows: "138.4 medical establishment person with disabilities national forecast settled for scheduled health care services that are focused on a person's functional capacity, improvement or restoration to prevent disability and which are included in the health and integrity of the expertise of doctors approved by the National Commission persons with disability in the individual forecast rehabilitation plan, launched the following periods of time: 1.138.4 outpatient health services to 15 working days;
2.138.4 elective outpatient and inpatient medical rehabilitation services to 15 working days;
3.138.4 elective surgery-five calendar months. ';
1.48 to supplement paragraph after the words "147.9 health inspectorate said the decision" by the words "Noting the charges under which the calculated penalty";
1.49. replace paragraph 179.1 word "hospital" with the words and figures "hospital group in accordance with the provisions of annex 3, paragraph 22, of the specific division";
1.50. deleting subparagraph 3 179.1;
1.51. Express chapter XII1 as follows: "XII. 1 order, the patient health home care if the patient requires 233.1 outpatient curative medical help, but he could not because of indications to attend treatment in outpatient care, he provides health care services in the home, if: 1. the patient has chronic 233.1 disease and movement disorders in which the patient is unable to attend a medical institution;
2 233.1. patient is discharged from the Hospital Authority for treatment or from the date fixed by surgical intervention.
233.2 health care home patient receives when he has a family physician referral or referral by the hospital or discharged from the hospital the day of health care at home. Referral shall specify: 1. the diagnosis, 233.2 which would mean health care home;
2. diagnosis of 233.2, which is movement disorder;
3.233.2 referring physician appointment for home health care, including medications;
4. period of 233.2 to provide health care at home.
233.3 health home care includes the following services:

1. medicinal products entering 233.3;
2. skin damage 233.3 care;
3. artificial openings 233.3 care, including patient and his loved ones on education and training on artificial openings (stoma) care centre one patient paid for not more than five times, with the exception of the traheostom and the gastrostom care center shall pay according to the number of services actually provided;
4. the feeding tube of 233.3 through the probe.
If the patient receives 233.4, this provision 233.3 referred to health care, the doctor may refer to the following services: 1. studies and 233.4 study the materials into the laboratory;
2 233.4. vital signs;
3 233.4. patient and his loved ones on education and training on health promotion and patient care;
4. enema 233.4.
233.5 health care home provides certified nurse or physician assistant (paramedic), who works in a medical institution that has entered into a contract with the Centre for health services – health home care – and pay.
233.6 service provider providing services – health – home care, within three working days, inform the patient's family doctor practices or mainland family doctor practices according to the patient's actual place of residence of the service started, making their mark on the patient's medical card.
a patient with chronic illness 233.7 and movement disorders-health services home care-one episode duration is up to 30 calendar days. If health home care requires a longer, two working days before the expiry of that period the family doctor visits the patient and the provider for the opinion-health home care – suspension or continuation.
upon discharge from hospital 233.8 treatment or day hospital due to surgical intervention services-home health care-life is up to 10 calendar days. If health home care need longer family physicians at the request of the service provider attending the patient and give an opinion on the health service – home care – suspension or continuation.
After this provision 233.2 233.9 points specified in the posting referred to services-home health care-the end of the provision service provider shall provide the patient's family doctor or general practitioner in the Mainland according to the patient's actual residence, as well as patient epikrīz or epikrīz stage.
233.10 financial means for the next calendar year service – home care – Health Center plan on population according to the current calendar year in the actual volume of services per capita, calculated using the data for at least six months of the year, from January 1. "
1.52. replace paragraph 240 words and figure "except this provision referred to the case of 240.1" with the words "and included";
1.53. delete paragraph 270;
03. supplement with 279, 280, 281, 282.., 283 and 284. the following paragraphs: "279. This rule 31.1, 110.14 and point and 15 110.15.17.1. subparagraph shall enter into force on July 1, 2011.
280. This provision does not apply to 130.5 points at 30 June 2011.
281. The fixed premium for the ambulances and patient Admissions Office action in the national society with limited liability "Orthopaedics and orthopaedic hospital" and the national society with limited liability "the State hospital" Straupe Center contract provides for the period up to 30 June 2011.
282. This provision and paragraph 81.82. is valid until June 30, 2011.
283. Outpatient laboratory service providers who have concluded agreements with the Centre by 2010 through December 31, 121.2.1.1 of these rules do not apply.
284. the emergency medical service in these rules referred to in paragraph 85 of the hospitalization plans until 30 June 2011. Emergency medical team delivered to the patient for emergency medical assistance at the nearest hospital where the profile according to the Health Minister approved the arrangements for the hospitalization of patients up to 30 June 2011. From July 1, 2011 for the emergency medical service team delivers patient to the nearest hospital where the profile according to the emergency medical assistance service for hospitalization plan established. ";
1.55. to supplement paragraph 2 to annex 2 table with 2.4, 2.5, 2.6, 2.7 and 2.8. the following subparagraphs: ' 2.4.
50106 Mammography (both breasts, each in two planes). The result of the study 1-Norma R 2.5.
50107 Mammography (both breasts, each in two planes). The study result R 2 – potentially benign found/separate benign formations of 2.6.
50108 Mammography (both breasts, each in two planes). The study result R 3 – suspected pathology/local pathological changes in 2.7.
50109 Mammography (both breasts, each in two planes). The study result R 4-potential/suspected malignancy malignant formations of 2.8.
50110 Mammography (both breasts, each in two planes). The study result R 5-proven malignancy/cancer was "delete 1.56. in annex 2 section 1.15 p.m..;
1.57. Supplement 2. paragraph 13 of the annex table with 13.23. subparagraph by the following: "13.23.
Koronarogrāfij hospital and 60071 days hospital "1.58. delete paragraph 15.4., annex 2;
1.59. deletion of annex 2.15.30.
1.60. to supplement paragraph 15 of the annex 2 table with section 15.32.15.31 and by the following: "15.31.
50553 bonus on contrast of Iopamidol 300 (200 ml) 15.32.
50554 supplement for contrast medium (200 ml) of 370 Iopamidol "1.61. Express 2. paragraph 18 of the annex tables, 18.405. and 18.406.18.404. subparagraph by the following:" 18.404.
coronary angioplasty stent 60072 without the implantation site and day-hospital 18.405.
coronary angioplasty with stent 60073 the implantation site and day-hospital 18.406.
60074 coronary angioplasty using stent grafts by medicine filled (DES), stationary and stationary 1.62. "the day deleting annex 5 section 6.6;
1.63. the express new version of annex 6 (annex 1);
1. Express 11. section 5.1 of the annex by the following:

"5.1. the total amount of kapitācij is not less than 6.55% of Physicians" sub-programme for the national budget for the current year January 1; ";
1.65. the deletion of point 15 of annex 12, first sentence;
to complement the 1.66. Annex 15, paragraph 2.1 the following: "2.1 nurses or physician's Assistant (feldšer) working time Center contract with family doctors may not agree with some of the same nurse or physician's Assistant (feldšer) working time agreement with other Centre family physicians.";
1.67. Supplement 15. paragraph 12 of the annex behind the words and figures "in accordance with the provisions of section 180.2." with the words and the number "and" this annex 12.2;
1.68. the supplement to annex 15, 12.1, 12.2 and 12.3 points as follows: "Feldšerpunkt work volume 12.1 determination used: 12.1 1. agreements with the center of the existing number of visits feldšerpunkt Center management information system of the previous contract period;
12.1 2. so far the contractual relationship with the Center in the current feldšerpunkt of the data submitted by the Centre for health economic number of visits feldšerpunkt in the previous year.
12.2 Feldšerpunkt pay monthly the amount calculated by multiplying these provisions set out in subparagraph 180.2. pay by the number of such visits, the appropriate load volume: 12.2 1. number of attendance, if feldšerpunkt on average per month is up to 105, – 0.25 loads;
12.2. If the feldšerpunkt 2 visitors per month on average is 106-210,-0.50 loads;
12.2. If the feldšerpunkt 3 visitors on average per month is 211-325,-0.75 loads;
12.2. If the feldšerpunkt 4 visitors on average per month is 326-420-1.00 loads;
12.2. If the feldšerpunkt 5 visitors per month on average is 421-525,-load 1.25;
12.2. If the feldšerpunkt 6 visitors on average per month is more than 525,-1.50 loads.
12.3 for the Newly feldšerpunkt wage amount is determined by the load 0.5 per six months. Then the amount of remuneration calculated according to the number of visits by feldšerpunkt Center management information system data. ";
1.69. deletion of annex 15 and 15.4 15.5. section;
1.70. Express 15.16 and 17 of Annex paragraph by the following: "15.1. This annex 16 referred to the list of persons deprived of family doctor submit Center immediately after you create it, and then two times a year, until 15 January (for the period from 1 July of the previous year to 31 December 2004) and to 15 July (for the period from 1 January to 30 June).
17. the Centre each year, and 1 March (for the period from 1 July of the previous year to 31 December 2004) and until 1 September (for the period from 1 January to 30 June), on the basis of the Centre's management information system data, assess its family medical practice, receiving 14 of this annex, paragraph payment, taking into account the relevant general practitioner practice registered the adult patient magazine designated for needy persons and specified in this annex, the list referred to in subparagraph 15.1 (health assessment due to illness or preventive). Covers every six months must be no less than 45% and a year-not less than 90%, subject to the following conditions: 17.1. Center valued family physician practices throughout the assessment period (six months or one year) is provided for the needy person health care charge nurse or physician's Assistant (paramedic);
17.2. the Centre carried out the evaluation regarding the family medical practice included in the list submitted for needy persons throughout the assessment period are registered at a particular family doctor;
17.3. the Centre scored relevant management information system of the Centre entered into records that contain information about services that are paid from the State budget. ";
1.71. Supplement 15. attachment with 17.1 points as follows: "17.1 if the family doctor has not fulfilled this paragraph 17 of the annex to the conditions referred to in the Centre for the following six months reduced this annex referred to in point 14 of the 25% payment. ';
1.72. supplement to annex 15, paragraph 19 by the following: "19. Center contracts with those primary health care providers, which, in accordance with paragraph 14 of this annex are increased nurse and physician's Assistant (feldšer) operating payment amount, provides funds to Medical Assistant or nurse (feldšer) jobs for no more than 83 premises lats (not more than 55 pounds of Office table and up to 28 late in the Office Chair purchase). These features cost centre family physicians in practice at the Office desk and Chair of formal acquisition receipt according to their actual costs, but not more than that amount. "
1.73. Annex 17 to express new version (annex 2);
74. Express 18. new annexes (annex 3);
1.75. Express 22. new annexes (annex 4);
1.76. Express 24. section 1.2.2 of annex by the following: ' 1.2.2. limited liability company "Ziemeļkurzem regional hospital" 2; ";
1.77. replace paragraph 7 of annex 24 to the introductory paragraph number and the word "1.7." in the number and the word "2.7." in subparagraph;
1.78. make the new version of annex 26 (annex 5);
1.79. Express 27. new version of the annex (annex 6);
1.80. Express 29. new version of the annex (annex 7);
1.81. deletion of Annex 31 point 1.1.17.;
1.82. Express 37. subparagraph 3.1.4 of the annex by the following: "no PO box
The name of the program to diagnosis and preventive examination results manipulations of coding a shipment for further examinations and the examination results of coding (point according to patient group) 3.1.4. Cervical cytological smear examination diagnosis Z 12.4 cytological smears of 42019-cervical and mugurēj investigation of the arches (one product). The result of the C0-study can not be read (small material, red deck FOV) C0-unable to read (small red deck material field of vision);
C1-the norm group I;
C2-the norm group II (inflammation);
Q3-CIN 1 = LSIL (mild cervical intraepiteliāl not in oplāzij);
C4-CIN 2/CIN3 = HSIL (mild or cervical intraepiteliāl not, expressed in oplāzij);
C5-cancer cells;
C6-torn glass, technical error if there is a pathological finding, the family physician or specialist konsultācijaun study, including repeated examinations by observation or treatment of the patient: (according to the pamatdiagnoz found: C 32.9 – 9; 06.0 – 9 d; N 87.0; N 87.1; N 87.2; N 54.6;
Blakusdiagnoz Z 12.4) "diagnosis Z 12.4

42020-cytological smears from cervix and mugurēj investigation of the arches (one product). The study result C1 norm group I diagnosis Z 12.4 42021-cytological smears from cervix and mugurēj investigation of the arches (one product). The result of the study-group II rules for C2 (inflammation) diagnosis Z 12.4 42022-cytological smears from cervix and mugurēj investigation of the arches (one product). The results of the study-CIN 1 = C3 LSIL (mild cervical intraepiteliāl not in oplāzij) diagnosis Z 42023-12.4 cytological smears from cervix and mugurēj investigation of the arches (one product). The result of the study 2/C4-CIN = HSIL CIN3 (mild or cervical intraepiteliāl not, expressed in oplāzij) diagnosis Z 12.4 42024-cytological smears from cervix and mugurēj investigation of the arches (one product). The study result C5-cancer cell diagnosis Z 12.4-42025 cytological smear of cervix and mugurēj investigation of the arches (one product). The study result C6-torn glass, technical error 1.83. Express 37.3.3 subparagraph by the following: "no PO box
The name of the program to diagnosis and preventive examination results manipulations of coding a shipment for further examinations and the examination results of coding (point according to patient group) 3.3.
Breast tumor diagnosis early diagnosis Z 12.3-supplement for standartmamogrāfij 50097 following additional mamogramm to local compression increases or other non-standard projection R 1.
R 2-potentially benign found/separate benign formations;
R 3 – suspected pathology/local pathological changes;
R 4-malignancy potential/suspected malignant formations;
R 5 – proven malignancy/cancer was already is a pathological finding, the family physician or specialist consultations and examinations, including examinations again after observation or treatment of the patient: (according to the pamatdiagnoz found: C: 50.09 N63; N64 or other.
Blakusdiagnoz Z Z 12.3 12.3) "diagnosis-50101 mammography description (both breasts, each in two planes) diagnosis, mammography 50102 12.3 Z description of additional planes, if the study diagnosis 50105 50097 Z 12.3-supplement for the use of digital technology for x-ray examinations, diagnosis, Mammography 50106 12.3 Z (both breasts, each in two planes). The result of the study 1-Norma R diagnosis 50107-Mammography-Z 12.3 (both breasts, each in two planes). The study result R 2 – potentially benign found/separate benign formations of the diagnosis, Mammography 50108 12.3 Z (both breasts, each in two planes). The study result R 3 – suspected pathology/local pathological changes in diagnosis, Mammography 50109 12.3 Z (both breasts, each in two planes). The study result R 4-potential/suspected malignancy malignancy diagnosis structure Z-50110 Mammography 12.3 (both breasts, each in two planes). The result of the study – proven malignancy R 5/was the diagnosis of malignant Z 12.3 60258-premium on mammography screening mobile skrīningizmeklējum Office 1.84. to supplement annex 37 to 4.3.5. subparagraph by the following: "4.3.5. outside of organized cervical tumors early diagnostic programs in accordance with the Centre's management information system the information during the year up to the date of the letter of invitation has made cervical cytological study;".
2. This rule 1.11. and 1.12. subparagraph shall enter into force on July 1, 2011.
3. rules applicable to January 1, 2011.
The Prime Minister, regional development and local Government Minister v. dombrovsky Health Minister j. Bārzdiņš the Ministry of health submitted version of annex 1 of the Cabinet of Ministers of 28 December 2010 regulations No 1217 annex 6 "Cabinet on 19 December 2006, regulations no 1046 pay outpatient laboratory study list no PO box
 Manipulation of the code name of the laboratory study of pay 1 culpably violate applicable
capillary blood sampling 40001 to Pančenkov pipette pay children up to 18 years of age and pregnant women 2.
40002 Serum (plasma) getting paid for children up to 18 years of age and pregnant women 3.
40003 blood sampling in a closed system in one tube pay in children up to 18 years of age and pregnant women 4.
40004 blood sampling in a closed system in two vials in Pay children under 18 years of age and pregnant women 5.
blood sampling with 40005 closed system three vials pays the children up to 18 years of age and pregnant women 6.
capillary blood sampling 40006 with mikrotainer pay for children up to 18 years of age and pregnant women 7.
40010 hemoglobin 8.
40014 and erythrocyte Count morphology 9.
40016 erythrocyte sink rate, using a special set of sampling (seditainer, etc.)
 
10. Retikulocīt. 11 40018
Retikulocīt – automated 40019 investigation with haematology analysers, 12.
40025 flowing blood time after Duke the methods 13.
40028 blood clotting time after Lee-White methods 14.
40034 an investigation Sternālpunktāt 15.
40040 blood test with part 3 of the discriminatory blood Analyzer 16.
40041 blood test with a 5 part Blood analyser. discriminatory In addition to not specify a manipulation-40010, 40012, 40013, 40014, 40017 and 40029 17.
40043 Not full blood analysis, determined by the analyser 18.
40085 Protrombīn and INR 19.
40086 Protrombīn complex and INR 20.
40087 activated partial tromboplastīn time the (APTL) 21.
40088 Fibrinogen 22.
40089 Antitrombīn III (AT-III) 23.
40090 Thrombin time 24.
40098 factor VIII activity detection for 25.
determination of factor IX 40099 26.
40100 factor VIII activity determination of C 27.
40105 factor IX activity determination of Age 28.
determination of the activity of factor XI 40106 29.
determination of protein C 30 40107.
determination of protein S 40108 31.
40109 Von Villebrand factor of 32.
40119 protein C resistance test (APC-R) 33.
40123 D-dimēr (quantitative) 34.
40131 Protein (quantitative reaction with red pirogalol) 35.
36. Ketonviel-40133
40134 specific weight and glucose quality 37.
40135 glucose and ketonviel in the urine of 38.
40140 urine sediment quantitative investigation

 
39. in the analysis of urine with teststrēmel 40148 (9-10 parameters) 40.
40150 urine sediment microscopy for standardised 41.
40160-42 Koprogramm.
40161 hidden blood in the feces 43.
40164 Scrape from perianālaj folds to spalīš eggs charged children up to 18 years of age 44.
40168 Unicellular cyst and helminth investigation with the enrichment method paid for children up to 18 years of age and pregnant women 45.
40169 helminth detection with Kato method paid for children up to 18 years of age and pregnant women 46.
40170 Helmint and determination of 47 fragments.
40171 Unicellular parasites of the intestinal natīv and determination with Lugol's solution dyed in preparation in children up to 18 years of age and pregnant women 48.
40172 hidden blood with teststrēmel (positive) 49.
40173 hidden blood with teststrēmel (negative) 50.
clinical analysis of Sputum 40183 51.
Eozinofīl-white sputum-40184 52.
40188 investigation of prostate eksprimāt 53.
40190 material (nails, skin, hair) investigation on fungi 54.
Iztriepj of bakterioskopij to the microbial 40191 and sexually transmitted diseases, 55.
40193 examination of bakterioskopisk 56 Mikobaktērij.
40194 a bakterioskopisk Mikobaktērij investigation method of enrichment with 57.
40300 determination of blood group ABO system with planes method (direct response) 58.
40301 determination of blood group ABO system with planes method (dubultreakcij) 59.
40302 Rh (D) signs with planes method (reagents 2) 60.
40303 Rh (D) determination of gel-technical features (with reagent 1) 61.
40304 determination of blood group ABO and Rh systems-gel technique in 62.
40307 RH phenotype (CcE) and the determination of the Kell-gel technique 63.
40309 partial antieritrocitār antibody screening technique with gel-2 skrīningeritrocīt samples (ID card List/Coomb) 64.
40315 partial antieritrocitār antibody titration technique with gel 1 Antigen (ID card – list/Coomb) 65.
40325 drop anti-human globulin test (DAT)-gel technique (ID card List/Coomb) 66.
40330 quality Krioglobīn 67.
40335 cold gel-aglutinīn detection technique in 68.
69. The total egg 41001
41002 albumin 70.
41003 protein fractions in serum 71.
41004 urea 72.
41005 uric acid 73.
41006 creatinine 74.
41020 alkaline fosfotāz (SF) 75.
41021 fosfotāz of 76 in Acid.
AL-Alanīnaminotransferāz-77 41022.
41023 a 78-Aspartātaminotransferāz AXIS.
41024 glutamīntransferāz 79. Gamma-
41025-Kreatīnkināz 80.
41026 Laktātdehidrogenāz is 81.
41027 lipase 82.
41030 Kreatīnkināz MB fraction of 83.
41031 Kreatīnkināz MB of weight 84.
Alpha amilāz of 85 41034.
41035 konvertāz 86 of angiotensin.
41045 total cholesterol 87.
41046 triglyceride 88.
41047 HDL-cholesterol (direct method) 89.
41052 Bilirubin fractions, 90.
41054 HDL-cholesterol (precipitation) 91.
41055 LDL-cholesterol (direct method) 92.
41065 potassium 93.
41067 sodium 94.
41068 calcium 95.
41069 phosphorus 96.
41070 chlorides 97.
41071 iron 98.
41072 magnesium 99.
41077 Copper blood 100.
41095 blood glucose 101.
41096 glucose loads test of 102.
(C) Pay to the peptide 41099 endokrinolog and children's referral or endokrinolog family physician referral if the specialists received written advisory opinion for 103.
41100 Insulin pays with and children of endokrinolog endokrinolog referral or referral by a family physician, if those experts written advisory opinion for 104.
105. Mikroalbumīnūrij detection 41101
41102 glucose determination by the disposable cuvettes 106.
41103 Glikohemoglobīn. The result of the study-6.4% HbA1C level and lower Pay, the child of endokrinolog endokrinolog shipment, or, if the patient has diagnosis E10-E16 107.
41104 Glikohemoglobīn. The result of the study-level HbA1C 6.5-7.4% Due to the children of endokrinolog endokrinolog shipment, or, if the patient has diagnosis E10-E16 108.
41105 Glikohemoglobīn. The result of the study-7.5% HbA1C level and more Due to the children of endokrinolog endokrinolog shipment, or, if the patient has diagnosis E10-E16 109.
41116 Antistreptolizīn (quantitative) 110.
111. Transferīn of 41117
41122 Ceruloplazmīn for 112.
41124 Ferritin is 113.
41127 CRO quantitative 114.
41128 rheumatoid factor (quantifiable) 115.
41129 immunoglobulin light chain-116.
41130 Paraproteīn through imūnfiksācij-117.
41142 the hormone (TSH) Tireotrop 118.
41143 tiroksīn free (FT4) 119.
41144 free trijodtironīn (FT3) with the pay and child of endokrinolog endokrinolog referral or referral by a family physician, if those experts written advisory opinion for 120.
41150 Prolactin in 121.
41151 the hormone (FSH) Folikulstimulējoš 122.
41152 Luteinizētājhormon (LH) 123.
41153 oestradiol 124.
41154 testosterone 125.
41155 progesterone 126.
41156 Estriol (free) 127.
41161 128 Dehidroepiandrosteron sulphate.
41163 Androstendion is 129.
41164 Horiongonadotropīn is 130.
41170 Aldosterone is 131.
41172 the Somatotrop hormone (STH) 132.
41173 Cortisol to 133.
41175 to 134 Parathormon.
41176 Adrenokortikotrop the hormone (ACTH SEE SECTION) 135.
41184 Ciclosporin and Tacrolimus (radioimunoloģisk method) 136.
determination of Ethanol by enzymatic 41189 137.
41200 vitamin B 12 138.
41203 Troponin I, 139.
41205 Myoglobin is 140.
41209 Erythropoietin for 141.
41230 ekspresdiagnostik syphilis (VDRL, RPR, SED) 142.
41232 syphilis-TPH a 143.
41233 syphilis-TPH a quantitative method (the title) 144.
41234 Plating for gonorrhea (negative) 145.
41235 on gonorrhea Culture (positive) 146.
41236 pale treponemal immobilization reaction (Nelson test) 147.
41237 IgG immunofluorescence antibody response to syphilis (VFR ABS. IgG) 148.
41240 Chlamydia detection by direct method (TIFR) imūnfluorescenc-Antigen 149 MOMP.
41245

 Chlamydia detection by direct method (TIFR) imūnfluorescenc-MOMP antigens for women (from the cervical canal and the urethra) 150.
41247 Plating on Mycoplasma 151.
on the culture of 152 41248 ureaplazm.
41251 Imūnfluorescenc response to the syphilis IgM antibodies (VFR ABS. IGM) 153.
41253 Imūnfermentatīv analysis for the detection of IgG or IgM antibodies to syphilis 154.
41254 Imūnfermentatīv analysis for the detection of chlamydia IgG Pay children up to 18 years of age and pregnant women 155.
41255 Imūnfermentatīv analysis for the determination of the Pay of Ig Chlamydia in children up to 18 years of age and pregnant women 156.
41260 Plating on pathogenic skin, hair, nail fungi 157.
41262 Chlamydia trachomatis-specific DNA (PCR) paid for children up to 18 years of age and pregnant women 158.
41263 anti-IgM in the pay of the Toxoplasm manmad children up to 18 years of age and pregnant women 159.
41264 anti-IgG in the pay of the Toxoplasm manmad children up to 18 years of age and pregnant women in 160.
41280 anti Borrelia burgdorferi IgG 161.
41281 anti Borrelia burgdorferi IgM-162.
41283 anti-Mycoplasma pneumoniae IgG 163.
41284 anti-Mycoplasma pneumoniae IgM 164.
isseri's gonorrhe's Not 41286 RNA determination by the method of hybridisation to 165.
41287 Chlamydia trachomatis RNA determination by the method of hybridisation to 166.
41290 anti-Chlamydia pneumoniae IgG (ELISA) 167.
41291 anti-Chlamydia pneumoniae IgM (ELISA) 168.
41301 HBS Ag 169.
41303 anti-HBS (quantitative) 170.
41304 HBS Ag (confirmatory test) 171.
41307 anti-HAV IgM 172.
41309 anti-HCV 173.
anti-HBc IgM 41321 174.
41322 anti-HBc 175.
41401 anti-HIV 1 and HIV 2 + HIV Ag Elisa (not reactive) 176.
41404 antibodies against HIV-1 or HIV-2 (the Western blot confirmatory test –) (without the diagnostiskum) 177.
41405 anti-HIV 1/2 ekspresdiagnostik (no jets) 178.
42004 Cytological studies of cervical canal (three preparations) 179.
42005 Cytological studies of uterus (three preparations) 180.
42006 Cytological studies of abdominal cavity, pleural and Douglas (three preparations) (serous fluid in the cavity) 181.
42007 Cytological studies of specific therapy (radiation, hormones or chemotherapy) (three preparations) 182.
42008 urine or bladder washings for cytology studies (five preparations) 183.
42012 At bronhoskopij the cytological investigation of the material (three preparations) 184.
42013 Footprint or scrape of the skin or mucous membrane damage of cytological investigation (two preparations) 185.
42014 cytological swab from the mammary glands (one product) 186.
biopsy and surgery material 42015 footprint cytological investigation of 187.
42016 Formations and organs of cytological investigation of punktāt (three preparations) 188.
42019 cytological smears from cervix and mugurēj investigation of the arches (one product). The result of the C0-study can not be read (small material, red deck FOV) 189.
42020 cytological smears from cervix and mugurēj investigation of the arches (one product). The study result C1 norm group I 190.
42021 cytological smears from cervix and mugurēj investigation of the arches (one product). The result of the study-group II rules for C2 (inflammation) 191.
42022 cytological smears from cervix and mugurēj investigation of the arches (one product). The results of the study-CIN 1 = C3 LSIL (mild cervical intraepiteliāl not in oplāzij) 192.
42023 cytological smears from cervix and mugurēj investigation of the arches (one product). The result of the study 2/C4-CIN = HSIL CIN3 (mild or cervical intraepiteliāl in terms of oplāzij not) 193.
42024 cytological smears from cervix and mugurēj investigation of the arches (one product). The study result C5-cancer cells 194 42025 cytological smears from cervix and mugurēj investigation of the arches (one product). The study result C6-torn glass, technical error 195.
44001 blood on the microbial culture-negative 196.
44002 blood on microbial culture-negative with automatic system for 197.
blood on the microbial inoculum 44003-positive 198.
44004 blood on microbial culture-positive with the automatic system of 199.
44008 wound separation, cavities, exudation, iztriepj punktāt (t.sk. neck and nose), washings, and material plating on aerobic and anaerobic microbial-optional negative 200.
44009 wound separation, cavities, exudation, iztriepj punktāt (t.sk. neck and nose), washings, and material plating on aerobic and anaerobic microbial-optional positive 201.
44015 urine on microbial inoculum and count the number of micro-organisms-negative 202.
44016 urine on microbial inoculum and count the number of micro-positive 203.
sputum culture on the microbial 44017-negative 204.
sputum culture on the microbial 44018 – positive 205.
44025 Faecal Enterobacteriaceae or of plating on micro-organisms — negative. 206.
44026 Faecal Enterobacteriaceae of plating on micro-organisms — positive nor. 207.
44028 faecal culture on Shigella, salmonella-negative 208.
44029 faecal culture on pathogenic intestinal microbial-positive (Shigella, Salmonellaidentifikācij to serogrup) 209.
faecal culture on pathogen 44030 intestine microbial-positive (Shigella, salmonella serotype identification to) 210.
faecal culture on 44031 selection of e. coli – negative 211.
faecal culture on 44032 selection of e. coli-positive 212.
Group A haemolytic streptococci 44045-the quick test is 213.
44046 Plating from the neck and nose to c. diphtheriae – negative 214.
44047 Plating from the neck and nose to c. diphtheriae – positive 215.
44048 Plating from the neck and nose to c. diphtheriae – positive using the computerised system 216 identification.
44049 Plating from the neck-wear detection of n. meningitidis negative 217.
44050 Plating from the neck to the detection of n. meningitidis a carrying-positive (no serological detection of n. meningitidis tipēšan) 218.
44051 Plating from the neck to the detection of n. meningitidis a carrying-positive (with n. meningitidis serological tipēšan) 219.
44055 Plating to b. pertussis and b. Parapertuss, negative 220.
44056

 Plating on b. pertussis and b. Parapertuss – positive 221.
plating to beta haemolytic 44057 in Streptococcus pneumoniae – negative 222.
44058 Plating to beta haemolytic Streptococcus pneumoniae-positive for (to Lensfild group identification) 223.
44059 Plating on Methicillin-resistant S aureus (MRSA). over-the-negative 224.
44060 Plating on Methicillin-resistant S aureus (MRSA). over-the-positive 225.
44064 Plating on the fungi of the genus Candida – negative 226.
44065 Plating on the fungi of the genus Candida – positive 227.
44105 Plating on the fungi of the genus Candida – positive (using the computerized identification system identification) 228.
the sensitivity of micro-44106 determination against antibiotic substances, 229.
44107 Plating on ureaplazm and mycoplasmas with medication sensitivity detection 230.
44108 Helycobacter pylori antibody against the determination by quick method to 231.
44110 agglutination reaction to bacterial infections (whooping cough, brucellosis, tularemia, etc.)
 
232. The HA response to 44115 bacterial infections (infectious enteritis, šigelloz) 233.
44116 serological antibody response to y. enterocolitica and y. pseudotuberculos of 234.
44119 IgG antibodies against diphtheria toxin-235.
the material handling 44127, inoculation and grown colonies to the Mycobacterium genus microscopy micro-organisms (without feed preparation) 236.
45001 tuberculosis diagnosis with plating automatic system 237.
45002 the genus Mycobacterium detection sensitivity of micro-organisms to medications in row 1 with automatic system of 238.
45003 genus Mycobacterium detection sensitivity of micro-organisms to the line 1 and 2 medications with automatic system for 239.
45004 diferenciāltest micro-organisms Mycobacterium genus (NAP) with automatic system for 240.
45005 Mycobacterium genus micro-determination of sensitivity to pirazinamīd (PZ) with automatic system for 241.
micro-organisms Mycobacterium genus 45006 sensitivity determination against 1. medications to the hard line feeds 242.
45007 genus Mycobacterium detection sensitivity of micro-organisms from row 2 to hard drugs feeds 243.
45008 the sensitivity of micro-organisms of the genus Mycobacterium detection against 1 and 2 rows on hard drugs feeds 244.
micro-organisms Mycobacterium genus 45009 sensitivity detection to row 2 medicines with automatic system for 245.
Mycobacterium genus 45010 micro-determination of sensitivity to one medication with the automatic system 246.
Mycobacterium genus 45011 microscopic investigation of micro-organisms with fluorescent method for 247.
Mycobacterium genus 45012 micro-determination of sensitivity to one medication to rigid feeds 248.
45014 hard Lēvenštein-Jansen's medium preparation of 249.
46010 T and B lymphocyte subpopulācij (one position) 250.
46015 CD3 + and CD19 + cell detection 251.
T and B cell 46017 surface receptor (CD3, CD4, CD8, CD19 +, CD3/CD16 56 HLA-DR, HLA-DR) (citofluorimetrij) 252.
46020 Leikož cell phenotype (citofluorimetrij) 253.
46051 immunoglobulin G (A, M) 254.
46054 circulating imūnkompleks (HOW) does not felometrisk to 255.
immunoglobulin IgG 46056 no felometrisk (turbidimetrisk) 256.
of immunoglobulin Ig 46057 no felometrisk (turbidimetrisk) 257.
determination of immunoglobulin Ig 46058 M felometrisk (turbidimetrisk) No 258.
detection of immunoglobulin Ig E 46059 (ELISA) 259.
46060-specific Ig E (panel-5 Ag) Due to the pneimonolog, baby pneimonolog, allergist, allergist, imunolog children's referral or referral by a family physician, if those experts written advisory opinion for 260.
specific Ig E 46065 Discovery (panel-12 Age) Due to the pneimonolog, baby pneimonolog, allergist, allergist, imunolog children's referral or referral by a family physician, if those experts written advisory opinion 261.
determination of specific Iga 46066 E-20 single Antigen panel Due to the pneimonolog, baby pneimonolog, allergist, allergist, imunolog children's referral or referral by a family physician, if those experts written advisory opinion 262.
total and specific 46067 IGE (IGE + total IGE specific) (ELISA) Due to the pneimonolog, baby pneimonolog, allergist, allergist, imunolog children's referral or referral by a family physician, if those experts written advisory opinion 263.
Cistatīn determination of Payment C 46074 with Nephrologists, Nephrologists, children's referral or urolog family physician referral if the specialists received written advisory opinion 264.
determination of HEPA-46085 2 cell culture (screening-indirect imūnfluorescenc) 265.
46089 ANC detection (screening-indirect imūnfluorescenc) 266.
46092 anti DNA antibody detection (quantitative) 267.
EN 46100 detection (screening, BIOASSAY) 268.
46102 ENA subtip (position 1 of the six specified in point 409101,) (ELISA) 269.
46104 EN screening and Ana HEP-2 determination of cell culture 270 46107 antibody against Helicobacter pylori IgG detection (ELISA) 271.
46108 antibody against Helicobacter pylori IGA (ELISA) 272.
46110 Autoantiviel against tireoglobulīn detection with Pay, child of endokrinolog endokrinolog referral or referral by a family physician, if those experts written advisory opinion for 273.
Autoantiviel for determination of phospholipids 46111 against payment for children up to 18 years of age and pregnant women 274.
46112 Autoantiviel against the determination of the 275 MPS.
determination of Autoantiviel against PR3 46113 276.
46115 Antimikrosomāl antibody (ELISA) 277.
pay with Tireoglobulīn 46116 endokrinolog, the child of a shipment or to endokrinolog family physician referral if the specialists received written advisory opinion for 278.
Antigliadīn determination of antibodies against 46117 (IgG) paid for children up to 18 years of age and pregnant women 279.
46118 Antigliadīn antibodies (IGA) paid for children up to 18 years of age and pregnant women 280.
46119 Antispermāl IgG, IgM antibody determination of total (ELISA) 281.
46120

 Antiadrenāl antibody (indirect imūnfluorescenc) Due to the children of endokrinolog endokrinolog referral or referral by a family physician, if those experts written advisory opinion for 282.
Antisēkliniek antibody detection 46121 (indirect imūnfluorescenc) 283.
46122 Antiolnīc antibody (indirect imūnfluorescenc) 284.
anti-GBM antibody 46123 Discovery (indirect imūnfluorescenc) 285.
46124 Antihiston antibody (ELISA) 286.
Antikardiolipīn antibody detection 46125 287.
46132 TSH receptor antibodies due to the children of endokrinolog endokrinolog referral or referral by a family physician, if those experts written advisory opinion for 288.
46148 CYFR citokeratīn 19 21-1 fragment with Pay oncologist, oncologist, Oncology gynecologist ķīmijterapeit, Oncology surgeon, imunolog the shipping or with family physician referral if the specialists received written advisory opinion for 289.
SCC-46149 squamous cancer Antigen Due to oncologist, oncologist, Oncology gynecologist ķīmijterapeit, Oncology surgeon, radiologist, imunolog's therapist referral or referral by a family physician, if those experts written advisory opinion for 290.
46150 But-HGH-free horiongonad-tropīn settles with oncologist, oncologist, Oncology gynecologist ķīmijterapeit, Oncology surgeon, imunolog the shipping or with family physician referral if the specialists received written advisory opinion for 291.
46151 Alpha-Alpha fetoproteīn in FP-292.
46152 CE-Karcioembrionāl Antigen Due to oncologist, oncologist, Oncology gynecologist ķīmijterapeit, Oncology surgeon, gynecologist obstetrician, baby, birth, endokrinolog, endokrinolog, the children's therapist, the radiologist of the shipment or the imunolog family physician referral if the specialist received a written advisory opinion for 293.
46153 tumor marker CA-125 Due to oncologist, oncologist, Oncology gynecologist ķīmijterapeit, Oncology surgeon, gynecologist obstetrician, baby, birth, endokrinolog, endokrinolog, the children's therapist, the radiologist of the shipment or the imunolog family physician referral if the specialist received a written advisory opinion for 294.
46154 tumor marker CA 19-9 Due to the oncologist, oncologist, Oncology gynecologist ķīmijterapeit, Oncology surgeon, gynecologist obstetrician, baby, birth, endokrinolog, endokrinolog, the children's therapist, the radiologist of the shipment or the imunolog family physician referral if the specialist received a written advisory opinion for 295.
46155 NS-specific neuronal enolāz due to the oncologist, oncologist, gynecologist ķīmijterapeit Oncology, surgical oncology, endokrinolog, endokrinolog, the imunolog of the child shipment or with a family doctor referrals, if those experts written advisory opinion for 296.
PSA-prostate specific 46156 Antigen 297.
46157 PSA, free-prostate specific antigen Due to oncologist, oncologist, surgical oncology ķīmijterapeit, shipment of urolog, imunolog or with a family doctor referrals, if you get the specialist advisory opinion writing to 298.
46158 tumor marker CA 15-3 Due to the oncologist, oncologist, Oncology gynecologist ķīmijterapeit, Oncology surgeon, gynecologist obstetrician, baby, birth, the therapist, the radiologist of the shipment or the imunolog family physician referral if the specialist received a written advisory opinion for 299.
BMG-46159 Beta 2 mikroglobulīn settles with oncologist, oncologist, Oncology gynecologist ķīmijterapeit, Oncology surgeon, hemotolog, imunolog, or the shipment with family physician referral if the specialist received a written advisory opinion for 300.
46164 transglutamināz antibodies (IGA) paid for children up to 18 years of age and pregnant women in 301.
46165 transglutamināz antibodies (IgG) paid for children up to 18 years of age and pregnant women 302.
46171 down syndrome and Trisomy 18 (Edwards syndrome) diagnosis (AFP + HGH + free estriol) (ELISA) 303.
spontaneous abortion risk 46172 immunological control (to test + HGH) 304.
47026 Rotavirus Ag 305.
47027 quantitative CMV or EBV DNA DNA Discovery (polymerase chain reaction) 306.
47035 IgM class antibodies to tick-borne encephalitis virus 307.
47038 anti-CMV-IgG Pay for children under 18 years of age and pregnant women in 308.
anti-CMV-IgG 47039 (quantitative) paid for children up to 18 years of age and pregnant women 309.
anti-CMV-IgM 47040 paid for children up to 18 years of age and pregnant women 310.
47042 anti-EBV IgM 311.
anti-EBV IgG 47043 312.
Bunell heterofil 47052 Paul-test for the detection of antibodies of 313.
47053 anti-herpes simplex IgM in (I), (II) Payment for children up to 18 years of age and pregnant women 314.
47054 anti-herpes simplex I, II IgG pay for children up to 18 years of age and pregnant women 315.
47055 anti-IgG herpes simplex I, II (quantitative) paid for children up to 18 years of age and pregnant women 316.
anti-Varicell-47056 Zoster (VZV) IgM-pay for children up to 18 years of age and pregnant women 317.
anti-Varicell-47057 Zoster (VZV) IgG pay children up to 18 years of age and pregnant women 318.
anti-Varicell of 47058 Zoster (VZV) IgG (quantitative) paid for children up to 18 years of age and pregnant women 319.
47059 IgG class antibodies to tick-borne encephalitis virus 320.
47061 anti-rubella (rubella) or anti-Rubeol (measles) IgG pay for children up to 18 years of age and pregnant women 321.
47062 anti-rubella (rubella) or anti-Rubeol (measles) IgM pay for children up to 18 years of age and pregnant women 322.
47065 IgG class antibodies against mumps virus in children Due to 18 years of age and pregnant women 323.
47066 IgM class antibodies against mumps virus in children Due to 18 years of age and pregnant women 324.
48002 anti-Trichinella spiralis 325.
Compatible with the trofozīt of lambli 48004 and cyst Ag 326.
anti-Toxocar-48006 Canis IgG 327.
48007 Echinococcus anti-sp.
 
328. Investigation on demodekoz, 48010 dziedzerērc, 329.
Materials check-out Inves 48013 on pathogen of skin, hair, nail fungi or dziedzerērc, or a mite from one fight from inside the 330.

Materials check-out Inves 48014 on pathogen of skin, hair, nail fungi or dziedzerērc, or from a number of mite scabbers foci (average 2-3 foci) 331.
48015 material (nails, skin and hair) from multiple foci of investigation on fungi 332.
determination of the amino acid spectrum 49001 blood with liquid chromatography 333.
determination of the amino acid spectrum 49002 urine by liquid chromatography of 334.
determination of the amino acid spectrum 49003 amniotisk liquid with liquid chromatography 335.
49004 carbohydrate thin layer chromatography urine 336.
49005 carbohydrate TLC's blood serum in 337.
neonatal screening of phenylketonuria 49006 338.
49007 newborn screening for congenital hipotireoz-339.
PAPP-A 49008 determination in serum of pregnant women at risk first trimester 340.
horionisk in the free beta 49009 gonadotrophin discovery in serum of pregnant women at risk in the first and second trimester 341.
49010 Alpha-fetoproteīn and horionisk in the free beta determination of serum gonadotrophin in groups at risk pregnant women in the second trimester (pregnant women two biochemical markers in screening for fetal Trisomy risk percentage) 342.
49015 Alpha-fetoproteīn detection in serum of pregnant women at risk (prenatal screening the fetal neural tube defects) 343.
49016 Alpha-fetoproteīn discovery amniotisk liquid risk groups pregnant women 344.
organic acids spectrum 49017 detection in urine with gas chromatography 345.
49021 Mukopolisaharīd (MP) screening and quantitative spectrometric determination in the urine in 346.
49022 Mukopolisaharīd (MP) quantitative Spectrophotometric Determination of liquid amniotisk 347.
49023 Mukopolisaharīd (MP) spectrum detection in urine with electrophoresis of 348.
49025 human genome DNA extraction of 349.
49026 Himērism monitoring after allogeneic bone marrow or peripheral blood stem cell transplantation using STR loci genotipēšan-350.
49027 Ph (Philadelphia) chromosome identification using RT-PCR, two stage (La/MoB 075) 351.
49028 Ph (Philadelphia) chromosome positive leikož therapy control effectiveness using BCR/ABL gene expression quantification analysis (La/MoB 089) 352.
49030 DNA analysis using polymerase chain reaction in human genetic pathology diagnosis of 353.
49031 genomic DNA extraction from Guthrie to papīrīš human genetic pathology diagnosis of 354.
49032 gene mutation by DGG selective screening analysis 355.
49033 SMA gene mutation detection of 356.
49034 Fenilalanīnhidroksilāz synthase gene mutations (one mutation) 357.
49035 medium length Acyl dehydrogenase gene (A)-what is mutation detection K329 358.
49036 Fragile X syndrome in the selective screening by PCR method in 359.
Fragile X syndrome 49037 mutation detection by using Sauzern's not radioactive bloting features on the 360.
49038 rough cell fluorescent in situ hybridisation methods (cost of one patient one pathology) 361.
49039 Fibroblast chromosome analysis of culture (one patient) 362.
additional number of chromosomal 49040 fluorescent in situ hybridisation methods (cost of one patient one pathology) 363.
the additional chromosome C 49045 bar painting with barium hydroxide 364.
49046 additional chromosome CHOIR band painting with color Gimza 365.
in fragile X chromosome 49047 Postnatāl analysis (cost per patient) 366.
49048 blood and bone marrow chromosome analysis of culture (one patient) to the standard method of 367.
49049 Amniocīt cultural analysis of chromosomes (one patient) (prenatal diagnosis in) 368.
49050 chorionic villus biopsy cultures chromosome analysis (cost per patient) (prenatal diagnosis in) 369.
49061 VNTR (minisatelīt) system analysis in the gene FAH 370.
49062 STR (mikrosatelīt) system analysis of the gene FAH 371.
49063 Y chromosome deletion, using the "Promeg system, Version 1.1" kit with PCR method in 372.
54007 operation and biopsy material, primary processing, microscopic examination, fitting blocks, preparation and histological diagnosis, forcing archive (items 1 – 4 preparations), category 1 (mild degrees of complexity studies) 373.
54008 operation and biopsy material, primary processing, microscopic examination, fitting blocks, preparation and histological diagnosis, forcing archive (items 5-10 after preparation), as well as additional painting techniques; displastisk and priekšvēž status and diagnosis of the benign tumors, regardless of the number of preparations. Skin, muscle, soft tissue tumors are benign. category 2 (moderately complex investigations) 374.
54009 operation and biopsy material, primary treatment, paraffin blocks, lay preparations for the manufacture, fitting the archives and microscopic investigation of 2-20, as well as preparation of the material collected during the endoscopy and biopsy of malignant tumor regardless of the number of the preparation, if used in addition to the painting techniques (serežģīt study with the diferenciāldiagnostisk difficulties). Microscopic investigation, forcing blocks, preparation and histological diagnosis, forcing the archives (by objects over 10 preparations, including histotopogramm, intraoperācij and endobiopsij, bronhobiopsij, trepanobiopsij, kidney, liver, testes, prostate, lymph node biopsy, all types of cancers; regardless of the number of the preparation, if used in addition to the painting techniques), category 3 (complex), if there is difficulty in 375 diferencialdiagnostisk.
54010 operation and biopsy material, primary treatment, paraffin blocks, lay preparations for manufacture, in addition to making the cut, painting with traditional and special staining methods over 20 preparation of extensive operations with several organs or tissues of the investigations, as well as mesothelioma (citobiopsij) and biopsy material from endocrine organs, CNS, artroskopij, eye, thyroid, Lung transuretrāl resection of the prostate, and biopsy of the kidneys, liver, lymph nodes, bones; regardless of the number of preparations (especially complex morphological study) 376.
54015

 Operation and electron microscopy of 377 of the biopsy.
54016 operation and biopsy material Immunohistochemistry 378.
Kidney biopsy 54017 light microscopy (report preparations, PASSPORT, Masson trihrom) 379.
54018 kidney biopsy material examination of 380 imūnfluorescenc.
54019 kidney biopsy material electron microscopy of 381.
54050 testing with the imūnmetod to the enzimatisk 1 group 382 of the substance.
54051 testing with enzimatisk to the imūnmetod group of the substance 2 383.
54052 testing with the imūnmetod enzimatisk to 3 substances group 384.
54053 testing with the imūnmetod enzimatisk to 4 groups of substances to 385.
enzimatisk imūnmetod of 54054 testing with 5 groups of substances to 386.
54055 testing with the imūnmetod enzimatisk to 6 groups of substances to 387.
54056 testing with the imūnmetod to the enzimatisk group of 388 substances 7.
54057 testing with the imūnmetod enzimatisk to 8 groups of substances to 389.
54058 testing with the imūnmetod to the enzimatisk group of to 390 9.
54059 testing with enzimatisk on the imūnmetod substance groups 391 10.
54060 testing with enzimatisk to the imūnmetod group of to 392 11.
54061 testing with the imūnmetod enzimatisk to 12 groups of substances to 393.
54062 "full" chemical toxicological analysis of 394.
Chemical toxicological analysis 54063 to opium alkaloids in 395.
54064 chemical toxicological analysis of 396 on ephedrine and efedron.
54065 chemical toxicological analysis on amphetamine and MDA 397.
54066 chemical toxicological analysis on methamphetamine and MDMA (ecstasy) 398.
54067 chemical toxicological analysis to hashish (marihuan); object-urine, washings from the oral cavity, nomazgājum from the hands of toxicological analysis 399 54068 Chemical to hashish (marihuan); object-urine 400.
54069 chemical toxicological analysis to hashish (marihuan); object-washings of the oral cavity, nomazgājum from hand-401.
54070 chemical toxicological analysis on barbiturate-402.
54071 chemical toxicological analysis on 1.4-benzodiazepine derivatives (tranquilizer) 403.
54072 chemical toxicological analysis on cocaine 404.
54073 chemical toxicological analysis on the 405 promedol.
54074 chemical toxicological analysis on ciklodol of 406.
54075 chemical toxicological analysis to the 407 dimedrol.
54076 chemical toxicological analysis on klofelīn-408.
54077 chemical toxicological analysis on triciklisk of antidepressants (amitriptyline, notriptilīn, imipramīn) 409.
54078 chemical toxicological analysis on fenotiazīn derivatives (iroleptiķ) 410.
54079 chemical toxicological analysis to acetone, 411.
toxicological analysis in 54080 chemically to the 412 imovān.
Chemical toxicological analysis 54081 to tramadol of 413.
54082 chemical toxicological analysis to beta-adrenoblokator-414.
Chemical toxicological analysis 54083 on ketamine 415.
54084 chemical toxicological analysis to gamma-oksibutirāt-416.
54085 drunk studies of izelpojam air 417.
54086 drunk laboratory studies biological environment 418.
Himērism analysis after 60257 allogeneic bone marrow or peripheral blood stem cell transplantation using real time PCR (real time PCR) ";
 "Health Minister j. Bārzdiņš the Ministry of health submitted in annex 2 to the Cabinet of Ministers of 28 December 2010 regulations No 1217" Annex 17. Cabinet of Ministers of 19 December 2006, regulations no 1046 fixed monthly payment (premium) specialist physician office calculated and departments 1. Criteria for the fixed premium for the ER (emergency) for the detection of N.p.k. action
The estimated annual number of patient load together specialist/office number 1.1.
3 500 and more area aid schemes 2 1.2.
up to 3.25 1 2 this provision 3499.93. point out the specialist and the medical departments of the operations of the funds necessary for the annual volume of dollars down: No.
Specialty or department name Ls for 1 load Ls 0.25 0.5 Ls for the loads loads loads of 0.75 Ls Ls Ls for 1.5 for 1.25 loads loads loads of Ls for $1.75 2.0 loads about loads of Lst 2.25 Ls 3.00 Ls for 3.25 loads loads ** of 4.50 Ls loads 1 2 3 4 5 6 7 8 9 10 11 12 13 14 2.1. Psychiatrist 1 732 433 866 1 299 2 165 2 599 3 032
3 249 3 898 4 419-5 067 of 1 743 436 872 1 307 2 179 2 615 3 051 3 270 3 922 4 447 Narkolog 2.2-2.3 Pneimonolog of 1 831 458 915 1 373 2 288 2 746 3 203 3 433 4 119 4 669 5 099-5 355 2.4. Diabetic foot care study 1 940 485 970 1 455 2 425 2 909 3 394 3 638 4 364 4 947-5 674 2.5. Palliative care Cabinet-5 801 1 983 496 992 1 487 2 479 2 975 3 471 3 720 4 462 5 059 2.6. Asthma study 1 831 458 915 1 373 2 288 2 746 3 203 3 433 4 119 4 669-5 355 2.7. Er (emergency) 3 456 864 1 728 2 592 4 320 5 184 6 048 6 481 7 776 8 814 5 789 10 109 2.8. Stoma Cabinet of 3 020 755 1 510 2 265 3 775 4 529 5 284 5 663 6 794 7 701-8 833 2.9. The duty doctor's Office 1 945 486 972 1 458 2 431 2 916 3 402 3 647 4 375 4 960-5 688 2.10. Palliative care study of 22 318-BK----------2.11. Er BK * 4 525 1 131 2 263 3 394 5 656 6 788 7 919 8 486 10 181 11 540-13 236 2.12. Psychologist Cabinet 1 656 414 828 1 242 2 070 2 484 2 898 3 106 3 726 4 224-4 844 2.13. Methadone substitution therapy Cabinet 1 656 414 828 1 242 2 070 2 484 2 898 3 106 3 726 4 224-4 844 3. Monthly fixed payment amount for running make up 1/12 of a year specified in the table. 
4. Doctors and nurses pay calculated in accordance with the provisions of paragraph 180, having regard to the agreement with the Center, the doctor and nurses work. Through the multidisciplinary rehabilitation of addicts and outpatient palliative care provision for children, wage calculation also includes psychological wages according to the rules laid down in paragraph 180 of the doctor's pay.
4.1 the methadone substitution therapy Office work plan, subject to the following principles:

4.11. the methadone therapy provides a multiprofesionāl drug addiction rehabilitation team consisting of certified medical narkolog, certified nurses and psychologists. All team members have undergone special training in methadone treatment;
4.12. the initiation of methadone treatment within the first month of the number of narkolog adoption plan each patient every working day (a dose adjustment and evaluation of side effects), then 1-2 times a week;
4.13. number of visits psychologist supportive psychotherapy for the rational planning to once a week for each patient;
4.14. the nurse's total working time consumption of methadone for service plans, noting that one patient one methadone procedure lasts 7 minutes. Methadone procedure includes the following steps: receipt of ordination of the patient when the patient arrived; check medications; medications nomērīšan device and pouring into the patient; patient drug prevalence, subscription page on ordination drink; medicine bottle refill, if there is more than one patient; medication dosage and comparison of drug registration dossier; urinalysis and remove transmission; remove a blood test for alcohol use a parallel;
4.15. the urinalysis removal and sent to the laboratory for frequency, starting treatment, each patient is a 1 time a week for the first 6 months, then-1 time per month. In cases of infringement, as well as suffering from the disease, next remove the frequency analyses of urine can be up to 4 tests per month.
5. one full load corresponds to: 5.1 10 visits to the narkolog day;
5.2.13 visits to psychiatrists of the day;
5.3.8 visits to child psychiatrists of the day;
5.4.14 visits to the pneimonolog day.
6. the Centre on 1 January of each year and the July 1 assess the medical authorities, health care services, which receives this annex 1.1., 1.2. and 1.3. referred to a fixed payment of at least six consecutive months. If the amount of work done in the last semester is less than 0.5 loads, the Center shall make any amendments to the Treaty, stipulating that future health care services provided by the Centre shall pay according to the tariffs of episodes of care (in accordance with the provisions of annex 19) and referred to in annex 18. manipulation according to the treatment of personal competence.
Before the conclusion of the contract for this rule 93.1, 93.2. and 93.3. referred to health services centre shall assess the management information system for the information entered in the medical institution that provided health care services during the preceding period and, if: 7.1. amount of the work carried out last semester is less than 0.5 loads, the Center concludes a contract for health services provided to pay according to the tariffs of episodes of care (in accordance with the provisions of annex 19) and referred to in annex 18. manipulation according to the treatment of personal competence;
7.2. the medical institution in the previous period is not provided for the following health care services, the fixed payment amount shall be determined, subject to one specialist is determined not more than 0.5.
8. If the Centre, evaluation of health care services provided in compliance with this annex for the amounts in paragraph 5 above, finds that the medical establishment that receives a fixed payment for the duty doctor's Office is not provided for at least three days of patient visits, Centre have the right to terminate the contract with the medical establishment for such health care services.
9. This annex specified in point 2.7. er (emergency) can pay for surgical, therapeutic profile profile specialists and Anesthesiologists-visit his acquaintance Peteris Klava services.
10. Total monthly fixed payment shall be made to this annex 2 and in paragraph 4, the calculated payment amount.
Note: * the State limited liability company "children clinical University Hospital".
** Determine working time in working days from noon. 8.00 and 18.00 and weekends and holidays 24 hours a day (3.25 load). "
Health Minister j. Bārziņš the Ministry of health submitted to the annex 3 of the Cabinet of Ministers of 28 December 2010 regulations No 1217 annex 18 "Cabinet of 19 December 2006, regulations no 1046 of health services for the prevention, diagnosis, treatment and rehabilitation services in the General provisions 1. Health services specified in the tariff for the prevention, diagnosis, treatment and rehabilitation services to manipulate and divided into separate sections on health care services.
2. Manipulation of the other sections can be used if the specialist is not functioning in the appropriate section of the appropriate manipulation, but the specialist is manipulation requires specialisation, qualification and methods.
3. Manipulation of medical documentation presented, if the manipulation is made in full.
4. the manipulation of implant makers and other medical supplies for use in medical documentation may be presented by any independent experts from the specific manipulation of the materials used for the performance.
5. Calculation of one patient in a hospital, treatment costs are taken into account only the pursuit of this annex, which are marked with an asterisk (*) 6.  Manipulation requires that manipulation of the materials included in the tariff, unless indicated otherwise.
General outpatient services, (01004-01083 tampering) no PO box
Manipulation of code manipulation name tariff 1. 
01004, childbirth specialist gynecologist gynecological examinations organised national cancer skrīningprogramm (according to annex 37 of these regulations) 2 2.84 
01018 medical examination prior to vaccination (not presented together with manipulation and 60404 01061) 0.48 3. 
01019 Assistant inspection before vaccination 0.51 4. 
01029 midwife first or repeated pregnant or not viewing of dēļniec (corresponding to the Cabinet of Ministers of 25 July 2006, regulations No 565 "maternity assistance assurance procedures") 1.57 5. 
preventive examinations of children 01061 by family doctors (in accordance with annex 5 of these rules) 2.38 6. 
01062 family doctor first or repeated viewing of pregnant women (according to annex 5 of these rules) 2.90 7. 
01063

Family doctor's gynecological examinations organised national cancer skrīningprogramm (according to annex 37. these provisions) 2.47 8. 
01064 preventive examinations of children by family physician at the children's home (in accordance with annex 5 of these rules) 2.83 9. 
01065 ophthalmologist perform preventive examination (in accordance with annex 5 of these rules) 4.82 10.
01066 premium for family doctor perform a preventive examination, investigation of patients with disease (pay only for children) 1.20 11.
01070 gynecologist, birth of first-time or repeated viewing of pregnant women (under the Cabinet of Ministers of 25 July 2006, regulations No 565 "maternity assistance assurance procedures") 12 3.26
01074 cytological smears from cervix check 0.86 13.
check out the Swab 01078 sexually transmitted disease diagnosis 0.66 14.
check out the material for bacteriological 01083 plating for sexually transmitted disease diagnosis 1.22 Rheumatology (manipulation 02034-02043) no PO box
Manipulation of code manipulation name tariff 15.
* 02034 intravenous drug Methylprednisolon input hands veins hand finger intra-falangiāl in case of damage to the joints with tourniquet entrapment 5.40 16 for 30 minutes.
the medicinal product is pulse 02035 Cyclophosphamid therapy for children under 5 years of age; 24-hour course 40.03 17.
the medicinal product is pulse 02036 Cyclophosphamid therapy for children from 5 to 10 years of age; 24-hour course 41.67 18.
the medicinal product is pulse 02037 Cyclophosphamid therapy children above 10 years of age; 24-hour rate 43.12 19.
* drug Methylprednisolon 02038 pulse therapy of children up to 5 years of age; 3 day course by 2 hours 57.49 20.
* drug Methylprednisolon-02039 pulse therapy for children from 5 to 10 years of age; 3 day course over 2 hours 61.32 21.
* drug Methylprednisolon 02040 pulse therapy of children above 10 years of age; 3 day course over 2 hours 22 65.13.
02041 * combo drug Methylprednisolon and Cyclophosphamid pulse therapy of children up to 5 years of age; 3 day course over 2 hours 57.87 23.
02042 the combo drug Methylprednisolon and Cyclophosphamid pulse therapy in children from 5 to 10 years of age; 3 day course over 2 hours 62.88 24.
02043 * combo drug Methylprednisolon and Cyclophosphamid pulse therapy of children above 10 years of age; 3 day course over 2 hours 69.07 Not ONATOLOĢIJ and paediatrics (manipulation 02077-02405) for manipulation of this section is made to 02077 02156 if they presented for the onatāl not fixed and the infant (if manipulation is not otherwise specified) children. Pay for manipulation are not, if they exhibit an adult treatment.
Payment for the manipulation of this section: 02400; 02401; 02402; 02404 02405 is performed, and if they show a public JSC "sports medicine centre". One visit to one child may display only one of these manipulations.
No PO box
Manipulation of code manipulation name tariff 25.
02077 bonus on light sensitive drugs injection syringe and application of 1.74 26 interconnecting.
* drug-02078 vein infusion, parenteral nutritional support 7.25 27.
* Zematslēgkaul-02079 vein (v. subclavi) or jugular vein (v. jugular) puncture, Catheter, infusion of medication administration, parenteral nutritional support with the catheter for x-ray-kontrastējam 9.44 28.
02080 * supplement for single use of a catheter 6.62 kontrastējam 29.
* Supplement for parenteral 02082 feeding and infusion solutions (24 hours) 30 4.89
sustained positive 02083 expiration pressure (continuous positive airway pressure, CPAP by) "infant flow" preparation, taxation, and use the first hour (includes all costs of using the system) 31 59.06
sustained positive 02084 expiration pressure (continuous positive airway pressure, CPAP system of "bubble", the imposition and use the first hour (includes all costs of using the system) 32 44.23.
* CPAP 02085 "bubble" and the "infant flow" system-for each next hour starting from the second hours 1.60 33.
* high frequency follow-on 02086 lung ventilation in children with disposable breathing circuit first hour 154.20 34.
* high frequency 02087 artificial lung ventilation in children for each subsequent hour, starting from the second hour 2.15 35.
* oxygen supply through 02088 nose kanil ("whiskers") or a mask for the first 36.3.45 hours
* oxygen supply through 02089 nose kanil ("whiskers") or a mask for each subsequent hour, starting from the second hour 1.91 37.
the blood Exchange operation 02090 via umbilical vein (v. umbilical) enter the catheter 48.10 38.
02091 * Exchange operation of blood newborn with disposable blood Exchange System 100.61 39.
02101 lumbar puncture 6.30 40.
02103 * diagnostic lumbar puncture 7.85 41.
02105 * Lateral ventricular puncture through the large pool is controlled by the ultrasonoskopij 42.7.68
the pleural cavity puncture 02107-19.93 43.
02120 child preparation and adding monitors and first time measurement and monitor assay 5.31 44.
preparation of the Child for phototherapy 02130 4.12 45.
02131 * Phototherapy 12-hour course for 34.06 46.
* Supplement for phototherapy 02132 each hour, starting from 13 hours (applied at manipulation 02131) 2.99 47.
02139 the cane bone artery (radial) or femur artery (a. femoralis) arterial blood gas puncture control 10.36 48.
02140 * upper respiratory discharge and taktīl stimulation 5.56 49.
02141 * with positive pressure Respirator breathing (bag-mask) 6.32 50.
* at the respirator of 02142 ekstratorakāl heart massage 6.35 51.
the respiratory release, 02147 intubēj and rinsing Airways 6.98 52.
the artificial lung ventilation 02148 (MPV) up to 2 hours. Manipulation of pay in children up to the age of 3 16.65 53.
the artificial lung ventilation 02149 (MPV) on each hour, starting from the third hour. Manipulation of pay in children up to the age of 3 12.52 54.
02150 * infusion catheter, umbilical vein or entering the umbilical artery 8.49 55.
02151 from peripheral to central vein catheter in disposable Rtg-kontrastējam (line) input power provisioning parenteral newborns 38.40 56.
02152 * premium manipulation 02148 for disposable use contour to the artificial lung ventilation 5.67 57.
02153 * premium manipulation 02148 for disposable breathing circuit with heating device at the artificial lung ventilation 11.34 58.
02154 *

Infusion catheter, umbilical vein and entering the umbilical artery 10.46 59.
* Supplement for Phospholipid 02156 ex pulmonib-su (the medicine 120mg/1, endotraheopulmonār 5 ml Curosurf in instilācij, suspension) uses 311.85 60.
sports doctor of 02400 in-depth preventive medical examination 7.68 61.
Sports physician make 02401 in addition to the preventive medical examination 2.28 62.
02402 sports doctor stage preventive medical examination 2.28 63.
Sports physician make 02403 routine preventive medical examination 2.37 64.
sports doctor made 02404 medical observations 4.75 65.
sports doctor of 02405 physical fitness by the EUROFI methods and musculoskeletal system assessment of children and adolescents aged 6 to 18. May show together with manipulation and Emergency VACCINATION 06021 8.48 assistance (03004-03225 tampering) no PO box
Manipulation of code manipulation name 66 fare.
03004 head, shoulder, hip or body bandage 1.32 doughnut on 67.
03006 joint stabilisation dressing taxation 0.62 68.
longet, 03015 plaster covering two large joints (shoulder, elbow, wrist, knee, foot) or a temporary bandage on fracture case 7.79 69.
03016 upper arm bone fracture immobilization after Turner's 9.78 70.
Plaster casts 03017 taxation to stick broken bone in place, a typical one wrist immobilization (wrist, knee) 5.25 71.
longet's taxation 03018 gypsum metatarsal bone fracture in the event of 6.75 72.
03019 feet and ankle joint immobilization with plaster longet off Shin bone distal 1/3 fracture or other pathologies of the ankle joint area 8.95 73.
03028 circular plaster bandage on the wrist (tutor) 1 7.14 74.
two plaster 03029 longet or circular plaster casts, including 2 large joints. Circular plaster casts of the neck to the shoulder and head restraints 11.07 75.
03030 circular plaster bandage 3 joints (gonit type bandage) 16.11 76.
circular plaster bandages 03035 (tutor) remove 1 wrist 1.90 77.
03036 Circular patch removal of plaster joints 2.52 78 2.
circular plaster bandages 03038 taxation both hip joints 36.40 79.
03040 gypsum beds and night creating the dish body 13.99 80.
Plaster bandage removal 03041 0.55 81.
03081 Vaccine administered, appendages and muscle 0.34 82.
the vaccine is administered orally 03082 0.16 83.
* Supplement for 03138 BCG (Bacillus Calmett-Guerin) (BCG vaccine to enter intravezikāl) use 84 62.78.
03148 * bonus on anti-d (rh) gene (1250I) use 22.27 85.
03173 * bonus on anti-d (rh) gene (250 IU) 9.77 86.
03180 joint puncture 4.00 87.
03183 pleural cavity puncture through single-use Kit 8.25 88.
the abdominal cavity puncture 03184 4.92 89.
03185 heart bag puncture 5.48 90.
bone marrow puncture 03186 4.36 91.
03187 mammary, thyroid, salivary gland or testicle puncture 4.00 92.
03188 liver, spleen, pancreas puncture 5.48 93.
03189 bladder or hidrocēl of puncture 3.42 94.
03203 * upper respiratory opening, with the help of the konikotomij, including intubation of endotracheal 12.13 95.
for basic life sustaining 03205 standard-artificial respirator mouth-mouth or with a mask and ekstratorakāl heart massage for over 20 minutes 6.29 96.
* Advanced basic life 03206 maintenance standard (asistolij, pulseless electrical activity, fibrillation or pulseless ventrikuļ ventrikuļ of tachycardia) 34.07 97.
* Transkutān in kardiostimulācij, 03207 using the multipurpose electrode 21.94 98.
* urgent 03208 kardiostimulācij with the transvenoz catheter 75.42 99.
03209 * artificial lung ventilation Apparatus (MPV) up to 1 hour. Patients who depend on long-term artificial lung ventilation (MPV), but is periodically disabled respiratory stimulation for independent, manipulations applied once 11.78 100.
03210 * artificial lung ventilation Apparatus (MPV) for each next hour up to 4 hours (future MPV costs up to the end of the first day included the total bed days value) 101 8.14.
* Supplement for 03211 artificial lung ventilation (MPV) for each subsequent day of expendable materials and hardware use, starting from the second 24-hour 19.36 102.
03221 direct blood transfusion 34.70 103.
* Supplement for traheostom-03224 kanil 9.20 the use of 104.
* Supplement for traheostom-03225 reinforced the use of ANESTHESIA in kanil 18.17 services (manipulation 04100-04199) 1.  Payment for the manipulation of this section if the start and end of anaesthesia fixed medical documentation. About the beginning of anesthesia suggests mark anesthesia map is dotted in the vein, infusion therapy, initiated direct premedikācij, drug injection. About the end of anesthesia shows a check mark, the patient of anaesthesia card is moved to the next phase of medical care (the awakening of the Chamber, CPR – intensive care or patient wards) within one hour after the end of the operation. The anaesthetists monitoring work included days of the tariff.
2. If after the operation you need artificial lung ventilation, the documentation must specify the medical manipulation and 03210.3 03209.  Potencēšan in the case of the patient may not be specified for general anesthesia manipulation, since the cost of potencēšan included in the days of the tariff.
4. the cost of Sedation and the regional spinal/epidurāl case included the anesthesia manipulation tariff.
No PO box
Manipulation of code manipulation name tariff 105.
Retrobulbār anaesthesia 04100 one eye 2.50 106.
04101 surface anesthesia in the throat, larynx, bronchial area for deeper areas of the nose, the eardrum, the drum cavity or the ureter and bladder 2.59 to 107.
04103 infiltration anesthesia with local anesthesia, anaesthesia cord foot or hand to 2.89 108.
04106 Spinal cord nerves of anaesthesia 109 6.60.
04107 nerve or nerve root runs in the base of the skull or anaesthesia anaesthesia retrobulbār skull base 4.46 110.
back 04108 brain nerve spinal ganglion and sympathetic to communican anesthesia of Ram on one side 3.80 111.
04115 * patient sedation under the supervision of Anesthesiologists various manipulation for 30 minutes. May be presented together with manipulation 04103 7.95 112.
04116 *

Nerve plexus anesthesia the first hour 28.72 113.
04117 * nervous Plexus anesthesia for each subsequent hour, starting from the second hour 10.48 114.
intravenous regional anesthesia 04118 * (Opposite block) 17.65 115.
the Epidurāl anaesthetic 04119 surgical operations and childbirth pain management for the first two hours 39.03 116.
* Prolongēt of the spinal analgesia 04120 's taxation system and receiving the first day 33.07 117.
* Prolongēt of epidurāl-04121 analgesia system. Cannot show together with manipulation, 04119 04135 19.56 118.
in the Caudal anaesthesia 19.74 04122 119.
* Prolongēt in epidurāl in 04123 analgesia with drugs Bupivakaīn (Bupivacain) on the first day-16.60 120.
* Prolongēt in epidurāl in 04124 analgesia with drugs Bupivakaīn (Bupivacain) for every 12 hours the 8.33 nākošaj 121.
the premium regional anaesthesia 04125 about the medicine Bupivakaīn (Bupivakain) use the first two hours 3.23 122.
* Supplement for 04126 medicine Levobupivakaīn (Levobupivacain for hydrochlorid) 1 ampoule (50 mg/10 ml) 2.23 123.
04127 with General anesthesia mask for the first hour 18.04 124.
04128 * Premium for each next hour at general anesthesia with mask, starting from the second hour 10.60 125.
* Prolongēt of spinal analgesia 04129 for every next day-starting from the second 24-hour 7.97 126.
* Supplement for 04130 mechanical infusion devices (easy pump or analog) to a single 24-hour State 15.12 127.
04131 * bonus on mechanical infusion devices (easy pump or analog) use up to three 24-hour 19.09 128 countries.
04132 * bonus on mechanical infusion devices (easy pump or analogue) and eight 24-hour 22.68 129 States.
* Spinal anaesthesia 04133 first 38.11 130 for two hours.
* spinal and epidurāl 04134 anaesthetic for each subsequent hour, starting from the third hour 9.66 131.
the combined spinal-04135 epidurāl anesthesia in the first two hours 60.36 132.
in controlled analgesia 04138 (PC) or sedation with perfuzor for the first 24 hours 7.57 133.
04139 bonus on the controlled analgesia (PCA) for every subsequent 12 hours 3.03 134.
* temporary intravenous anaesthesia 04140 up to 30 minutes. Hide together with manipulation and 04143 19.26 04142 135.
* temporary intravenous anaesthesia 04141 for every next 30 minutes. Hide together with manipulation and 04143 8.46 04142 136.
general anaesthetic 04142 with endotracheal method for the first hour 50.61 137.
* 04143 Premium for general anesthesia with endotracheal method for each next hour starting from the second hour 20.82 138.
general anaesthetic 04144 with endotracheal method in cardiology and vascular surgery in artificial circulation for the first hour 247.81 139.
* 04145 Premium for general anesthesia with endotracheal method kardioķirurģij and vascular operations artificial circulation for each subsequent hour, starting from the second hour 27.31 140.
* total intravenous anesthesia 04146 (TIV) for the first hour. Hide together with manipulation and 04143 56.51 141 04142.
04147 * total intravenous anaesthesia (TIV) for each next hour starting from the second hour. Hide together with manipulation and 19.59 04142 04143 142.
04149 * intravenous narcosis tooth extraction in the event of reorganisation or 7.89 143.
the Implantable port the 04150 '' Insert '' with implantable "port" values 162.62 Bill 144.
* 04155 premium for drug use Halotān per hour 145 1.32.
* 04156 premium on Isoflurane (Isofluran) use the first hour 10.33 146.
04157 * bonus on medicine Sevoflurān (Sevofluran) use the first hour 11.24 147.
* Supplement for medicine 04158 Isoflurane (Isofluran) or Sevoflurān (Sevofluran) to use for each nākamam hours ranging from 6.90 148 of the second hour.
* Supplement for medicine 04159 Mivakūrij use the first hour 11.22 149.
* Supplement for 04160 drug use Mivakūrij for each next hour starting at 7.49 hours the other 150.
* Supplement for medicine 04161 Cisatrakūrij (Cisatracuri) use the first hour 5.10 151.
* Supplement for 04162 medicine Cisatrakūrij (Cisatracuri) for each subsequent hour, starting from the second hour 2.56 152.
* Supplement for Remifentanīl 04163 (Remifentanil) 6.62 153 per hour.
* Supplement for 04164 rocuronium (Rocuroni Museum ") on one ampoule (50 mg) 6.62 154.
Supplement for laringeāl 04165 masks use 3.97 155.
* Supplement for shared 04166 intubation tubes use 52.15 156.
04170 * bonus on high frequency Jet ventilation (Jet) 29.37 157.
04171 central vein catheter puncture and kateterizācij without values 10.96 158.
* Supplement for 04172 central venous catheter use 7.56 vienlūmen 159.
* Supplement for 04173 central venous catheter use 11.53 divlūmen 160.
04174 * bonus on central venous catheter use 11.25 trīslūmen 161.
* Supplement for 04175 central venous catheter use 21.27 četrlūmen 162.
04176 * bonus on central venous catheter with antimicrobial coating for use 33.08 163.
* Supplement for haemodialysed 04177 dubultlūmen catheter use 24.57 164.
* Supplement for haemodialysed 04178 trīslūmen central venous catheter use 27.41 165.
* long-term 04179 haemodialysed kateter insert or without transposition kateter values 14.01 166.
* Supplement for haemodialysed 04180 long-term use 75.60 kateter 167.
* 04185 pulmonary artery (a. pulmonal) kateterizācij with fibrooptisk VIGILANC the SvO2/CCO type catheter with input value 248.07 set 168.
04186 of invasive blood pressure monitoring (IBP metering). Hide with manipulation 04144 32.03 169.
* 04187 Premium for ar1 signal converter. Hide with manipulation 04144 7.75 170.
* Supplement for 04188 system with 2 signal converter, use the hide with manipulation 04144 15.50 171.
* Supplement for 04189 system with 3 signal converter. Hide with manipulation 04144 23.25 172.
04190 * pulmonary artery (a. pulmonal) with kateterizācij (SWAN-GANZ) catheter with indicators of heart functional assessment 103.95 173.
the haemodynamic monitoring 04191 using Picco system on the first day-with a value of 174 127.58 catheter.
the haemodynamic monitoring 04192 using Picco system on every next day-starting from the value of the second without kateter 13.61 175.
* Supplement for 04193 krikotireotomij use of the suite 48.62 176.
04194 *

The premium for combined pipe (Combi-tube) 32.74 177.
* Supplement for special 04195 anesthesia machine with a monitor and the application of perfuzor magnetic resonance examination procedure 7.02 178.
04196 * bonus on sensor use anesthesia depth monitoring (the zip Bispektrāl) 179 21.93.
* Supplement for parenteral 04198 feeding per 24 hours. Hide with manipulation 04199 22.85 180.
* Supplement for one 04199 clock on tube feeding. Hide with manipulation 04198 11.27 physical medicine (05017-05104 manipulation) ultrasound, fonoforēz, darsonvalizācij therapy sessions (manipulation, 05031 and 05044 05023) are to be considered as one single medical manipulation, regardless of the specified number of field therapy, except in the following cases: 1. If the individual therapy to process medical and field technologically based various illuminant (electrodes) or a different therapeutic equipment, with this therapy field processing characteristics of medical documentation.
2. If the individual therapy field, according to the diagnosis of the disease and founded the physical therapy appointment, localized in different regions of the body, t.sk. also the symmetric limbs, including the hip and shoulder joints at bilateral of pathological processes.         
No PO box
Manipulation of code manipulation name tariff 181.
electrophoresis 05017 (pay only for children) 182 1.53.
Transkutān in elektroneirostimulācij-05021 (TEN) (pay only for children) 1.42 183.
05023 Fonoforēz (pay only for children) 184 2.14.
05024 Diadinamisk power (DD) therapy (pay only for children) 1.42 185.
05025 Diadinamisk power (DD) forēz (pay only for children) 1.68 186.
the Sinusoidal modulated current 05026 (SM) therapy (pay only for children) 1.42 187.
the Sinusoidal modulated current 05027 (SMS) forēz (pay only for children) 1.68 188.
05031 Darsonvalizācij (pay only for children) 1.90 189.
Induktotermij 05035 (pay only for children) 190 1.20.
05036 Ultraīsviļņ therapy, centimeters or decimetre wave therapy-wave therapy (pay only for children) 0.94 191.
the changing magnetic field 05041 therapy or a permanent magnetic field therapy (pay only for children) 0.94 192.
05044 ultrasound therapy (pay only for children) 2.12 193.
Aerosolterapij (inhalation) 05045 (pay only for children) 1.29 194.
Ultraviolet irradiation 05047 (pay only for children) 1.42 195.
laser therapy or 05048 magnetolāzer therapy (pay only for children) 1.90 196.
05053 paraffin-ozokerite therapy (pay only for children) 2.29 197.
05102 General massage for children under 1 year of age (40 minutes) (pay only for children) 2.03 198.
05103 General massage for children 1 to 3 years of age (50 minutes) (pay only for children) 199 2.57.
05104 General massage for children from 3 to 18 years of age (60 minutes) (pay only for children) 3.34 cardiovascular system (06003-06202 tampering) no PO box
Manipulation of code manipulation name tariff 200.
06003 ECG leads record with 12 201 0.91.
with 12 leads ECG 06004 Description 1.66 202.
06005 ECG tracings with less than 12 leads from the limbs and/or chest 0.18 203.
with less than 12 06006 ECG leads description 0.79 204.
06007 ECG leads record with 12 children up to the age of 3 1.57 205.
06008 ECG description compared to no less than 5 above the sign in the ECG. Hide together with manipulation and 06006 2.37 06004 206.
06011 ECG leads with 12 to audition, drug medication entering per os 2.64 207.
Ecg leads with 12 06012 drug to audition, entering the Hall i/2.80 208 v.
ECG tracings 06013 with a portable machine at a nursing home in 209 2.50.
06014 myocardial perfusion scintigraphy (MPS) with 12 leads ECG and drug-audition 11.45 210.
06015 Holter monitoring for 18 to 24 hours 10.43 211.
myocardial perfusion scintigraphy 06016 cardiac part of the load test, with results and archival work station. Hide with manipulation 06021 10.54 212.
myocardial perfusion scintigraphy 06017 cardiac part of combined load test with a drug of the audition, with result evaluation and archival work station. Hide with manipulation 06021 19.93 213.
Veloergometrij load test 06021 8.41 214.
06032 Ehokardiogrāfij with haemodynamic indicators of 5.88 215.
* Ehokardiogrāfij with doplerogrāfij-06033 16.77 216.
* Stressehokardiogrāfij with physical 06034 loads or medical audition. Hide together with manipulation and 06021 29.44 06011.06012 217.
06035-218 Skrīningehokardiogrāfij 8.75.
06040 * Stressehokardiogrāfij using the sinus node irritation 26.14 219.
the ehokardiogrāfij of the Transezofageāl 06041 M and B modes with color doplerogrāfij, spectrum analysis and haemodynamic indicators 22.08 220.
Doplerogrāfisk-06042 manipulation of pregnant women and fetal investigation 5.18 221.
06050 Transezofageāl elektrokardiostimulācij load test of 9.31 222.
06051 Transezofageāl elektrofizioloģisk investigation of the arrhythmia diagnosis 9.31 223.
* Transezofageāl of elektrokardiostimulācij arrhythmia 06052 treatment 10.54 224.
* Premium 06053 manipulation, 06051 transezofageāl 06050 on electrodes of elektrofizioloģisk investigation 35.91 225.
* Supplement for 06054 electrode (probe) manipulation 6,052,108.68 226.
* temporary, 06056 transvenoz heart elektrostimulācij, including vein puncture, the electrode entry chest x-ray controls 26.29 227.
06057 * premium manipulation on the probe for transvenoz 06056 heart elektrostimulācij for 228 51.98.
06060 temporary adjustment of the ESA system 76.38 229.
the elektrofizioloģisk investigation of Intrakardiāl 06061 arrhythmia diagnosis 23.43 230.
* Radiofrekvent in ablation catheter 06062 with three-dimensional potential use of registration 238.08 231.
* Supplement for electrode 06063 endokardiāl investigation and use of a catheter ablation 488.33 232.
* Supplement for special 06064 extended radio frequency ablation electrode input and use the stabilisation system 61.43 233.
* Premium at 06065 manipulation 06061, 06062 endokardiāl investigation on electrode 118.13 234.
06066 *

Supplement to the manipulations of the coronary sinuses 06061, 06062 electrode (CSL) 170.10 235.
* Supplement for 06067 input RF ablation Kit and elektrofizioloģisk invasive examinations use 10.32 236.
06068 Elektroimpuls scheduled therapy (defibrilācij) 7.90 237.
Elektroimpuls of emergency therapy 06069 (defibrilācij) 4.76 238.
06070 * invasive elektroimpuls therapy (defibrilācij) 15.98 239.
06070 06071 * premium manipulation of special probe 108.00 240 defibrilācij.
central venous pressure in 06075 measuring 241 2.66.
06076 premium manipulation of the catheter use 11.34 06075 242.
06080 limb arterial trunk functional State of non-invasive evaluation 4.79 243 pletismogrāfisk.
pulse wave spreading 06081 speed discovery trunk artery 0.61 244.
main artery obliterācij 06082 level and after a determination of the degree of pressure gradient 1.86 reģionār 245.
06085 digital artery pulse pressure measurement of the sign or 0.96 246.
06086 digital artery pulse sign or pressure before and after cold exposure or medical audition 4.12 247.
06087 limb veins functional State of non-invasive assessment pletismogrāfisk 248 1.86.
the vascular doplerogrāfij Brahiocefāl 06100 with spectrum analysis and functional audition 4.34 249.
06101 Transkraniāl vascular doplerogrāfij and spectrum analysis 4.34 250.
the vascular duplex Brahiocefāl scan 06102 with color doplerogrāfij and spectrum analysis 12.48 251.
06103 ankle index detection with 6 measurements 4.60 252.
the two lower limbs 06104 segmental measurements in doplerogrāfij with 12 253 7.43.
06105 both upper limb line vascular doplerogrāfij and spectrum analysis 3.91 254.
06106 both lower limb trunk blood vessel doplerogrāfij and spectrum analysis 7.44 255.
06107 both upper limb doplerogrāfij with segmental measurements 2.95 256 8.
06109 both lower limb skin mikroasinsvad laser doplerogrāfij notation of 2.86 257.
06110 both lower limb skin mikroasinsvad laser description of 1.40 258 doplerogramm.
06111 both lower limb skin of postokluzīv hiperēmij mikroasinsvad of doplerogrāfij of the laser trace 259 5.50.
06112 both lower limb skin of the hiperēmij of postokluzīv mikroasinsvad laser description 3.35 260 doplerogramm.
abdominal aorta 06115 and all its branches krāskodēt of duplex scanning 14.07 261.
06116 aortic arch and descendējoš parts krāskodēt of duplex scanning 7.51 262.
06117 Both arm artery duplex scan of 6.15 263 krāskodēt.
06118 Both leg artery duplex scan of 11.76 264 krāskodēt.
Transkraniāl-krāskodēt-06119 duplex scanning (including newborns) 16.52 265.
Transkraniāl-krāskodēt-06121 duplex scan with contrast 66.43 266.
two 06122 vein krāskodēt a duplex scan 9.70 267.
06123 Both leg vein krāskodēt a duplex scan 13.45 268.
06124 abdominal vein krāskodēt a duplex scan 15.79 269.
* Hiperbār in oksigenācij, 06125 for every full hour 8.76 270.
pacemaker implantation * 06130 Unicameral operations without a pacemaker values 170.35 271.
06131 * Divkamer Permanent pacemaker implantation without a pacemaker and endokardiāl electrode values 234.85 272.
the Unicameral 06132 pacemaker check and programming 10.28 273.
06133 * Divkamer pacemaker check and programming 14.90 274.
* the Unicameral ventricular 06134 ICD and programming 14.90 275.
* Divkamer (DDD) 06135 ICD and programming 18.78 276.
the ICD implantation without 06136 ICD and endokardiāl values 234.22 277 the electrode.
06137 permanent EC system reconstruction of the system of adjustment of the electrodes and the electrode without EC adapter value 174.38 278.
the Endokardiāl electrode 06138 change 174.38 279.
the pacemaker box 06139 Exchange 174.38 280.
ekstirpācij 174.38 of the pacemaker 06140 281.
06141 * long-term ECG monitoring equipment implantation without system value 112.18 282.
the pacemaker implant 06150-752.40 283 miokardiāl.
* Supplement for unicameral 06151 pacemaker SS type without extra functions and type with loads of SSIR Adaptive function use 212.63 284.
* Supplement for unicameral 06152 pacemaker SSIR type with load Adaptive function and automatic stimulation of the use of the measuring system 482.08 285.
* Supplement for divkamer-06153 pacemaker VDD and DDD type without the use of additional functions 512.03 286.
* Supplement for divkamer of 06154 pacemaker DDDR type with load Adaptive function use 657.03 287.
06155 * premium manipulation of complex divkamer 06131 pacemaker-antitahikardītisk, biatriāl or biventrikulār of the resinhronizācij of the ventricles (CRT) 1980.41 288.
06156 * premium manipulation of intrakardiāl in the unicameral 06136 defibrillator (ICD) 2707.43 289.
* Premium manipulation 06136 06157 on intrakardiāl or divkamer of the implantable defibrillator for ventricular kardioverter-defibrillators with atrium and biventrikulār functions use the stimulation 6369.30 290.
* Premium manipulation 06141 06158 implantable sustained ECG monitoring diagnostic equipment '' to '' use of REVAL 291 1370.25.
06160 * myocardial biopsy as a stand alone manipulation 273.03 292.
06165 * bonus on pace with the physical load Adaptive function and telemetry capabilities with two bipolar electrodes use 2079.00 293.
* Supplement for 06166 electrode for coronary sinus biventrikulār or biartriāl incentives for the use of 374.22 to 294.
* Supplement for 06167 input Kit sinus Coronaria electrode input use 400.68 295.
* Supplement for active 06168 fixation bipolar electrode for permanent use of 154.96 296 elektrokardiostimulācij.
* Supplement for miokardiāl in 06169 bipolar electrode for Permanent pacemaker implantation for miokardiāl use 210.69 297.
06170 * bonus on permanent implantable electrode adapter use 298 33.08.
* Supplement for introduction 06171 system permanent implantation of electrodes use 10.84 299.
* Supplement for 06172 temporary pacemaker electrode input devices with the ievadsistēm and the temporary use of electrode 35.34 elektrostimulācij 300.

06173 * bonus on temporary external stimulation cables mesothelioma measurements use 47.25 301.
06174 * bonus on a temporary pacemaker electrode active fixation the use of bipolar 168.77 302.
06175 * supplement for adult defibrilācij kontaktspilventiņ kardiostimulācij-use of 303 14.36.
06176 supplement for the connecting device of katetrablācij recorded electrode use 189.00 304 AMAZR.
06177 * bonus on the 9670590 compatible with Localis passive electrode use 65.21 305.
* Supplement for transezofagiāl-06178 elektrokardiostimulācij sešpolār use of electrode 170.10 306.
* Supplement for one 06179 heart camera used for external stimulation of the use of temporary pacemaker 18.90 307.
Intravascular ultrasound in the 06201 * (IV) with material values. Do not use together with manipulation, 60072 60073, 60,074,647.19 308.
06202 * and get a congenital heart defect correction with interventional cardiology Pulmonology 3500.68 method (manipulation 07002-07060) for manipulation of this section is made, if they produce a ftiziopneimonolog. The invasive diagnostic and therapeutic services manipulation in section ' thoracic surgery ' (31001-31230 tampering).
No PO box
Manipulation of code manipulation name 309 fare.
07002 expiration maksimumplūsm (IMP) Discovery (PEF-metrij) 0.66 310.
external respiration 07004 KPI and analysis using a portable spirogrāf (pneimotahogrāf) 311 2.56.
07017 Spirogrāfij (pneimotahogrāfij) with automatic datoranalīz to 3.75 312.
07018 Spirogrāfij (pneimotahogrāfij) with automatic datoranalīz and bronhodilatācij test 5.08 313.
07023 non-specific airway reactivity determination by the inhalation of 14.32 314 metaholīn.
whole-body pletizmogrāfij-07025 7.06 315.
whole-body pletizmogrāfij with 07026 bronhodilatācij test 7.78 316.
Lung diffusion capacity 07028 discovery 7.80 317.
Premium manipulation 07002 07029 for children up to 10 years of age, training (training medical staff carried out 20-30 minutes before the test) 0.94 318.
07030 premium manipulation, 07004 07017, 07018 for children up to the age of 10 training spirogrāfij (pneimotahogrāfij) takes place (out of training medical staff for 20-30 minutes before the test) 1.42 319.
07043 sweat screening made by prov cistisk fibrosis (CF) of the indicator 8.36 320.
07044 * prov screening made of sweat with sweat analysis system (NANODUC) (also the result of the evaluation) 321 21.83.
Kardiopulmonāl loads the test 07045 11.11 322.
07060 inhaler correctly training, also repeated 0.00 Gastroenterology (manipulation 08001-08152) If performed in the manipulation, but 08113 08061 08111, unforeseen circumstances fail to enter an endoscope (anatomical characteristics, the patient is ill prepared for the investigation or pull the entered an endoscope) for manipulation is carried out in full.
No PO box
Manipulation of code manipulation name tariff 323.
08001 24 hour esophageal and/or gastric pH-metrij adults with vienelektrod probe for multiple use 29.33 324.
08002 24 hour esophageal and/or gastric pH-metrij for children with vienelektrod probe for multiple use 37.77 325.
08003 24 hour esophageal and/or gastric pH-metrij adults with two electrode probe for multiple use 47.31 326.
08004 esophageal manometrij with water četrkanāl perfusion catheter for multiple use 31.54 327.
Odds of sphincter manometrij 08005 with water perfusion catheter is a single conduit multiple use 38.86 328.
Anorektāl-manometrij 08006 with water perfusion catheter četrkanāl multiple use 31.30 329.
08007 lactose malabsorption diagnostic with hydrogen of 17.69 330 elptest.
diagnosis of intestinal disbakterioz 08008 with hydrogen elptest-21.64 331.
08009 oral cekāl transit time with hydrogen elptest of diagnostic 21.64 332.
08010 esophageal manometrij with astoņkanāl water perfusion catheter 37.14 333.
Anorektāl-manometrij with astoņkanāl 08011 water perfusion catheter 34.69 334.
08012 24 hour esophageal pH and/or GI-metrij adults with četrektrod probe for multiple use 55.86 335.
08013 24 hour esophageal pH and/or GI-metrij adults with trīsektrod probe 53.03 336 for multiple use.
elektrogastrogrāfij 41.64 337-08014 portable.
sphincter in vector Anorektāl 08015 volumetric with astoņkanāl catheter 19.90 338.
Gastroskopij pH-08016 simultaneously 7.92 339 metrij.
08017 premium manipulation 08061, 08062, 08111 08112 08113, 08136, on probe, entered with an endoscope for 6.46 340.
pH-metrij-08030 stomach one patient 8.53 341.
the pH-metrij of Endoscopic 08035 8.23 342.
08036 gastric-esophageal reflux investigation 8.39 343.
08037 automated pH-metrij of the stomach of one patient 9.95 344.
08050 probing 4.19 345 Duodenāl.
08051 premium manipulation 08059, 08062 of esophageal bužēšan with ezofagoskopij of 6.94 combined 346.
08052 premium manipulation 08059, 08062 of esophageal bužēšan children 7.12 347.
08053 * esophageal insertion of endoprotēz without a endoprotēz value. May be presented together with manipulation 08059 15.81 348.
08054 * premium manipulation 08053 on esophageal metallic stent with polyester mantle and Platinum markers 633.15 349.
08058 Gastroskopij and/or partial sample of duodenoskopij without ekscīzij and/or puncture 14.27 350.
08059 Ezofagoskopij without ekscīzij the sample and/or puncture 5.93 351.
08060 * Ezofagoskopij with ekscīzij of the sample and/or puncture 11.06 352.
08061 * Gastroskopij and/or partial sample of duodenoskopij with ekscīzij and/or puncture and urease reporting 19.37 353.
08062 * emergency ezofagoskopij and/or gastroskopij and/or partial duodenoskopij of 354 19.95.
* Hemostāz-08063 emergency top or bottom time without endoscopy disposable material values. May be presented together with the manipulation, 08062, 08111 08061 08112 08113 17.41, 355,.
* Supplement for hemostāz-08065 clips use 11.99 356.
* Supplement for endocilp 08066 use 44.31 357.
the esophageal strictures 08070 laser coagulation 9.18 358.
the removal of foreign bodies from 08071 oesophagus, stomach and duodenum to the rectum. May be presented together with manipulation and 08062 16.29 359 08061.
08072 *

Endoscopic varicose veins therapy of the upper and lower digestive system without varikož the clips and Ligature cost emergency situation the bleeding veins. May be presented together with the manipulation, 08062, 08111 08061 08112 08113 23.74 360,,.
* Supplement for 08074 disposable loop varicose veins liģēšan use of 361 14.18.
08075 * bonus on an endoscope distal end cap for the vairākreizlietojam local aspiration to one procedure 0.63 362.
08076 * Endoscopic stomach ulcers and duoden treatment in one session. Do not use together with manipulation 08135 13.54 363.
the Papilla of Vater in endoscopic 08077-kanulācij with contrast medium injection and/or secretions (ERHP) without taking disposable heads, dilation balloon and catheter values 35.65 364.
* Supplement for disposable 08078 bile in the path of balloon dilation use 123.90 365.
* Supplement for the disposable 08079 bile path using 93.45 366 catheters.
* 08080 premium manipulation of stent removal from 08077 žultsceļ-6.62 367.
08081 * never perform manipulation due to unforeseen circumstances. Do not use together with manipulation 08077 20.36 368.
08085 patient sedation during endoscopic examination 3.24 369.
* selective 08086 granulocytes, Apheresis, monocīt, macrophage to Adacolumn System 370 881.60.
* the papillosfinkterotomij without Endoscopic 08090 disposable heads, dilation balloon and catheter values 51.68 371.
08091 * premium manipulation 08090 on disposable catheters and the use of 85.05 372 drivers.
in papillosfinkterotomij with the Endoscopic 08093 konkrement of litotripsij and/or 41.12 373 extraction.
08094 * premium manipulation on the use of catheters, 08093 42.53 374.
* Premium manipulation 08093 08095 on groziņveid using 153.09 Extractor 375.
the premium for 08093 08096 manipulation on the use of motor litotriptor with one variable the value of the basket 207.90 376.
* in papillosfinkterotomij and Endoscopic 08097 stent into bile or aizkuņģdziedzer wires without endoprotēž values 48.25 377.
* Supplement for the disposable 08098 plastic drain kit use 115.50 378.
08099 * bonus on the disposable nazobiliār drain kit use 73.50 379.
* Percutaneous endoscopic gastrostomij 08100 in in the 380 17.33.
* Premium manipulation 08101 08100 for percutaneous endoscopic gastrostomij (PEG) set 94.50 381.
372.29 of the capsule endoscopy 08108 382.
* capsule endoscopy 08109 processing 24.39 383.
08110 Rektoskopij 384 of 3.65.
08111 Sigmoidoskopij with flexible instruments, including the rektoskopij 13.27 385.
08112 colon examination with flexible instruments, including the rektoskopij to the lean angle 18.18 386.
08113 * colon examination with flexible an endoscope, including rektoskopij and sigmoidoskopij, the ekscīzij and/or puncture 34.51 387.
* up to two 08114 mucous sampling due to cutting and/or polip node biopsy, using high-frequency power tools. Premium manipulation, 08060 08061, 08062, 08063, 08110, 08111, for up to two 08113 08112, mucous, sampling with high frequency power tools 17.77 388.
* more than two 08115 mucous sampling due to cutting and/or polip node biopsy, using high-frequency power tools. Supplement to the manipulations, 08060 08061, 08062, 08063, 08110, 08111, for more than two 08113 08112, a mucous sample with high frequency power tools 22.02 389.
08120 * Endosonogrāfij using elastic for an endoscope 13.25 390.
* therapeutic endoscopic ultrasound in 08121 with sectoral detector of an endoscope 73.12 391.
the diagnostic endoscopic ultrasound in 08122 with sectoral detector of an endoscope 57.18 392.
08125 * bonus on ultrasound aspiration needle biopsy and histology kit use 393 100.33.
* Supplement for Plex-08128 coeliac irolīz not use the needle Kit 210.00 394.
* Supplement for 08130 disposable injector use digestive endoscopy-30.98 395.
08132 * premium manipulation of endoprotēz-08097 žultsceļ metallic stent with Platinum markers use 519.75 396.
* Premium 08133 manipulation, 08058 08059, 08060, 08062, 08077, 08061, 08090 08111 08112 08081,,,,,, on videoendoskopij 08113 08121 08122 hardware use 5.67 397.
* Supplement for argonplazm of 08134 coagulation equipment use 56.38 398.
08135 * laser coagulation through an endoscope for one session. Do not use together with manipulation 08070 6.50 399.
* an endoscope-08136 automatic processing (including disinfectants) 400 3.76.
elptest of Helicobacter pylori 08140 C13 discovery 401 27.70.
metacetīn of elptest for C13 08141 liver function for determining 38.91 402.
08142 C13 elptest acetic acid stomach evacuation functions discovery 32.30 403.
08143 fat gut clean-up method for the preparation of the patient thick intestinal endoscopic examination or irigoskopij with Enema of 2.84 404.
the mixed triglyceride 08144 C13 elptest for the determination of lipase deficiency 52.12 405.
08152 slender casings biopsy with Watson's capsule in children x-rays controls 14.78 ENDOKRINOLOĢIJ (manipulation-09189 09004) no PO box
Manipulation of code manipulation name tariff 406.
09004 detection of Foot loading podogrāf (static) 2.52 407.
09005 feet load detection with podogrāf (dynamic and postural) 408 4.09.
* hormonal 09182 diagnostic tests – STH stimulation without promoters of prov 13.36 409.
09183 * hormonal diagnostic tests – the process of Synacthen 14.11 410.
09184 * hormonal diagnostic tests – GnRH (also, ACTH, TRH analogue GHRH) prov 15.02 of 411.
09185 * hormonal diagnostic tests, insulin and C-peptide levels or discovery in the oral glucose tolerance test 10.03 412.
09186 * hormonal diagnostic tests – test the gonadotrophin 4.60 horionisk 413.
09187 premium manipulation of promoters-09182 Insulin (human) use 0.48 414.
* Premium manipulation 09182 09188 for promoters-GHRH (Somatropin and somatropin agonists) 9.45 415.
09189 * premium manipulation of promoters-09182 glikagon (Glicagon) use 11.34 Allergology (manipulation of 10008-10044) no PO box
Manipulation of code manipulation name tariff 416.
10008 skin prick test (prick test) with 1 allergen 2.21 417.
10009 skin prick test (prick test) for each of the next allergen 0.80 418.
10010

Skin prick tests (prick test) with a single bee, WaSP venom allergens dose 6.57 419.
10011 skin puncture test (prick test) for each bee, WaSP venom allergens dose 4.30 420.
leather stitch-10012 stab tests (prick-prick test) with one allergen 1.20 421.
10013 leather stitch-stitch tests (prick – prick test) for each allergen 0.25 422.
10020 Intrakutān test tampering with one allergen 4.87 423.
10021 Intrakutān offence for each test in the next allergen 0.94 424.
10022 Intrakutān test made with one bee, WaSP venom dose 5.07 425.
10023 For each bee, WaSP venom dose infusion 2.73 426.
specific immunotherapy with allergens 10025 injection (hiposensibilizācij) for each injection 0.95 427.
allergen specific immunotherapy with 10026 injection (hiposensibilizācij) with the bee, WaSP venom, including allergens 6.53 428 value.
10033 leather applications test preparation and execution of three allergens, including the value of 4.90 429 allergens.
10034 skin applications of the test for each allergen 0.61 430.
10037 leather applications test with UV irradiation fotosensibilizācij for one patient diagnosis 431 25.26.
10038 Pneimotahogrāfij with auto datoranalīz in asthma patients before and after repeated injection immunotherapy 432.3.55
10041 a Nasal provocation test with allergen extract, clinical evaluation and rinomanometrij of 9.01 433.
the bronchial provocation test 10042 with the allergen extract using pneimotahogrāf and allergen extract (use only stationary) 434 44.21.
* Oral provocation test of 10043 with food or drug allergens 20.22 435.
10044 "induced sputum" acquisition and preparation analysis 9.76 Neurology (11001-11103 tampering) no PO box
Manipulation of code manipulation name tariff 436.
11001 lumbar puncture with anesthesia 3.32 437.
11002 lumbar puncture in children with anesthesia 6.07 438.
11003 11001, 11002 bonus manipulation of dynamic likvor provj check 2.21 439.
11004 classical electromyography and evaluation of 7.14 440 data.
11005 is not irogrāfij and quantitative electromyography with needle electrodes and computerised data processing 23.51 441.
11006 the individual muscle fiber electromyography with needle electrodes 9.68 442.
not irogrāfij with computerized 11007 processing 14.70 443.
11008 Tremor analysis and investigation of the system ekstrapiramidāl 8.01 444.
11009 vegetative nervous system examination tests 8.86 445.
determination of the reaction Miastēnisk 11010 3.86 446.
11011 trigeminal ganglia nerve (n. trigemin) and facial nerve (n. facial) investigation test 4.40 447.
11021 brain lateral ventricles puncture through the large pool of 7.50 448 for infants.
11022 Child investigation after Vojt methodology using Landau, Collis vertical, horisontal, Peiper Collis-Laber. 449 of the prov 3.79
11025 indicative field of vision inspection and data analysis 0.79 450.
11028 olfactory and taste testing 2.52 451.
11035 muscle strength assessment and verification with special complex and instrumental tests by 2.37 452 muscle groups.
11036 coordination and balance testing with tests (other tests, with the exception of finger-tip Romberg, heel, knee, adiodohokinēz tries) 1.57 453.
11037 vibration feeling with kamertoņ for 454 1.90.
11038 Stereognoz and other types of complex sensory test with accessories 0.96 455.
11040 higher nervous system functions targeted testing, using special tests 0.79 456.
11041 compression neuropathy clinical test to check one level 1.57 457.
11051 * Elektroencefalogrāfij with sleep 26.32 458 indicated.
11052 * Elektroencefalogrāfij with additional functional and drug tests 20.78 459.
11053 * Elektroencefalogrāfij with transportable equipment 20.40 460.
11054 Elektroencefalogrāfij with standard functional testing of children, parents and adults for 7 years 9.29 461.
Elektroencefalogrāfij 11055 with standard functional testing of children up to the age of 3 21.53 462.
11056 Elektroencefalogrāfij with standard functional tests for children from 3 to 7 years of age 14.69 463.
11057 computerized encefalogrāfij with biopotenciāl mapping with coloured pictures 19.52 464.
11058 the computerized elektroencefalogrāfij with EEG-video synchronous monitoring (the first 12 hours) 51.54 465.
11059 the computerized elektroencefalografij with Premium Video synchronous monitoring (for every nākošaj 12 hours) 466 38.00.
11060 * computerized elektroencefalogrāfij with video synchronous monitoring data processing work station (the first 12-hour notation) 28.45 467.
11061 * computerized elektroencefalogrāfij with video synchronous monitoring data processing work station (next to the 12-hour notation) 468 14.23.
11065 nerve sensory fibre investigation 469.3.55
11066 vision called the potential discovery 9.54 470.
11067 hearing called the potential discovery 9.45 471.
11068 Somatosensor call potential discovery 6.00 472.
11101 Infiltrējoš the blockade, blockade the nerve channels, epidurāl and peridurāl of the blockade with the material and medicinal value of 5.64 473.
11102-Infiltrējoš blockade, blockade the nerve channels, epidurāl and peridurāl of the blockade without materials and medicinal values 3.79 474.
11103 star types, and other autonomic ganglia of the blockade with the material and medicinal values of 5.64 Psychiatry and ADDICTION (manipulation, 12016 13015-13026) no PO box
Manipulation of code manipulation name tariff 475.
12016 one court in outpatient or inpatient psychiatric or psychological examination and the preparation of an opinion (except the VSI "Riga psychiatric and addiction centre" the Court examiner's psychiatric department with security guards perform inspection). Complex judicial psychiatric-psychological expertise the court case show a 2 (two) times 99.54 476.
13015 * acute intoxication treatment hospital 2.27 477.
13016 * severe alcohol withdrawal treatment hospital 1.75 478.
13017 * alcohol motivation stationary 0.42 479.
13018 * drug abstinence treatment hospital 480 2.27.
13019 * teen motivation stationary 0.42 481.
13020 * addicts motivation stationary 0.42 482.
13021 * teenage detoxification hospital 1.75 483.
13022 * Minnesota hospital 0.42 484.
13025 Opioid-dependent patient abstinence syndrome blending up to 10 days for one day the day fixed in 6.96 485.
13026

Opioid-dependent patient abstinence syndrome blending from 11 to 20 days for the one-day day-hospital Dermatology and Venereology 4.46 (14020-14028, 15008 tampering) no PO box
Manipulation of code manipulation name 486 fare.
14020 Phototherapy with ultraviolet "B" rays (UVB) 3.84 487.
Fotoķīmijterapij (ROT) 14021 9.84 488.
14022 local fotoķīmijterapij (ROT) 6.51 489.
14023 Photodynamic therapy 9.37 490.
Supplement to the manipulations 14023 14024 on medicines for one procedure 90.72 491 methyl esters.
14025 skin, mucous membrane and skin dermatoskopij 0.51 492 of derivatives.
Dermatož of laser-14026 4.91 493.
Dermatož of the phototherapy 4.81 494 14027.
14028 skin pigmentveidojum with a datordermatoskop diagnosis of 3.21 495.
15008 drug provocation on sexually transmitted diseases in OBSTETRICS-Gynecology 0.95 (manipulation 16001-16136) no PO box
Manipulation of code manipulation name tariff 496.
16001 vaginal wall and cervix biopsy by using kolposkop of 11.07 497.
16007 * cervical cone of 15.30 498 elektroekscīzij.
the vaginal wall and 16008 cervical biopsy 12.47 499.
16009 uterus aspiration cytology investigation and preparation of 3.23 500.
16010 uterine mass correction with rings 2.94 501.
16015 entering 3.12 502 spirals.
16016 spirals removal 2.04 503.
vaginal foreign body removal 16017 children 5.62 504.
16018 in Bartolīn gland incision 14.42 505.
16019 in Bartolīn gland cysts of shelling 34.12 506.
16020 in the Cervical Canal polip removal 11.67 507.
16026 * Cervical Canal dilation and abrāzij and/or abrāzij of uterus 10.64 508.
16027 * diagnostic amniocentēz and fruit amniocentēz material for 48.57 509.
16028 * Amniocentēz pregnancy termination 45.12 510.
* Histeroskopij-511 28.58 16029.
vagina mugurēj the vault 16032 puncture 5.53 512.
* Vaginal Douglas 16033 space open, kolpotomij with drainage 11.57 513.
* Transvagināl of puncture 16034 USA controlled horionbiopsij, getting follicle 37.83 514.
16040 * cervical amputation 92.29 515.
* vaginal and perineal 16041 plastics 100.70 516.
venterofiksācij 96.82 of the uterus 16042 517.
16043 rezektoskopij 69.07 518 of the endometrium.
16044 operation on uterus of 95.45 519 suffix.
* Premium 16045 manipulation, 16117 16115, 16050, 16052, 16044, on another at 16072 operation 46.55 520.
* Supplement for pretsaaugum-16046 intraperitoneal (1, 5 l ikodekstrīn 4% solution). Also, surgery and may be presented in urology 69.56 521.
* Supplement for natural 16047 collagen implant (2 x 7 cm). Also, surgery and may be presented in urology 85.05 522.
16048 * bonus on natural collagen implant (4 x 7 cm). Also, surgery and may be presented in urology 141.75 523.
16050 * tubal plastic surgery 81.04 524.
16051 tubal permeability with dye 4.97 525.
the uterine perforation 16052 openings of suturing 95.08 526.
16053 supravagināl amputation of uterus with or without removal of the thymus. Uterine rupture is a suturing 133.64 527.
miomektomij 116.72 of the conservative 16054 528.
16060 * uterine amputation during delivery or early postpartum period with or without removal of the suffix 138.11 529.
16061 * uterus ekstirpācij with or without removal of tubal 139.17 530.
* 16062 uterine vaginal ekstirpācij of 148.45 of 531.
16063 * uterine ekstirpācij during childbirth or in the early postpartum period, with or without removal of the suffix 164.08 532.
* simple vulvektomij of 59.13 16064 533.
16065 * vulvektomij 172.56 534 of the radical.
16070 * Vertheim operation 187.56 535.
the uterus ekstirpācij with 16071 small pelvis deomentizācij of 169.18 limfadenektomij or 536.
16072 * surgical contraception (sterilisation) of 537 54.20 laparatomij.
16073 * premium for surgical contraception (sterilisation) at the same time other operations 8.45 538.
Retroperitoneāl-ileakāl-limfadenoektomij * 16074-539 169.53.
16075 sutures of the cervix in the istm-cervical insufficiency 32.66 540.
16076 Suture removal of the cervix in the istm-cervical insufficiency 541 10.11.
16080 * diagnostic laparoskopij. Hide together with other operations 147.38 542.
* laparoscopic surgery-16082 salpingectomij, salpingostomij with fruit eggs evacuation, cistektomij, cistovazektomij 495.84 of 543.
the saaugum of the Laparoskopisk 16087 separation and salpingolīz of the small pelvis 336.28 544.
* Laparoskopisk-16088 hysterectomy with or without suffixes of 572.75 545.
the Laparoskopisk of ovarian 16089 permeability test, ovarian kauterizācij-546 318.41.
16100 birth outside hospital 30.48 547.
16101 external kardiotokogrāfij, starting with the 22 pregnancy weeks 3.05 548.
16102 * family labor. Hide along with the manipulation, and 549 16106 16107 16108 67.00.
16103 external fetal ultrasound control turnover 5.87 550.
16106 * physiological birth. Hide along with the manipulation, and 551 16102 16107 16108 65.00.
16107 * birth maternity pathology. Hide with 16102, 16106 and 16108 82.99 552.
the birth of ekstraģenitāl 16108 pathology. Hide, and together with the 70.17 553 16102 16106 16107.
16109 * vakuumekstrakcij or akušierisk the fruit of imposition of window pole 6.33 554.
the inner Fruit 16110 turnover and extraction 15.19 555.
* Tuboligācij-16111 after childbirth 47.11 556.
* Amnioinfūzij-22.24 16112 557.
16115 106.11 558 * caesarean.
16117 * small caesarean 79.01 559.
* Vaginal caesarean 57.10 16118 the 560.
the Fruit of the Division 16119 operation 30.71 561.
16120 manual separation of the Placenta and distribute 10.50 562.
16121 the uterus and placenta of the audit manual manual ablation a 10.46 563.
16130 * cervix I-II degree of cross-linking 18.92 564 tear.
16131 * cervical suturing in grade III tear of 565 30.82.
16132 * I and II degree perineal and vaginal tear of suturing 16.69 566.
16133 * III and IV degree perineal tears of suturing 51.39 567.
* an episiotomy, 16134 perineotomij welder-14.06 568.
16135 * bonus on newborn care during childbirth 7.09 569.
16136 * bonus on newborn care one day postpartum period (once a day) 7.54 Ophthalmology (manipulation 17001-17406) 1.   Pay for manipulation, 17406 only 17360 if they produce a VSI "children clinical University Hospital".

2. all studies in ophthalmology include the study and evaluation of results.
3. Pay for manipulation 04101 "surface anesthesia in the throat, larynx, bronchial area for deeper areas of the nose, the eardrum, the drum cavity or the ureter and bladder" is carried out, if it is presented in ophthalmology.
No PO box
Manipulation of code manipulation name tariff 570.
subjective refraction determination 17001 0.67 571.
subjective refraction determination 17002 children up to the age of 0.95 572 8.
17003 subjective refraction determination in the case of 0.95 573 astigmātism.
subjective refraction 17004 detection in the case of astigmātism to 8 years of age 1.20 574.
Objective determination of the refraction 17005 with the method of 0.46 575 skioskopij.
Retinoskopij-17006 adult and children at 8 years of age 1.04 576.
children up to 8 Retinoskopij 17007 age 1.54 577.
17008 Accommodation reserve determination 0.53 578.
Oftalmometrij (keratometrij) 17009 0.40 579.
17010 vision examination indicative estimate 0.48 580.
17015 determination of Visual acuity in the vicinity or in the distance, children up to 8 years of age 0.80 581.
17016 Visual acuity correction near or far in the distance for children up to 8 years of age 0.80 582.
17017 determination of Visual acuity or in the distance near 0.66 583.
17018 Visual acuity correction near or distant 0.66 584.
17019 determination of Visual acuity in children with Cardiff sight activity test 1.27 585.
lens refraction determination 17020 children up to 8 years of age with skioskopij method 0.67 586.
the dynamic objective refraction 17025 detection (dynamic retinoskopij) 1.26 587.
the withdrawal quantity 17028 Tear and/or break time (break-up-time) detection 0.94 588.
17029-0.32 589 Refractometry.
17030. Autorefraktometrij of 2.17 590
17040 hidden squint squint and qualitative assay 1.20 591.
17042 Stereoredz check around in the distance (Lang, TNC and "flies" tests) 0.79 592.
17045 binocular function test using sinoptofor (Maddox) 0.81 593.
17046 positive and negative determination of 0.81 fūzij 594.
17052 both eye movements the 1.57 595 diferenciālanalīz.
17056 Kampimetrij (Kampimetr) near and/or distance 0.79 596.
17060 field discovery 0.79 597.
the color of the perimetrij Projection 17061 1.57 598.
17062 computerized projection static color perimetrij the one eye 3.62 599.
17065 Eyes a crack and movement evaluation 1.57 600.
17066 Eyes lift muscle function assessment and schematic notation 1.42 601.
* laser treatment in infants 17070 Indirekt age one eye 28.61 602.
* laser treatment in infants 17071 Indirekt age while the other eye 22.31 603.
the combined estimated 17072 and laser treatment of infants aged one eye 41.16 604.
the combined estimated 17073 and laser treatment for age infants at the other eye 27.40 605.
17080 eye biomikroskopij 1.46 606 of both eyes.
Gonioskopij of both eyes 17081 1.75 607.
17082 Biomikrooftalmoskopij (with Goldmaņ lens) for both eyes and comparative evaluation of results 2.23 608.
Diafonoskopij of both eyes 17083 0.46 609.
Eksoftalmometrij-0.40 610 17084.
direct oftalmoskopij-17085 both eyes 0.94 611.
17086 indirect both eyes oftalmoskopij 0.85 612.
Oftalmohromoskopij of both eyes 17087 0.29 613.
17088 binocular indirect-1.62 614 oftalmoskopij.
the oftalmoskopij of the Binocular 17089 indirekt was carrying children with duktor use both eyes 4.67 615.
eye blood vessel doplerogrāfij-17095 0.92 616.
17096 Fluorescent angiography with contrast 13.38 617.
Fund of ocul photography 17097 without contrast medium 4.12 618.
17098. Elektroretinogrāfij 619 of 1.60
17100 tear novadceļ contrast investigation and probing 3.20 620.
17101 Tonometrij of both eyes 0.65 621.
Tonogrāfij or elastotonometrij-17102 0.90 622.
Oftalmodinamometrisk investigation 1.03 623 17112.
17113 eye axis length determination by ultrasound biometry, including comparative investigation of the other eye to 1.03 624.
the retrobulbār room Ehobiometrij 17114 and muscle thickness detection 1.38 625.
17120 Sonogrāfisk investigation one eyeball tissue diagnosis with A picture and (B) the image method, including the fotodokumentācij, as well as the other eye comparative investigation of 2.70 626.
17122 but one use the applicator eye for one session 5.40 627.
17123 foreign matter removal from eye conjunctiva bag or mechanical Eyelash hairs removal 0.87 628.
17135 Korneosklerāl or corneal seam removal 7.52 629.
17136 rust ring izfrēzēšan of corneal 10.95 630.
the eye conjunctiva or 17138 eye arrangement clearance 18.22 631.
* orbital arrangement ekstirpācij 17139 of 27.32 632.
* Foreign bodies or 17140 silicone seal removal from the orbital cavity 20.87 633.
17141 tear the bag cut in the case of abscess 21.28 634.
cutting the eyelid abscess 17142 case 22.68 635.
the cross-linking of the Eyelid 21.33 17143 636.
* Dakriocistorinostomij-637 28.93 17151.
17153 tear channel bužēšan and rinsing one side of infants 2.57 638.
17156 tear channel bužēšan and probing babies one side 2.57 639.
17157 * tear and nasal passages with biomaterials operational bužēšan the road on one side of the 640 26.20.
17165 * tear ducts a 25.64 641 suturing rupture.
17166 * tear dots on one side of the operations of the 642 11.88.
17170 * tear bag removal 34.38 643.
17171 * tear gland removal 34.38 644.
17172 * extended or narrow lid opening plastic in, as well as epikant, ektropion, entropion or improper eyelid position correction 30.39 645.
17180 * eyelid sagging (ptos) operation with direct lift eyelid cut short 41.31 646.
17181 * eyelid sagging (ptos) operation with direct lift for eyelid 35.83 647.
17182 * premium manipulation 17180 and use bio 56.70 17181 648.
the Tenon space bioplombēšan 17183 operation at progressive myopia in one eye 32.84 649.
the eye conjunctiva of 17186 saaugum plastic 37.27 of operating with 650.
the Pterīg operation 29.09 17187 651.
17188 * Pterīg operation with the keratoplastik of layered 33.57 652.
17189 wound suturing of the Subjunctive 9.88 653.
17195 * corneal suturing of wounds or sklēr, putting up 5 stitches 40.29 654.
17196 * corneal suturing of wounds or sklēr, putting more than 5 stitches. Hide with 53.64 655 17195 manipulations.
the cornea covering by 17197 subjunctive of 31.60 656.
the discīzij between the Saaugum 17199 eyeball and eyelid 27.04 657.
17205 *

The removal of the foreign bodies in Intraokulār with magnet 45.96 658.
the Intraokulār of the amagnētisk foreign bodies 17206 removal 158.17 659.
* Intraokulār of the foreign body removal 17207-diasklerāl, localized to the inverse of the binocular, and oftalmoskopij sklēr of local piešūšan of the sklēr of the seals in place of the cut 73.14 660.
17215 * eye muscle tenotomij of 33.64 miotomij and 661.
one eye one 17216 muscle surgery to squint in 38.88 662.
17217 repair operation of the Squint, even during a pitched muscle 43.38 663.
17218 * premium manipulation, 17217 per 17216 next muscle in the eye, starting from the second 16.16 664.
17219 * premium, on the other the manipulation 17216 17217 eye operation 10.24 665.
17225 * foreign body in conjunctival axis evacuation path 12.98 666.
* corneal foreign body 17226 evacuation with magnet 13.36 667.
* Keratotomij-668 25.02 17227.
17228 corneal transplantation in the layered 41.46 669.
17229 * corneal transplantation 64.53 total 670.
17230 chemical piededzināšan of the cornea 10.22 671.
17231 * corneal scraping 10.97 672.
17232 Subjunctive and of corneal termoterapij and cryotherapy 8.93 673.
17233 * eye front camera open, Leach and/or restore again with sutures for 38.42 674.
17240 secondary cataract laser discīzij with the help of 3.07 675.
17241 eye the external parts of the lāzerkoagulācij 2.77 676.
17242 * capsulotomy, or secondary cataracts of the 677 38.30 discīzij.
the cataract operation 17243 cataract krioekstrakcij the 678 47.02.
17244 * Luksēt lenses with iridektomij of krioekstrakcij 679 16.97.
17245 * Luksēt lens extraction with the iridektomij of the 46.23 loop and 680.
* Intrakapsulār of ekstirpācij cataract 17250 after antiglaukomatoz operations 47.49 681.
* cataract extraction of Ekstrakapsulār 17251 after antiglaukomatoz operations (only charged if ambulatory or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications take days in hospital) 72.47 682.
17252 Ekstrakapsulār extraction of cataract by * concurrently with the antiglaukomatoz operation (only charged if ambulatory or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 683 64.93.
17253 Ekstrakapsulār cataract extraction of * with intraokulār lens implantation and antiglaukomatoz at the operation (only charged if ambulatory or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 79.86 684.
* cataract extraction with 17254 front vitrektomij and intraokulār lens implantation 239.46 685.
cataract extraction of Ekstrakapsulār 17255 * using irrigation-aspiration (only charged if ambulatory or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications take days in hospital) 686 73.31.
the cataract extraction of Ekstrakapsulār 17256, using irrigation-aspiration of lens value (only charged if ambulatory or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 687 98.52.
cataract extraction of Ekstrakapsulār 17257 * using the 120.28 688 fakoemulsifikācij.
17258 * premium manipulation of single fakoemulsifikācij 17257 kit use 44.45 689.
17259 * bonus on folding lens use 49.14 690.
17270 * Intraokulār lens implantation in 74.29 691 front camera.
17271 * Intraokulār lens implantation in mugurēj Chamber 71.67 692.
17272 * Intraokulār lens removal or relocation 59.38 693.
* Mugurēj sklerotomij-32.32 17273 in 694.
17274 * Ciklodiatermij or ciklokriotermij operation 26.09 695.
17280 * laser iridektomij-3.99 696.
Laser trabekuloplastik of 17281 8.87 697.
the open corner 17285 glaucoma surgery 42.75 698.
17286 * Antiglaukomatoz operation (trabekulotomij, trabekulostomij, trabekulektomij) 46.09 699.
closed corner of 17287 glaucoma surgery with fistulizējoš elements 42.75 700.
the iridektomij of the Basal 35.50 17288 701.
ovaskulār's not glaucoma 17289 operation-modified antiglaukomatoz operation with fistulizējoš elements 46.09 702.
17290 operation at the IRIS, traumatic damage 37.04 ciliārķermeņ 703.
17295 retinal lāzerkoagulācij (one session) 3.70 704.
17296 retinal lāzerkoagulācij (for each subsequent session of the same treatment in the eye) 3.78 705.
17297 retinal lāzerkoagulācij by fluorescent angiography data 7.74 706.
17298 ** supplement for medicine use of Verteporfin (1) 846.74 707.
the Sklēr of the bakling with 17300 implant or the cirklāž-64.66 708 sklēr.
the front part of the eye 17301 reconstruction 81.11 709.
eksenterācij 79.78 of the orbital 17302 710.
the Sklēr of the bakling with 17303 intravitreāl operations 212.62 711.
17304 * Vitreāl surgery (through the plan) 712 191.05.
17305 * premium for silicone entry 120.96 713.
17306 * bonus on perfluordekalīn solution – using ACR DEC intraokulār applications 124.74-714.
17307 * premium manipulation 17304 on disposable vitrectomy kit use 208.94 715.
17308 * premium manipulation 17304 on intravitreāl gas use 30.24 716.
the Skleroplastisk operation 61.95 17310 717.
17320 * eyeball's 24.77 718 eviscerācij.
17321 * eyeball's 24.97 719 enukleācij.
17322 * premium manipulation, 17321, 17325 17320 on temporary prostheses usage in postoperative period 23.63 720.
17323 material preparation of Donor corneal transplantation 30.28 721.
the Rutēn and iodine 17324 applicator to use eye melanoma treatment 282.82 722.
17325 * eyeball enukleācij with 4 muscle suturing and/or iešūšan 66.19 723 of the implant.
* Orbitotomij 83.48 724 of 17326.
17335 * cryotherapy one eye not carrying children in case of 725 12.64 retinopātij.
* at the second 17336 cryotherapy eyes 8.01 726.
the molluscs of ekstirpācij 17340 face and eyelids District 9.71 727.
17360 vision assessment of low vision and blind children-disabled children with difficult to contact or children up to the age of 3 with the ambiguity of vision ability 2.18 728.
17361 Kontrastredz inquiries at various distances 1.72 729.
17362 color vision examination at different Visual abilities children 1.81 730.
Twilight vision assessment 17363 tests, Visual adaptation assessment 1.71 731.
17364

Indicative of the determination of the field of vision in children with restricted vision, disabled children with difficult contact 2.09 732.
17365 sighted and blind children's vision and the perception of the alternative assessment fotodokumentācij and the possible Dynamics 7.83 733 comparison.
17366 parental training kontaktkorekcij 1.81 734 for use in children.
the application of Kontaktkorekcij 17367 children up to 8 years of age 2.76 735.
17368 driving Lesson, children, parents and educators advising after living and training places 16.09 736.
17369 premium on working with low vision, blind children or handicapped children with difficult contact (premium manipulation, which is not an indication of low vision, not redzīb or impeded contacts) 737 2.72.
17370 binocular vision field, identifying and assessing 2.78 738.
an 3.05 17371 Koordimetrij 739.
17372 digital fotodokumentācij assessment of the dynamics of pathology (strabismus, congenital abnormalities) 5.96 740.
17373 Prism adaptation test 3.26 741.
17374 Squint angle determination of qualitative view directions 2.38 742 7.
17375 Squint angle of detection quality 9 view directions 3.18 743.
17380 Visual exercise and sensory Visual function reference use activation and stimulus 5.78 744.
17381 blind, visually impaired child cognitive performance evaluation, psychological pedagogical research 4.27 745.
17382 Haptic develop sensitivity lessons 3.89 746.
17383 orienteering and develop capacity building of low vision and blind children 3.80 747.
17384 parents and educators training for individual to work with visually impaired or blind children 3.94 748.
17390 visually impaired and blind children with speech disorder diagnostic tests 6.02 749.
parents and educators 17391 consulting and training for individual to work with visually impaired or blind children 3.58 750.
17392 language development classes for low vision or blind children 3.56 751.
17393 Mikrologopēdisk sessions for children up to 1 year of age, including the face, articulation, breathing apparatus and a stimulating massage. Point and finger the tiny motor skills and stimulating the palmār reflex massages 2.77 752.
17394 visually impaired and blind children language development period of stimulating pirmsrun 1.99 753.
alternative communication methods 17395 use low vision and blind children with language disabilities 3.56 754.
17400 low-vision and blind, hearing impaired and deaf children in psychological research first (up to 10 tests) 8.95 755.
17401 low-vision and blind, hearing impaired and deaf children in psychological research first (over 10 tests) 756 13.41.
17402 repeated patient position detection and comparison with prior results 757 2.14.
17403 discussions with parents about the adjustment to home work developing psychic process development 4.08 758.
17404 Psihokorekcij lesson psychic process development 3.12 759.
17405 psychological counselling 3.64 760.
17406 support group management 3.12 Otorhinolaryngology (18012-18351 tampering) no PO box
Manipulation of code manipulation name tariff 761.
18012 tamponād from the front of the nose 6.49 762.
Mugurēj in tamponād-9.84 18013 763.
Elektrokoagulācij application of Otorhinolaryngology 18014 3.61 764.
Rinomanometrisk 18020 investigation with flow measurement (nasal, nasal capacity in seconds, the maximum flow) in one visit 8.05 765.
18021 main cavities in the nose and/or nasal throat cavity endoscopic investigations, including investigations of the vocal cords 3.61 766.
18022 * nose shells partial or complete removal of 59.32 767.
18023 Operational polip removal of nose 6.47 768.
18024 * complex core nose or big neoplasia polip removal from the nose 59.32 769.
18030 premium manipulation, 18023 18022, laser coagulation of 4.13 18024 770.
18031 cryotherapy-use ear, nose, throat ailments if it carried out using specialised cavities LAURA tools 2.55 771.
18032 * Abscess opening nose bulkhead 4.60 772.
* Submukoz the resection of 18033 nasal septum (pay only outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 59.32 773.
18034 * Submukoz the resection of nasal septum with a distorted skrimšļaud resection (pay only outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 59.32 774.
* Plastic Surgery 18035 nose bulkhead hole closing 59.32 775.
18036 operational focus of the nasal passages 59.32 776.
* Skrimšļain-hoān 18037 stenosis or closing of prevention 59.32 777.
the nasal bone 18038 operational repozīcij open in the event of 56.56 778.
18040 * nose corrective surgery in the case of birth defects after heiloplastik of 59.32 779.
18041 * nose corrective and Reconstructive operations 59.32 780.
the congenital cysts or 18042 fistula of nasal mugurēj ekscīzij of 59.32 781.
18045 sinus sonogrāfisk investigation 2.66 782.
18046 Haimor cavity puncture, including brainwashing and/or medication infusion 3.65 783.
18047 * sinus endoscopic surgery 47.40 784.
18048 * forehead, sfenoidāl, etmoidāl mutual cavities in probing and rinsing by natural or artificial opening, including medicines (operation) 51.88 785.
* endonazāl-18055 functional sinus surgery technique 82.01 786 Messerklinger.
18056 * partial or complete purge of haimor cavities in the nose side 52.74 787.
18057 * Haimor cavities unilateral radical surgery 56.32 788.
18058 * Retroaurikulār or be a reciprocal haimor cavity fistula closure of operational 56.32 789.
18059 * forehead cavities trepanācij from the outside. You can only perform a stationary 56.32 790.
18060 operational forehead cavities and etmoidāl cells eventually opening from the inside of the nose 56.32 791.
18061 * forehead and sfenoidāl cavity probing and rinse using drain 10.78 792.
the Sphenoid bone surgery or 18062 etmoidāl cell purging through nose 56.32 793.
18063 operational forehead or etmoidāl opening and emptying the cell from the outside 56.32 794.
18064 * orbital reconstructive surgery of the lower wall by injuries without values 82.46 795 bio.
18065 * premium manipulation on biomaterials 75.60 796 18064.
18066 * orbital decompression 82.46 797.
18070

Stab foreign matter removal from the mouth or throat 3.02 798.
* check-out of 18071 Bioptāt throat 5.79 799.
18073 * Tonsilektomij-one or both of the Palatine tonsil resection with shelling and capsule 47.91 800.
18075 * conservative unstoppable bleeding after the treatment of operational tonsilektomij 47.91 801.
18076 Peritonsilār open the abscess 5.18 802.
* Peritonsilār abscess 18077 reopen a 4.38 803.
* Retrotonsilār, retrofaringeāl 18078 abscess opening 5.31 804.
* Adenotomij-18079 increased throat tonsils removal 47.91 805.
18080 * conservative unstoppable bleeding after the treatment of operational adenotomij 47.91 806.
18088 voice link stroboscopic examination 2.87 807.
18089 voice link stroboscopic examination using a videostroboskop 808 9.40.
18091 direct mikrolaringoskopij with microscope and laringoskop 809. support of 9.53
* check out Bioptāt from 18092 larynx during 31.73 mikrolaringoskopij 810.
the Endolaringeāl of the mikrolaringoskopisk of 18093 operation 47.31 811.
18094 * medicine (botulin toxin (botulinum toxin), Silicon or FAT) entering the larynx during mikrolaringoskopij with medicinal value 48.90 812.
Fibrorinofaringolaringoskopij-7.19 18100 813.
a biopsy of the Microsurgical 18101 checkout, using fibroendoskop of larynx 13.85 814.
18102 * bonus on CO2 laser use in ear, throat and nose operations 85.05 815.
18103 Endobronhiāl treatment with a flexible tube, bužēšan-816 4.17 larynx.
18106 or other neoplasia Polip removal of larynx 4.75 817.
18107 or other neoplasia Polip removal of larynx children up to 7 years of age 5.31 818.
18108 larynx abscess opening 3.06 819.
18109 * or other neoplasia Polip Microsurgical removal of larynx 5.62 820.
18110 * closing 49.95 Traheostom 821.
18115 sulphur removal Cork, also a reciprocal 1.90 822.
18118 still removing foreign bodies from the tunnel hears 2.29 823.
18126 operation outer hearing passage-benign skin neoplasia removal 54.79 824.
* one or more 18127 polip removal from hearing the aisles or the drum cavity, multiple procedures (stationary) 54.79 825.
one or more 18128 polip removal from hearing the aisles or the drum cavity (outpatient) 6.45 826.
18129 * stenosis or eksostenoz's operational prevention hearing part of the cartilage of the passage 54.79 827.
18135 eardrums and/or drum cavity with the investigation of 2.52 828 binokulārmikroskopij.
18140 Eardrum incision (paracentēz) of 2.59 829.
18141 * drum drain fitting with prosthesis value 65.19 830.
18142 * Eardrum prostheses or insertion or replacement of permanent tubes insertion or removal of repeating with prosthetic value 65.19 831.
18152 Miringoplastik from the hearing canal side 55.70 832.
18153 * rear wall of the passageway of hearing, plastic reconstruction 70.50 833.
18154 * radical middle ear operation 70.50 834.
18155 * middle ear operation 70.50 holesteatom 835.
* Timpanoplastik-836 70.50 18156.
* Timpanoplastik with interpozīcij 18157 and hearing vertebrae chain, without replacements values 70.50 837.
18158 * premium manipulation for prosthesis 212.63 838 18157.
18159 * bonus on Kohleār (hearing aid) implants use 8845.20 839.
18160 * bonus on Kohleār (hearing) implant external parts using 7093.17 840 CPU.
18161 * bonus on inner ear implant (Kohleār) system with speech processor use 16065.00 841.
18162 * Kohleār implant without implant values 156.47 842.
18163 Bone to insert in the hearing aids (Baha) part of the Insert without the implant implant values 94.47 843.
18164 * premium manipulation of bone to insert in 18163 hearing aids (Baha) 844 4490.96.
the equilibrium rotational 18167 Pilot and/or heat checking at the horizontal and vertical effects with intelligent digital control and stimulation 8.20 845.
18168 Elektronistagmogrāfij spontaneous and/or experimental recording and evaluating nistagm 8.59 846.
* Mastoidantrotomij-70.50 18175 847.
18177 * external ear incision down to open the abscess 4.92 848.
18178 * damaged the external ear of 849 55.70 resection.
18179 external ear plastic, reconstructive surgery 55.70 850.
18180 * Parotid fistula ekscīzij district of innate 55.70 851.
18187 * benign neoplasia of the tongue the 49.78 852 ekscīzij.
18188 incision of salivary gland output or to the District of inflammatory cases 4.66 853.
18196 the submaxillary salivary gland ekstirpācij, and/or liģēšan the 49.78 854 output.
18198 * Abscess and flegmon in the face, the jaw area 4.54 855.
incision of abscess of palate 18199 case 4.66 856.
18205 * benign neoplasia in 857. ekscīzij palate 49.78
* 18206 benign neoplasia ekscīzij in other locations in the oral cavity (excluding palate) 858 49.78.
18207 * reconstructive operations of plastic and oral cavity with local tissue 49.78 859.
18208 * reconstructive operations of plastic and the oral cavity with the flap to the blood vessels in the legs 146.31 860.
the cheek bone osteosintēz 18209 without implant values 59.40 861.
18210 * maxilla fracture operational adjustment 59.40 862.
18211 * facial fracture operational adjustment (except the maxilla), 59.40 863.
18212 * face bone lesion ekscīzij inflammation or benign neoplasia 59.40 864 cases.
* an example of 18213 scar (keloīd) ekscīzij the head, face and neck area 59.40 865.
18214 Faringostom in plastic 49.78 of 866.
18215 * Faringoplastik with skin flap 136.86 of 867.
The Benign tumors of the throat 18220 removal 47.91 868.
the larynx resection 18221, horizontal or lateral 136.86 869.
* Laringektomij 136.86 870 of 18224.
18225 * Laringektomij to thyroid resection or resection of 871 136.86 throat.
* Hordektomij of 136.86 872 18229.
* Traheostom-18230 temporarily or permanently 21.46 873.
* Supplement for larynx 18231 stent 118.13 874.
the Laringostom of plastic 49.78 18240 875.
* Laringofaringostom-18241 plastics 136.86 876.
18242 * neck cyst removal 49.78 877.
* Preskalēn-18243 in biopsy of the lymph nodes of the neck extended out 49.78 878.
* Moura 18244 operation 161.40 879.
18245 * maxilla bone resection of malignant tumor case 180.41 880.
a total of Maksilektomij-18246 maxilla bone malignant tumor removal case 240.32 881.
18247 external resection of malignant tumors in the ear's case 76.05 882.
18248 external ear amputation malignant tumor case 112.78 883.
18249 *

Conservative unstoppable bleeding emergency treatment for carotid artery (a. Carota) system with cancerous tumors of the head-neck area 151.31 884.
18250 radical neck lymph node ekstirpācij of malignant tumour in the case of one side (Crileoperācij) 170.56 885.
18260 * Parotid salivary gland ekstirpācij, saving face nerve (n. facial) nodes in the case of the malignant tumour 153.42 886.
18261 * complicated Parotid salivary gland resection of malignant tumor case 221.62 887.
part of the mandibular resection 18262 malignant tumour 153.25 in case of 888.
* total resection of mandibular 18263 malignant tumour 180.09 in case of 889.
18264 radical neck lymph node ekstirpācij malignant tumors on both sides in the case 245.48 890.
18265 * leather and Malignant soft tissue tumor of 75.86 891 ekscīzij.
18266 * complex fault closure with flap for face, neck area 119.63 892.
18267 * base resection of malignant mouth tumors in case 119.63 893.
18268 * lips malignant tumour resection in applicable 119.63 894.
18269 * complex of malignant tumor resection of lip the case 170.62 895.
* plastic and Reconstructive 18270 operations with local oral tissue malignant tumor case 144.09 896.
Audiometrij-18280 hearing threshold test 3.75 897.
18281. Virssliekšņ tests 3.77 898
18282 language audiometrisk investigation one ear 3.83 899.
18283 language audiometrisk investigation hearing AIDS control free sound field 2.85 900.
Timpanometrij with impedance measuring 18284, unbroken, hearing of the lumbar mobility detection apparatus with a graphical display of the curve of the road (one-way or two-way) 4.65 901.
18285 reflex discovery inner ear muscles with impedance measurement, with at least four test frequencies, with kontralaterāl leads, determining also the disappearance of reflexes while (unilateral or bilateral) 4.55 902.
the fitting of the hearing aids 18286 6.43 903.
18287 hearing aids and raksturlīkņ of adjustment of 6.91 904 nomērīšan.
18340 * emission Otoakustisk 5.48 905.
the Objective of the audiometrij-18341 brain induced potential measuring 37.09 906.
18344 * Kohleār in implant speech processor programming 73.91 907.
18351 individual ear inserts and customize 32.20 Urology (manipulation 19009-19309) 1.   Any endouretrāl for manipulation in addition to the necessary manipulations can produce 04101 "surface anesthesia in the throat, larynx, bronchial area for deeper areas of the nose, the eardrum, the drum cavity or the ureter and bladder".
2. Manipulation of 19281 tariff contains all the required patient laboratory examination.
No PO box
Manipulation of code manipulation name tariff 908.  
* the urethra and 19009 Endoscopic bladder investigations and/or operational intervention of 909 19.50, using elektrokoagulācij.  
19015 kateterizācij without vienreizietojam the bladder catheter values 1.36 910.  
19016 bladder kateterizācij with the value of the disposable catheter 2.30 911.  
19017 permanent catheter insertion, bladder katetrizācij by flushing, drug instilācij and/or sarecējum in the blood of leaching 4.57 912.  
19018 bladder flushing and/or instilācij was placed in the case of a permanent catheter 2.11 913.  
* Meatotomij of 61.30 19019 914.  
Parafimoz not bleeding the 19020 clearance 8.80 915.  
19021 * Cirkumcīzij (only charged outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications take days in hospital) 916 60.67.  
separation of the Prepuce 19022 salipum 2.77 917.  
* plastic 19030 foreskin and/or frenul operation of 918 58.59.  
* Skrotāl in vazotomij of 19031 (sterilization) 919 63.39.  
* 19032 veins (varicose) operation with the testicle bag, Snip (only charged outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 920 63.39.  
19033 * veins (varicose) operation with v. nosiešan the spermatic (abdomen cut) (pay only outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications take days in hospital) 63.39 921.  
19034 * hydro-and/or spermatocēl operation 63.39 922.  
the removal of the testicles 19035, including removal of the testis thymus 63.39 923.  
* the 63.39 of mutual orhektomij 19036 924.  
* Orhopeksij of 63.39 925 19037.  
19038 * groin surgery 63.39 kriptorhism 926.  
the eggs produced at 19039 high or retenc removal 63.39 927.  
* Vazovazostomij 63.39 928-19045.  
19046 * penis Arthroplasty without prosthesis value 929 63.39.  
19047 * prostate removal of operational 63.39 adenom 930.  
* in the transuretrāl Adenom 19048 resection or incision of the bladder neck resection of 96.27 931.  
19049 * premium at manipulation, 19067, 19075, 19085 19048 Cistofix use of the suite 18.90 932.  
* Supplement for 19050 capsules of knife use 24.57 iešķelšan 933.  
Mikcij of the cistometrij with 19052 data processing work station 85.07 934.  
Mikcij 19053-cistometrij and urethra pressure profilometrij with data processing work station 119.58 935.  
19055 * lower urinary tract urodinamisk studies 44.57 936.  
19056 * Transuretrāl microwave therapy (TUM) 80.17 937.  
uretrotomij 50.91 of the optical 19057 938.  
the urethra resection of 19058 58.22 939.  
19059 * Cistoskopij, including uretroskopij and/or biopsy 14.86 940.  
19060 * unilateral or reciprocal ureter probing, including unilateral or bilateral kidney Bowl rinse and/or medication and/or contrast medium injected into kidney bowls 23.27 941.  
19061 * Bioatgriezenisk method to link pāraktīv bladder 81.92 942.  
19062 * Bioatgriezenisk link method to load incontinence 22.48 943.  
* Intravezikāl 19063 stimulation to hypotonic bladder 132.28 944.  
19064 perineal musculature of the electromyography 16.94 945.  
the ureter 19065 permanent splints or fitting replacement 88.26 946.  
19066 Urofloumetrij-urine retention, including registration of measuring 4.75 947.  
* bladder fistula of 19067 percutaneous placement, including flushing, catheter fixation and looped the taxation and the value of the catheter 56.90 948.  
19068 operational bladder fistula on 949 59.54.  
19069 *

Bladder stones in fission and removal using electrodes 35.67 950.  
19070 * bladder blood tamponād cleansing of 23.90 951.  
19075 operational intervention, transuretrāl a large urinary bladder and/or presence of a large tumor removal and removal of stent 96.00 952.  
19076 * stone chipping or foreign matter, the extraction from the ureter or kidney (with loop) 109.01 953.  
the Ureter opens extension 19077 with spins 35.75 954.  
19078 operational one or more stones from ureter or kidney bowls 121.87 955.  
19079 * kidney cysts by percutaneous puncture 86.75 956.  
19080 * kidney fistula operational and/or percutaneous placement 116.24 957.  
* litotripsij of 68.98 in Percutaneous 19081 958.  
19085 bladder fistula with catheter insertion, including flushing, catheter and catheter fixation bandage and value 16.29 959.  
19086 bladder fistula catheter Exchange, including flushing, catheter and catheter fixation bandage and value 4.58 960.  
19088 Urostom service (without changing the catheter) 4.01 961.  
19089 operational kidneys fistula catheter including catheter change of value 56.74 962.  
* Paranefrīt 19095 drain 44.42 963.  
not the frektomij 116.24 964 19097.  
19098 * kidney cysts resection of the percutaneous 70.32 965.  
* Percutaneous kidney pielouretrāl-19099 segment plastics 96.58 966.  
not the fropeksij 116.24 967 19100.  
19101 * kidney bowls-anastamoz 121.87 968 of the ureter.  
* Kidney dekapsulācij, 19102 perinefrāl saaugum 121.87 the separation of 969.  
* Uretrokutaneostomij unilateral 19103, 116.24 970.  
* Ureterocistoanastomoz-121.97 971 19104.  
* cistektomij the 121.97 partial 19105 972.  
* cistektomij with partial 19110 ureterocistoanastomoz a 132.22 973.  
19111 * Cistektomij with the transplantation of the intestine and ureter or urinary reservoir created from intestines 974 237.87.  
the Ureter, bowel 19112 anastamoz (with current value) 121.84 975.  
* Cistektomij with ureterokutoneostomij of 19113 121.84 976.  
* Orhofunikulektomij of 116.24 977 19114.  
the prostatektomij of the 134.57 radical 19115 978.  
19116 * bladder fistula closure of plastic, the operational 59.65 979.  
the ekscīzij of Periuretrāl cysts 19117-53.94 980.  
19118 * Ekstraperitoneāl, pararenāl or paravezikāl, flegmon of the hematoma incision and drainage 116.25 981.  
* Retrosimfizār of the urethra and 19125 bladder neck fixation 116.25 982.  
* Premium at manipulācijām19125 and 19126 19201 on retrosimfizār polypropylene bladder neck locking 283.50 endoprotēz use of 983.  
the proximal urethra 19127 parts plastic surgery 116.25 984.  
the urethra Arthroplasty 19134 at lower urinary tract obstruction in men 50.87 985.  
* Supplement for 19135 urethra at the benign prostate endoprotēz hyperplasia (UroLum or similar) 1213.38 986.  
the distal urethra 19145 (front) part of the plastic surgery 116.25 987.  
* Transvagināl of vezikovagināl fistula of 19146 close 988 116.25.  
* Transabdomināl of vezikovagināl of 19147 fistula closure of 989 116.25.  
19148 * penis ekscīzij of the foreign matter 53.94 990.  
19149 * penis amputation 53.94 991.  
the Hipospādij and epispādij of 19150 plastics 53.94 992.  
the Cavernous body of 19151 puncture, the ekscīzij of 54.37 indurācij 993.  
19155 suturing at the kidney injury 121.97 994.  
suturing the bladder at 19156 injuries with transabdomināl 59.65 995 approach.  
suturing the bladder at 19157 injuries with transvezikāl 59.65 996 approach.  
the prostate and testicles 19158 biopsy with disposable needles value 32.57 997.  
19159 * prostate abscess opening 53.94 998.  
* Emaskulācij-999 53.94 19160.  
* Flexible bottom 19161 urinary tract uroendoskopij-78.52 1000.  
19162 * Flexible upper urinary tract uroendoskopij-173.83 1001.  
19170 * limfadenektomij, unilateral inguinal 53.94 1002.  
Retroperitoneāl-limfadenektomij-116.25 * 19171 1003.  
the Ureter of suturing 19172 1004 116.25.  
19173 * Ureterorenoskopij (with current value) 88.44 1005.  
19174 * Ureterorenoskopij with litoekstrakcij of the loop (the loop value) 188.42 1006.  
* Ureterorenoskopij to contact 19175 litotripsij (with current value) 194.17 1007.  
not the froskopij 1008 53.92 19176.  
19177 operational removal of stones from bladder 59.65 1009.  
* Kidney resection of 19185 1010 121.97.  
* Adrenalektomij of 121.97 1011 19186.  
litotripsij of 135.01 in Extracorporeal 19187 * 1012.  
19195 * diagnostic laparoskopij. Hide together with other operations 147.38 1013.  
Laparoskopisk-adrenalektomij-540.58 * 19196 1014.  
* Laparoskopisk testikulār of the 19197 vein liģēšan a 236.05 1015.  
Laparoskopisk-transperitoneāl-limfadenektomij * 19198-t.sk. testicular tumor cases 306.77 1016.  
19199 Ekstraperitoneāl laparoskopisk of of the iliac ekstirpācij a t.sk. Prostate Tumor cases 165.91 1017.  
Laparoskopisk-ureterolitotomij-224.67 * 19200 1018.  
19201 * Laparoskopisk bladder neck fixation (stress adjustment of inkontinenc) 1019 255.01.  
* frektomij not the Laparoskopisk 19202 431.31 1020.  
with hand asistēt-19203 laparoskopij (at the Uro tract operations) 313.77 1021.  
19204 with hand frektomij the 594.98 not asistēt 1022.  
19249 * bonus on medicines for the treatment of the trem steroīdrezistent 4297.44 1023.  
check out the Donornier of 19250 862.71 1024.  
19251 Donornier 177.11 * preparation of 1025.  
19252 * kidney transplantation 3190.50 1026.  
19254 * premium manipulation of divbalon catheter use 19250 organ perfusion 189.00 to 1027.  
19270 * chronic hemodialīz (not included in the erythropoietin and iron preparation costs) 53.14 1028.  
* Supplement for medicine 19273 Erythropoietin 3000 IU (or equivalent mcg) 17.26 1029.  
19275 * acute hemodialīz (not included in the erythropoietin and iron preparation costs) 78.41 1030.  
or Haemofiltration and hemodiafiltrācij of 19276 * (not included in the erythropoietin and iron preparation costs) 1031 64.25.  
19277 * Hemodialīz after transplantation (not included in the cost of erythropoietin and iron preparations) 63.31 1032.  
19278 * automated peritoneāl in acute dialysis session 45.81 1033.  
* Supplement for peritoneoskop 19279 Y-TEC kit use 94.50 1034.  
* Peritoneāl-19280 dialysis catheter implantation with catheter value 82.85 1035.  
19281 *

Peritoneāl-dialysis patient training, care and control in one patient one time per month (outpatient or inpatient; laboratory examination included in the tariff) 33.95 1036.  
19282 * bonus on intravenous iron preparation input substitution to 8.21 1037 renal.  
* Supplement for medicine 19285 Erythropoetin 2000 IU (or equivalent mcg) 12.29 1038.  
* Supplement for medicine 19286 Erythropoetin 4000 IU (or equivalent mcg) 1039 24.72.  
* Supplement for medicine 19287 Erythropoetin 6000 IU 36.39 1040.  
* Supplement for medicine 19288 Erythropoetin 10 000 IU (or equivalent mcg) 61.81 1041.  
* Supplement for medicine 19289 Erythropoietin 30 000 IU (or equivalent mcg) 185.43 1042.  
* Supplement for medicine 19290 Erythropoietin 40 000 IU 9 (or equivalent mcg) 1043 280.71.  
19300 slow continuous or haemofiltration (SCUF) one day without dialysis catheter values 136.48 1044.  
19302 * continuous venovenoz or haemofiltration (CVVH) in one day without dialysis catheter values 267.23 1045.  
19304 * continuous venovenoz hemodialīz (CVVHD) in one day without dialysis catheter values 267.23 1046.  
19305 * continuous venovenoz hemodiafiltrācij (CVVHDF) in one day without dialysis catheter values 398.02 1047.  
in the continuous venovenoz 19307 high flow dialysis (CVVHFD) for one day without dialysis catheter values 267.23 1048.  
19309 * continuous venovenoz plasma filtration and adsorption (CPF) for one day without dialysis catheter values, orthopaedics, Traumatology 307.00 PURULENT surgery (manipulation of 20010-20417) no PO box
Manipulation of code manipulation name tariff 1049.  
20010 Small wounds the primary finish, toilet. Primary wound-healing pārsiešan (wound length less than 5 cm, a surface less than 10 cm ², capacity less than 3 cm ³) 1050 2.95.  
20013 a wound primary finish, toilet. Primary wound-healing pārsiešan (length greater than 5 cm, a surface greater than 10 cm ², capacity greater than 3 cm ³) 3.63 1051.  
20014 * primary surgical wound decoration, including cutting and sealing 8.95 1052.  
20015 thread or klambur removal of wounds in one or more visits 1.78 1053.  
20019 ligature, foreign body that is visible in the wound, removal (outpatient) 4.07 1054.  
large, not primarily 20028-healing wounds treatment and/or cutting krož (outpatient) 8.82 1055.  
20029 krektomij tissues Not over 150 cm2 surface 15.88 1056.  
20030 medicines, cavity lavage strutojoš wound abscesses and case drain Exchange 3.74 1057.  
Antirabisk 20031 work (first making) 1.70 1058.  
20039 * puncture biopsy surgery 16.07 1059.  
20040 Superficial tissue puncture biopsy (outpatient) 5.39 1060.  
20041 the loose bones, muscles, tendons, lymph node biopsy, malignant skin and soft tissue formation ekscīzij (the Theatre) 30.28 1061.  
20043 * Bursa ekstripācij (Theatre) 38.22 1062.  
20044 superficial incision with/without drainage (furunkul, anthrax, panarīcij, abscess, mastitis, flegmon) 11.72 1063.  
20050 skin transplantation small skin defect for settlement (up to 10 cm2) 4.93 1064.  
Hemangiom of the flamme 20051 Naeva withdrawal with the help of one laser session 3.24 1065.  
20053 Hypertrophic Scar, hemangiom, kapilaropātij, and teleangiektāzij pathologies of pigments of the selective fototermolīz (1 impulse, the area up to 3 cm2) 3.77 1066.  
20056 * Lāzerdestrukcij-benign and malignant skin and subcutaneous formations for 6.93 1067.  
20057 * Kriodestrukcij, elektrokoagulācij-one skin or subcutaneous formations of liquidation. Payment is made not more than three formations one visit 6.52 1068.  
20059 * local benign cutaneous and subcutaneous formations of ekstirpācij, superficial tissues (skin, subcutaneous) biopsy surgery 24.22 1069.  
20060 local benign cutaneous and subcutaneous formations of ekstirpācij, superficial tissues (skin, subcutaneous) biopsy ambulatory 15.00 1070.  
the pulse laser ablation 20065. Autodermoplastik with up to 100 cm2 area 17.90 1071.  
20066 * premium manipulation 20065 100 cm² for every next 20.92 1072.  
20070 hands or feet toe nail resection of the trepanācij or 1073 4.70.  
20071 legs or arms of the toe nail ablation with partial or complete destruction of the nail root 9.41 1074.  
20072, 20071 20070 manipulation of the premium for each nail, starting with the second 0.75 1075.  
20073 bone and tendon sheath, panarīcij open, including drainage, hands open 17.13 1076 flegmon.  
20075 one or more drain into the joints, the bones or soft tissues, using individual approach, including rinsing (operating room) 11.43 1077.  
20085 * finger bone ekscīzij, resection of tumors, injuries or other ailments. Finger ekskohleācij and plastics 63.00 1078.  
the large joints 20087 "Z" plastics to 43.15 1079 contractures.  
20098 * muscle and/or fascia of the weld, including processing of fresh wounds 29.18 1080.  
* Iztaisnotāj-20100 preparation and suturing of tendons. Injury cases, including the processing of fresh wounds 22.07 1081.  
20101 * Binder preparation and suturing of tendons. Injury cases, including the processing of fresh wounds 27.94 1082.  
20108 the Ahill tendons weld 41.84 1083.  
20119 skeletal ekstenzij of 6.45 1084.  
the removal of the foreign bodies in the outpatient setting 20127 Rtg controls 12.31 1085.  
20128 the bone or cartilage material sampling free transplantation or osteonekrektomij the 37.28 1086.  
20130 * pelvic bone osteotomij-1087 143.10.  
20139 * hands, feet or jaw joint operational reponēšan the wrench 30.33 1088.  
20140 mežģījum of the large joints loose the 114.99 repozīcij 1089.  
the clavicle end 20141 or mežģījum of the repozīcij of the knees loose 60.05 of 1090.  
20145 * shoulder joint stabilising operation 134.50 1091.  
20146 * joint ligaments, suturing of the plastic arms and legs, hands, fingers, feet and jaw joints 55.00 1092.  
20147 * deep sleeping foreign body from soft tissue, bones with surgery (also controlled by the Rtg) 1093 35.64.  
20149 * wire fixation several small joints or the base of the thumb across the Palm or foot 18.30 in 1094.  
the hands or feet 20155 finger joint resection (artrodēz) 21.92 1095.  
20159 bone tumor or cavity of the ekskohleācij 64.41 of 1096.  
20161 * Osteotomij for large barrel bones (no locking) 137.43

1097. the supplement for osteosintēz of 20164 screws hand bones use 71.37 1098.  
20165 * bonus on implant-the upper plate with screws use 71.82 1099.  
* Supplement for implant 20166-thigh interlocking Rod use 1100 163.49.  
20167 * bonus on implant-angle plate with screws use 124.74 1101.  
20168 * bonus on implant-the kondiļ tibij T-plate with screws use 132.30 1102.  
20169 * bonus on implant-tibij plate with screws use 55.76 1103.  
20170 * bonus on implant-tibij rod (Universal) 115.29 1104.  
* Supplement for implant 20171-tibij rod (unreamed) 1105 215.46.  
* Supplement for implant 20172-pelvic and osteosintēz of plate with acetabul screws use 166.32 1106.  
20173 the bonus on the implant with screws-dynamic hip screw-plate or dynamic kondiļ screw-plate (DHS or DCs) use 179.55 1107.  
20174 * bonus on implant-clavicle plate with screws use 39.69 1108.  
20175 * bonus on implant-upper arm bone plate with screws use 64.80 1109.  
20176 * bonus on implant-plate with the screw in the end distal humer fixation use 52.92 1110.  
20177 * bonus on implant-tension band (Zuggurtung) use of 7.56 1111.  
20178 * bonus on implant-forearm plate with screws (one bone) 44.42 1112.  
* Supplement for implant 20179-6.5 mm spongioz screw use 6.62 1113.  
20180 * bonus on implant-kortikāl use in screw. 3.78 1114  
20181 * bonus on implant-Ender Rod use 34.02 1115.  
20182 * bonus on implant-Kinčer Rod use 58.59 1116.  
* Supplement for 20183 implant distal end of Radium-plate with screws use 1117 25.52.  
* 20184 bonus on implant-hands or fins and phalanx bone plate and screws use 25.52 1118.  
20185 * bonus on implant ankle lineside plate with screws use 23.63 1119.  
20186 * bonus on implant-medial ankle screw use 5.67 1120.  
20187 the bonus on the implant screw use 28.35 Barouk-1121.  
20188 * bonus on implant-"Tomofix" with screws use 278.59 1122.  
20189 * bonus on implant-7.0 mm kanulēt screw use 35.91 1123.  
20190 * bonus on implant-3.5 mm kanulēt screw use 26.46 1124.  
* Supplement for implant 20191-heel plate with screws use 155.93 1125.  
20192 * bonus on implant-Vail-osteotomij screw use 15.12 1126.  
20193 * bonus on implant-bone of the upper arm blocked Rod use 151.20 1127.  
20194 * bonus on the implant calcium salts (1 unit 25ml) 207.90 1128.  
20195 * bonus on hip joint surface substitution of metal-metal endoprotēz the use of 1795.50 1129.  
20196 * bonus on the proximal femur locking metal-metal 1795.50 endoprotēz use of 1130.  
the small stobrkaul of 20200 remedial osteotomij, "Z" type I metatarsāl the osteotomij bone 112.59 1131.  
* Supplement for compression 20201-distrakcij apparatus (external fixation apparatus) 378.00 1132.  
20202 large barrel bone osteosintēz with rod (without implant value) 130.63 1133.  
20203 * small barrel bone, hand and foot bones, phalanx of osteosintēz (without the value of the implant) 1134 107.52.  
20204 * internal fixation of bone removal from large barrel bones. 1135 65.75  
* latch removal from 20205 small bones, locking bolt removal 49.29 1136.  
20206 * Reparatīv operations at the long barrel of pseidoartroz bones and/or bone transport, extension of the limbs, Hahutov operation (without implant value) 159.28 1137.  
20207 * closed repozīcij with transosāl or transartikulār of the fixation 44.23 1138.  
the great stobrkaul of osteosintēz 20208 with plate (without implants values) 1139 100.39.  
20209 additional wire (rod) for the external fixation of entering machine 18.51 1140.  
20210 external fixation apparatus without taxing the value of 1141 54.85 apparatus.  
20211 * bonus on bone cement single serving (20gr) 1142 17.96.  
20212 external fixation apparatus for removal (surgery) 19.71 1143.  
the great stobrkaul of osteosintēz 20214 with screws (without implants values) 1144 86.85.  
20215 the big barrel bone resection, pelvic bone, a bone tumor resection and plastic (without implant value) 165.37 1145.  
20217 * feet and hands finger joints of 1146 25.39 artrotomij.  
20218 large joints, meniskektomij artrotomij and/or other wrist structure removal (links, and other foreign bodies), joint taxation of rinsing system 39.85 1147.  
20219 * Sinovijektomij path wrist 56.90 1148.  
20220 large joints artrodēz (without locking) 129.15 1149.  
20222 * fingers and toes, hands and feet artroplastik 91.53 of 1150.  
20224 the forearm of one of 85.46 bone osteosintez 1151.  
20225 bone heads the cane osteosintēz (without the value of the implant) 1152 82.65.  
20226 * Olecranon osteosintēz (without implant value) 65.89 1153.  
20227 proximal end of humerus with osteosintēz plate (without implants values) 98.47 1154.  
20228 a proximal to the upper arm bone to the end osteosintēz with wires and/or astringent loop (without implants values) 1155 79.25.  
20229 * OS with clavicle plate blade OS with the plate (without the value of the implant) 1156 68.95.  
20230 * total hip joint arthroplasty with cementējam of the endoprotēz (without dentures) 226.54 1157.  
the hip joint arthroplasty of the 20231 with bezcement a endoprotēz (without dentures) 224.99 1158.  
20232 * knee arthroplasty (without dentures) 1159 269.86.  
* Supplement for bezcement of 20233 hip joint use of endoprotēz 1157.63 1160.  
20234 * bonus on the hip cementējam use of 363.83 1161 endoprotēz.  
20235 * bonus on knee endoprotēz the use of 755.06 1162.  
20236 Femurokapitāl of the hip joint arthroplasty (without dentures) 178.01 1163.  
20237 * bonus on the femurokapitāl hip endoprotēz use of 83.16 1164.  
20239 * shoulder joint arthroplasty (without dentures) 193.48 1165.  
20240 *

Cementējam audit of hip joint implantation of endoprotēz (without dentures) 248.47 1166.  
* Bezcement-20241 hip joint audit of endoprotēz implantation (without dentures) 233.72 1167.  
20242 * joint audit operations of endoprotēz (without dentures) 1168 282.15.  
20243 * bonus on tool kit for hip 77.02 1169 operation audit.  
20244 * bonus on tool kit for the implantation of 127.48 bezcement endoprotēz 1170.  
20245 * the distal upper arm bone of osteosintēz metaepifīz (without implant value) 77.80 1171.  
20246 * forearm distal bone of osteosintēz metaepifīz (without implant value) 68.44 1172.  
20247 * roller bone osteosintēz (without the value of the implant) 1173 81.54.  
20248 * heel bone fracture osteosintēz (without the value of the implant) 1174 62.20.  
20249 * hands and feet finger eksartikulācij or amputation, amputation of trunk handle 17.08 1175.  
20250 premium manipulation 20249, 20149 for each finger, starting from the second 2.65 1176.  
20251 * upper or lower limb amputation, eksartikulācij, amputation of trunk processing, audit (per limb) 82.79 1177.  
20253 large joints of 75.31 1178 eksartikulācij.  
20255 disposable operation dry-hip joint (thigh) Kit 16.54 1179.  
20256 disposable operation dry-set limbs 9.37 1180.  
20257 * Acetabul and/or pelvic bone osteosintēz (without implants) 1181 172.29.  
osteosintēz of the Symphysis 20258 (without implant value) 114.73 1182.  
20259 Femur fracture osteosintēz the transtrohanter with the wires (no implant value) 61.06 1183.  
20260 the Femur neck with kanulēt screws osteosintēz (without implant value) 116.41 1184.  
20261 the thigh bone fracture with dynamic hip osteosintēz screw-plate or dynamic kondiļ screw-plate (DHS or DC) (without implant value) 110.93 1185.  
the thigh bone 20262 trohanter zone osteosintēz with screw (without implants values) 1186 54.59.  
20263 large barrel of diafīz bones osteosintēz with plate (without implant value) 88.52 1187.  
20264 large barrel bone osteosintēz with the block bar (without implant value) 121.53 1188.  
20265 * Osteosintēz with angle plate (without implants values) 1189 90.78.  
the Knees of 20266 osteosintēz (without the value of the implant) 1190 65.29.  
on a large lielkaul of the proximal 20267 final osteosintēz (without the value of the implant) 1191 114.80.  
the Tībij of distal 20268 metaepifīz OS (no implant values) 108.91 1192.  
the little big 20269 bone osteosintēz with plate (without implant value) 91.19 1193.  
20270 * ankle fracture osteosintēz (without implant value) 105.71 1194.  
20271 the tipping osteosintēz Trīspotīš (without the value of the implant) 1195 183.54.  
20272 * bonus on tool kit for 169.11 of bezcement endoprotēz of audit 1196.  
20273 * bonus on tool kit for hip joint implantation of 128.84 cementējam endoprotēz 1197.  
20274 * bonus on tool kit for Arthroplasty of the shoulder 186.64 1198.  
20275 * the bonus of using the navigation system for orthopaedic operations 58.96 1199.  
20276 evaluations of the Hybrid type hip joint arthroplasty 249.35 1200.  
20279 * bonus on the shoulder joints the use of endoprotēz 1367.42 1201.  
20280 * bonus on tool kit for knee arthroplasty 56.70 1202.  
20281 * Arthroscopy (knee, elbow, ankle joint) 137.61 1203.  
20282 * Artroskopisk shoulder joints in subakromiāl decompression or stabilising operations (pay only outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 344.85 1204.  
20283 * bonus on implant-PIN or anchor Suretac artroskopisk operation (x 1) 61.90 1205.  
20284 * Artroskopisk shoulder rotator tendons of the suturing 319.54 1206.  
* Artroskopisk-20285 knee ligament reconstruction of the cross (without the interference screw value) 266.28 1207.  
* Supplement for cruciform 20286 links implantation Kit with sinew or transfik systems use 87.89 1208.  
20287 * bonus on one screw using the interference 35.91 1209.  
20288 * Arthroscopy (shoulder, hip joint) 195.61 1210.  
* Supplement for one 20289 anchor use shoulder operation 26.08 1211.  
20290 Artroskopisk of the knee meniscus suturing 360.17 of 1212.  
20291 * Artroskopisk of knee cartilage defect of 199.12 mozaikplastik 1213.  
* Artroskopisk-20292 knee bone osteosintēz (without implants) 1214 271.55.  
20293 a knee Artroskopisk of sinovijektomij 278.04 of 1215.  
20300 5-10% of the burn wound primary treatment pārsiešan face and hands or feet 42.55 1216.  
20301 11-30% large burn wound treatment and pārsiešan 83.68 of 1217.  
20302 above 30% of the burn wound treatment and pārsiešan of 123.50 1218.  
20303 krotomij and not krektomij at 5-10% burn face, hands or feet, also deep soft tissue necrosis off injuries and trauma consequences 66.46 1219.  
20304 krotomij and not krektomij at 11-30% burns in the surface, also deep soft tissue necrosis off injuries and trauma consequences 101.21 1220.  
20305 krotomij and not krektomij at the burns over 30% of the surface, also burn deep soft tissue necrosis off injuries and trauma consequences 144.01 1221.  
20306 * Autodetermoplastik at 5-10% of the surface of burn 61.91 1222.  
20307 * Autodetermoplastik at 11-30% Burns surface 105.00 1223.  
20308 * Autodetermoplastik at Burns over 30% 149.69 1224.  
20309 * Reconstructive surgery after Burns 80.78 1225.  
20400 * bonus on spiral type and bezcement acetabulār of the spherical part of the Hip Arthroplasty for hybrid 656.31 1226.  
20402 * bonus on spiral type acetabulār of the standard bezcement of the hip joint arthroplasty in 1227 1209.60 the audit.  
20403 * bonus on spherical acetabulār of the standard bezcement of the hip joint arthroplasty for 1131.17 1228 audit.  
20404 * bonus on spiral type acetabulār of bezcement of diafizār fixation of Hip Arthroplasty 1274.81 the audit to 1229.  
20405 *

The bonus of spherical acetabulār of bezcement of diafizār fixation of Hip Arthroplasty 1246.46 the audit to 1230.  
20406 * bonus on spiral type acetabulār of the bezcement of distal locking hip joint arthroplasty for 1393.88 1231 audit.  
20407 the bonus on the spherical part of the acetabulār of distal fixation bezcement hip joint arthroplasty for 1232 1315.44 the audit.  
* 20408 bonus on the hip joint endoprotēz cementējam in cementējam of the hip joint arthroplasty for 1233 429.98 audited.  
20409 the bonus on the spiral type bezcemet acetabulār part of the hybrid hip replacement Arthroplasty of the audit 695.52 1234.  
20410 * bonus on the acetabulār part of the bezcemet spherical hybrid hip replacement Arthroplasty of the audit 617.09 1235.  
20411 * bonus on standard endoprotēz for knee arthroplasty of the audit 740.88 1236.  
20412 * tibiāl-augmentācij premium endoprotēz of the knee joint arthroplasty in 1237 the audit 979.02.  
20413 * bonus on augmentācij of the endoprotēz of the femoral knee arthroplasty for 1612.17 1238 audit.  
20414 * bonus on femoral tibiāl of endoprotēz in the augmentācij and knee arthroplasty 1850.31 1239 for the audit.  
the path audit 20415 Arthroplasty with enhanced stability in prostheses model 2212.25 1240.  
20416 the bonus on the endoprotēz shoulder Arthroplasty 1587.60 the audit to 1241.  
* Supplement for endoprotēz of 20417 shoulder joints Arthroplasty audit for 1644.30 reverse ABDOMINAL surgery and PROKTOLOĢIJ (manipulation 21015-21193) no PO box
Manipulation of code manipulation name tariff 1242.  
the ultrasound of the Mesothelioma 19.15 21015 1243.  
* laparotomij of the Prov 66.29 21017 1244.  
21018 * conventional 66.29 1245 of an appendectomy.  
21019 the prevention of bleeding 71.86 Intraabdomināl 1246.  
21020 * Saaugum realignment. Stand alone operation. Hide together with other operations 71.86 1247.  
21021 * Intraabdomināl biopsy or abscess opening 71.86 1248.  
21022 milk gland resection of sectoral 70.51 1249.  
the Hollow organ perforation 21023 welder 71.86 of 1250.  
21024 * conventional herniorafij (pay, if performed in hospital outpatient or day, in all cases, the 24-hour inpatient only stuck in hernia and in cases where the patient is not possible contraindications to carry the day in the hospital. Children up to 8 years of age pay the 24-hour fixed in all cases) 1251 62.14.  
* Supplement for non absorbent 21025 plastic materials (MeSH) hernia operations (11x 6 cm, 12x10cm) 22.68 1252.  
21026 * hernia Postoperatīv plastics 105.73 1253.  
21027 the liver biopsy 77.69 1254.  
* Supplement for non absorbent 21030 plastic material-(MeSH) hernia operations (15x10 cm 15x15 cm) 32.13 1255.  
21031 the bonus on the plastic material is not absorbent-(MeSH) hernia operations (30 x 30 cm) 125.69 1256.  
* Supplement for partially 21032 absorbent material of lightweight plastic-(MeSH) hernia operations (6 cm 12x10 11x cm) 31.19 1257.  
* Supplement for partially 21033 absorbent material of lightweight plastic-(MeSH) hernia operations (15x10 cm 15x15 cm) 1258 45.84.  
* Supplement for partially 21034 absorbent material of lightweight plastic-(MeSH) hernia operations (30x15 cm) 89.78 1259.  
* Supplement for partially 21035 absorbent material of lightweight plastic-(MeSH) hernia operations (30 x 30 cm) 226.80 1260.  
* Gastroenteroanastomoz, enteroenteroanastomoz-21040 136.30 1261.  
resection of the intestine 21041 1262 140.89.  
21042 * Gastrotomij, gastrostomij, enterotomij, enterostomij, kolostomij, stoma closing 136.30 1263.  
the Distal stomach resection 21043 or ekscīzij the 140.89 1264.  
* Vagotomij of 136.30 1265 21044.  
21045 * conventional holecistektomij with the path audit of bile 143.22 1266.  
* the anastamoz of 143.22 Biliodigestīv 21046 1267.  
21047 radical mastectomy 149.63 1268.  
21048 * Lean operation 138.25 1269.  
* diaphragm operation with 21049 laparatomij approach 138.25 1270.  
the Total of gastrektomij, 21050 proximal gastric resection-1271 140.89.  
21051 * Transduodenāl papill of the duoden of the operation to the major 141.79 1272.  
21060 * pancreatic drenējoš operations; krektomij not the 137.66 1273.  
* adrenal surgery 21061 141.47 1274.  
21062 * rectal resection or ekstirpācij the 146.95 1275.  
a Total of 149.47 * kolektomij 21063 1276.  
with resection of the 21064 ' recto ' Sigma discharge anal channel 149.47 1277.  
the limfadenektomij or the Intraabdomināl 21065 great collector radical limfadenektomij (intraabdomināl, armpits and groin collectors) 1278 152.32.  
21066 repeated or reconstructive operations of abdominal, obstetric fistula surgery 149.48 1279.  
21067 * thyroid and epitēlijķermenīš operations, deep cyst formation and localized surgery neck 148.36 1280.  
21068 * liver resection, pancreatic resection of 159.94 1281.  
21069 * ekstripācij 146.14 Retroperitoneāl formation of 1282.  
21079 * premium manipulation, hepatobiliār 21046 21066 21068 on diseases, surgical treatment with the creation of liver anastamoz biliodigestīv gate area with the intrahepātisk, examine the bulk (not less than 2 segment) liver resection, liver resection for patients with echinococcosis or hepatitis B and C, liver resection with v. cave or a plastic porta 46.55 v. 1283.  
21081 * bonus on operations in various locales orthopaedics one extremity limits (thigh, Shin, foot, upper arm, forearm, hand). If the operation is carried out simultaneously in different parts of the limbs, then displays the appropriate manipulation. If you used 2 or more implants, the implant manipulation are presented. The premium operations in Otorhinolaryngology at the two or more operations on the ear, the nose, the nose and the neck blakusdobumo. Presentation of the bonus of operation, at the same time, hide other operations 46.55 1284.  
21082 repeated operation due to bleeding in the operation area during post-operative 42.77 1285.  
21100 * diagnostic laparoskopij. Hide together with other operations 147.38 1286.  
Laparoskopisk-holecistektomij-162.11 * 21101 1287.  
Laparoskopisk of the 320.40 of an appendectomy 21102 1288.  
21103 *

Of total plastic ekstraperitoneāl hernia (TEC) (pay only outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 1289 183.92.  
21104 Transabdomināl of preperitoneāl hernia of plastics (TAPPU) (pay only outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 257.85 1290.  
21105 a postoperative hernias * Laparoskopisk plastic 558.31 1291.  
Laparoskopisk-adrenalektomij-540.58 * 21106 1292.  
Laparoskopisk-fundoplikācij-470.82 * 21107 1293.  
21108 * Laparoskopisk kardiomiotomij the 419.93 of 1294.  
21110 * Laparoskopisk the right hemikolektomij 833.84 of 1295.  
* Laparoskopisk-21111 left hemikolektomij, Sigma resection resection of the 994.97 front, 1296.  
Laparoskopisk-splenektomij-582.67 * 21112 1297.  
21113 asistēt laparoskopij with hand of the intestinal tract operations 313.77 1298.  
21114 with hand on the right side of the asistēt hemikolektomij of the 745.69 of the intestinal resection, 1299.  
21115 * hand asistēt the left hemikolektomij, Sigma resection resection of the 906.82 front, 1300.  
21130 * Saaugum realignment (laparoskopisk operation). Hide together with other operations 124.49 1301.  
21131 * bonus on pretsaaugum film (1 page) 7.67 1302.  
21132 * bonus on mechanical sewing machine-linear 66.15 1303. a dressmaker  
21133 * bonus on mechanical sewing machine-linear griezējšuvēj (55 mm) 66.15 1304.  
21134 * bonus on mechanical sewing machines-circular of the righteous seamstress 146.48 1305.  
21135 * bonus on mechanical sewing machines-circular curved 193.73 1306 of the seamstress.  
21137 * bonus on the hemostātisk sponge with fibrinogen and Thrombin the 4.8 x 4.8 x 0.5 cm 89.66 1307.  
21138 * bonus on the hemostātisk sponge with fibrinogen and Thrombin to 2.5 x 3 x 0.5 cm 32.13 1308.  
* Supplement for the hemostātisk 21139 sponge with fibrinogen and Thrombin the 4.8 x 9.5 x 0.5 cm 164.98 1309.  
21140 * bonus on every next griezējšuvēj the magazine 54.81 1310.  
21141 * bonus on every next linear seamstress magazine 44.98 1311.  
21142 * bonus on the seamstress of the 34.02 1312 shoved.  
21147 * bonus on mechanical sewing machine-linear griezējšuvēj (75 mm) 92.61 1313.  
21148 * bonus on mechanical sewing machine-linear griezējšuvēj (100 mm) 147.42 1314.  
21175 prolaps of the rectum of 9.90 reponēšan 1315.  
21176 kolostom care Iliostom, 3.69 1316.  
21180 rectum the end part with infrared coagulation (1 session) 7.96 1317.  
21181 rectal tamponād, including rektoskopij. Hide with manipulation 08110 6.79 1318.  
Perianāl, perisakrāl-21184 blockade 7.92 1319.  
21190 operation at proktoloģisk conditions with perineal approach 59.62 1320.  
21192 operation at proktoloģisk conditions with the abdominal approach. Hide together with manipulation and 21065 89.40 21063 21064, 1321.  
21193 * premium at hemoroidektomij, prolaps of perineal and plastiskaj operations with Long dressmaker of the circular set of 33 mm (PPH) 213.71 Vascular Surgery (manipulation 22001-22062) for manipulation of this section is made, if they produce a vascular surgeon, except manipulation 22062. No PO box
Manipulation of code manipulation name tariff 1322.  
22001 * breast reconstructive surgery of aortic 382.16 1323.  
22002 * chest aorta arc branch reconstructive surgery (intratorakāl) 284.72 1324.  
22003 * chest aorta arc branch reconstructive surgery (ekstratorakāl) 1325 196.71.  
22004 * upper limb arterial reconstructive surgery 163.51 1326.  
22005 * abdominal aortic reconstructive operations on okluzējoš diseases 284.39 1327.  
22006 * abdominal aortic visceral branches of the reconstructive operations 297.57 1328.  
22007 * abdominal aorta aneurysm of reconstructive surgery at the 325.54 1329.  
* abdominal aortic 22008 reconstructive surgery at the aneurysm ruptures, detachment 355.69 1330.  
22009 * pelvic artery shunt replacement surgery, reconstructive surgery 205.08 1331.  
22010 the pelvic arteries in reconstructive operations 246.78 endarterektomij 1332.  
22015 the femur artery reconstructive operations 186.28 1333.  
22016 * Lift and lower arterial reconstructive surgery 224.32 1334.  
* Ekstraanatomisk-vascular šuntējoš 22017 operations of the vessels 227.20 brahiocefāl 1335.  
* Ekstraanatomisk-vascular šuntējoš 22018 operations lower limbs 149.62 1336.  
the audit of the vessel with 22019 periarteriāl simpatektomij of 59.34 of 1337.  
22020 * simpatektomij of 97.15 of thoracic 1338.  
the belt part simpatektomij 22021-84.84 1339.  
22022 * veins reconstructive surgery for congenital and disease cases, 263.36 1340.  
22023 operation varicose veins enlarged complication cases 127.16 1341.  
congenital malformation of blood vessels 22024 operations 191.38 1342.  
the trunk 22025 vascular embolisms cases 159.48 1343.  
22030 * premium acute thrombosis cases, manipulation, 22003, 22002 22004, 22007, 22009, 22010, 22006, 22015, 22016, 22017 and 1344 18.31 22018.  
22031 the acute aortic bypass operations, the hollow vein damage cases 247.79 1345.  
22032 * acute vascular reconstructive surgery one vessel in the event of failure 167.62 1346.  
22033 * bonus on every other blood vessel reconstructive surgery of vascular lesions of multiple cases, 83.02 1347.  
22034 * Arteriovenoz fistula creation 128.11 1348.  
22035 * Arteriovenoz shunt created 76.92 1349.  
* Supplement for 22040 vein graft extraction 59.36 1350.  
* Supplement for endarterektomij of 22041 anastamoz area 57.71 1351.  
* Supplement for additional 22042 vascular reconstructive surgery surgery area 58.04 1352.  
22043 * bonus on simpatektomij vascular reconstructive surgery during 41.83 1353.  
22044 * bonus on a. use a shunt Carota 94.79 1354.  
22045 * bonus on artificial circulatory connecting 359.10 1355.  
22046 * bonus on synthetic vascular prostheses use 232.47 1356.  
22047 * bonus on vascular stent use in metallic 519.75 1357.  
* the subfasciāl of Endoscopic 22062 perforant veins of 197.96 klipēšan

Plastic (RECONSTRUCTIVE and hand) surgery using optical magnification (23002-23121 tampering) no PO box
Manipulation of code manipulation name tariff 1358.  
23002 * peripheral nerve, primary or secondary seam 131.94 1359.  
23003 * peripheral nerve autoplastik. Operation the 200.75 1360.  
23004 * peripheral nerve autoplastik. Transplant the 72.68 1361.  
23005 two peripheral nervous autoplastik interfascikulār the nerve, or plastic. Operation the 228.09 1362.  
23006 two peripheral nervous autoplastik. Transplant the 89.59 1363.  
replantācij the 233.52 the ear 23007 1364.  
replantācij 398.64 of the scalp 23008 1365.  
23009-irolīz not microsurgical technique 106.91 in 1366.  
irinom of the ekscīzij not 23010 150.25 1367.  
* irolīz is not Intraneirāl 23015 153.05 1368.  
23016 * vein graft extraction technique of Microsurgical 61.50 1369.  
23017 * large soft tissue defect with Microsurgical vaskularizēt plastic skin, subcutaneous an autologous graft. Operation the 270.40 1370.  
23018 * large soft tissue defect with Microsurgical vaskularizēt plastic skin, subcutaneous graft (TDL, skapulār, ingvināl, deltoid muscle, with tram, serratus anterior). Sampling and skin graft closure defects (AD) 150.33 1371.  
23019 * medium to large soft tissue defect with Microsurgical plastic skin, subcutaneous an autologous graft. Operation the 134.79 1372.  
23020 * medium soft tissue defect with Microsurgical plastic skin, subcutaneous an autologous graft (radial, ulnār, arm, arm medial lateral, mugurēj in the starpkaul artery, the deltoid, the dorsal fasciokutān ped). Sampling, skin graft the defect closure 129.35 1373.  
23021 * small soft tissue defect with Microsurgical plastic skin, subcutaneous an autologous graft. Operation the 128.22 1374.  
23022 * small soft tissue defect with Microsurgical plastic skin, subcutaneous an autologous graft (digital artery flap, Thenar flap, the venous flap to 3 cm2). Sampling, skin graft the defect closure 92.53 1375.  
23023 * barrel bone defects or pseidartroz plastic vaskularizēt of Microsurgical with an autologous graft of bone (bone, gut fibul fragments). Operation the 392.41 1376.  
23024 the barrel bone defects or pseidartroz plastic vaskularizēt of Microsurgical with an autologous graft of bone (bone, gut fibul fragments). Graft taking fault closure 1377 221.22.  
23025 * hands, I or another finger using Microsurgical reconstruction of the foot finger II, II-III finger pad or Morrison. Operation 347.82 of 1378.  
23030 * hands, I or another finger using Microsurgical reconstruction of the foot finger II, II-III finger pad or Morrison. Graft taking fault closure (ADP) 1379 171.97.  
23031 * muscle failure replace with free Microsurgical muscle graft. Operation 208.11 of 1380.  
23032 * muscle failure replace with free Microsurgical muscle graft. Graft taking fault closure 148.57 1381.  
* for a full brachial Plex 23033 damage secondary Microsurgical plastics with an autologous graft of sural nerves. Operation the 393.85 1382.  
shall 23034 "tenderloin" flap autotransplantācij of acute trauma case. Operation the 371.22 1383.  
23035 "tenderloin" flap autotransplantācij of acute trauma case. Amputāt processing, structure ID 1384 73.87.  
23036 * radial, temporal, TDL flap rotation (medium, large) 202.60 1385.  
23037 * local, local or rotate the flap (flap-pārkrustot, V-Y flap, small) 1386 108.17.  
the Limfovenoz of anastomoz at 23038 primary or secondary lymph reflux condition (not less than 6) 1387 323.99.  
the Microsurgical treatment of Impotence 23039 (Dick revaskularizācij) 272.31 1388.  
the Sēklvad of the caurejamīb recovery 23040-vazostomij, vazoepididimo 225.12 in 1389.  
23045 * mechanical tightness tubal reconstruction Microsurgical technique-the 86.71 salpingoneostomij salpingolīz and 1390.  
23046 Salpingostomij of Microsurgical technique in the 99.86 1391.  
23047 * breast reconstruction following mastectomy, tissue, use espander without values 123.16 1392 espander.  
23048 * breast reconstruction following mastectomy, using free miokutān flap (TDL, tram) 231.72 1393.  
23049 * breast reconstruction following mastectomy, using a rotated miokutān flap (TDL, tram) 238.82 1394.  
23050 * reduction mamoplastik (medical indications) 1395 162.94.  
23051 * breast pea 77.29 1396 create.  
23052 * Distortionary scars correction. Operation the 97.46 1397.  
* closing the defect with 23053 full thickness skin graft or plānināt to 10 cm2 97.57 1398.  
23054 * fault with full thickness skin graft or plānināt up to 100 cm2 123.16 1399.  
23055 * premium for each subsequent 100 cm2 19.55 1400.  
23056 * breast reconstruction following mastectomy, flap closure, sampling and fault 238.27 1401.  
23060 the small bone graft (distal end of radium, tibij, not vaskularizēt) 80.28 1402.  
* large bone graft 23061 (bowel bone, the thigh bone, not vaskularizēt) 128.06 1403.  
23062 the big flap operation stand separation 70.12 1404.  
23063 * small and medium flap stand isolation operation 54.83 1405.  
23064 the root operation 91.16 1406.  
23065 * finger scars Z, V-Y plastics 75.01 1407.  
the large joints 23066 scar correction with Z, V-Y plastic help to contractures 106.19 1408.  
23067 * premium manipulation of tissues, 23047 23066 use espander 213.57 1409.  
23068 * tendons vaginal stenosis surgery with a sample cut 78.93 1410.  
23069 * Tendovagināl radical operation (tendosinovialektomij) with the bone and tendon resection 135.47 1411.  
23070 * deep existing tumor ekstripācij Palm and forearm with nerves and blood vessels release 178.80 1412 amalgamated.  
23075 * Sindaktilij 125.25 1413 of reconstructive surgery.  
* Dubultveidojum-23076, izoperēšan coming out of the finger joints, including the side links for reconstruction, including service manipulation 23,075,116.60 1414.  
23077 * legs feet and hands the wrong bone, tendons and ligaments formations operation (congenital deformities) 1415 175.86.  
23078 *

Iztaisnotāj preparation and suturing of tendons, including processing of fresh wounds 69.16 1416.  
the Tightening of the tendon 23079 preparation and suturing, including processing of fresh wounds 76.27 1417.  
23080 * Tightening, shortening, extension or plastic cutting tendons, fascia or muscle (reconstruction) 62.06 1418.  
23081 * tenolīz, a miolīz tendon 71.00 1419.  
23082 * premium manipulation for each subsequent 23081 tendon or muscle, from the second 4.29 1420.  
23083 the transposition of 80.78 tendon 1421.  
23084 free tendon graft sampling 48.90 1422.  
23085 * premium manipulation, 23079, 23080, 23083 23078, for each subsequent 23084 tendons, beginning with the second tendon 10.32 1423.  
23090 a Contracture surgery Dipitrēn (pay only outpatient or day hospital) 87.84 1424.  
* Dipitrēn's Contracture 23091 operation with the release of the amalgamated 109.47 irovaskulār 1425.  
23092 * Karpāltuneļ or tarzāltuneļ syndrome operation with neural decompression (also another tunnel syndrome surgeries) 59.85 1426.  
23093 * primary link seam and/or joints bags of suturing hands and feet fingers, hands and feet and jaw joints 60.12 1427.  
23094 * wire fixation of small bone in his hand or foot in the open in the event of failure 89.66 1428.  
23095 * premium manipulation for each subsequent 23094 finger, from the second 12.87 1429.  
23096 hand or toe joint resection (artrodēz) 1430 142.84.  
23097 * finger prostheses or artificial joints, pot 147.72 1431 in operational.  
23098 * Osteotomij and/or resection of the small wrist bones 152.15 1432.  
23099 * Artrotomij (capsulotomy) feet or hands finger joints 47.25 1433.  
23100 * premium manipulation of tendons, 23084 23105 passive use of 56.70 1434 endoprotēz.  
* Supplement for 23101 Swanson type prostheses (fingers) 1435 80.33.  
23102 cementējam-the premium for replacements (fingers) 1436 207.90.  
23105 * Divetap sinew plastic I phase (operation) 1437 96.42.  
23106 * hands and feet finger amputation eksartikulācij or stem processing 43.02 1438.  
23106 23107 * bonus for every manipulation, 23094 finger, starting with the second finger 8.96 1439.  
23108 * tendon fixation 94.96 1440 transosāl.  
the annular ligaments of 23109 plastics 1 finger 97.34 1441.  
23110 * finger joints of 88.38 tenodēz 1442.  
* finger Z, V 23111-Y fresh plastic trauma case 44.53 1443.  
23112 * vessel Microsurgical technique in seam 126.13 1444.  
23113 * Premium for each subsequent vascular (starting with the second) in the 1445. Microsurgical technique 53.81  
23115 * bonus on VAC dressing application (Basic). Hide along with the other manipulation 35.51 1446.  
23116 * bonus on VAC dressing application (optional). Hide along with the other manipulation 9.63 1447.  
23120 * premium for micro tools use one set of operation 30.35 1448.  
23121 * bonus on heating system of the patient and the blanket application of one operation 11.02 neurological surgery (manipulation 24004-24129) no PO box
Manipulation of code manipulation name tariff 1449.  
24004 * Laminektomij in the event of injury (no hard brain membrane opening) 97.61 1450.  
24005 * Laminektomij in the event of injury (with hard brain membrane opening) 1451 107.91.  
the ekstradurāl of the Laminektomij 24006 spinal tumor or epidurīt of the evacuation 118.33 1452.  
the intradurāl of the Laminektomij 24007 spinal tumor or epidurīt of the evacuation 129.46 1453.  
Laminektomij of the intramedulār of 24008 spinal tumor 152.95 1454 of the evacuation.  
* Spinal tumor 24015 reoperācij (no laminektomij) 1455 107.71.  
24016 * Trefinācij (single hole) 19.85 1456.  
24017 * Trefinācij the stereotaktisk operations 20.80 1457.  
the trepanācij of the Osteoplastisk 55.56 24018 1458.  
Osteoklastisk-trepanācij-49.78 * 24019 1459.  
24020 * skull of 101.61 mugurēj pit trepanācij 1460.  
Bifrontāl-trepanācij-63.94 * 24021 1461.  
* chronic subdurāl hematoma of 24022-evacuation 12.79 1462.  
the acute subdurāl of 24023 hematoma evacuation 16.90 1463.  
24024 Epidurāl evacuation of hematoma of 12.79 1464.  
24025 * focus of Concussion and intracerebral hematoma evacuation 20.43 1465.  
spontaneous intracerebral hematoma 24026 * of the evacuation with the cerebrotomij 20.43 1466.  
24035 * internal carotid artery aneurysm of the suprafenoidāl part of the klipācij 49.41 of 1467.  
24036 * Bazilār arteries aneurysm klipācij-1468 68.77.  
24037 other cerebral artery aneurysm klipācij (manipulation, 24035 24036, 24037) (without clip) 60.46 1469.  
* Premium 24038 manipulation, 24036, 24035 24037 per clip 89.78 1470.  
* Premium 24039 manipulation, 24035 24036, 24037 per amagnētisk clip 189.00 1471.  
24040 * premium manipulation, 24008 24005, 24018, 24019, 24020, 24021, 24050, 24052, 24053, 24095, 27020 on synthetic 24094, brain skin substitute 1472 98.28.  
* Supplement for the unilateral 24041 in elektroneirostimulator (EN) use 9255.33 1473.  
* Supplement for bilateral 24042 elektroneirostimulator (EES) 14019.60 1474.  
the unilateral action of the EN 24043 test and programming 6.48 1475.  
Bilateral activities EN 24044 and programming 9.31 1476.  
* Infiltratīv the supratentoriāl part, 24050 evacuation 40.85 1477.  
* Infiltratīv the subtentoriāl part, 24051 evacuation 1478 68.41.  
* designated part supratentoriāl 24052 evacuation 46.42 1479.  
* designated part subtentoriāl 24053 evacuation 68.45 1480.  
the pituitary adenom 24054 transkraniāl evacuation of 68.45 1481.  
* Supplement for ironavigācij not 24055 application (also otorinolaringolog in the ear and sinus operations) 1482 122.85.  
* Supplement for 24056 operation use 1483 34.97 microscope.  
* Premium 24057 manipulation, 24017 24016, 24018, 24020, 24021 on the head fixation one in 1484 28.35 klemm.  
the skull and the brain 24060 injuries wounds finish 18.96 1485.  
the skull brain abscess 24061 evacuation (no trepanācij value) 19.49 1486.  
24062 operation parasitic brain diseases (no trepanācij value) 19.49 1487.  
24063 Intrakraniāl arteriovenoz of the ekstirpācij of the malformations 68.50 1488.  
24064 * brain nerve decompression of cranial mugurēj pit 20.11

1489. the brain operation 24065 at in temporal epileptic (manipulation 24022-24064) (no trepanācij value) 25.96 1490.  
* Ventrikulostomij-1491 15.65 24070.  
24071 * Ventrikuloatriostomij (without the equipment value šuntējoš) 21.19 1492.  
24072 * Ventrikuloperitoneostomij (without the equipment value šuntējoš) 1493 28.61.  
the Ventricle 24080 shunt revision 26.77 1494.  
* Premium 24082 manipulation, 24070 24071, 24080 on šuntējoš equipment 24072, one valve for shunt 335.48 1495.  
* Premium 24083 manipulation, 24070 24071, 24080 on šuntējoš equipment 24072, two valve for shunt 587.79 1496.  
* 24084 premium manipulation on pressure intrakraniāl 24016 sensor catheter 330.75 1497.  
* Supplement for the antibiotics 24085-impregnated ventricular peritoneal shunt catheter and Kit 1498 240.98.  
* Supplement for 24086 programmable shunt for Hydrocephalus using 938.28 1499.  
* Supplement for fixed 24087 pressure hydrocephalus shunt of (90 0 angle 90 0 angle or with a antisifon) 631.55 1500.  
* Supplement for the antibiotics 24088-impregnated ventricular peritoneal shunt or catheter use 141.75 1501.  
* Supplement for the antibiotics 24089-impregnated external drainage catheter use 170.10.1502  
24090 * brain stereotaksisk operations (no trefinācij value) 25.10 1503.  
24091 * bonus on stereotaksisk systems use operations (expendable materials) 20.79 1504.  
24092 * cerebrospinal stereotaksisk operations 25.10 1505.  
* Ekstraintrakraniāl of anastamoz of 24093 design 88.60 1506.  
the skull defect 24094 plastic (no plastic material cost) 64.57 1507.  
the base of the Skull bone 24095 fault plastic (no plastic material cost) 78.78 1508.  
24096 operation congenital CNS diseases 112.89 1509.  
the fun of epidurīt 24097 the disinfecting 52.14 1510.  
24098 * spinal cord and/or nerve roots audit with plastic 28.85 1511.  
24099 * peripheral nerve of Microsurgical suturing technique 33.26 in 1512.  
24105 * cerebral vascular ekstrakraniāl parts deformation correction 23.32 1513.  
24106 bifurcation of the carotid arteries of 1514 51.26 endarterektomij.  
24107 Ekstrakraniāl formations operations 8.91 1515.  
24108 Subokcipitāl the puncture 2.84 1516.  
* Endovazāl of the neurosurgical 24109 operation (translumināl the angioplasty, occlusion, dilation, selective intraarteriāl of Pharmacotherapy without special catheterization Kit) 89.13 1517.  
24110 * premium manipulation for catheterization Kit 24109 use 945.00 1518.  
pituitary adenom 24111 * transfenoidāl of ekstirpācij of 131.11 of 1519.  
* Premium at 24112 manipulation 24016, 24017, 24018, 24019, 24020, 24095 kranioplastik Kit 24094, about the use of 95.45 1520.  
the ventrikulostomij is not iroendoskopisk 24120 likvor 53.38 1521 to restore circulation.  
24121 Intraventrikulār * formation of ekstirpācij with iroendoskop 1522 58.59.  
24122 of various genesis of intracerebral hemorrhage by endoscopic stereotaktisk evacuation of 51.11 1523.  
24123 iroendoskopisk of mesothelioma not nerve roots decompression 49.59 1524.  
not iroendoskopisk 24124 brain biopsy 51.11 1525.  
* Premium 24125 manipulation, 24070, 24072 24080 šuntējoš 24071, use the apparatus for a child up to 1 year old 330.75 1526.  
* Supplement for kavitron-24126 ultrasonic aspirator (CUS) (also in abdominal surgery in urology) 1527 210.74.  
24127 of nerve and muscle biopsy at the neuromuscular dystrophy-14.90 1528.  
24128 * Vertebroplastij to one vertebroplastij Kit 400.63 1529.  
* Supplement for additional 24129 needle use cement or entering the second vertebrae in detoxification and IMUNOKOREKCIJ bipedikulār 75.60 operations (manipulations 25001-25023) no PO box
Manipulation of code manipulation name tariff 1530.  
25001 Intrakorporāl laser irradiation of blood (AL) (impressions) 4.44 1531.  
25002 Extracorporeal blood processing in magnetic (AM) (session 1) 6.25 1532.  
ultraviolet irradiation of blood 25004 (AUV) (session 1) 5.97 1533.  
25005 * Hemosorbcij (HS) (1operācij) 51.95 1534.  
25008 * Plazmaferēz (PA) with the centrifuge manual mode (one operation) 31.98 1535.  
25009 * Citaferēz with the centrifuge manual 29.88 1536.  
* detoxifying and imūnmodulēšan of 25010 complex (AUV, AL, AM) 9.63 1537.  
25014 * Plazmosorbcij (PS) 92.99 1538.  
* antibacterial therapy with 25016 treated erythrocytes (ATA) 20.24 1539.  
25018 sorption of colon dialysis (RZSD) 19.67 1540.  
* Plazmaferēz of 96.73 1541 25020.  
25021 * Hemoperfūzij with carbon absorbent 183.80 1542.  
25022 * healing plazmaferēz with auto blood separator (2 hours) 1543 127.55.  
25023 * Plazmosorbcij with carbon sorbent and automatic blood separator 127.49 blood stem cell transplant (manipulation 26001-26013) no PO box
Manipulation of code manipulation name tariff 1544.  
26001 * peripheral blood stem cell collection unit 1 of Apheresis procedure the patient (for one day) 168.71 1545.  
26002 * peripheral blood stem cell in treatment of special unit 1 before freezing procedures 301.79 1546.  
26003 * stem cell freezing in freezing mode programmed to 180 C 61.08 1547.  
* stem cell 26004 unfreeze 6.31 1548.  
26005 * stem cell 1 unit storage in liquid nitrogen-180 C for one month (assuming average annual store the 54 units) 19.05 1549.  
the potential donor 26010 investigation to assess their compliance with the criteria of the donor. Hide with manipulation 26012; 26013; 60,055,244.97 1550.  
* patient investigation, 26011 to determine compliance with the criteria for transplantation of the recipient allogēn. Hide with manipulation 26012; 26013; 60055 1 105.92 1551.  
26012 of patient treatment and care special with insulation and a protective mode ensure chambers after allogeneic stem cell transplantation to 100 days for one day. The service's "stem cell transplant ' patients 100.47 1552.  
26013 *

Patient treatment and care special with insulation and a protective mode ensure chambers after allogeneic stem cell transplantation from 101 days till full. 2 years after transplantation for one day. The service's "stem cell transplant ' patients 21.23 paediatric surgery (27001-27066 tampering) no PO box
Manipulation of code manipulation name tariff 1553.  
dezinvaginācij-9.11 27001 conservative 1554.  
27002, miogēn natural * Miotomij crooked neck case 60.43 1555.  
27003 * soft tissue and bone sastrutojum operations 79.53 age in 1556.  
the feet or hands 27004 finger reconstructive surgery for children congenital or acquired defects of distortion, and contracture cases 78.52 1557.  
27005 * Ramšted Šēd Piloromiotomij by the 78.12-1558.  
* Klitoroplastik of 97.88 1559 27006.  
omfolocēl of the small plastic 27007 without alloplastik of 93.42 1560.  
27008 * belly front wall plastic newborn period with alloplastik (allotransplantāt values) 114.43 1561.  
27009 * chest front wall plastic 192.07 1562.  
* diaphragm hernias 27010 plastic newborn 137.92 1563.  
27011 * chest front wall plastic-Pect-Bar modifications with the feeding value of the implant Pect 1286.99 1564.  
27015 * esophageal and gastric intestinal tract congenital caurejamīb of newborn surgery not 147.72 1565.  
27016 * Artēzij operations in newborns 134.23 1566.  
27017 * Gill circle of operational treatment of derivatives 144.57 1567.  
27018 * plastic vaginas atrēzij 158.26 in the case of 1568.  
* Proktoplastik-anorektāl abnormalities 27019 case 171.31 1569.  
27020 * congenital CNS pathologies operation children aged 170.23 1570.  
the rare congenital anomalies 27021 correction newborn 254.71 1571.  
27022 * reconstructive foot surgery and congenital defects and acquired deformations of the cases with the tendons, muscles, joints the capsule tissue of redistribution and/or implementing 167.87 1572.  
27023 * Reconstructive Surgery hip, knee, wrist or elbow joints in the area, including the tendon and muscle pāršķelšan, extension or transposition, capsulotomy, or free with osteotomij and osteosintēz, preventing child cerebral stroke effects 173.10 1573.  
27024 * Reconstructive operation of the long barrel of the child bone phony joints, tumors, shortening, deformity including osteosintēz, osteotomij and t.sk. with external fixation method with or without bone graft (without external fixation apparatus) 1574 177.74.  
27025 * hip joint reconstructive surgery for children congenital and acquired defects and deformities (congenital dysplasia and wrench, the upper head aseptic necrosis, juvenīl epifiziolīz, distrofisk of the coxa may), including the osteotomij and osteosintēz of 172.22 1575 and/or.  
27030 Parenhimatozo organs of tillage operations in children traumatic damage 239.60 1576.  
27031 * bonus on absorbent synthetic net (Vycril) (24 cm x 30 cm), use 93.56 1577.  
27032 operation Hiršpung in the event of sickness with circular mechanical bowel seamstress, including seamstress value 299.54 1578.  
27034 * big omfalocēl gastrošīz of plastic or without graft values 135.15 1579.  
27035 * premium 27034 on allotransplantāt manipulation of 3.78 1580.  
bone cyst of the Solitaire 27037 treatment method of brainwashing children with 39.19 1581.  
* congenital sakrokokcigeāl of 27038 teratogenic ekstripācij neoplasia of the tail vertebrae bone resection 152.21 1582.  
27039 * deep venous or lymphatic malformations of the ekstripācij or surgical correction 128.62 1583.  
27040 * Ureterocistoneostomij with the lower third of the ureter modelling 249.75 1584.  
27041 * bladder neck bladder ekstrofij in plastic at the Microsurgical technique in 1585 in 276.10.  
27042 * Hipospādij and/or epispādij in the plastic arts for children in 260.86 1586. Microsurgical technique  
* Premium manipulation 27043 27042 fibrin glue for firm (1 ml) 108.68 1587.  
27050 * bonus on 10 mm a scalpel in the harmonious use of the warp. Pay only laparoskopisk operations 217.35 in 1588.  
* Supplement for harmonious 27051 scalpel 5 mm margin. Pay only laparoskopisk operations 236.25 1589.  
* Supplement for 5 27052 mm blade or hook. Pay only laparoskopisk operations 89.78 1590.  
* Supplement for 27053 sterile, open četrkanāl silicone drain use 17.96 1591.  
27054 * bonus on the use of the vakuumatsūkšan reservoir 8.51 1592.  
27055 * premium silicone, sterile double reservoirs pressed drain with flood valve system and Y connector use 24.57 1593.  
* Supplement for polyurethane 27065 endoscopic bag use 51.98 1594.  
* Supplement for local 27066 leather 2-oktilcianoakrilāt of the adhesīv with the use of the micro-organism barrier 12.92 surgery of facial congenital anomalies and HEAVY FLAKE (manipulation 28001-28042) manipulation of this section are paid for only if they are presented in the VSI "Paul stradins clinical University Hospital" no PO box
Manipulation of code manipulation name tariff 1595.  
28001 * tongue string release with Z plastic or free skin transplantation in children 81.06 1596.  
* nasal plastic-28003 osteotomij 1597 the 93.10.  
* plastic-28004 nose osteotomij with correction of nasal septum 96.88 1598.  
the partial 28005 upper lip Flake's case 82.39 1599.  
28006 operation through unilateral lip Flake's case 110.01 1600.  
28007 operation through mutual lips Flake in the case 144.83 1601.  
28008 * soft palate closure of Flake (phase 1) 116.68 1602.  
28009 * hard palate closure of Flake (phase 2) 111.94 1603.  
the palate of the Flake 28010 Through closure of one stage 119.37 1604.  
* palate operation Flake 28015-velofaringoplastik 111.09 of 1605.  
28016 * palate surgery-Flake faringoplastik at the velofaringouvuāl lack 111.09 1606.  
28017 * palate of operation vestibuloplastik flake or residual defect closure 100.66 1607.  
28018 * Vestibuloplastik with free skin graft with residual defect closure 102.62 1608.  
28019 * Vestibuloplastik with free skin transplantation without defect limits the closing of 1609 99.76.  
28020 maxilla defects of the osteoplastik 121.46

1610. the adjustment for 28021 congenital lip flake, with local tissue 98.35 1611.  
28022 correction after congenital lip flake, with flap from remote areas 127.23 1612.  
28023 correction after congenital flake, nose without entering the cartilage 111.43 1613.  
28024 correction after congenital flake, nose with cartilage entering 117.02 1614.  
28025 hereditary correction after the mouth and nose, flake, without entering the cartilage 129.14 1615.  
28026 correction after congenital lip flake, and nose with cartilage entering 142.06 1616.  
28030 * palate closure defect diameter up to 0.5 cm 89.85 1617.  
* palate closure defect 28031 diameter up to 1 cm 89.85 1618.  
the palate defects 28032 closure diameter larger than 1 cm 117.93 1619.  
28033 * Faringoplastik by Flake's 131.62 1620 palate.  
28034 * fault with Palate flap of foot-1621 131.62.  
the palate closure defect 28035 after bilateral palate closure of Flake 145.30 1622.  
osteotomij by the maxilla 28036 Le-Fort type 1 127.79 1623.  
the mandibular osteotomij 28037 with i/o access to the mandibular branch district 144.90 1624.  
the mandibular osteotomij by 28038 i/o access to the mandibular body in Division 127.79 1625.  
28039 * osteotomij with the lower jaw i/o access to mental 115.61 in the District of 1626.  
the mandibular osteotomij 28040 with e/o approach to mandibular branch district 141.92 1627.  
the mandibular osteotomij 28041 with e/o approach the lower jaw housing district 116.31 1628.  
the mandibular osteotomij by 28042 e/o approach to mental 110.03 in the district face injuries and DISEASES of the musculoskeletal treatment facial-Jaw surgery (manipulation-29001-29260) no PO box
Manipulation of code manipulation name tariff 1629.  
29001 superficial cutaneous and subcutaneous soft tissue damage to the primary veneer in length and 3 cm outpatient 7.42 1630.  
29002 superficial cutaneous and subcutaneous soft tissue damage to the primary finish over 3 cm long ambulatory 8.43 1631.  
29003 deep skin and subcutaneous soft tissue damage to the primary veneer in length and 3 cm outpatient 8.95 1632.  
29004 deep skin and subcutaneous soft tissue damage to the primary finish over 3 cm long ambulatory 10.48 1633.  
29005 * soft tissue injury secondary to finish off through skalpēt of wounds with foreign matter (operations room) 28.38 1634.  
29006 more soft tissue damage to the primary finish (over 3 cm in length), complex wounds (damaged) (operations room) 1635 36.76.  
29007 ligature, foreign body, which shows the wound, removal (outpatient) 4.07 1636.  
29008 foreign body removal from the subcutaneous or zemgļotād after opening it with the help of 15.00 1637 cut.  
the presence of deep sleeping 29009 from soft tissues or bones with surgery (surgery Hall) 35.64 1638.  
the lower jaw wrench-29010 reinforcements and clamping bandage 5.45 1639.  
29015 * lower jaw reinforcements in case of an old luksācij (operation) 51.72 1640.  
29016 * nose repozīcij with disabilities (operation) 48.64 1641.  
Locking the plaster casts of 29017 on nose 5.45 1642.  
change the nose Swab 29018 4.95 1643.  
* the Zygomatic orbital complex 29019 damage, operating cheek bone repozīcij-48.50 1644.  
* the Zygomatic orbital complex 29020 damage osteosintēz of the 54.77 of his 1645.  
* the Zygomatic orbital complex 29021 damage orbital base plastics 60.91 1646.  
the cheek bone repozīcij 29022 through sinus surgery 57.87, 1647.  
the nasal bone 29023 septum repozīcij with operation 47.62 1648.  
29024 mandibular šinēšan in one place broken jaw 10.57 1649.  
29025 * Repozīcij and retensij in several places to the mandible, lower jaw broken by rock fracture or fractures with bone tissue defects 57.87 1650.  
the imposition of This 29030 whole jaw to 1651 9.55 unscathed.  
transfokāl osteosintēz of the mandibular 29031 with wire in the event of unilateral 50.19 1652.  
in the mandibular transfokāl 29032 osteosintēz with wire in many places broken jaw 51.72 1653.  
the lower jaw fragment 29033 ekstrafokāl of osteosintēz of distrakcij of compression 54.77 1654.  
29034 * repozīcij and ekstrafokāl mandibular fixation with Kiršner wire (operating room) 49.68 1655.  
29035 the mandibular osteosintēz with metal Ligature in the event of unilateral 53.26 1656.  
29036 * osteosintēz with metal lower jaw plate with e/o approach in the event of unilateral 54.77 1657.  
the mandibular osteosintēz with 29037 metal plate with i/o access in the event of a unilateral 57.87 1658.  
osteosintēz by the maxilla 29038 Adams 57.87 1659.  
29039 maxilla with the osteosintēz i/o access with ligatures or metal plate 60.91 1660.  
29040 * Perimandibulār Ligature taxation (operation) 53.26 1661.  
the heads of 29045 Joints out at the complicated fractures 57.87 1662.  
29046 the joints head repozīcij, fixation on fractures 60.91 1663.  
the facial bone osteosintēz 29047 through Coronal incision 67.07 1664.  
the joint pathology 29048 surgical treatment (osteotomij, plastic arts) at mežģījum for chronic 67.07 1665.  
29049 * joints treatment of surgical pathology (osteotomij, plastic arts) at the ankiloz 70.17 of 1666.  
29050 * Orthopaedic and plastic operations of spontaneous breakage in case of osteomielīt or JAWS in the case of 54.77 resection 1667.  
29051 simple ekstraorāl bandage, elastic links, Chin lingveid's URu.tml patch. the imposition of 4.43 1668.  
29052 wire ligatures, hook, a simple wire loop or analogous to taxation (Aiv) 12.61 1669.  
Snap-on bandage 29053 jaw fracture or tooth of 5.45 1670 after replantācij.  
29060 impose Chin graves 4.95 1671.  
29061 impose head graves 5.45 1672.  
29062 impose head tomb with special accessories 5.45 1673.  
29063 impose head-Chin graves 6.98 1674.  
29064 based devices, turētājierīč or accessories, or closing of the connecting plates, pelot or similar taxation as plastic surgery, in order to prevent or to treat the scar Contracture or trizm to make exposure – light cases 9.56 1675.  
29065

Turētājierīč support devices, or accessories, or closing of the connecting plates, pelot or similar taxation as plastic surgery, in order to prevent or to treat the scar Contracture or trizm to make an exposure-severe cases 12.60 1676.  
29066 jaw splint correction 6.49 1677.  
29067 seam removal 5.45 1678.  
29068 checking again the jaw injury cases (oral hygiene, stretched-out rubber or Ligature replacement, intraorāl wound treatment) 1679 4.95.  
29069 Remove This prior to treatment, replacement, or Finally, including oral hygiene 5.45 1680.  
29070 * Pseidoartroz or bone fracture operation associated with the bone sutures taxation 57.87 1681.  
29071 * Pseidoartroz or bone fracture operation associated with the bone Assembly, sanaglošan or the transplant of bone implantation 64.00 1682.  
29080 * Osteotomij after we deployed fracture 60.91 1683.  
stop the Bleeding after tooth 29081 extraction 8.41 1684.  
stop the Bleeding with tamponād 29082 in 1685 9.56.  
* stop the Bleeding with 29083 vascular liģēšan, a. communis, by a. carota carota the extern 57.87 of 1686.  
* stop the Bleeding with 29084 vascular liģēšan, a., a. the superficial temporal facial a 1687 54.77.  
29085 nose tamponād from front 6.49 1688.  
mugurēj in tamponād-29086 nose 9.84 1689.  
29087 Hematoma i/o opening 9.58 1690.  
29088 Hematoma puncture and e/o opening (superficial) 6.51 1691.  
29089 * deep hematoma i/o opening (the Theatre) 50.19 1692.  
* Osteosintēz plate of 29090 removal (surgery) 51.72 1693.  
* bone 29095 weld (wire) or removal (surgery) 51.72 1694.  
29096 one place broken jaw – šinēšan (broken and jaw to hurt not) (operating room) 51.72 1695.  
29097 one place broken jaw – šinēšan (broken jaw to hurt and not) and the tooth extraction of fracture gaps (operating room) 54.77 1696.  
29098 one place broken jaw – šinēšan (broken jaw to hurt and not) and the extraction of a tooth fracture and intraorāl in Kiršner in ekstrafokāl fixed with wire (operating room) 57.87 1697.  
29099 two and several places for broken jaw šinēšan (broken and jaw to hurt not) (operating room) 53.76 1698.  
and two more 29100 places broken jaw šinēšan (broken and jaw and teeth to hurt not the extraction of fracture gaps) (operating room) 56.83 1699.  
and two more 29101 places broken jaw šinēšan (broken and jaw and teeth to hurt not the extraction of fracture and intraorāl in Kiršner in ekstrafokāl fixed with wire) (the Theatre) 59.89 1700.  
29102 * Abscess and open the zemgļotād or furunkul zemperiostal abscess (operating room) 17.87 1701.  
29103 (subcutaneous) Superficial furunkul opening (the Theatre) 14.77 1702.  
29104 * deep abscess or open the karbunkuļ (the Theatre) 19.05 1703.  
* Flegmon e/o 29110 opening one topographic area limits (operating room) 40.74 1704.  
* Flegmon e/o 29111 opening two topographical area limits (operating room) 42.08 1705.  
* Flegmon e/o 29112 opening more than two topographical area limits (operating room) 47.11 1706.  
sekvestroektomij 54.77 of the jaw 29113 1707.  
* Antrotomij-29114 51.72 1708.  
* Antrotomij with oroantrāl-29115 fistula closure in diameter up to 1.0 cm 54.77 1709.  
* Antrotomij with oroantrāl-29116 fistula closure in diameter over 1 cm (with dubultlēver) 57.87 1710.  
* Antrotomij 29117 with flap from the or and of solid vestibul palate 57.87 1711.  
29118 open jaw cavity plastic sealing with simple gum plastic help 51.72 1712.  
the jawbone 29119 trepanācij 48.64 of 1713.  
29125 mucous or kauterizācij of ekscīzij 1714 5.46.  
the proliferation of mucosal ekscīzij 29126-izoperēšan of a 8.05 epul 1715.  
the proliferation of mucosal ekscīzij 29127-izoperēšan, Papilloma of fibrom 6.51 1716.  
the ekstirpācij of Fisurāl cysts 29128-51.72 1717.  
the ekstirpācij of Radikulār cysts 29129 without root end resection in diameter to 2 cm 51.72 1718.  
* Radikulār of ekstirpācij 29130 cysts without root end resection in diameter over 2 cm 54.77 1719.  
* Radikulār of ekstirpācij 29131 cysts with viensakņ teeth end resection 54.77 1720.  
* Radikulār of ekstirpācij 29133 cysts with molar dangling from it after resection of root 57.87 1721.  
* Radikulār of ekstirpācij 29135 cysts with tooth root resection with end-sealing viensakņ retrogrād teeth and molar dangling from it in 1722 51.72.  
29140 * Cistektomij (cyst of the diameter over 2 cm) and fill the cavity with bone autotransplāt 60.91 of 1723.  
29141 * Cistektomij (cyst of the diameter over 2 cm) and fill the holes with artificial materials 57.87 1724.  
29142 * Cistektomij (cyst of the diameter over 2 cm) and fill the holes with the maxilla and the lower jaw of immobilization 64.00 1725.  
29143 * folikulār and radikulār Cistotomij to the cyst for 51.72 1726.  
29144 mucus cysts of izoperēšan 1727 6.51.  
29145 oral cistotomij (ranul) 9.58 1728.  
29146 the submaxillary salivary gland of 57.86 1729 ekstirpācij.  
29147 intra oral salivary gland fistula operation 60.93 1730.  
29148 extra oral salivary fistula closure 64.00 1731.  
29149 * intra oral salivary gland of the siekalakmen withdrawal from output 51.72 1732.  
29150 * intra oral salivary gland removal from the siekalakmen gland 57.87 1733.  
29151 * Parotid salivary gland ekstirpācij, subtotāl or the total resection, salivary gland cysts ekstirpācij, including regional lymphatic system, saving face nerve (n. facial) nodes 70.17 1734.  
* operation 76.30 29155 Vanah 1735.  
Non surgical treatment iralģij 29156 method-alkoholizācij-9.01 1736.  
not iralģij of surgical 29157 method of treatment – not a 1737 51.72 irekserēz.  
not iralģij of surgical 29158 treatment-open decompression 53.26 of 1738.  
not iralģij of surgical 29159 treatment method-channel decompression 57.87 1739.  
Non surgical treatment iralģij 29160 method – basal blockage 8.30 1740.  
29165 * nervous injury case-intrafascikulār weld (shell, seam to fascikul) 64.00 1741.  
29166 * nervous injury case-epineirāl seam (nerve skin seam) 64.00 1742.  
29167

Benign skin formations cutting (aterom, wart, papillomavirus, Lipoma) 7.29 1743.  
the Odontom and osteom of 29168 removal 50.19 1744.  
the Hemangiom and limfangiom of 29169 ekstirpācij-1745 37.32.  
29171 * deep formations placed the cut (neck cyst, cyst of dermoīd) 1746 54.77.  
29172 * maxilla or lower jaw of the alveolar processes of the parts nokalšan 54.77 1747.  
29173 * maxilla or mandibular resection of part of one of the parties is 64.00 1748.  
29174 * maxilla or mandibular resection of part of one party with the radical regional lymphatic system removal 70.17 1749.  
29175 all mandibular resection of maxilla or 70.17 1750.  
the mandibular branch of 29180-1751 osteotomij 57.87.  
the tongue or 29181 full tongue resection of 1752 60.91.  
29183 soft tissue and/or lymph node biopsy 8.05 1753.  
* Supplement for implant 29185 at manipulation, 29021 29020, 29036, 29039 29046, 29071 29037,,,, 29101-29098 facial bone miniplāksn with screws 58.09 1754.  
* Supplement for implant 29186 at manipulation, 29172 29173, 29180-29175, 29174, facial bone reconstruction plate with screws 97.16 1755.  
29187 interfering mucous, muscle of the space for mounting or deformed parts of the alveolar wart prevention district or one of the front teeth in the jaw on one side session 10.46 1756.  
the Alveolar bone spur 29188 resection, to prepare the site for dental prostheses erupted or one area on the side of the jaw (self help in one session) 51.72 1757.  
29189 * oral base or plastic of incisors district vestibul or one side of the jaw 51.72 1758.  
29190 * plastic on one side of the Tuber 51.72 1759.  
29195 lips string release and the SEPTA of attrition marked in the case of 6.25 diastēm 1760.  
29196 * tongue string release with Z plastic 28.58 1761.  
29197 * tongue string release with free skin transplantation 37.02 1762.  
29198 * nose osteotomij a 54.77 plastic-1763.  
29199 * nose plastic-osteotomij with correction of nasal septum 59.41 1764.  
* the Zygomatic orbital complex 29200 deformation-based plastic, orbital corrections 64.00 1765.  
29201 scars cut without plastic techniques – up to 5 cm 7.29 1766.  
29202 * 5-10 cm scar excision without plastic techniques 25.33 1767.  
29203 * longer than 10 cm scar excision without plastic techniques 30.86 1768.  
29204 * local excision Scar tissue plastic from adjacent topographic zones 57.87 1769.  
29205 * soft tissue defect by substitution with adjacent tissue 57.87 1770.  
29206 * soft tissue defect with tissue substitution from remote areas 64.00 1771.  
* soft tissue defect 29207 substitution facial area with flap on the blood vessels in the legs 64.00 1772.  
29208 * soft tissue defect by substitution of other parts of the body 70.15 1773.  
the scar cut 29209 using free skin plastic method 60.91 1774.  
* one part 29224, or frontal area of 1775 54.77 kortikotomij.  
29225 * face mimic muscle paralysis surgical correction of intraorāl in miotomij-1776 51.72.  
29226 * face mimic muscle paralysis surgical correction, skin and subcutaneous ekscīzij 54.77 of 1777.  
29227 * face mimic muscle paralysis surgical correction-mioplastik with m. Masseter 64.00 1778.  
29228 * face mimic muscle paralysis surgical correction-mioplastik with m. temporal States 64.00 1779.  
29229 * face mimic muscle paralysis surgical correction – Microsurgical nerve reconstruction 76.30 1780.  
29230 * face mimic muscle paralysis surgical correction-blephororrhaphi 54.77 of 1781.  
29235 * sampling: Bone Graft material (anterior, superior to the iliac Crista, cortical lamina) 1782 54.77.  
the taking of the graft-29236 rib 54.77 1783.  
the taking of the graft-29237 free skin 51.72 1784.  
29238 * Expander pot 57.87 1785.  
29239 * Expander is removed, and plastic with stretched tissue 70.15 1786.  
29240 * Kontūrplastik facial area with car, all artificial Transplant 60.91, 1787.  
29244 Kriomasāž (on the whole course) 15.69 1788.  
29257 one tooth implant insertion of 1789 57.87.  
29258 one tooth implant with augšžokl antrotomij of Pan sinus preparation 60.91 1790.  
29259 * premium manipulation on the tooth implant 78.13 29258 1791.  
29260 * premium manipulation on implant-Expander 29224 350.60 spine surgery (30001-30080 tampering) no PO box
Manipulation of code manipulation name tariff 1792.  
the spine scoliosis 30001 operation without implant values 227.71 1793.  
30003 premium – the manipulation of mugurēj in fixation 30001 implant scoliosis (the total fixations) 2328.06 1794.  
30004 * premium – mugurēj-30001 manipulation fixation implant for scoliosis (lower part) 1950.06 1795.  
30005 * premium – mugurēj-30001 manipulation fixation implant scoliosis (belt part) 1115.52 1796.  
* spine fixation 30006 trauma, spinal instability where 180.70 1797.  
30007 * premium manipulation of transpedikulār fixation of the implant 30006 vertebral column of breast-belt part 567.00 1798.  
* spine channel 30010 decompression spondilodēz with stabilization (Olb) 1799 93.56.  
the vertebral column fixation with 30011 laminektomij, with/without keel nokalšan of Urban 155.14 1800.  
* thoracic vertebral column 30012-belt parts of 153.43 without laminektomij 1801 fixation.  
the vertebral column fixation with 30013 laminektomij, spinal cord, radikulolīz, with/without keel nokalšan Urban Microsurgical technique of 189.80 in 1802.  
the front spondilodēz-30020-thoracic vertebral column and/or belt part 183.20 1803.  
30022 * neck vertebral column parts mugurēj 158.23 1804 in fixation.  
30023 * premium manipulation on cervical 30022 module 1237.95 1805.  
30024 * premium on papildmodul in 30022 manipulation 357.25 1806.  
30025 * premium manipulation of the module 618.98 okcipitāl 30022 1807.  
* Supplement for the 30026 intervertebral disc endoprotēz of 901.89 1808.  
30027 tail bone resection of 65.42 1809.  
* Hello 30028 machine stamping 26.63 1810.  
the vertebral column tumors 30029 removal 212.79 1811.  
30030 * Implant removal of spinal 163.94 1812.  
the Izgulējum of plastic 66.51 30031 1813.  
* Supplement for 30032 carbon neck intervertebral disc replacement frame-cage (cage)

368.55 1814.  
* Supplement for Carboniferous 30033 lumbar intervertebral disc of part aizvietotojoš boxes-cage (cage) 491.40 1815.  
* Premium 30034 30032, 30033 manipulation of calcium phosphate pellets use 85.05 1816.  
* Supplement for 30040 universal spinal implant system equivalent to the injuries 767.34 1817.  
* Supplement for 30041 universal spinal implant system equivalent to the degenerative diseases 945.00 1818.  
30042 * bonus on implant-plate with screws for fixation of the anterior part of the neck (CSLP or equivalent) 261.77 1819.  
* Supplement for implant 30043-torakolumbāl mugurēj in the plate with screws use 64.26 1820.  
* Supplement for 30044 implant – allotransplantāt use 17.22 1821.  
* Supplement for implant 30045-cervical-mugurēj plate with screws use 109.62 1822.  
30046 * bonus on rope to the neck of mugurēj fixation 48.20 1823.  
30047 * bonus on the use of the apparatus 567.00 Hall, 1824.  
30049 * bonus on implant-plate with screws for fixation of the front part of the neck to use 24.57 1825.  
* Supplement for implant 30050-mugurēj of the transpedikulār of the vertebral column fixation for Thoracic-lumbar part (TENOR or equivalent) to the degenerative diseases of distrofisk use 689.85 1826.  
30050 30051 manipulation on the premium šķērsstieņ use 189.00 1827.  
30053 * premium manipulation for each subsequent 30050 segment of the vertebral column 292.95 1828.  
30056 * bonus on each additional level of the cervical level 225.47 mikrodiskektomij 1829.  
* Supplement for microscope 30057 sterile covers use 8.51 1830.  
* Supplement for Cell Saver 30058 (blood Gatherer) 1831 143.52 use.  
30059 * Hemifasetektomij, hemilaminektomij diskektomij or epineirāl with the redistribution of radikulolīz connective tissue, nerve roots, spinal cord decompression and intra/extra durāl a tumor removal, reoperācij by diskektomij 167.42 of Microsurgical technique in 1832.  
30060 * bonus on operations the use of vertebral column surgery microscope in 1833 10.40.  
* thoracic vertebral column 30065-torakoskopisk operations 268.92 1834.  
* Supplement for ironavigācij not 30066 systems use the vertebral column operations 113.40 1835.  
30070 * bonus on US implant component-side opening screw use 113.40 1836.  
* Supplement for the USS 30071 implant components – the soft Rod use 10.87 1837.  
* Supplement for the USS 30072 implant components-hard Rod use 11.82 1838.  
* Supplement for the USS 30073 implant components – the use of exception 8.51 1839.  
30074 * bonus on USS implant components-šķērsstieņ connector use 57.65 1840.  
* Supplement for the USS 30075 implant components – the use of laminar hook 142.70 1841.  
30076 the bonus on US – the components of the implant the hook 153.09 pedikulār use of 1842.  
* Supplement for the USS 30077 implant components – Chance screw use 21.74 1843.  
* Supplement for the USS 30078 implant components-connector with uniform screw use 83.16 1844.  
* Supplement for the USS 30079 implant component – closed connector for use 33.08 1845.  
* Supplement for USA 30080 implant components – the open connector use 86.00 thoracic surgery (31001-31230 tampering) no PO box
Manipulation code name of the 1846 tariff Manipulation.  
31001 * pleural drain on 43.63 1847.  
31002 * pleural drain taxation with rib resection 67.43 1848.  
the intercostal arteries 31003 nošūšan 54.77 of 1849.  
31004 pleural spaces rinsing, medicines for 2.59 1850.  
the Mediastinal drainage 31005 68.19 1851.  
* Mugurēj-31006 Mediastinal drainage with rib resection 70.98 1852.  
31007 * Torakotomij diagnostic purposes, including tissue sampling, and torakotomij with heart massage 134.18 1853.  
the Bronchial arteries 31008 liģēšan 155.99 of 1854.  
31009 * breast lymphatic damage to cladding of 183.43 headed by 1855.  
* Bronhotomij of foreign bodies or 31010 tumor removal 214.21 1856.  
* Pneimotomij 143.22 1857-31015.  
31016 * lung foreign body evacuation 190.70 1858.  
31017 lung injury nošūšan 196.25 of 1859.  
the lobe bronchi 31018 tear nošūšan 198.83 of 1860.  
the main bronchial rupture 31019-nošūšan 198.83 of 1861.  
the bifurcation of the trachea, 31020 tracheal fracture nošūšan 211.49 of 1862.  
31021 primary and other bronchial rupture of plastic reconstruction 221.89 1863.  
the removal of foreign bodies from 31022 breast wall 69.78 1864.  
31023 * breast wall structure ekstirpācij. The 1865 99.40 Torakotomij.  
31024 * breast wall plastic 107.90 1866.  
* Rib resection of 64.57 31030 1867.  
31031 * two or more rib resection of 74.02 1868.  
31032 * chest wall on 61.12 ekstenzij 1869.  
the sternum fracture 31033 fixation 65.39 1870.  
31034 * one or more rib fracture fixation 65.39 1871 case.  
* Torakoplastik-31035 123.30 1872.  
31036 * marginal resection of the lung 165.29 1873.  
31037 * two or more atypical of resection of segment 200.06 1874.  
31038 * typical pulmonary resection of segment of 213.34 1875.  
31039 * two or more pulmonary resection of segment of the typical 231.37 1876.  
* Lobektomij the 201.80 1877.31045  
31046 * Lobektomij with mediastinal lymph node ekstirpācij of 206.51 1878.  
* Lobektomij with circular 31047 main bronchial 228.54 resection of 1879.  
31048 * Lobektomij with the main bronchial wedge resection 214.21 1880.  
* Lobektomij with the main 31049 bronchial and vascular circular resection of marginal 234.22 1881.  
* Lobektomij with vascular 31050 and main bronchial resection of circular 249.22 1882.  
* Lobektomij with marginal 31051 vascular resection of 214.21 1883.  
* Lobektomij and segmentār in 31052 resection of 232.17 1884.  
31053 * Lobektomij with pericardial resection 209.08 1885.  
* Bilobektomij of 206.51 1886 31054.  
31055 * Bilobektomij and vascular resection of 216.76 1887.  
* Pneimonektomij of 211.63 31056 1888.  
* extended pneimonektomij-31057 pericardial lymph node resection, ekstripācij of Mediastinal 228.54 1889.  
31058 * Pneimonektomij with marginal vein resection 221.90 1890.  
31065 * pleural scarification 111.94 1891.  
the pleural space 31066 saaugum 118.36 1892 realignment.  
31067 * blood clot evacuation from the pleural space 126.50 1893.  
* Retorakotomij and hemostāz-31068 126.50 1894.  
* Pleirektomij 225.07-31069

1895. the Pleirektomij and lung 31070 marginal resection of 1896 212.30.  
* Pleirolobektomij of 247.30 31071 1897.  
* Pleirobilobektomij the 237.85 1898 31072.  
* Pleiropneimonektomij of 256.26 1899 31073.  
31074 * Pneimonlobektomij with the diaphragm and chest wall resection of 237.04 block in 1900.  
31080 * Trahe (bronchial) – esophageal fistula of 224.49 of ekstirpācij in 1901.  
31081 * Trahe (bronchial) – esophageal fistula and the 229.60 of the ekstirpācij lobektomij in 1902.  
resection of the trachea of Circ. 31082 with thoracic approach 237.04 1903.  
resection of the trachea bifurcation 31083-349.28 in 1904.  
resection of the trachea of Circ. 31084 with cervical approach 177.52 in 1905.  
wedge resection of the Trachea 31085 with thoracic approach 214.21 1906.  
wedge resection of the Trachea 31086 with cervical approach 134.90 1907.  
31087 the trachea of a circular resection with sternotomij spins 234.30 1908.  
31088 * Retorakotomij, nošūšan the 127.30 of bronchial fistula in 1909.  
31095 * Transsternāl and/or transperikardiāl of the nošūšan of the bronchial fistula 230.42 1910.  
* Retrosternāl of the Struma 31096 ekstirpācij with cervical approach 57.09 in 1911.  
31097 * Mediastinoskopij with mediastinal lymph node biopsy 49.23 1912.  
31098 * arrangement ekstirpācij of Mediastinal 141.89 in 1913.  
the Mediastinal structures 31099 ekstirpācij resection of lung tissue and the 206.51 in 1914.  
* diaphragm resection of the 31105 136.55 in 1915.  
the nošūšan of the 136.55 diaphragm 31106 1916.  
31107 * old traumatic injury of diaphragm of 141.67 nošūšan in 1917.  
31108 * diaphragm rupture of spleen nošūšan and ekstirpācij and stomach-bowel resection of 170.40 1918.  
31115 * Sternotomij – ekstirpācij of Mediastinal tumor 111.76 1919.  
31116 * Sternotomij-Butterfly ekstirpācij-1920 109.04 gland  
* Sternotomij with traheotomij of 31117 104.62 1921.  
Transtorakāl-trunkulār-vagotomij * 31118 of 96.37 1922.  
* Torakotomij and ezofagomiotomij-31119 136.55 1923.  
31125 * esophageal resection of divertikul with thoracic approach 133.97 in 1924.  
31126 * esophageal leiomiom of 133.97 of ekstirpācij in 1925.  
31127 * esophageal tear nošūšan with thoracic approach 128.87 in 1926.  
31128 * esophageal resection of divertikul and nošūšan with a neck fracture approach 87.87 1927.  
31129 * esophageal ekstirpācij 154.58 of 1928.  
31130 * esophageal stent implantation of the stent-free values 59.02 in 1929.  
31131 * with premium silicone encapsulated in polyester non woven esophageal stent use 259.88 in 1930.  
* Supplement for traheobronhiāl-31132 stenosis using stent 348.71 in 1931.  
31133 tracheal or bronchial Stents in the 1932 8.32 repozīcij  
31134 tracheal or bronchial stents evacuation 8.32 1933.  
31135 esophageal stent is a 1934 repozīcij 7.51  
31136 esophageal stent evacuation 7.51 1935.  
31137 * esophageal ekstirpācij with following esophageal-gastric or esophageal anastamoz-gut anastamoz-building 239.89 in 1936.  
31138 * esophageal bypass anastamoz of creation with stomach 119.48 1937.  
* Antesternāl-31139 esophageal anastamoz 187.06 of 1938.  
31145 * Torakoskopij with biopsy 100.56 1939.  
31146 * Torakoskopisk breast tumor of ekstirpācij wall 130.82 1940.  
* Torakoskopisk of 31147 blood clots escape 157.08 1941.  
* Torakoskopisk of 31148 pericardial cysts resection of divertikuļ-125.54 1942.  
31149 * Torakoskopisk the marginal resection of lung tissue of the 201.92 in 1943.  
Torakoskopisk-pleirektomij-162.22 * 31150 1944.  
* Torakoskopisk of Mediastinal tumor 31151 and ekstirpācij of 175.03 of bronhogēn cysts in 1945.  
the divertikuļ of the Videoskopisk 31152 Cenker resection with cassettes of the value 193.35 in 1946.  
31153 * Torakoskopisk esophagus mobilization 123.16 1947.  
31160 * pleural biopsy with disposable guillotine type biopsy needle (Tru-cut, si-cut, bio-cut or analog) 17.13 1948.  
31161 * premium manipulation on disposable 31160, 31215 semi-automatic biopsy needles use 6.62 1949.  
31162 * premium manipulation, disposable 31160 31215 on automatic biopsy needle use 9.45 in 1950.  
* Premium 31163 manipulation of daudzkārtlietojam in 31215 31160, puncture biopsy device (gun) 2.84 1951.  
31164 premium 31160, 31215, manipulation of manipulation in 31216 Rtg tv controls 2.65 1952.  
31165 premium 31160, 31215, manipulation of manipulation in CT 31216 controls 7.58 1953.  
31166 premium 31160, 31215, manipulation of the manipulation of US committing 31216 controls 3.08 1954.  
31167 * premium manipulation on pleural aspiration 31160 content with single-use Kit 6.25 1955.  
31175 * breast wall biopsy 13.65 1956.  
is 2.37 katetrizācij 31176 trachea in 1957.  
Mikrotraheostom-31177 8.64 1958.  
31178 artificial pneimotorak, pneimomediastinum and pneimoperitoneum a 3.30 1959.  
Bronhoskopij the 1960s 11.03 31185  
31186 * Fibrobronhoskopij. May be presented together with manipulation 08136 17.37 1961.  
the Endobronhiāl formation in elektrokoagulācij 31187-46.44 in 1962.  
31188 * bonus on videoendoskopij equipment for 5.67 1963.  
* Premium 31189 manipulation, on the trachea and 31185 31186 bronchial mucosa biopsy 7.10 in 1964.  
* Premium 31190 manipulation, 31186 on cytological 31185 procurement (brushes biopsy) of the trachea and the bronchial mucous 8.99 1965.  
31191 * premium manipulation, 31186 on cytological 31185 procurement (brushes biopsy) of lung peripheral 41.40 1966.  
* Premium 31192 manipulation of material acquisition, 31185 31186 bacteriological investigation to protect the brush 14.93 1967.  
* Premium 31193 manipulation of transbronhiāl lymph nodes of 31185, 31186 or puncture after Wang 38.47 build in 1968.  
31194 * premium manipulation, transbronhiāl of 31185 31186 on lung tissue biopsy 8.19 1969.  
31195 * premium manipulation on bronchial-alveolar 31186 lavāž (BALA) 3.43 1970.  
the tracheal-bronchial 31196 dilation (bužēšan). Premium manipulation, 31186 11.77 31185 1971.  
31205 * enter in tracheal Stent Rtg controls (without stents values) 45.16 1972.  
31206 * enter main bronchial Stent RTGS controls (without stents values) 46.30 1973.  
removal of foreign bodies from the bronchial 31207. Premium manipulation 31185, 31186 5.01 1974.  
31208 esophageal bužēšan adults 7.15 1975.  
Esophageal dilation 31209 9.05 1976.  
31215 *

Transtorakāl lungs (formations) biopsy with disposable guillotine type biopsy needle (Tru-cut, si-cut, bio-cut or analog) 22.54 1977.  
31216 * Transtorakāl lungs (formations) puncture-aspiration biopsy aspiration with disposable biopsy needle and syringe for aspiration of 15.79 located in 1978.  
* Premium 31217 manipulation, 31036-31017 31081, 31125, 31128 31148, 31149, 31152, for each motor used seamstress one cassette 53.87 1979.  
* Premium 31218 manipulation, 31021, 31037 31016, 31038, 31046, 31054, 31045, 31056, 31070, 31088, 31099, 31105 31107, 31125, for each additional hour over three hours of operation 1980 46.42.  
31220 * premium manipulation, 31206 on straight 31205 traheobronhiāl des 245.70 in 1981.  
* Premium 31221 manipulation, 31206 on encapsulated 31205 with silicone polyester non woven tracheal stent use 219.24 1982.  
* Premium 31223 manipulation on the trachea, 31206 31205 uncoated stent nitinol for use in 637.88 in 1983.  
* Supplement for vadstiegr 31224 use of tracheal stent for entering 79.65 1984.  
31205 31225 * premium manipulation, 31206 dynamic tracheal stent for 562.28 in 1985.  
the trachea and bronchi-31230 balondilatācij after entering the stent with disposable balloon 119.76 heart-bypass operations (manipulations 32050-32081) no PO box
Manipulation of code manipulation name fare in 1986.  
32050 * myocardial revaskularizācij, aortokoronār, mamarokoronār, repeating the shunt (redo) surgery myocardial revaskularizācij, a heart tumor surgery, plastic surgery, valvular heart removal of foreign bodies in the artificial circulation (the national society with limited liability "Paul stradins clinical University Hospital") 853.21 in 1987.  
32051 operation with a mechanical heart connection (Novocor) system (without system values) artificial circulation (the national society with limited liability "Paul stradins clinical University Hospital") 871.08 1988.  
32052 * breast aorta (aneurysm rupture) operation of artificial circulation artificial circulation (the national society with limited liability "Paul stradins clinical University Hospital") 883.74 1989.  
32053 * valve prosthetics, repeat (redo) heart valve adjustment (prosthetics) artificial circulation (the national society with limited liability "Paul stradins clinical University Hospital") 848.74 1990.  
32054 * myocardial revaskularizācij (aortokoronār the shunt) with valve replacement of artificial circulation (the national society with limited liability "Paul stradins clinical University Hospital") 832.05 in 1991.  
32055 * myocardial revaskularizācij (mamarokoronār the shunt) (not used in conjunction with manipulation 32065) artificial circulation (the national society with limited liability "Paul stradins clinical University Hospital") 850.42 1992.  
* Premium 32065 32050, 32051, manipulation, 32052 32053 32054 on materials, operations with artificial blood circulation (MARIE) (national society with limited liability "Paul stradins clinical University Hospital") 2936.96 1993.  
32070 * heart surgery without artificial circulatory-torakotomij, closed komisurotomij, Mediastinal tumor surgery, congenital heart ailments adjustment, chest or heart trauma, surgery, resternotomij pericardial 316.09 of 1994.  
32071 * premium manipulation operations on materials without 32070 artificial circulatory 1629.50 1995.  
the sirdskaiš of complex congenital 32075 correction artificial circulation, valve replacement, valve plastic surgery, heart surgery, tumor (redo) surgery society with limited liability "children clinical University Hospital" 533.09 1996.  
32076 * premium manipulation 32075 for material operations with artificial blood circulation (MAR) national society with limited liability "children clinical University Hospital" 3533.25 1997.  
32080 * heart surgery without artificial circulatory-torakotomij, Mediastinal tumor surgery, congenital heart disease, the adjustment of the chest or heart trauma, pericardial surgery society with limited liability "children clinical University Hospital" 199.40 1998.  
32081 * premium manipulation 32080 on materials operations without artificial circulatory society with limited liability "children clinical University Hospital" 2952.50 laboratory of Hematology (40001-40043 tampering) no PO box
Manipulation of code manipulation name Tariff in 1999.  
capillary blood sampling 40001 to pipette Pančenkov 0.16 in 2000.  
40002 Serum (plasma) getting 0.20 2001.  
40003 blood sampling in a closed system in one tube 0.52 2002.  
40004 blood sampling in a closed system in two vials 0.62 2003.  
blood sampling with 40005 closed system three vials 0.73 2004.  
capillary blood sampling 40006 with mikrotainer-0.39 2005.  
40010 hemoglobin 0.25 2006.  
40011 hemoglobin using disposable cuvettes 0.53 2007.  
40012 red cells (counting Chamber) 0.33 2008.  
40013 leucocytes (counting Chamber) 0.27.  
40014 and erythrocyte Count morphology 0.56.  
40016 erythrocyte sink rate, using a special set of sampling (seditainer, etc.) 0.34 2011.  
40017 platelets (the camera) is 0.58 2012.  
Retikulocīt in 2013.0.66 40018  
Retikulocīt – automated 40019 investigation with haematology analysers 3.40 2014.  
40025 flowing blood time after 2015 the Duke method 0.35.  
40028 blood clotting time after Lee-White methods 0.59 2016.  
40029 Haematocrit (HCT when setting the centrifuge) 0.33 2017.  
40034 an investigation Sternālpunktāt 9.65 2018.  
40035 erythrocyte in osmotisk resistance (haemolysis value test) 3.26 2019.  
40040 blood test with part 3 Blood analyser 1.05 discriminatory in 2020.  
40041 blood test with a 5 part Blood analyser. discriminatory In addition, hide manipulation-40010, 40012, 40013, 40014, 40017 40029 2.01 and 2021.  
40043 Not full blood analysis, determined by the analyser Koaguloģij 0.83 (40085-40123 tampering) no PO box
Manipulation of code manipulation name tariff 2022.  
40085 Protrombīn and INR 0.96 2023.  
40086 Protrombīn complex and INR 1.01 2024.  
40087 activated partial tromboplastīn time the (APTL) 1.09 2025.  
40088 Fibrinogen 1.09 2026.  
40089 Antitrombīn III (AT-III) 3.37 2027.  

40090 Thrombin time 1.03 2028.  
40095 Fibrin degradation products 2.97 2029.  
40096 D-relating to Dimer (qualitative and semi-quantitative) 2.66 2030.  
40097 soluble fibrin monomer complexes 2.86 2031.  
40098 factor VIII activity detection 6.54 2032.  
determination of factor IX 6.45 40099 2033.  
40100 factor VIII activity detection C 4.97 2034.  
40105 factor IX activity determination of Ag 4.10 2035.  
40106 factor XI activity detection 4.10 2036.  
determination of protein C 10.63 40107 2037.  
determination of protein S 10.63 40108 2038.  
40109 Von Villebrand factor 6.64 2039.  
40115 Plazminogēn activity determination 5.08 2040.  
determination of the concentration of Plazminogēn 40116 5.08 2041.  
40117 A Fibrinopeptīd quality determination 4.99 2042.  
40118 heparin determination 3.46 2,133.  
40119 protein C resistance test (APC-R) 6.93 2044.  
40120 platelet function investigation Inches/EPI 10.64 2045.  
40121 platelet function investigation Inches/ADP 10.64 2046.  
40123 D-dimēr (quantitative) analysis of urine 4.54 (40131-40151 tampering) no PO box
Manipulation of code manipulation name tariff 2047.  
40131 Protein (quantitative reaction with pirogalol red) 0.50 2048.  
Ketonviel-0.24 40133 2049.  
40134 specific weight and glucose qualitative 0.25 2050.  
40135 glucose and ketonviel in the urine of 0.24 2051.  
40140 urine sediment quantitative investigation 0.76 2,052.  
40148 urine analysis with teststrēmel (9-10 parameters) 0.58 2053.  
40149 the specific weight of urine with a Refractometer, urometr a 0.12 2054.  
40150 urine sediment microscopy for standardised 0.64 2055.  
40151 Glukuronīd in urine 5.71 Stool analysis (40160 tampering-40173) no PO box
Manipulation of code manipulation name tariff 2056.  
40160-1.28 2057 Koprogramm.  
40161 hidden blood in the feces 0.27 2058.  
40164 Scrape from perianālaj folds on eggs spalīš 0.44 2,060.  
40165 investigation for sticky Enterobioz with tape method 0.75 2060.  
40168 Unicellular cyst and helminth investigation with the enrichment method 2.65 2061.  
40169 helminth discovery by Kato method 0.88 2062.  
40170 Helmint and fragment detection 1.35 2063.  
40171 Unicellular parasites of the intestinal natīv and determination with Lugol's solution dyed in 1924 in preparation 1.47.  
40172 hidden blood with teststrēmel (positive) 0.76 2065.  
40173 hidden blood with teststrēmel (negative) 0.76 other clinical analysis (40180-40194 tampering) no PO box
Manipulation of code manipulation name tariff 2066.  
40180 bile microscopic investigation (1 serving) 0.94 2067.  
clinical analysis of Likvor 40181 1.68 2068.  
clinical analysis of Sputum 40183 1.07 2069.  
Eozinofīl-white sputum-40184 1.00 2070.  
40188 investigation of prostate eksprimāt 1.56 2071.  
40190 material (nails, skin, hair) investigation on fungi 1.26 2072.  
Iztriepj of bakterioskopij to the microbial 40191 and sexually transmitted disease 1.35 2073.  
40193 examination of Mikobaktērij bakterioskopisk 0.99 2074.  
40194 a bakterioskopisk Mikobaktērij investigation by the enrichment method 1.83 Imūnhematoloģij (manipulation 40300-40348) no PO box
Manipulation of code manipulation name tariff 2075.  
40300 determination of blood group ABO system with planes method (direct response) 0.63 2,262.  
40301 determination of blood group ABO system with planes method (dubultreakcij) 1.08 2077.  
40302 Rh (D) signs with planes method (with 2 reagents) 1.14 2078.  
40303 Rh (D) determination of gel-technical features (with reagent 1) 1.21 2079.  
40304 determination of blood group ABO and Rh systems-gel technique 2.76 2080.  
40305 newborn blood gel-imūnhematoloģisk investigation techniques (DiaClon ABO/ID card Rh newborn) 3.01 2083.  
40306 RH phenotype (CcE) and the determination of the Kell with plane method 5.06 2082.  
40307 RH phenotype (CcE) and the determination of the Kell-gel technique 4.27 2083.  
40309 partial antieritrocitār antibody screening technique with gel-2 skrīningeritrocīt samples (ID card List/Coomb) 2.23 2084.  
40315 partial antieritrocitār antibody titration technique with gel 1 Antigen (ID card – list/Coomb) 5.20 2085.  
40316 partial antieritrocitār antibody identification with ID-gel-technology panel (ID card List/Coomb) 10.58 2086.  
40317 partial antieritrocitār antibody identification with ID enzyme panel gel-technique (ID card NaCl enzyme) 9.59 2087.  
40318 Recipient and donor's blood tests in the individual compatibility Lab (ABO compatibility-plane test, Rh and other systems-gel-technology) 4.55 2088.  
40320 int. anti-human globulin test (DAT) with tube method 6.00 2089.  
40325 drop anti-human globulin test (DAT)-gel technique (ID card List/Coomb) 1.22 2090.  
40326 anti-human globulin test directly (data) gel-technical graduation (IgG + C3d ID card +/IgG + C3d ctl + ctl) 3.32 2091.  
40327 anti-human globulin test directly (data) gel-technical graduation (ID card-IgM-IgG IGA-C3c-C3d-ctl) 6.80 2092.  
40328 * special blood matching for sensitized recipients (antibody identification with ID cards List/Combo + fenotipizācij + 1 compatibility test) 17.84 2093.  
40329 * special blood matching for sensitized recipients (antibody identification with ID cards List/Combo and Na/Cl + fenotipizācij + enzyme 1 compatibility test) 26.41 2094.  
40330 Krioglobīn quality 0.68 2095.  
40335 cold determination of gel-aglutinīn technique 4.09 1955.  
40336 AB0 system antieritrocitār antibody titration in 1.65 2097. sērum  
* 40337 acid elūcij test with antieritrocitār antibody identification technique of the eluate-gel (ID card List/Coomb) 15.15 2098.  
the M and N Antigens 40338 fenotipizācij-gel technique 2.71 2099.  
40339 Antigen Jk and Jkb-fenotipizācij gel technique 3.64 2100.  
40340 K and k fenotipizācij of Antigen-gel technique 2.90 2101.  
40341 P1 Antigen detection-techniques in 2102 2.30 gel.  
40342 Antigen Lu and Shakes fenotipizācij-gel technique 3.64 2103.  
40343 Antigen Lea and fenotipizācij-gel technique He 3.94 2104.  
40344 Antigen kPa and Kpbs-gel technique in fenotipizācij 3.64 2105.  
fya and Fyb antigens 40345 fenotipizācij-gel technique 5.68 2106.  
40346 Antigen S and s fenotipizācij-gel technique 5.68 2107.  
40347

Of the recipient and the donor's personal compatibility tests are not investigated for recipient imūnhematoloģisk (full imūnhematoloģisk investigations; ABO compatibility-on the plane; Rh compatibility and other systems-gel-technology) 2108 5.44.  
40348 premium manipulation, 40328 40329 40347, for each additional dose of erythrocyte mass betrothed, starting from second clinical chemistry 4.55 Protein substances (41001-41006 tampering) no PO box
Manipulation of code manipulation name tariff 2109.  
total protein is 0.55 41001 2110.  
41002 0.55 albumin 2111.  
41003 protein fractions in serum 2.33 2112.  
41004 urea 0.80 2113.  
41005 uric acid 0.76 2114.  
41006 creatinine 0.64 enzymes (41020-41035 tampering) no PO box
Manipulation of code manipulation name tariff 2115.  
41020 alkaline fosfotāz (SF) 0.63 2116.  
41021 fosfotāz 1.23 2117 of acid.  
AL-Alanīnaminotransferāz-0.63 41022 2118.  
SHARP Aspartātaminotransferāz-0.63 41023-2119.  
gamma glutamīntransferāz-41024 0.83 2120.  
41025-Kreatīnkināz 0.73 2121.  
41026 Laktātdehidrogenāz-0.63 2122.  
41027 lipase 1.70 2123.  
41028 Laktātdehidrogenāz fractions of 2.54 2124.  
41030 Kreatīnkināz-MB fraction 2.43 2125.  
41031 Kreatīnkināz-MB mass 3.73 2126.  
41032 a 1.06 2127 Cholinesterase.  
41033 fosfotāz fractions of alkaline 2.68 2128.  
Alpha amilāz-1.18 41034 2129.  
41035 konvertāz-angiotensin 1.91 Lipids (manipulation 41045-41055) no PO box
Manipulation of code manipulation name tariff 2130.  
41045 total cholesterol 0.56 2131.  
41046 triglycerides 0.95 2132.  
41047 HDL-cholesterol (direct method) 1.24 2133.  
41048 Apolipoproteīn A1 1.91 2134.  
41049 Apolipoproteīn B 1.91 2135.  
41050 lipoprotein fractions 2.92 2136.  
Lipoprotein (A) 2.04 41051 2137.  
41052 Bilirubin, fractions of 0.63 2138.  
41054 HDL-cholesterol (precipitation) 1.03 2139.  
41055 LDL-cholesterol (direct method), an acid Electrolyte 1.68-base balance, inorganic items (manipulation 41065-41085) no PO box
Manipulation of code manipulation name tariff 2140.  
41065 potassium 0.65 2141.  
41067 sodium 0.65 2142.  
41068 calcium 0.63 2143.  
41069 phosphorus 0.63 2144.  
41070 chlorides 0.63 2145.  
41071 iron 0.64 2146.  
41072 magnesium 1.31 2147.  
Iron binding capacity 41073 1.54 2148.  
41077 Copper blood 1.68 2149.  
41079 * blood gas and Ph analysis 9.15 2150.  
41081 ionized calcium 1.49 2151.  
41082 potassium, sodium and ionized calcium determination with the disposable Cuvette 5.11 2152.  
41085 oximetry (different hemoglobin fractions and the automated detection of oxygen content) 8.02 glucose Regulation (41095-41105 tampering) no PO box
Manipulation of code manipulation name tariff 2153.  
41095 glucose blood 0.56 2154.  
41096 glucose loads test 1.89 2155.  
41099 C peptide 3.54 2156.  
41100 insulin 3.08 2157.  
determination of Mikroalbumīnūrij 2.21 41101 2158.  
41102 glucose determination by the disposable cuvettes 0.72 2159.  
41103 Glikohemoglobīn. The result of the study-6.4% and HbA1C level below 2.65 2160.  
41104 Glikohemoglobīn. The result of the study-level HbA1C 6.5-7.4% 2.65 2161.  
41105 Glikohemoglobīn. The result of the study-7.5% HbA1C level and more Reimotest, 2.65 acute phase proteins (41115-41130 tampering) no PO box
Manipulation of code manipulation name tariff 2162.  
41115 Antistreptolizīn (qualitative) 1.12 2163.  
Antistreptolizīn (quantitative) 41116 1.34 2164.  
2165. Transferīn of 1.33 41117  
41122 Ceruloplazmīn of 1.95 2166.  
41124 Ferritin in 2167.3.45  
41125 CRO qualitative 0.95 2168.  
41126 rheumatoid factor (high quality) 2169 0.95.  
41127 CRO quantitative 1.22 2170.  
41128 rheumatoid factor (quantifiable) 1.23 2171.  
41129 immunoglobulin light chain 4.98 2172.  
41130 Paraproteīn through imūnfiksācij of the thyroid hormones 9.83 (41142-41144 tampering) no PO box
Manipulation of code manipulation name tariff 2173.  
41142 the hormone (TSH) Tireotrop 2.76 2174.  
41143 tiroksīn free (FT4) 2.74 2175.  
41144 free trijodtironīn (FT3) and Sexual 2.74 pregnancy tests (41150-41164 tampering) no PO box
Manipulation of code manipulation name tariff 2176.  
41150 a 2.74 2177 Prolactin.  
41151 Folikulstimulējoš hormone (FSH) the 2.65 2178.  
41152 Luteinizētājhormon (LH) 2.65 2179.  
41153 oestradiol 2.97 2180.  
41154 testosterone 2.83 2181.  
41155 progesterone 2.83 2182.  
41156 Estriol (free) 3.73 2183.  
41161 2.98 2184 Dehidroepiandrosteron sulphate.  
41163 an 3.05 2185 Androstendion.  
41164 Horiongonadotropīn for other hormone analysis 3.80 (41170-41176 tampering) no PO box
Manipulation of code manipulation name tariff 2186.  
41170 Aldosterone for 3.90 2187.  
41172 the Somatotrop hormone (STH) 2.83 2188.  
41173 Cortisol is 2.48 2189.  
41174 Catecholamine (adrenaline, noradrenaline d/n in urine) 5.70 2190.  
41175 Parathormon of 3.90 2191.  
41176 Adrenokortikotrop hormone (ACTH SEE SECTION) the drug therapeutic dose 3.21 Discovery (manipulation 41180-41191) no PO box
Manipulation of code manipulation name tariff 2192.  
41180 Primidon 6.23 2193.  
41181 the St.johns 6.23 2194.  
41182 phenytoin 6.23 2195.  
41183 Carbamazepine in 6.23 2196.  
41184 Ciclosporin and Tacrolimus (radioimunoloģisk method) 10.12 2197.  
2198. Valprojskāb 41186-5.00  
41187 theophylline 5.58 2199.  
41188 ethanol with fluorescence polarization detection of immunological method 3.33 2200.  
determination of Ethanol by enzymatic 41189 3.20 2201.  
41190 Methotrexate (high metered dose) 2202 9.43.  
41191 a Methotrexate other specific analyses 5.06 (41200-41223 tampering) no PO box
Manipulation of code manipulation name tariff 2203.  
41200 vitamin B 12 4.67 2204.  
41201 folic acid 4.58 2205.  
41202 a 7.46 2206 Deoksipiridolīn.  
41203 Troponin I 3.71 2207.  
41204 Troponin T 3.91 2208.  
41205 Myoglobin to 3.37 2209.  
2210. Osteokalcīn of 3.81 41206  
41207 Prokalcitonīn of 7.78 2211.  
2212. Homocisteīn of 5.03 41208  
41209 an Erythropoietin 5.56 2213.  
41210-soluble transferīn receptor of 4.39 2214.  
41223 reduced glutathione 5.70 infections (manipulation 41230-41291)

No PO box
Manipulation of code manipulation name tariff 2215.  
41230 ekspresdiagnostik syphilis (VDRL, RPR, SED) 2216 0.85.  
41231 syphilis ekspresdiagnostik (quantitative method, RPR, VDRL titles SUCK) 2217 3.04.  
41232 syphilis-TPH-1.29 2218.  
41233 syphilis-TPH a quantitative method (the title) 3.01 2219.  
41234 Plating for gonorrhea (negative) 3.03 2220.  
41235 on gonorrhea Culture (positive) 2221 3.04.  
41236 pale treponemal immobilization reaction (Nelson test) 4.15 2222.  
41237 IgG immunofluorescence antibody response to syphilis (VFR ABS. IgG) 2.65 2223.  
41238 Imūnfluorescenc's response to the syphilis-quantitative method (title) 6.93 2224.  
41240 Chlamydia detection by direct method (TIFR) imūnfluorescenc-Antigen 3.35 2225 MOMP.  
detection of Chlamydia 41245 with direct method (TIFR) imūnfluorescenc-MOMP antigens for women (from the cervical canal and the urethra) 6.69 2226.  
41246 Vaginoz's DNA/RNA Diagnostics (trihomon, gardnerella, Candida) 7.36 2227.  
41247 Plating on Mycoplasma 4.73 2228.  
41248 plating on ureaplazm to 3.74 2229.  
41249 chlamydial Antigen preparations of washings (imūnfermentatīv method) 2230 6.25.  
41250 Chlamydia by trahomat Ag (affirmative) 5.62 2231.  
41251 Imūnfluorescenc response to the syphilis IgM antibodies (VFR ABS. IGM) 4.99 2232.  
41252 Imūnfluorescenc IgM antibody reaction to syphilitic-quantitative method (title) the 12.67 2233.  
41253 Imūnfermentatīv analysis for the detection of IgG or IgM antibodies to syphilis 2.64 2234.  
41254 Imūnfermentatīv analysis for the detection of chlamydia IgG 2.34 2235.  
41255 Imūnfermentatīv analysis for the detection of chlamydia IGA 2.56 2236.  
41260 Plating on pathogenic skin, hair, nail fungi 3.19 2237.  
41262 Chlamydia trachomatis-specific DNA (PCR) 2238 8.10.  
41263 anti-IgM 4.43 2239 of Toxoplasm manmad.  
41264 anti-IgG of the Toxoplasm manmad 3.34 2240.  
41265 Kriptosporīdij Ag (ELISA) to 4.06 2241.  
41275 Plasmodi Ag of blood (imūnhromatogrāfij) 5.26 2242.  
41276 7.57 2243 Kriptosporīdij cysts.  
41277 Pneumocist carini in the 9.49 2244.  
41279 anti-Hg Ehrlichi sp. IGM 13.37 2245.  
41280 anti Borrelia burgdorferi IgG 3.35 2246.  
41281 anti Borrelia burgdorferi IgM 3.35 2247.  
41282 Borrelia burgdorferi (total) 5.09 2248.  
41283 anti-Mycoplasma pneumoniae IgG 4.78 2249.  
41284 anti-Mycoplasma pneumoniae IgM 4.52 2250.  
members of the Mycobacterium 41285 determination by ligāz chain reaction 22.69 2251.  
isseri's gonorrhe's Not 41286 RNA determination by the method of hybridisation 3.41 2252.  
41287 Chlamydia trachomatis RNA determination by the method of hybridisation 3.86 2253.  
41288 Chlamydia trachomatis and gonorrhea detection method of calling "Gen-Probe" ("combi") 5.87 2254.  
41290 anti-Chlamydia pneumoniae IgG (ELISA) 5.68 2255.  
41291 anti-Chlamydia pneumoniae IgM (ELISA) Hepatitis 5.68 (41301-41328 tampering) no PO box
Manipulation of code manipulation name tariff 2256.  
41301 HBS Ag 1.56 2257.  
41302 anti-HBS (qualitative) 4.00 2258.  
41303 anti-HBS (quantitative) 2259 5.18.  
41304 HBS Ag (confirmatory test) 5.32 2260.  
41305 HBS Ag (ekspresdiagnostik) 2.29 2261.  
the HBV DNA 15.96 41306 2262.  
41307 anti-HAV IgM 3.94 2263.  
41308 anti-HAV 3.37 2264.  
41309 anti-HCV 4.04 2265.  
41310 * anti-HCV (WB) (affirmative) 2266 28.95.  
41316 * anti-HCV (serotype 1 6) 33.82 2267.  
* 41317 HCV RNA (PCR) 2268 35.41.  
41318 the HCV load (PCR) quantitative (viral load) 2269 70.64.  
41319 genotipēšan 67.74 2270 of the HCV.  
41320 anti-HCV IgM 5.69 2271.  
anti-HBc IgM 4.19 41321 2272.  
41322 anti-HBc 3.82 2273.  
41323 anti-HBE 5.19 2274.  
41324 HBE Ag 5.19 2275.  
2276.3.55 41325 HDV Ag  
41326 anti-HDV IgM 3.70 2277.  
41327 anti-HDV IgG 3.70 2278.  
preparation of the material under consideration 41328 (bonus to manipulation: 41302 41306 41307 41303,,,,,,, 41308 41309 41310 41316, 41317, 41319 41320 41321 41318,,,,,,, 41325 41322 41323 41324 41326 41327, 41401,,,,,, 47039 41405 47035 47038, 47043, 47044, 47055, 47057 47052, 47054, 47058, 47059, 47065, 47066 0.33, HIV (AIDS) (41401-41406 tampering) no PO box
Manipulation of code manipulation name tariff 2279.  
41401 anti-HIV 1 and HIV 2 + HIV Ag Elisa (not reactive) 2.23 2280.  
41402 HIV 1 Ag (IFA) (with diagnostiskum price) 5.11 2281.  
41403 HIV 1 Ag (confirmatory) 23.08 2282.  
41404 antibodies against HIV-1 or HIV-2 (the Western blot confirmatory test –) (without diagnostiskum price) 4.48 2283.  
41405 anti-HIV 1/2 ekspresdiagnostik (no jets) 1.57 2284.  
41406 HIV 1 RNA quantitative (HIV load) (PCR) (with diagnostiskum price) 78.88 cytology (42004-42025 tampering) no PO box
Manipulation of code manipulation name tariff 2285.  
42004 Cytological studies of cervical canal (three preparations) 2.92 2286.  
42005 Cytological studies of uterus (three preparations) 2.74 2287.  
42006 Cytological studies of abdominal cavity, pleural and Douglas (three preparations) (serous fluid in the cavity) 2288 2.73.  
42007 Cytological studies of specific therapy (radiation, hormones or chemotherapy) (three preparations) 3.38 2289.  
42008 urine or bladder washings for cytology studies (five preparations) 3.86 2290.  
42012 At bronhoskopij the cytological investigation of the material (three preparations) 3.67 2291.  
42013 Footprint or scrape of the skin or mucous membrane damage of cytological investigation (two preparations) 3.29 2292.  
42014 cytological swab from the mammary glands (one product) 1.84 2293.  
biopsy and surgery material 42015 footprint cytological investigation 4.71 2294.  
42016 Formations and organs of cytological investigation of punktāt (three preparations) 2295 5.11.  
42017 urgent and emergency (during operations) material cytological investigation 10.21 2296.  
42019 cytological smears from cervix and mugurēj investigation of the arches (one product). The result of the C0-study can not be read (small material, red deck FOV) 2297 2.10.  
42020 cytological smears from cervix and mugurēj investigation of the arches (one product). The study result C1 norm group I 2.10 2298.  
42021

Cytological smears from cervix and mugurēj investigation of the arches (one product). The result of the study-group II rules for C2 (inflammation) 2299 2.10.  
42022 cytological smears from cervix and mugurēj investigation of the arches (one product). The results of the study-CIN 1 = C3 LSIL (mild cervical intraepiteliāl not in oplāzij) 2.10 2300.  
42023 cytological smears from cervix and mugurēj investigation of the arches (one product). The result of the study 2/C4-CIN = HSIL CIN3 (mild or cervical intraepiteliāl not, expressed in oplāzij) 2301 2.10.  
42024 cytological smears from cervix and mugurēj investigation of the arches (one product). The study result cancer cells C5-2.10 2302.  
42025 cytological smears from cervix and mugurēj investigation of the arches (one product). The study result C6-torn glass, technical error in Hematopatoloģij 2.10 (43002-43007 tampering) no PO box
Manipulation of code manipulation name tariff 2303.  
43002 cell lipid to 5.90 2304.  
cell glycogen is 2305 7.79 43003.  
43004 acetātesterāz and acetātesterāz cells with inhibition 11.32 2306.  
43005 butirātesterāz-2307 cell 9.23.  
43006 hloracetātesterāz cells of 9.40 2308.  
43007 cell acid phosphatase and acid phosphatase inhibition studies with microbiological 12.02 (manipulation 44001-44136) Microbiology section of the kontrolanalīž costs include handling tariff.
No PO box
Manipulation of code manipulation name tariff 2309.  
44001 blood on the microbial culture-negative 7.28 2310.  
44002 blood on microbial culture-negative with automatic system 7.79 2311.  
blood on the microbial inoculum 44003-positive 10.60 2312.  
44004 blood on microbial culture-positive with the automatic system 11.47 2313.  
44005 Lumbar punktāt plating on the microbial-negative 6.26 2314.  
44006 Lumbar punktāt plating on the microbial-positive (without isseri the serological tipēšan meningitidis) 7.69 2315.  
44007 Lumbar punktāt plating on the microbial-positive (with a isseri of serological tipēšan meningitidis) 12.61 2316.  
44008 wound separation, cavities, exudation, iztriepj punktāt (t.sk. neck and nose), washings, and material plating on aerobic and anaerobic microbial-optional negative 6.02 2317.  
44009 wound separation, cavities, exudation, iztriepj punktāt (t.sk. neck and nose), washings, and material plating on aerobic and anaerobic microbial-optional positive 10.83 2318.  
44015 urine on microbial inoculum and count the number of micro-organisms-negative 5.18 2319.  
44016 urine on microbial inoculum and count the number of micro-positive 5.58 2320.  
sputum culture on the microbial 44017-negative 4.31 2321.  
sputum culture on the microbial 44018 – positive 7.78 2322.  
44019 bile on the microbial culture-negative 5.41 2323.  
44020 bile on the microbial culture-positive 10.31 2324.  
44025 Faecal Enterobacteriaceae of plating on micro-organisms – either. negative 5.01 2325.  
44026 Faecal Enterobacteriaceae of plating on micro-positive songs 6.27 2326.  
44027 Faecal Enterobacteriaceae of plating on micro-positive songs (using the computerised fingerprint identification systems) 7.20 2327.  
44028 faecal culture on Shigella, salmonella-negative 4.42 2328.  
44029 faecal culture on pathogenic intestinal microbial-positive (Shigella, Salmonellaidentifikācij to serogrup) 7.51 2329.  
faecal culture on pathogen 44030 intestine microbial-positive (Shigella, salmonella serotype identification to) 8.45 2330.  
faecal culture on 44031 selection of e. coli – negative 4.81 2331.  
faecal culture on 44032 selection of e. coli-positive 4.81 2332.  
44033 faecal culture on e. coli-157 negative 4.25 2333.  
44034 faecal culture on e. coli-157 positive 8.26 2334.  
44035 faecal culture on cholera izsaucējmikroorganism-negative 4.53 2335.  
44036 Faecal culture on izsaucējmikroorganism-positive cholera 6.04 2336.  
44037 faecal culture on cholera izsaucējmikroorganism-positive (using the computerised fingerprint identification systems) 8.94 2337.  
Group A haemolytic streptococci 44045-the quick test 2.20 2338.  
44046 Plating from the neck and nose to c. diphtheriae – negative 6.07 2339.  
44047 Plating from the neck and nose to c. diphtheriae – positive 6.08 2340.  
44048 Plating from the neck and nose to c. diphtheriae-positive identification by using computerised systems 10.36 2341.  
44049 Plating from the neck-wear detection of n. meningitidis negative 3.68 2342.  
44050 Plating from the neck to the detection of n. meningitidis a carrying-positive (no serological detection of n. meningitidis tipēšan) 2343 7.94.  
44051 Plating from the neck to the detection of n. meningitidis a carrying-positive (with n. meningitidis serological tipēšan) 11.62 2344.  
44055 Plating to b. pertussis and b. Parapertuss-negative 4.36 2345.  
44056 Plating to b. pertussis and b. Parapertuss – positive 6.79 2346.  
plating to beta haemolytic 44057 in Streptococcus pneumoniae – negative 5.95 2347.  
44058 Plating to beta haemolytic Streptococcus pneumoniae-positive for (to Lensfild group identification) 7.52 2348.  
44059 Plating on Methicillin-resistant S aureus (MRSA). over-the-negative 3.82 2349.  
44060 Plating on Methicillin-resistant S aureus (MRSA). over-the-positive 6.06 2350.  
44061 Plating on micro-organisms of the genus Yersinia – negative 3.81 2351.  
44062 Plating on micro-organisms of the genus Yersinia – positive 3.81 2352.  
44063 Plating on micro-organisms of the genus Yersinia-positive (using the computerised fingerprint identification systems) 2353 6.96.  
44064 Plating on the fungi of the genus Candida – negative 2.81 2354.  
44065 Plating on the fungi of the genus Candida – positive 4.02 2355.  
44070 Plating on micro-organisms of the genus Campylobacter – negative 4.87 2356.  
44071 Plating on micro-organisms of the genus Campylobacter-positive 17.41 2357.  
44072 Plating on micro-organisms of the genus Helicobacter-negative 6.52 2358.  
44073 Plating on micro-organisms of the genus Helicobacter-positive 9.44 2359.  
44074 Plating on anaerobic microbial-negative 8.18 2360.  
44075 * Plating on anaerobic microbial-positive 14.93 2361.  
the Study on the disbioz of 44080 18.59 2362.  
44081

Fagotipēšan 7.12-2363.  
the sensitivity of micro-44082 determination against antibiotic substances by diffusion method using agār drives 4.78 2364.  
44096 washings from the surrounding environment (drugs, surgical operation) – 2365 4.63.  
microbiological investigation of waste water 44097 – negative 6.04 2366.  
* waste water microbiological investigation 44098-positive 22.83 2367.  
44105 Plating on the fungi of the genus Candida – positive (using the computerized identification system identification) 6.64 2368.  
the sensitivity of micro-44106 determination against antibiotic substances 5.76 2369.  
44107 Plating on ureaplazm and mycoplasmas with medication sensitivity detection 6.52 2370.  
44108 Helycobacter pylori antibody against the determination by quick method to 4.29 2371.  
44109 neutralization test on animals for the determination of botulotoksīn (bioprov) 12.22 2372.  
44110 agglutination reaction to bacterial infections (whooping cough, brucellosis, tularemia, etc) 2.28 2373.  
44115 HA response to bacterial infections (infectious enteritis, šigelloz) 2374 3.10.  
44116 serological antibody response to y. enterocolitica and y. pseudotuberculos by 2.93 2375.  
the material preparation of 44117 first serological analysis for bacteriological laboratory. Supplement to the manipulations 44110, 44115 and 0.80 44116 2376.  
preparation of the material under consideration 44118 to each subsequent serological analysis for bacteriological laboratory. Premium manipulation 44110, 44115 and 44116 0.26 2377.  
44119 IgG antibodies against diphtheria toxin 4.28 2378.  
44125 serological reaction to leptospirosis 5.52 2379.  
44126 feed preparation of micro-organisms in the genus Mycobacterium growing 0.87 2380.  
the material handling 44127, inoculation and grown colonies to the Mycobacterium genus microscopy micro-organisms (without feed preparation) 2381 3.03.  
44128 Mycobacterium genus to species identification of micro-organisms and microorganisms detection sensitivity to antimicrobial substances 10.12 2382.  
44129 * Atypical Mycobacterium of micro-organisms of the genus to species identification and microbial sensitivity to antimicrobial substances determination 13.21 2383.  
the Mycobacterium genus 44130 micro-automated determination of drug sensitivity to antimicrobial substances, using automatic systems 28.48 2384.  
the Mycobacterium genus 44131 micro speed up investigations using the prepared feeds: Septa-Check or BACTEC 12B ATB, the MGI 13.06 2385.  
44132 Aspargill Ag (lateksaglutinācij) 5.53 2386.  
44133 Candida Ag (lateksaglutinācij) 5.53 2387.  
44134 Legionell Ag (imūnhromatogrāfij) in the urine 9.53 2388.  
44135 Cryptococc of Antigen express of the biological fluids with 5.17 2389.  
44136 difficill Clostridium toxin a Antigen or A determination to express the feces microbiological examinations of tuberculosis 6.25 (45001-45014 tampering) no PO box
Manipulation of code manipulation name tariff 2390.  
45001 * plating tuberculosis diagnosis with automatic system 17.15 2391.  
45002 the Mycobacterium genus micro-determination of sensitivity to medications in row 1 with automatic system 85.29 2392.  
the Mycobacterium genus 45003 micro-determination of sensitivity to line 1 and 2 medications with automatic system 198.00 2393.  
45004 * diferenciāltest micro-organisms Mycobacterium genus (NAP) with automatic system 57.20 2394.  
45005 * the sensitivity of micro-organisms of the genus Mycobacterium detection against pirazinamīd (PZ) with automatic system 35.17 2395.  
micro-organisms Mycobacterium genus 45006 sensitivity determination against 1. medications to the hard line feeds 9.73 2396.  
45007 genus Mycobacterium detection sensitivity of micro-organisms from row 2 to hard drugs feeds 10.87 2397.  
45008 the Mycobacterium genus micro-determination of sensitivity to 1 and 2 rows on hard drugs feeds 18.13 2398.  
the Mycobacterium genus 45009 micro-determination of sensitivity to row 2 medicines with automatic system 113.43 2399.  
the Mycobacterium genus 45010 micro-determination of sensitivity to one medication with the automatic system 40.70 2400.  
Mycobacterium genus 45011 microscopic investigation of micro-organisms with fluorescent method 2.08 2401.  
Mycobacterium genus 45012 micro-determination of sensitivity to one medication to rigid feeds 6.38 2402.  
45014 hard Lēvenštein-Jansen's medium preparation 0.81 Immunology cell Immunology (46002-46040 tampering) no PO box
Manipulation of code manipulation name tariff 2403.  
46002 metabolic activity in leucocytes (NZ) 5.73 2404.  
46006 metabolic activity and leukocyte "oxidative burst" (NZ + chemiluminescent method) to 6.37 2405.  
46009 DNA investigations 15.70 2406 citofluorimetrisk.  
46010 T and B lymphocyte subpopulācij (one position) 4.70 2407.  
46015 CD3 + and CD19 + cell * detection 12.34 2408.  
* CD4 + and CD8 + 46016 cell detection 12.34 2409.  
* T and B cell 46017 surface receptor (CD3, CD4, CD8, CD19 +, CD3/CD16 56 HLA-DR, HLA-DR) (citofluorimetrij), 22.05 2410.  
46018 Imūnregulējoš determination of the cell (CD, CD 3, CD 45 16, 19), four color citofluorimetrij-21.61 2411.  
* T-imūnregulējoš cells 46019 (CD, CD 3, CD 4 45, CD 8), four color citofluorimetrij-2412 22.56.  
46020 * Leikož cell phenotype (citofluorimetrij) 39.25 2413.  
46021 (CD34 +) the stem cell discovery 30.87 2414.  
46022 Cytokine determination of blood serum 7.14 2415.  
46023 induced interferon gamma (IFN y) cell culture testing (ELISA) 7.46 2416.  
46024 cytokine induced cell culture testing (ELISA) 7.75 2417.  
46035 HLA-A (B, C)-1 Antigen (limfocitotoksisk method) 2418 4.31.  
the HLA-B27 46036 Discovery (imūnfluorescenc method) 2419 7.98.  
determination of parameters of Imūnģenētisk 46037 patients with autoimmune diseases (HLA-B, HLA-DR) 8.19 2420.  
46038 HLA-DR Antigen 1 (limfocitotoksisk test) 2421 4.66.  
46039 HLA DR, DQ 1, genotipizēšan to 1, DQB polymerase chain reaction-single line 2422 7.39.  
46040 HLA DR, DQ 1, genotipizēšan to 1, DQB polymerase chain reaction 10.79 Humoral immunity (46051-46075 tampering) no PO box
Manipulation code

The name of the tariff manipulation 2423.  
46051 * immunoglobulin G (A, M) 5.72 2424.  
46053 humoral immunity activity detection (IgG, IgG1, IgG2, M, A, IgG3, IgG4) (Mancini + ELISA) 5.20 2425.  
46054 circulating imūnkompleks (HOW) does not felometrisk to 2.40 2426.  
the Oligoklonāl bar in 46055 IgG detection in likvor by isoelectric focusing (IEF) electrophoresis 25.54 2427.  
immunoglobulin IgG 46056 no felometrisk (turbidimetrisk) 1.80 2428.  
of immunoglobulin Ig 46057 no felometrisk (turbidimetrisk) 1.86 2429.  
determination of immunoglobulin Ig 46058 M felometrisk (turbidimetrisk) not 1.99 2430.  
detection of immunoglobulin Ig E 46059 (ELISA) 3.30 2431.  
46060 * specific Ig E (panel-5 Ag) 5.38 2432.  
specific Ig E 46065 Discovery (panel 12 Ag) 6.33 2433.  
* specific Ig E 46066 determination – 20 separate Antigen panel 17.39 2434.  
total and specific 46067 IGE (IGE + total IGE specific) (ELISA) 2435 6.60.  
46069 C1 inhibitor Discovery (radial Immunodiffusion) 2436 7.10.  
46070 complement components C3 no felometrisk (turbidimetrisk) 2.00 2437.  
46071 complement components C4 no felometrisk (turbidimetrisk) 2438 2.19.  
C the determination Cistatīn 3.17 46074 2439.  
46075 amiloīd A determination of Serum Autoimunitāt 3.83 (manipulation-46085 46136) no PO box
Manipulation of code manipulation name tariff 2440.  
determination of HEPA-46085 2 cell culture (screening-indirect imūnfluorescenc) 2441 3.90.  
the determination of AN HEP 46086-2 cell culture (titration-indirect imūnfluorescenc) 8.59 2442.  
46087, SM, GPC, LKM, AM discovery aspects of tissue (screening-indirect imūnfluorescenc) 6.41 2443.  
46088 *, SM, GPC, LKM, AM discovery aspects of tissue (titration-indirect imūnfluorescenc) 17.55 2444.  
46089 * ANC detection (screening-indirect imūnfluorescenc) 2445 4.67.  
46090 ANC Discovery (differentiation, indirect imūnfluorescenc) 6.31 2446.  
46091 anti-DNA antibodies to the Crithidi of the lucidi 4.83 2447.  
46092 anti DNA antibody detection (quantitative) 3.66 2448.  
rheumatoid factor detection 46095 (RF-RF IGA, IgG-RF-IgM) (ELISA) 7.89 2449.  
EN 46100 detection (screening, BIOASSAY) 3.41 2450.  
ENA subtip 46101 (SM, RNP, SSA, SSB, J0s-1 Scl-70) 12.52 2451.  
46102 ENA subtip (position 1 of the six specified in point 409101,) (ELISA) 2452 3.90.  
46103 * anti DNA antibody discovery and detection of subtip ENA (SM, RNP, SSA, SSB, Scl-70, JO-1) 15.44 2453.  
the screening and 46104 Ana HEP-2 determination of cell culture 8.43 2454.  
46105 antibody against cells of Langerhans islets of indirect imūnfluorescenc determination of 7.15 2455.  
46107 antibody against Helicobacter pylori IgG detection (ELISA) 2456 6.31.  
46108 antibody against Helicobacter pylori IGA (ELISA) 2457 6.31.  
Antitireoidāl antibody detection 46109 (indirect imūnfluorescenc) 7.37 2458.  
46110 Autoantiviel against tireoglobulīn detection 4.97 2459.  
Autoantiviel against Phospholipid-46111 discovery 5.35 2460.  
46112 Autoantiviel against MP determination 3.86 2461.  
determination of Autoantiviel against PR3 46113 3.39 2462.  
46115 Antimikrosomāl determination of antibody (ELISA) 6.03 2463.  
the 3.37 2464 Tireoglobulīn 46116.  
Antigliadīn determination of antibodies against 46117 (IgG) 5.56 2465.  
46118 Antigliadīn determination of antibodies against the (Ig) 5.56 2466.  
46119 Antispermāl IgG, IgM antibody determination of total (ELISA) 8.59 2467.  
46120 Antiadrenāl antibody (indirect imūnfluorescenc) 7.51 2468.  
Antisēkliniek antibody detection 46121 (indirect imūnfluorescenc) 4.43 2469.  
46122 Antiolnīc antibody (indirect imūnfluorescenc) 8.30 2470.  
anti-GBM antibody 46123 Discovery (indirect imūnfluorescenc) 2471 7.18.  
46124 Antihiston antibody (ELISA) 4.56 2472.  
Antikardiolipīn antibody detection 46125 3.75 2473.  
antibodies against skeletal muscle 46130 (indirect imūnfluorescenc) 2474 8.11.  
46131 antibodies against glutamildekarboksilāz of 10.07 2475.  
the TSH receptor antibody 46132 discovery 6.54 2476.  
46134 antibodies against receptors 8.95 2477 acetilholīn.  
anti-GM1 antibody 46135 discovery 7.11 2478.  
46136 anti-MAG antibodies for Tumor Marker determination 6.47 (46148-46163 tampering) no PO box
Manipulation of code manipulation name tariff 2479.  
* 21-46148 CYFR citokeratīn 19 1 fragment 5.36 2480.  
the SCC-46149 squamous cancer Antigen 5.38 2481.  
46150 but-HGH-horiongonad-tropīn for free 3.89 2482.  
46151 Alpha-alpha of fetoproteīn 2.64 FP-2483.  
46152 CE-Karcioembrionāl Antigen 3.38 2484.  
46153 * tumor marker CA-125 3.64 2485.  
46154 * tumor marker CA 19-9 3.64 2486.  
46155 * NS-specific neuronal enolāz» 7.04 2487.  
46156 * PSA-prostate specific antigen 3.42 2488.  
46157 * free-PSA, prostate specific antigen 6.43 2489.  
the tumor marker CA 46158 15-3 3.64 2490.  
the BMG-46159 Beta 2 of mikroglobulīn 4.57 2491.  
the Estrogen receptor 46160 quantitative and qualitative determination of tumor tissue 21.43 2492.  
the progesterone receptor 46161 quantitative and qualitative determination of tumor tissue 21.52 2493.  
46162 anti-p-53 determination in serum 13.17 2494.  
46163 BT-Urīnpušļ cancer Antigen 6.05 other immunological analysis (46164-46175 tampering) no PO box
Manipulation of code manipulation name tariff 2495.  
46164 transglutamināz antibodies (IGA) 5.58 2496.  
46165 transglutamināz antibodies (IgG) 5.58 2497.  
the antibodies against GM1, 46166 asial the GM2, GD1b, GQ1b 25.95 GD1, 2498.  
Renin-angiotensin 46170 determination in blood plasma (radioisotopes) 7.40 2499.  
the down syndrome and 46171 Trisomy 18 (Edwards syndrome) diagnosis (AFP + HGH + free estriol) (ELISA) 13.46 2500.  
* spontaneous abortion risk 46172 immunological control (to test + HGH) 12.63 2501.  
specific Bacterial DNA 46173 Discovery (Helicobacter pylori, Not the gonorrhe, gardnerella iseri, Trihomon-vaginal) 6.70 2502.  
Eozinofīl of the katjonisk protein in 46175 detection with radioimunoloģisk method 11.57 Virology (47001-47027 tampering) no PO box
Manipulation of code manipulation name tariff 2503.  
47001

Involved, t.sk. polivīrus isolation and tipēšan of tissue culture with negative result 8.03 2504.  
the t.sk Involved, 47002. polivīrus of isolation and tipēšan of tissue culture with positive results 15.43 2505.  
47003 Rotavirus Antigen-specific indication of feces 3.73 2506.  
hepatitis A virus 47004 specific antigen of the feces indicating 4.69 2507.  
hepatitis A virus 47005 specific antigen indication water 4.89 2508.  
47007 * respiratory virus (influenza A, B, adenovīrus, paragrip I, II, III RSV) isolation and tipēšan of tissue culture with positive results to 12.77 2509.  
47009 respiratory virus Antigen specific indication and tipēšan with monoclonal antibodies, quick method – imūnfluorescenc with positive results 8.62 2510.  
47010 respiratory virus Antigen specific indication 5.08 2511.  
47015 herpes virus-specific antigens in the tissue culture indicating 6.39 2512.  
47016 herpes virus Antigen specific indication 5.87 2513.  
Citomegalovīrus specific antigen 47018 indication 5.67 2514.  
47019 Citomegalovīrus specific DNA detection 7.25 2515.  
47020 Citomegalovīrus Discovery (quality) (polymerase chain reaction) 8.84 2516.  
Herpes Zoster Virus 47021 (polymerase chain reaction) 8.84 2517.  
47024 tick encephalitis virus isolation in tissue culture + Elisa with a positive outcome 2518 8.50.  
47025 human papilloma virus specific DNA detection 10.01 2519.  
47026 Rotavirus Ag 3.01 2520.  
47027 * quantitative CMV EBV DNA or DNA (PCR) 34.59 viruses specific antibody detection (manipulation – 47035 47072) no PO box
Manipulation of code manipulation name tariff 2521.  
47035 IgM class antibodies to tick-borne encephalitis virus 4.77 2522.  
47036 IgM class antibodies against B19 5.26 2523 of parvovīrus.  
47038 anti-CMV-IgG 3.72 2524.  
47039 anti-CMV IgG (quantitative)-5.07 2525.  
anti-CMV-IgM 47040 4.46 2526.  
* anti-47041-CMV IgM (WB) (confirmatory test) 2527 22.27.  
47042 anti-EBV IgM 3.22 2528.  
47043 anti-EBV IgG 3.22 2529.  
47044 anti-EBV IgG (quantitative) 4.64 2530.  
47045 anti-EBV total 2.63 2531.  
47050 antibodies to EBV nuclear antigen (EBV EBN) 3.88 2532.  
Bunell heterofil 47052 Paul-test for the detection of antibody 1.58 2533.  
47053 anti-herpes simplex (I), (II) IgM 3.73 2534.  
47054 anti-herpes simplex I, II IgG 3.71 2535.  
47055 anti-IgG herpes simplex I, II (quantitative) 4.58 2536.  
anti-Varicell-47056 Zoster (VZV) IgM 5.04 2537.  
anti-Varicell-47057 Zoster (VZV) IgG 4.08 2538.  
anti-Varicell of 47058 Zoster (VZV) IgG (quantitative) 2539 5.18.  
47059 IgG class antibodies to tick-borne encephalitis virus 5.05 2540.  
47061 anti-rubella (rubella) or anti-Rubeol (measles) IgG 2.54 2541.  
47062 anti-rubella (rubella) or anti-Rubeol (measles) IgM 2.97 2542.  
47065 IgG class antibodies against mumps virus 5.18 2543.  
47066 IgM class antibodies against mumps virus 5.41 2544.  
47067 virus specific IgG class antibodies (rabies virus) 7.16 2545.  
47070 influenza virus haemagglutinating antibodies specific for the detection of 5.37 2546.  
47071 Paragrip I, II, III virus specific antibody detection 4.86 2547.  
47072 complement fixation test (one sample) 5.89 Parasitology (48001-48015 tampering) no PO box
Manipulation of code manipulation name tariff 2548.  
48001 scabbers mite 2.74 2549.  
48002 anti-Trichinella spiralis 2.97 2550.  
48003 Echinococcus anti-sp. (Ag) 5.63 2551.  
Compatible with the trofozīt of lambli 48004 and cyst Ag 3.82 2552.  
48005 and Lamblij determination of helminth in preparation for native bile and sediment (one serving) 2553 1.19.  
anti-Toxocar-48006 Canis IgG 3.09 2554.  
48007 Echinococcus anti-sp.
2555 6.38.  
48008 anti-IgG Echinococcus granulosus 5.90 2556.  
48009 anti-IgM Echinococcus granulosus 5.90 2557.  
investigation on demodekoz 48010, dziedzerērc, 1.51 2558.  
48011 anti-Entamoeb-histolytik (HA) 7.34 2559.  
the histolytik Ag Entamoeb 4.82 48012 2560.  
Materials check-out Inves 48013 on pathogen of skin, hair, nail fungi or dziedzerērc, or mite from scabbers focus 0.21 2561.  
Materials check-out Inves 48014 on pathogen of skin, hair, nail fungi or dziedzerērc, or from a number of mite scabbers foci (average 2-3 foci) 0.31 2562.  
48015 material (nails, skin and hair) from multiple foci of investigation on fungi genetics 0.83 (49001-49064 tampering) no PO box
Manipulation of code manipulation name tariff 2563.  
the amino acid spectrum 49001 detection in the blood with liquid chromatography 90.48 2564.  
the amino acid spectrum 49002 detection in urine by liquid chromatography 90.48 2565.  
the amino acid spectrum 49003 discovery amniotisk liquid with liquid chromatography 90.48 2566.  
* carbohydrates 49004 thin layer chromatography urine 26.47 2567.  
49005 * carbohydrate TLC blood serum 26.47 2568.  
49006 * newborn screening for phenylketonuria 1.56 2569.  
the newborn congenital 49007-2.31 2570 hipotireoz screening.  
(A) determination of PAPP-49008 blood serum of pregnant women at risk first trimester 6.77 2571.  
49009 free beta horionisk gonadotrophin in detection in serum of pregnant women at risk in the first and second trimester 6.01 2572.  
49010 * Alpha-fetoproteīn and horionisk in the free beta determination of serum gonadotrophin in groups at risk pregnant women in the second trimester (pregnant women two biochemical markers in screening for fetal Trisomy risk percentage) 7.48 2573.  
49015 * Alpha-fetoproteīn detection in serum of pregnant women at risk (prenatal screening the fetal neural tube defects) 4.43 2574.  
49016 * Alpha-fetoproteīn discovery amniotisk liquid risk groups pregnant 4.43 2575.  
* organic acids 49017 spectrum detection in urine with gas chromatography 41.79 2576.  
* organic acids 49018 spectrum detection in serum by gas chromatography 45.29 2577.  
* organic acids spectrum 49019 discovery amniotisk liquid with gas chromatography 44.13 2578.  
49021 * Mukopolisaharīd (MPS) screening and quantitative spectrometric determination in the urine 15.59 2579.  
49022 *

Mukopolisaharīd (MPS) quantitative Spectrophotometric detection of amniotisk tincture 15.59 2580.  
49023 * Mukopolisaharīd (MPS) spectrum detection in urine with electrophoresis help 38.61 2581.  
49024 (MPS) * Mukopolisaharīd detection in liquid amniotisk with two-dimensional electrophoresis help 38.61 2582.  
49025 * human genome DNA extraction 16.31 2583.  
49026 * Himērism monitoring after allogeneic bone marrow or peripheral blood stem cell transplantation using STR loci of 2584 155.46 genotipēšan.  
49027 * Ph (Philadelphia) chromosome identification using RT-PCR, two stage (La/MoB 075) 2585 68.74.  
49028 * Ph (Philadelphia) chromosome positive leikož therapy control effectiveness using BCR/ABL gene expression quantification analysis (La/MoB 089) 186.18 2586.  
49030 DNA analysis using polymerase chain reaction in human genetic diseases diagnosis 35.52 2587.  
49031 genomic DNA extraction from Guthrie to papīrīš human genetic pathology diagnosis 4.54 2588.  
the gene mutation 49032 selective screening by DGG analysis 101.49 2589.  
49033 * SMA gene mutation detection 42.13 2590.  
49034 * Fenilalanīnhidroksilāz-gene mutation detection (one mutation) 29.18 2591.  
the Average length of the Acyl 49035-what A dehydrogenase gene mutation detection by 32.30 K329 2592.  
the Fragile X syndrome 49036 selective screening by PCR method 40.32 2593.  
the Fragile X syndrome in 49037 mutation detection by using Sauzern's not radioactive bloting features 55.12 2594.  
not cultivated cells 49038 fluorescent in situ hybridisation methods (cost of one patient one pathology) 2595 158.38.  
the Fibroblast culture 49039 chromosome analysis (cost per patient) 2596 139.06.  
49040 additional chromosome number of fluorescent in situ hybridisation methods (cost of one patient one pathology) 2597 159.24.  
the additional chromosome C 49045 bar painting with barium hydroxide 12.01 2598.  
the additional chromosome 49046 CHOIR band painting with color 13.34 Gimza 2599.  
* Postnatāl in the fragile X 49047 chromosome analysis (cost per patient) 65.20 2600.  
49048 * blood and bone marrow chromosome analysis of culture (one patient) to the standard method of 60.61 2601.  
49049 * Amniocīt cultural analysis of chromosomes (one patient) (prenatal diagnosis in) 2602 135.13.  
49050 chorionic villus biopsy of the cultural analysis of chromosomes (one patient) (prenatal diagnosis in) 139.08 2603.  
* medical ģenētiķ medical 49052 genetic counseling for the family (public limited liability company "children clinical University Hospital" medical genetics clinic) (first-time) 25.98 2604.  
* medical ģenētiķ medical 49053 genetic counseling for the family (public limited liability company "children clinical University Hospital" medical genetics clinic) (repeat) 9.01 2605.  
49061 (minisatelīt) the VNTR analysis system in the gene FAH 36.65 2606.  
49062 * STR (mikrosatelīt) system analysis FAH gene 41.49 2607.  
the Y chromosome deletion of 49063 detection using "Promeg system, Version 1.1" kit with PCR method 86.21 2608.  
49064 * genetic study of ultrasonic akušērij 6.25 Radiology (manipulation 50011-50853) 1.   Rentgendiagnostik (Rtg), computed tomography (CT) and magnetic resonance (MR) examination of archival images included in the tariff.
2. CT and MRI examination fees included in the radiologist's Diagnosta job costs that are made digital rentgendiagnostik image viewing and processing.
3. Rentgendiagnostik tariff includes the manipulation of image (picture) prints cost – one for each projection prints.
4. Manipulation 50012-50027 presented one day for one patient the examination conducted regardless of the number of examinations carried out by choosing their corresponding to the total number of projection radiography examinations.
5. the meaning of these provisions in the MR manipulation "one part of the body" are: head; neck; chest; mammary glands; stomach and small pelvis; both hip joints; each of the shoulder, elbow, wrist, knee and ankle joint; the neck part of the spine; the thoracic spine; lumbar spine; Spinal cross-tail section.
No PO box
Manipulation of code manipulation name tariff 2609.  
50011 lumbar vertebra and femur head osteodensitometrij in the study with a central osteodensitometrij (DX) apparatus 13.26 2610.  
X-ray study of 50012 in one plane 0.90 2611.  
X-ray studies of 50013 biplane 2.92 2612.  
X-ray studies of 3-50014 4 planes 6.16 2613.  
50027 X-ray tests 5-6 planes 9.48 2614.  
Mielogrāfij-50053 12.21 2615.  
Retrogrād in holepankreatogrāfij-50066 13.66 2616.  
50072 thoracic cavity organs or esophageal screened by companies, including esophageal kontrastēšan 2.90 of 2617.  
50073 gastric, duodenal and small intestine kontrastizmeklējum, including intestinal passage 14.29 2618.  
Urīntrakt kontrastizmeklēšan-50085 with i/v contrast medium (ekskretor in urogrāfij, including the reporting companies) 2619 8.74.  
50087 colon in kontrastizmeklēšan of retrogrād 25.47 2620.  
50088 urethra and/or bladder or uterine tubal kontrastizmeklēšan kontrastizmeklēšan, or fistulogrāfij, or galaktogrāfij, or pneimocistogrāfij of 4.90 2621.  
upper urinary tract 50094 investigation with contrast medium injection of 4.90 retrogrād 2622.  
50097 bonus on standartmammogrāfij following additional mammograms with local compression increases or other non-standard projection 1.53 2623.  
50101 Mammography description (both breasts, each in two planes) 1.57 2624.  
description in addition to Mammography 50102 planes, if carried out study 50097 0.40 2625.  
50104 digital rentgenizmeklējum teeth and facial-jaw area. Digital cefalogrāfij-4.47 2626.  
50105 bonus on digital technology uses x-ray examinations 2.66 2627.  
50106 Mammography (both breasts, each in two planes). The study result R 1-norm 3.54 2628.  
50107 Mammography (both breasts, each in two planes). The study result R 2 – potentially benign found/separate benign gimmick 3.54 2629.  
50108

Mammography (breast, two each in two planes). The study result R 3 – suspected pathology/local pathological changes 3.54 2630.  
50109 Mammography (both breasts, each in two planes). The study result R 4-potential/suspected malignancy malignancy formation 3.54 2631.  
50110 Mammography (both breasts, each in two planes). The study result R 5-proven malignancy/cancer found a 3.54 2632.  
* direct intraarteriāl of embolizācij 50118 or trombolīz, using mikrokatetr the 513.54 2633.  
50119 * hollow vein filter implantation 620.28 2634.  
* Percutaneous angioplasty of translumināl 50120, stentēšan 683.64 of 2635.  
one of the Superselektīv artery 50122 angiography (bronchial, lumbar, spleen, thyroid and other) using mikrokatetr 520.70 of 2636.  
Arteriovenoz of the embolizācij malformations 50123 * head and spinal brain 925.59 2637.  
50124 * Aortogrāfij, kavogrāfij, pulmangiogrāfij, splenoportogrāfij-2638 183.82.  
50130 * selective one artery angiography 255.21 2639.  
50131 * cerebral aneurysm using mikrokater of embolizācij, 674.68 2640.  
50134 * peripheral angiography 2641 146.38.  
* peripheral flebogrāfij of 99.97 50138 2642.  
the transhepatisk of the Percutaneous holangiogrāfij 50144 (PTH) 2643 93.53.  
* the transhepatisk's examine 50145 Percutaneous drainage (with disposable bile and pancreatic drain Kit) 2644 224.49.  
* the transhepatisk of 50146 Percutaneous dilation of 418.90 examine 2645.  
* Supplement for brain 50147 patronage systems use 2646 1685.88.  
* Supplement for embolizācij-50149 mikrosfēr PV 1 ml use 122.85 2647.  
* Supplement for embolizācij-50151 trace PV 1 ml use 71.82 2648.  
* Supplement for embolizācij-50152 spiral peripheral blood vessels (one spiral) 47.25 2649.  
* Supplement for embolizācij 50153 spiral brain aneurysm (one spiral) 365.85 2650.  
50154 * bonus on peripheral vascular stent use in bilār or 472.50 2651.  
* Supplement for the 50155 Carota stent use 756.00 2652.  
50156 * bonus on bilār Stents in the peripheral or the use of prostheses 652.05 2653.  
* Supplement for 50158 PTA balloon intracerebral indications use 2654 897.75.  
50159 * bonus on medicine Streptokināz (Streptokinas) 1.5 million. the use of the unit 74.38 2655.  
50160 * bonus on medicine Urokināz (Urokinas) 200 000 units use 28.35 2656.  
50161 * premium on N-butyl-1 ml use of cyanoacrylat 18.90 2657.  
50162 * premium on 131 I-Ethiodised oil 10 ml use 9.45 2658.  
50163 * bonus on embolizācij system of 1.5 ml using 930.83 2659 ONYX.  
* Supplement for 50165 arterial puncture site closure kit use 70.46 2660.  
* Supplement for transradiāl of 50166 puncture kit use 18.43 2661.  
50167 * Premium for each subsequent selective artery investigated in one procedure 70.88 2662.  
50168 * bonus on the examine the biopsy kit use 378.00 2663.  
* brain radionuclide angiography 50220 and static scintigraphy with TC-99m-pertehnetāt 6.44 2664.  
* Premium manipulation 50220 50221 on RFP use 642.60 2665.  
* Cistenogrāfij-2666 50222 13.38.  
50223 lung perfusion scintigraphy in 5.67 static 2667.  
50224 lung ventilation scintigrāfisk investigation using radioactive gas or radioactive aerosols 11.99 2668.  
50225 * heart muscle miokardiotrop for static scintigraphy with RFP rest position 23.00 2669.  
50226 * heart muscle with the static miokardiotrop of the RFP, scintigraphy synchronized with ECG at rest 25.15 2670.  
50227 * Kardioventrikuloscintigrāfij (with a marked plasma or erythrocytes), synchronized with ECG at rest 12.37 2671.  
50228 * Kardioventrikuloscintigrāfij (with a marked plasma or erythrocytes), synchronized with ECG at rest + load 17.59 2672.  
50229 * heart muscle miokardiotrop for static scintigraphy with RFP synchronized with ECG stress 27.68 2673.  
the main vascular 50230 dynamic and static scintigraphy 10.30 2674.  
* Premium 50231 50220, 50221, manipulation, 50225, 50223 50229 50234 50236 50226,,,,,,, 50302 50243 50260 50271 on SPEC to use 7.10 2675.  
50232 premium manipulation of radionuclide renal 50235 angiography 3.15 2676.  
Premium manipulation on 50233 50235 tubulār or glomerul clearance determination 2.95 2677.  
50234 * static renal scintigraphy 4.09 2678.  
50235 renal dynamic scintigraphy 5.98 2679.  
* adrenal scintigraphy 10.83 50236 2680.  
the skeletal parts scintigrāfisk 50237 investigation covering the kontralaterāl side 5.25 2681.  
50238 more skeletal part scintigrāfisk investigation 5.25 2682.  
50239 all skeletal 7.41 2683 scintigrāfisk investigation.  
* thyroid radiometrij with 50241 131J or 99m-TC pertehnetāt-10.21 2684.  
50242 thyroid scintigraphy in the static 8.41 2685.  
blakusķermenīš scintigrāfisk of the thyroid 50243 investigation 4.30 2686.  
the static sialoscintigrāfij of 8.77 50244 2687.  
50245 premium manipulation of dynamic sialoscintigrāfij of 3.15 50244 2688.  
the liver and spleen 50255 static scintigraphy with colloids in 4.53 2689.  
50256 * liver and bile izvadceļ dynamic scintigraphy 9.01 2690.  
50257 * selective splenic scintigraphy with radio-labelled erythrocytes 9.16 2691.  
50258 * lean scintigramm, including functions and/or capacity determination with radiolabelled, altered erythrocytes 11.55 2692.  
50259 * premium manipulation 50258 on selective in vitro blood cells labeled with radioactive India 12.31 2693.  
the lymphatic system scintigrāfisk 50260 investigation 25.57 2694.  
50261 * bone-marrow scintigrāfisk investigation by 99m-TC-labelled substances 11.26 2695.  
50262 * Imūnscintigrāfij with antiķermeņ of radio-marked 13.84 2696.  
50263 premium manipulation 50262 for two or three subsequent investigations 4.09 2697.  
50264 * premium 50262 for more manipulation not as three subsequent tests 7.74 2698.  
the oesophagus and 50265 gastric dynamic scintigraphy 12.37 2699.  
* in Duodenogastroezofageāl reflux 50270 Diagnostics 12.37 2700.  
* whole body scintigraphy 50271, tumors and metastases in the RFP or the diagnosis with tumorotrop to search inside the 6.44 2701.  

50272 premium manipulation for each subsequent study 50271 (during the day) 2.24 2702.  
Premium manipulation 50271 50273 on companies after 24 hours 2.06 2703.  
50274 * bonus on pulse to surface area and/or volume unit of quality assessment, measuring, documenting 16.46 2704.  
* venous vascular 50275 scintigraphy, preparation of entering the peripheral veins 10.50 2705.  
50277 * Radionefrogrāfij in one position with the lead analysis 4.96 2706.  
50278 * Radionefrogrāfij in one position with the lead analysis in several positions 7.31 2707.  
50279 * premium at manipulation, on heart and 50277 50278 bladder radiography of 13.31 2708.  
50280 * resorption or gut fat loss, iron, žultsskāb, protein or blood detection with radioactive substances 13.27 2709.  
50285 * blood volume determination with radio-labelled erythrocytes 10.64 2710.  
the erythrocytes, leucocytes 50286 and determination of platelet life span with radiolabelled cells, without indicating the location of the decay 20.54 2711.  
the erythrocytes, leucocytes 50287, platelet life span determination with radiolabelled cells, indicating the location of the decay 17.14 2712.  
* Premium manipulation 50288 50286 50287 on selective, in/in vitro blood cell labeling with radioactive India 11.90 2713.  
50289 * iron kinetics with radioactive iron 11.98 2714.  
* whole body external 50290 radiometrij to Cs + Cs 134 137 3.97 2715.  
* The Benign thyroid disease 50300 treatment with J131, including necessary to relate the 12.35 2716.  
50301 * malignant thyroid disease treatment with J131, including the necessary control of 83.56 2717.  
50302 * metastases or tumor detection asinsveidojoš organs, including the necessary control of 9.06 2718.  
50303 * cavity therapy using endostat or an endoscope JS entered 16.23 2719.  
* planning with irradiation 50340 dose calculation, the target area without the use of a computerized system for scheduling 2.37 2720.  
50341 * irradiation dose planning with the objective of determining the area using beam beam modeling, using a computerized system for scheduling 26.07 2721.  
* simulation of irradiation with 50342 beam time tuning, mark on the skin, and documentation for each of the exposure zone 27.00 2722.  
* CT topometrij head 50343 without kontrastēšan-39.40 2723.  
50346 * CT topometrij's neck without kontrastēšan-39.40 2724.  
* CT topometrij-50349 chest organs without the kontrastēšan 39.03 2725.  
* CT topometrij-50352 abdominal organs without the kontrastēšan 39.03 2726.  
* CT topometrij-50353 abdominal cavity organs with contrast GI gastrointestinal tract 38.81 2727.  
50356 * CT topometrij little pelvic organs without the kontrastēšan 39.03 2728.  
* CT topometrij 50357 small pelvic organs with contrast GI gastrointestinal tract 39.40 2729.  
50360 * CT topometrij kontrastēšan of the spine without 39.03 2730.  
* CT topometrij of extremities 50363 without kontrastēšan the 39.03 2731.  
50366 * premium at manipulation, 50342 50231 50341 50343, 50346,,,,,, 50356 50349 50352 50353, 50357, 50360, 50363, CT topometrisk and scintigrāfisk 50371 for examination data processing with reconstruction programs 11.47 2732.  
50370 * parameters for tumour irradiation fixation of the patient to State with rentgentopometrisk method 6.17 2733.  
the tumor parameters 50371 irradiation fixation of the patient to State with rentgentopometrisk method with the following data transmission to computerized scheduling system 6.17 2734.  
50372 * individual beam konfigurējoš block, modulating the field tiles cover with special plastic for templates and materials 32.65 2735.  
50373 * patient immobilization feature-thermoplastic material mask preparation, individual adjustment through the motherboard and pads 4.02 2736.  
the Immobilization of 50374-vacuum bag preparation, customize individual 4.02 2737.  
50376 * premium at manipulation, the thermoplastic mask 50396 50397 use 8.13 2738.  
* Premium at 50377 manipulation 50393, for vacuum bag 50397 50396, or chest pad use 6.07 2739.  
50378 premium manipulation, and the bolus 50393 50396 50397 (rays konfigurējoš material) 1.75 2740.  
50380 * premium manipulation on the block or 50372 electron field tiles material use 12.64 2741.  
* Premium at manipulation 50381 50397 on electron field modulation using 1.01 2742 plates.  
50382 * premium at manipulation, 50393, 50396 50390 as remedial and chocks, filter blocks according to the exposure protocols 0.79 2743.  
Supplement to the manipulations 50383 50390 50392 50393 50396,,,,, on patient 50398 50397 received irradiation dose verification using individual dosimetry with LEDs 1.42 2744.  
the Irradiation with x-rays 50390 (tuvfokus therapy), 1.34 2745.  
50391 supplement for apstarojam field of pārsiešan 0.25 2746.  
50393 * irradiation using cobalt-60 machines to 2 star range of input fields 2.83 2747.  
50394 * bonus on irradiation using cobalt-60 machines for each of the next 2 star entrance fields 1.96 2748.  
50396 * Irradiation by linear accelerator to 2 star entrance fields 4.04 2749.  
50397 * Irradiation by linear accelerator electron mode 4.04 2750.  
50398 * bonus on irradiation by Linear Accelerator for each of the next 2 star entrance fields 4.04 2751.  
50400 * premium manipulation using the RFP 16.63 50223 2752.  
50401 * premium at manipulation, 50226 50225, on the use of 50229 kardiotrop RFP 2753 100.17.  
50402 * premium at manipulation, not 50232 50238, frotrop the RFP 50239 use 8.51 2754.  
50403 * premium at manipulation, 50238 50237, osteotrop use the RFP for 50239 8.51 2755.  
50404 * premium at manipulation, the use of the RFP 50243 50271 100.17 2756.  
50405 * premium at the manipulation of the RFP, 50255 50256 11.34 2757 hepatotrop use.  
* Premium at manipulation 50406 50260 for RFP (colloidal) 20.79 2758.  
* Premium at 50407 manipulation, the use of the RFP 50277 50278 8.51 2759.  
* 50408 premium manipulation, 50300 50301 on radioactive iodine for every hundred MBq 18.90 2760.  
the premium for 50301 50409 manipulation of radioactive iodine for every thousand MBq 92.61 2761.  

50415 * premium manipulation of JS change 50303 (source) use 15.66 2762.  
50416 * cavity therapy planning using the dose distribution modeling using a computerized scheduling system 31.08 2763.  
* Brahiterapij of the applicator 50417 localization using the rentgenattēlošan methodology 11.96 2764.  
50418 * premium manipulation on the applicator heads 50303 use 1.12 2765.  
50419 * premium manipulation of each applicator 50303 material 0.50 2766.  
50425 * multi-layer CT topometrij of the head without kontrastēšan 47.47 2767.  
50426 * multi-layer CT topometrij kontrastēšan in the neck without 47.47 2768.  
CT topometrij of the multi-layer 50427 chest organs without the 55.03 2769 kontrastēšan.  
CT topometrij of the multi-layer 50428 abdominal organs without kontrastēšan 58.39 of 2770.  
CT topometrij of the multi-layer 50429 abdominal cavity organs with the konstratēt of gastric intestinal tract 59.31 2771.  
* CT topometrij multi-layer 50430 little pelvic organs without kontrastēšan 58.39 in 2772.  
* CT topometrij multi-layer 50431 little pelvic organs with kontrastēšan 59.31 of 2773.  
50432 * multi-layer CT topometrij kontrastēšan 53.23 of the spine without a 2774.  
CT topometrij of the multi-layer 50433 limbs without kontrastēšan 57.01 of 2775.  
the target volume and 50434 critical blakusorgān with localization procedure course dose rate irradiation of the appointment. Presented at manipulation, 50342 50341 50343, 50346 50349,,,,,, 503577 50352 50353 50356, 50360, 50363, 16.06 50371 2776.  
50436 * premium manipulation 50372 on individual profiling using 3 dimensional planning a mock 5.89 2777.  
50437 * bonus for each beam manipulation 50396 field positioning verification using electronic portal image acquisition equipment 1.28 2778.  
each individual 50438 star field image processing and analysis with an electronic portal system 3.10 2779.  
50450 target volume and critical blakusorgān localization, with the procedure of the appointment of the dose rate irradiation (used at topometrij and MR topometrij of CT) 43.59 2780.  
50451 radiation therapy planning parameter design verification of radiation therapy network (used for each radiation therapy plan) 2781 3.95.  
50452 radiation therapy planning parameter verification verification of radiation therapy and manual monitor dose check 3.95 2782.  
50453 radiation therapy clinical parameters of the plan analysis using 3D dose distributions in visualization and dose-volume histogram target volume and normal tissue 18.96 2783.  
CT and MR topometrisk 50454 study data in the tracking between spatial 9.47 2784.  
50455 Stereotaktisk in radiation therapy/exposure radioķirurģij planning using an inverse dose planning methodology with a dose of ionising radiation detection target and surrounding normal tissue with specialised stereotaktisk of radiation therapy machine inverse planning system 186.89 2785.  
50456 patient immobilization feature-customised radioķirurģij of thermoplastic material of the mask, adjust the individual using the motherboard and pads 15.47 2786.  
50457 patient immobilization feature-customised thermoplastic material in the stereotaktisk radiation therapy masks, individual adjustment through the motherboard and pads 11.69 2787.  
50458 bonus on the mask of radioķirurģij thermoplastic materials 330.88 2788.  
the bonus of the thermoplastic 50459 stereotaktisk in radiation therapy masks the material 270.57 2789.  
50460 doses ionizing radiation delivery patient after stereotaktisk in radiation therapy plan to personalize the material in stereotaktisk termoplastik radiation therapy masks application for irradiation of patient fixation position by using the stereotaktisk radiation therapy equipment with built-in micro-sandwich diaphragm 132.35 2790.  
50461 doses ionizing radiation delivery to the patient after the radioķirurģij plan data to personalize the material in stereotaktisk termoplastik radiation therapy masks application for irradiation of patient fixation position by using the stereotaktisk radiation therapy equipment with built-in micro-sandwich diaphragm 139.96 2791.  
Premium position detection 50462 before radiation therapy procedures, using linear accelerator room of the kilovoltāž procedure rentgenattēlošan system of images, with the patient's body position following adjustment 1.73 2792.  
Stereotaktisk-50463 radiation therapy/physical verifiksācij radioķirurģij plan before taking the patient's exposure to the radiation therapy verifiksācij pašattīstoš film use 25.10 2793.  
50464 multi-layer CT topometrij with a retrospective with the patient breathing movements of the chest organs without kontrastēšan-86.93 2794.  
50465 patient breathing training methodologies for further exposure in synchronization with the patient breathing movements (used at the patient's breathing movements synchronized CT topometrij), 9.93 2795.  
50466 bonus on ionizing radiation dose delivery with patient elošan movements 2.60 2796.  
patient position detection 50467 before radiation therapy procedures, using the lieār Accelerator gantry mounted kilovoltāž rentgenattēlošan system of conical beam CT cuts 1.73 2797.  
the patient's body position 50468 adjustments using the lieār Accelerator gantry mounted kilovoltāž rentgenattēlošan system of conical beam CT cut (used in conjunction with the previous point) 2798 0.86.  
50504 neck and chest, abdominal, pelvic organs, little of the vertebral column and spinal cord, bone-joint system, or percutaneous puncture biopsy by CT drainage control. Presented with the manipulation, 50726 50725 50731, 50732, 50733, 50735, 50736, 50737 5.79, 2799.  
50509 * head, sinus or neck CT soft tissue without kontrastēšan 5.54 of 2800.  
50515 * chest CT without kontrastēšan the 12.39 2801.  
50521 * abdominal, small pelvic CT without the kontrastēšan 2802 13.65.  
50529 * a portion of the spine (3 pulleys) CT-2803. without kontrastēšan 8.74  
50531 * CT without limbs and joints kontrastēšan (one part) 12.65 2804.  
* multilayer 50539 CT and cardiac functional koronogrāfij studies without kontrastēšan (Ca scoring) 2805 41.42.  
* CT Angiography 40.54 50540 2806.  
50542 * CT Perfusion or multi-layer diffusion 16.51

2807. osteodensitometrij of CT quantitative 11.10 50546 2808.  
* Supplement for 50551 i/v kontrastēšan. Hide with 50552 0.72 2809.  
50552 * bonus on bolus use the injector. Hide with 50551 9.45 2810.  
* Supplement for 50553 contrast medium (200 ml) of Iopamidol 300 37.01 2811.  
* Supplement for contrast medium 50554 Iopamidol (200 ml) of 370 2812 45.41.  
50555 * premium for contrast medium Iohexol 300 (20 ml) 4.10 2813.  
* Supplement for 50556 contrast medium Iohexol 300 (50 ml) 12.92 2814.  
* Supplement for 50557 contrast medium Iohexol 300 (100 ml) 26.65 2815.  
50560 * bonus on sodium amidotriozoic of Meglumin contrast is 60% (20 ml) 0.27 2816.  
50561 * bonus on sodium amidotriozoic of Meglumin contrast is 76% (20 ml) 0.48 2817.  
50562 * bonus on sodium amidotriozoic of Meglumin contrast is 76% (100 ml) 2818 10.55.  
* Supplement for 50563 contrast medium Iohexol-180 and Iopromid (10 ml) 1.80 2819.  
50564 contrast medium Iohexol * bonus on a 240 and Iopromid (10 ml) 2.27 2820.  
* Supplement for 50565 contrast medium Iohexol-240 and Iopromid (20 ml) 2821 3.28.  
* Supplement for 50566 contrast medium Iohexol-240 and Iopromid (50 ml) 9.31 2822.  
* Supplement for 50567 contrast medium (20 ml) Iopromid-300 4.70 2823.  
* Supplement for 50568 contrast medium (50 ml) Iopromid-300 13.97 2824.  
* Supplement for 50569 contrast Iopromid (100 ml) of 300 28.41 2825.  
50570 * bonus on contrast of 300 (200 ml) Iopromid 54.87 2826.  
50572 * premium for contrast medium Iohexol (20 ml) 350 4.23 2827.  
* Supplement for 50573 contrast medium Iohexol (50 ml) 350 14.78 2828.  
* Supplement for 50574 contrast medium Iohexol (100 ml) 350 29.96 2829.  
50575 * premium for contrast medium Iohexol (200 ml) 350 59.30 2830.  
* Supplement for 50577 contrast Iopromid (50 ml) of 370 15.66 2831.  
50578 * premium for contrast medium (100 ml) of 370 Iopromid 31.44 2832.  
* Supplement for 50580 contrast medium (20 ml) 270 5.91 Iodixanol 2833.  
* Supplement for 50581 contrast medium (50 ml) 270 19.14 Iodixanol 2834.  
* Supplement for contrast medium 50582 Iodixanol (100 ml) 270 38.50 2835.  
50583 * premium for contrast medium (200 ml) 270 74.15 Iodixanol 2836.  
50585 * premium for contrast medium (20 ml) Iodixanol 320 7.20 2837.  
* Supplement for contrast medium 50586 Iodixanol 320 (50 ml) 21.66 2838.  
* Supplement for 50587 contrast medium (100 ml) 320 43.07 Iodixanol 2839.  
* Supplement for contrast medium 50588 Iodixanol 320 (200 ml) 83.40 2840.  
* Premium 50600 manipulation, 50515 50509, 50521, 50529, 50531 and study with 50504 on 1 slice CT machine. Premium pay 50504 manipulation once study 13.95 2841.  
* Premium 50601 manipulation, 50515 50509, 50521, 50529, 50531 and study with 50504 as 2-layer CT apparatus. Premium pay 50504 manipulation once study 17.26 2842.  
* Premium 50602 manipulation, 50515 50509, 50521, 50529, and on carrying out a study 50531 50504 with 4-layer CT apparatus. Premium pay 50504 manipulation once study 20.08 2843.  
50603 * premium manipulation, 50515 50509, 50521, 50529, 50531 and study with 50504 about 6 layers of CT machines. Premium pay 50504 manipulation once study 29.01 2844.  
* Premium 50604 manipulation, 50515 50509, 50521, 50529, 50531 and study with 50504 on 8 layers of CT machines. Premium pay 50504 manipulation once study 30.77 2845.  
* Premium 50605 manipulation, 50515 50509, 50521, 50529, 50531, and on carrying out a study 50504 50542 with 16 slice CT machine. Premium pay 50504 manipulation once study 39.93 2846.  
* 50606 premium manipulation, 50515 50509, 50521, 50529, 50531, 50539 50504, 50540 and 50542 on, study with 64 slice CT machine. Premium pay 50504 manipulation once study 44.75 2847.  
50609 * head, sinus or neck CT soft tissue with i/v kontrastēšan on each of the next series, starting from the second series 11.34 2848.  
50610 * chest CT with i/v kontrastēšan on each of the next series, starting from the second series of 18.29 2849.  
50611 * abdominal, pelvic CT with small i/v kontrastēšan on each of the next series, starting from the second series 22.10 2850.  
one part of the spine 50612 (3 pulleys) or limbs and joints with i/v CT kontrastēšan for every next series starting from the second series 14.85 2851.  
* multilayer 50614 CT koronarogrāfij with i/v kontrastēšan on each of the next series, starting from the second series 45.12 2852.  
* Premium 50624 manipulation-50612 study on pursuit 50609 with 1 slice CT machine for every next series starting from the second series of 6.97 2853.  
* Premium 50625 manipulation-50612 on conducting study 50609 with 2 layers on each apparatus next CT series, starting from the second series 8.63 2854.  
50626 * premium manipulation-50609 50612 examination on with 4-layer CT apparatus for every next series starting from the second series 10.04 2855.  
* Premium 50627 manipulation-50609 50612 on examination with 6-layer CT machines for each of the next series, starting from the second series 14.51 2856.  
50628 * premium manipulation-50609 50612 to carry out examinations on the 8-layer CT machines for every next series starting from the second series 15.39 2857.  
* Premium 50629 50609-50612 manipulation for examination with 16 slice CT machine for every next series starting from the second series of 19.97 2858.  
* Premium 50630 50609-50612 and manipulations on study with 50614 64 slice CT machine for every next series starting from the second series 22.37 2859.  
Uropoētisk system of ultrasound 50696 1.76 2860.  
50697 Muskuloskeletāl in ultrasound, ultrasound examination in obstetrics 4.81 2861.  
50698 neck and other superficial tissues (thyroid and t.sk. epitēlijķermenīš) or mammary, ultrasound or pelvic organ ultrasound, women's transabdomināl and/or vaginal or Rectal Ultrasound in ultrasound, a 2862 3.18.  
50699 salivary gland or chest, or testicular or baby's hip ultrasound for 2.40 2863.  
Abdominal ultrasound is 2.92 50700 in 2864.  
50709 irosonogrāfij Not for infants (through the pool or transkraniāl) 2.39 2865.  
50720 * USA controls a puncture aspiration biopsy or by tumor localization labelling 14.79 2866.  
* puncture biopsy in 50721 Endokavitāl USA control 20.12

2867. * USE controls made 50722 "core" biopsy (without biopsy needles and devices) 2868 13.16.  
50724 * Liquid collection (abscess, cyst, hematoma) percutaneous drainage without a drain Kit value 17.14 2869.  
* Supplement for vienetap-50725 percutaneous drainage kit use 37.80 2870.  
* Supplement for divetap of 50726 percutaneous drainage kit use 85.05 2871.  
50730 * bonus on ultrasound contrast agent dose one use 51.60 2872.  
* Supplement for 50731 tumor localization application of needle 46.31 2873.  
50732 * bonus on first biopsy needle 14.18 2874.  
* Supplement for 50733 disposable needle for ablation of tumors for chemical 23.63 2875.  
* Supplement for 50735 disposable puncture biopsy device 23.63 2876.  
50736 * bonus on disposable puncture biopsy needle to puncture the device daudzkārtlietojam 11.34 2877.  
* Supplement for 50737 tumor metastases localization needle 21.74 2878.  
50740 premium 50696, 50698, manipulation, 50700, 50709, 50720 50699-50724 and 17120, 18045 on study with US up to $40000 value apparatus. Hide with doplerogrāfij studies of 1.35 2879.  
50741 premium manipulation, 50697, 50696 50698, 50700, 50709, 50720 50699,-50724 17120, 18045 for study and with the apparatus above the value USA $40000 to 70000 and $2.70 2880.  
50742 premium 50696-50700, manipulation, 50720 50709-50724 and 17120, 18045 on study with US in the value of the above machines $70000. Hide with doplerogrāfij studies of 5.40 2881.  
* Supplement for extra 50809 series after contrast medium injection apparatus with magnetic field up to 1.0 Tesla. Show one time visit 26.20 2882.  
* Supplement for MR. 50823 functional examinations (spectroscopic, perfusion, traktogrāfij, likvor, kontrastēšan evolution of dynamic curve, defekogrāfij and myocardial morphological analysis) with 1.0 Tesla or stronger magnetic field apparatus. Show one time visit 70.64 2883.  
* Supplement for extra 50824 series after contrast medium injection with Tesla field strength 1.0 or machine. Show one time visit 36.97 2884.  
50825 * MR. per body part the study without kontrastēšan with magnetic field apparatus up to 1.0 Tesla. One visit one patient can produce as many times as parts of the examinations taken 38.07 2885.  
* MR angiography 50827 one body part without kontrastēšan with magnetic field apparatus up to 1.0 Tesla. Hide with manipulation 50825 45.13 2886.  
* MR one study 50829 body part without kontrastēšan with 1.0 Tesla or stronger magnetic field apparatus. One visit one patient can produce as many times as parts of the examinations taken 50.16 2887.  
* MR angiography 50831 one body part without kontrastēšan with 1.0 Tesla or stronger magnetic field apparatus. Hide with manipulation 50829 57.69 2888.  
50833 * premium manipulation on the reel 72.53 transrektāl 50829 2889.  
50834 * premium for i/v contrast medium injection with bolus injector. Hide with manipulation 50836 11.49 2890.  
50836 * premium for i/v contrast medium injection. Hide with manipulation 50834 0.72 2891.  
* Supplement for contrast medium 50837 Gadopentetic acid (10 ml) 25.05 Meglumin 2892.  
* Supplement for contrast medium 50838 Gadopentetic acid (15 ml) 37.42 Meglumin 2893.  
* Supplement for contrast medium 50839 Gadopentetic acid (20 ml) 49.37 Meglumin 2894.  
* Supplement for 50840 contrast medium (10 ml) 23.16 Gadodiamid 2895.  
* Supplement for 50841 contrast Gadodiamid (15 ml) 32.24 2896.  
* Supplement for 50842 contrast Gadodiamid (20 ml) 41.30 2897.  
50843 * bonus on contrast of Meglumin Gadopentetic acid (5 ml) 11.82 2898.  
* Supplement for 50844 contrast Gadodiamid (5 ml) 11.25 2899.  
* Supplement for 50845 contrast Gadobutro (7.5 ml) 47.63 2900.  
* Supplement for 50846 contrast Gadobutro (15 ml) 89.50 2901.  
50848 * bonus on Gd-EOB-DTPA contrast media for disodi (disodi gadoxetic acid) (5 ml) 65.53 2902.  
* Supplement for 50849 contrast agent Gd-EOB-dtpa disodi (gadoxetic acid, disodi) (7.5 ml) 92.47 2903.  
50850 * bonus on Gd-EOB-DTPA contrast media for disodi (disodi gadoxetic acid) (10 ml) 119.39 2904.  
* Supplement for 50851 contrast Gadofosvese a trisodi (10 ml) 2905 67.33.  
50852 * bonus on contrast to trisodi Gadofosvese (15 ml) 96.96 2906.  
50853 * bonus on contrast to Gadofosvese (20 ml) 123.89 trisodi LOGOPĒDIJ (manipulation 52001-52013) 1.   Payment for the manipulation and is made by 52013 52012 if they are presented by the patient with the pace and rhythm of speech disorders (aphasia, dizartrij, logoneiroz and specific speech rhythm and tempo disorder) treatment.
2. Pay for manipulation is carried out if the 52012 presented the preparatory phase before the manipulation, 52004 52006 and 52009.3.   Pay for manipulation is carried out if the 52013 presented the preparatory phase before the manipulation 52005. No PO box
Manipulation of code manipulation name tariff 2907.  
52001 speech skills and language testing 2.37 2908.  
older adult language 52002 correction home 2.77 2909.  
individual patient dislālij 52003 treatment with language exercises, including respiratory therapy and physical measures (30 minutes) 2.77 2910.  
Individual patient treatment 52004, except in patients with dislālij language exercise, including respiratory therapy and physical measures (40 minutes) 2911 3.95.  
52005 Dislālij functional development of patient therapy individual response in the event of disruption-motor skills, sensorik, language learning and social behavior, group 3 patients (presented for each patient group) (30 minutes) is 2.37 2912.  
52006 functional development therapy except for patients dislālij, reaction in the event of disruption-motor skills, sensorik, language learning and social behavior, group 3 patients (presented for each patient group) (45 minutes) 3.56 2913.  
individual language adjustment 52007 therapy (45 minutes), 4.34 2914.  
individual language adjustment 52009 therapy (60 minutes) 5.53 2915.  
Individual child with 52011 neurological disabilities language development period of stimulating pirmsrun 2.37 2916.  
52012

Individual logoritmik the patient with organic natural language disorders 2.37 2917.  
52013 patients with organic natural language disorders logoritmik, group 3-5 patients (presented for each patient group) 1.99 morphology, Toxicology (54001-54086 tampering) no PO box
Manipulation of code manipulation name tariff 2918.  
54001 * section (adults, children); 1. category 34.38 2919.  
54002 * section (adults, children); 2. category (infectious diseases, home of the dead, is a clinical diagnosis, but the difficulty of tanatoģenēz) 40.72 2920.  
54003 * section (adults, children); 3. category (no clear clinical diagnosis, AIDS, death after several operations, particularly dangerous infectious diseases) 46.50 2921.  
54007 operation and biopsy material, primary processing, microscopic examination, fitting blocks, preparation and histological diagnosis, forcing archive (items 1 – 4 preparations), category 1 (mild degrees of complexity studies) 10.12 2922.  
54008 operation and biopsy material, primary processing, microscopic examination, fitting blocks, preparation and histological diagnosis, forcing archive (items 5-10 after preparation), as well as additional painting techniques; displastisk and priekšvēž status and diagnosis of the benign tumors, regardless of the number of preparations. Skin, muscle, soft tissue tumors are benign. category 2 (moderately complex investigations) 12.42 2923.  
operation and biopsy 54009 material primary treatment-paraffin blocks, forcing the construction preparation, archives and microscopic investigation of 2-20, as well as preparation of the material collected during the endoscopy and biopsy of malignant tumor regardless of the number of the preparation, if used in addition to the painting techniques (serežģīt study with the diferenciāldiagnostisk difficulties). Microscopic investigation, forcing blocks, preparation and histological diagnosis, forcing the archives (by objects over 10 preparations, including histotopogramm, intraoperācij and endobiopsij, bronhobiopsij, trepanobiopsij, kidney, liver, testes, prostate, lymph node biopsy, all types of cancers; regardless of the number of the preparation, if used in addition to the painting techniques), category 3 (complex), if you have diferencialdiagnostisk difficulties 17.68 2924.  
54010 operation and biopsy material, primary treatment, paraffin blocks, lay preparations for manufacture, in addition to making the cut, painting with traditional and special staining methods over 20 preparation of extensive operations with several organs or tissues of the investigations, as well as mesothelioma (citobiopsij) and biopsy material from endocrine organs, CNS, artroskopij, eye, thyroid, Lung transuretrāl resection of the prostate, and biopsy of the kidneys, liver, lymph nodes, bones; regardless of the number of preparations (especially complex morphological study), 32.77 2925.  
54015 operation and biopsy material of electron microscopy 54.97 2926.  
54016 operation and biopsy of the 47.71 Immunohistochemistry 2927 material.  
* Kidney biopsy 54017 light microscopy (report preparations, PASSPORT, Masson trihrom) 21.37 2928.  
54018 * kidney biopsy material examination of 9.56 2929 imūnfluorescenc.  
* Kidney biopsy 54019 material electron microscopy of 68.65 2930.  
judicial chemistry 54025 laboratory Toxicology Department, one study to unknown toxic substances (in acute ekspresanalīz poisoning case) 28.08 2931.  
* Department of toxicology study 54026 on karboksihemoglobīn of 2932 7.58.  
* Department of toxicology study 54027 to free hemoglobin (haemolysis value analysis of the degree of intoxication) 7.58 2933.  
* Department of toxicology study 54028 on psychotropic substances 18.55 2934.  
* Department of toxicology study 54032 on salicylate-2935 15.77.  
* Department of toxicology study 54046 on alcohol and its surrogate with gas chromatography method 5.68 2936.  
54050 * testing with the imūnometod to the enzimatisk 1 Group 3.82 2937 of the substance.  
* testing with enzimatisk-54051 imūnometod on 2 substances Group 4.95 2938.  
54052 * testing with the imūnometod enzimatisk to 3 substances Group 6.08 2939.  
* testing with enzimatisk-54053 imūnometod to 4 groups of substances 7.22 2940.  
Testing of 54054 * with enzimatisk imūnometod to 5 groups of substances 8.35 2941.  
54055-imūnometod * testing with enzimatisk for 6 groups of substances 9.49 2942.  
* testing with enzimatisk of 54056 imūnometod to 7 groups of substances 10.62 2943.  
* testing with the enzimatisk 54057 imūnometod to 8 groups of substances 11.75 2944.  
* testing with the enzimatisk 54058 imūnometod to 9 groups of 12.89 2945 substance.  
* testing with the enzimatisk 54059 imūnometod to 10 groups of substances 14.02 2946.  
* testing with enzimatisk-54060 imūnometod to 11 groups of substances 15.16 2947.  
* testing with the enzimatisk 54061 imūnometod to 12 groups of substances 16.29 2948.  
54062 "full" chemical toxicological analysis 33.82 2949.  
the chemical toxicological 54063 analysis on opium alkaloids to 16.75 2950.  
54064 * chemical toxicological analysis on ephedrine and efedron-9.82 2951.  
54065 * chemical toxicological analysis on amphetamine and MDA 9.82 2952.  
54066 * chemical toxicological analysis on methamphetamine and MDMA (ecstasy) 9.82 2953.  
54067 * chemical toxicological analysis to hashish (marihuan); object-urine, washings from the oral cavity, nomazgājum of arms 13.73 2954.  
54068 * chemical toxicological analysis to hashish (marihuan); object-urine 10.32 2955.  
54069 * chemical toxicological analysis to hashish (marihuan); object-washings of the oral cavity, nomazgājum of arms 11.08 2956.  
54070 * chemical toxicological analysis of the barbiturate 13.73 2957.  
54071 * chemical toxicological analysis on 1.4-benzodiazepine derivatives (tranquilizer) 15.25 2958.  
54072 * chemical toxicological analysis on cocaine 14.71 2959.  
54073 * chemical toxicological analysis on the 2960 11.48 promedol.  
54074 * chemical toxicological analysis on ciklodol-11.75 2961.  
54075 * chemical toxicological analysis to the 8.81 2962 dimedrol.  
54076 * chemical toxicological analysis on klofelīn of 10.23 2963.  
54077 * chemical toxicological analysis on triciklisk of antidepressants (amitriptyline, notriptilīn, imipramīn) to 11.37 2964.  
54078 *

Chemical toxicological analysis on fenotiazīn derivatives (iroleptiķ) 13.54 2965.  
54079 * chemical toxicological analysis to acetone 4.09 2966.  
the Chemical in 54080 toxicological analysis on imovān-11.75 2967.  
the chemical toxicological 54081 analysis on tramadol-11.75 2968.  
54082 * chemical toxicological analysis to beta-adrenoblokator-12.98 2969.  
the chemical toxicological 54083 analysis on ketamine 10.68 2970.  
54084 * chemical toxicological analysis of the gamma-oksibutirāt 10.80 2971.  
54085 studies of the influence of alcohol in the air izelpojam 2.20 2972.  
* drunk 54086 laboratory studies biological environment rehabilitation 10.57 (55072-55125 tampering) no PO box
Manipulation of code manipulation name tariff 2973.  
55072 patient functional examination (exhibit physiotherapist, physiotherapist Assistant, ergotherapist and ergoterapeit Assistant) 3.56 2974.  
individual rehabilitation plan 55073. Rehabilitation team meeting (presentation of each participating rehabilitation specialist) 1.20 2975.  
55074 patient training belonging one time during the treatment course (displays each involved rehabilitation specialist) 4.75 2976.  
individual physiotherapists, 55075 physiotherapist Assistant, ergoterapeit and ergoterapeit Assistant job, coaching the Compensator device use the patient (20 minutes) 3.15 2977.  
Multiprofesionāl of rehabilitation base 55076 service (2-3 hours). One patient once a day multiprofesionāl commands are presented. Included for all specialists involved in the multiprofesionāl team work 17.22 2978.  
multiprofesionāl is an intensive rehabilitation 55077 service (3-4 hours). One patient once a day multiprofesionāl commands are presented. Included for all specialists involved in the multiprofesionāl team work 21.33 2979.  
55078 study '' video gait analysis '' 22.87 2980.  
individual physiotherapists 55080 and physiotherapist Assistant jobs with the infant up to 6 months of age with lag and psihomotor development of the peripheral nervous system damage (20 minutes) 2.42 2981.  
55081 individual physiotherapists and physiotherapy Assistant working with a baby at 6 months of age with lag and psihomotor development of the peripheral nervous system damage (30 minutes) 3.34 2982.  
55082 individual physiotherapists and physiotherapy Assistant working in the pool with a new baby and an early age children with developmental delay and psihomotor peripheral nervous system damage to 30 minutes (physiotherapist outside the pool) 3.15 2983.  
Supplement for ergoterapeit, 55083 ergoterapeit Assistant, physiotherapists and physiotherapy Assistant working with the patient under the age of 2 years (presented at each visit) 0.64 2984.  
55084 supplement for ergoterapeit, ergoterapeit, physiotherapist, Assistant and physiotherapist Assistant's work with patients aged 2 to 5 years (presented at each visit) 2985 0.40.  
individual physiotherapists and 55085 physiotherapist Assistant working with patients in the pool (physiotherapist basin) 2986 3.95.  
55086 Physiotherapist and physiotherapist Assistant working with patients in the pool, group 3-8 people (physiotherapist outside the basin (presented for each patient group)) 0.64 2987.  
individual physiotherapists 55087 and physiotherapist Assistant jobs with neurological patients, spinal t.sk.ar brain damage (60 minutes) 5.53 2988.  
individual physiotherapists, 55088 physiotherapist Assistant, ergoterapeit and ergoterapeit Assistant working with patients with the support-system of movement and peripheral nervous system diseases (60 minutes) 5.53 2989.  
Physiotherapist, physiotherapists 55089 Assistant, ergoterapeit and ergoterapeit Assistant working with patients with the support-system of movement and peripheral nervous system affections, group 3-8 people (presented for each patient group) 0.64 2990.  
55090 individual physiotherapists and physiotherapy Assistant working with the patient after the presence of surgical treatment (30 minutes) 3.15 2991.  
55091 individual physiotherapists and physiotherapy Assistant working with pulmonoloģisk patients (30 minutes) 3.15 2992.  
55092 Physiotherapist and physiotherapist Assistant jobs with pulmonoloģisk patients, group 3-8 people (presented for each patient group) 0.76 2993.  
55093 individual physiotherapists and physiotherapy Assistant working with cardiac patient friendly mode (30 minutes) 3.15 2994.  
55094 individual physiotherapists and physiotherapy Assistant working with cardiac patient-friendly trenējoš mode (45 minutes), 4.34 2995.  
55095 individual physiotherapists and physiotherapy Assistant working with cardiac patients in trenējoš mode (60 minutes) 5.53 2996.  
55096 Physiotherapist and physiotherapist Assistant working with patients with oral diseases, group 3-8 people (presented for each patient group) 0.66 2997.  
55097 individual physiotherapists and physiotherapy Assistant working with patients with oral diseases (40 minutes) 2998 3.95.  
individual physiotherapists 55100 and physiotherapist Assistant working with patients with burns (60 minutes) 6.49 2999.  
55101 physiotherapists and physiotherapy individual Assistant working with psychiatric patients (60 minutes) of 4.34 3000.  
55102 Physiotherapist and physiotherapist Assistant working with psychiatric patients, a group of 2-5 people (presented for each patient group) 0.64 3001.  
55103 individual physiotherapists and physiotherapy Assistant working with gynecological patient 3.15 3002 (30 minutes).  
55104 individual physiotherapists and physiotherapist Assistant jobs by postural drainage, massage, dynamic breathing exercises (30 minutes) is 2.37 3003.  
55105 individual physiotherapists and physiotherapy Assistant working with patients with the support-system of movement and peripheral nervous system diseases by massage, and heat, and hidroprocedūr, and krioprocedūr (30 minutes) 2.37 3004.  
55110 individual physiotherapists and physiotherapist Assistant jobs, you work with the drawing of the vertebral column (trakcij) method with the trakcij device (30 minutes) to 6.27 3005.  
55111 physical environment assessment and adaptation (presented ergotherapist) 3006 2.37.  
55112 sensory stimulation and sensory integration is 2.37 (presented ergotherapist) 3007.  
55113 Hand therapy (presented ergotherapist) 3008 3.56.  
55114 Hand manufacture of orthoses-orthosis "peace" (presented at the ergotherapist) 28.85 3009.  
55115

Hand manufacture of orthoses-orthosis "functional" (presented at the ergotherapist) 24.13 3010.  
55116 self-care activities: eating training (presented ergotherapist) 2.37 3011.  
55117 self-care activities: eat Cook training (presented ergotherapist) 4.00 3012.  
self-care 55118 activities: get-training (presented ergotherapist) 3.58 3013.  
55119 self-care activities: care for the look of the training (presented ergotherapist) 2.37 3014.  
55120 self-care activities: washing training (presented ergotherapist) 2.61 3015.  
55121 self-care activities: using the toilet training (presented ergotherapist) 2.37 3016.  
55122 patient training free time activities (presented by the ergotherapist) 2.45 3017.  
55123 positioning (presented to the physiotherapist, the physiotherapist Assistant, ergotherapist and ergoterapeit Assistant) 3.56 3018.  
55124 accessories patient individual adaptation and training in the use of ancillary equipment (displays the ergotherapist) 4.75 3019.  
55125 games skills assessment and training (presented ergotherapist) 1.57 other sections not included manipulation (manipulation 60001-60400-60412 60339;) (1).  Manipulation of this section where the tariff value is $0.00, display cases, when according to this provision, paragraph 1 of the annex 22, or 14 and 16 treatment to annex the settlement calculation and statistical records of the services provided must be determined by the health services group.
2. Manipulation of the tariff includes 60107 accompanying persons stay in hospital: a costs of public utilities (energy, water, sewage, electricity) and operating expenditure.
3. home health care levels: level 1 (oral medication distribution; injection, subcutaneous injections intramuscular intrakutān;; injection intravenously; primary-healing wound care, removal of thread; kolostom care; ileostom; not care frostom care cistostom care) – manipulation 60259;
level 2 (infūz, intravenously; secondary healing wounds pārsiešan; izgulējum care; the trophic ulcers treatment; tube feeding through the probe; traheostom; gastrostom care care; urinary catheter care; home care for children up to 14 years)-60260. No PO box manipulation
Manipulation of code manipulation name tariff 3020.  
the rehabilitation measures 60001 stroke patients in hospital, 10-3021 kontaktminūt 0.85.  
60002 service "National Socialist mode of rehabilitation of victims" patients 0.00 3022.  
60003 service "Rehabilitation of patients with spinal cord šķērsbojājum (spinal patients)" patients 0.00 3023.  
60006 children with hearing impairments, the investigation and treatment of SIA "Health Center" Bikernieki "" (one visit) 13.82 3024.  
metered dose of MTX 60007 highly (metatrexāt) therapy for children with diseases of onkohematoloģisk 0.00 3025.  
* malignant tumor chemotherapy 60008 procedure 6.41 3026.  
60009 * bonus on drugs in patients with diagnoses N70, N71, N, N, N 73.3 73.0, O85, O86 73.5, T81, which transferred from other hospitals for surgical treatment and intensive therapy on the clinical University Hospital (one days) 52.20 3027.  
patient treatment days 60010 stationary while receiving chronic haemodialysed services (one day) 3028 1.22.  
the treatment of the patient kardioreanimācij 60011 chapter national society with limited liability "children clinical University Hospital" (for one days) 30.99 3029.  
60012 0.1% of the premium for the drug methadone solution (Methadon oral solution) once a 0.69 3030.  
60013 * bonus on botulinum toxin (botulinum toxin) for every 25 units 9.69 3031.  
the Chernobyl nuclear power plant accident 60014 relief actors and Chernobyl nuclear power plant accident victims as a result of treatment in a State hospital in the society with limited liability "Paul stradins clinical University Hospital" 0.00 3032.  
Treatment of thoracic surgery 60015 chapter national society with limited liability "Paul stradins clinical University Hospital". Service ' thoracic surgery ' patients 0.00 3033.  
60016 forced psychiatric treatment by a court decision 0.00 3034.  
60017 service "forced psychiatric treatment in the hospital security guards ' patients 0.00 3035.  
treatment of stroke unit 60023 (diagnosis I 63), per days (5 days). Service "Neurology (stroke unit)" patients 54.02 3036.  
treatment of stroke unit 60024 (diagnosis I 60, 61), one days (5 days). Service "Neurology (stroke unit)" patients 47.79 3037.  
60025 Arodslimniek treatment in the hospital public company limited "Paul stradins clinical University Hospital" 0.00 3038.  
the Cpr State 60028 society with limited liability "children clinical University Hospital" (for one days) 30.99 3039.  
the Surgery treatment of patients 60031-kardioreanimācij of the national society with limited liability "children clinical University Hospital" (including medicine) (for one days) 81.00 3040.  
60032 * anaesthesia kardioķirurģisk operation in the national society with limited liability "children clinical University Hospital" 77.03 3041.  
60045 * supplement for HIV-infected patients ' care during childbirth and operations in fixed 54.05 3042.  
60054 service "in the" multiple sclerosis ", hospital assistance" patients 0.00 3043.  
60055 * patient treatment and care special with insulation and a protective mode ensure chambers before and after Autologous stem cell transplantation, and these patients in Aplasia (one days). The service's "stem cell transplant ' patients 62.83 3044.  
60060 * preparatory perinatal care outings for children with MPV (artificial lung ventilation) 76.90 3045.  
60061 * Perinatal care outings service children with MPV (artificial lung ventilation) for every 10 km travelled 4.63 3046.  
60062 * preparatory perinatal care for children without an external service MPV (artificial lung ventilation) 59.00 3047.  
* Perinatal care 60063 itinerant service for children without the MPV (artificial lung ventilation) for every 10 km travelled 3.66 3048.  
60064 *

Mandatory State assistance to children after the family courts decision 0.00 3049.  
60065 service "adult burns treatment hospital" patients 0.00 3050.  
60070 hepatobiliār system of patients with pathology of university hospitals treat 0.00 3051.  
Koronarogrāfij hospital and 60071 days fixed 422.17 in 3052.  
coronary angioplasty stent 60072 without the implantation site and day hospital 1404.85 3053.  
coronary angioplasty with stent 60073 the implantation site and day hospital 2346.17 3054.  
60074 coronary angioplasty using stent grafts by medicine filled (DES) stationary and fixed 3245.68 3055 days.  
Services to 60077 "Mikroķiruģij-based program for adults" patients 0.00 3056.  
60078 service "Mikroķiruģij-adult" patients 0.00 3057.  
* bonus on 60080 medicine coagulation factor VIII (Coagulation factor VIII) 250 international units use 30.72 3058.  
* Supplement for medicine 60081 IX coagulation (Coagulation factor IX) factor of 250 international units use 35.44 3059.  
60082 * bonus on medicine Desmopresīn (Desmopressin) (15 micrograms/ml) 3060 7.18.  
60085 home death death fact evidenced 5.62 3061.  
60086 family physician home visit to patients, doing palliative care, health care at home and at flu patients during the influenza epidemic 7.32 3062.  
* Supplement for medicine 60087 VII coagulation factors (Baxter) 600 international units use 168.51 3063.  
* Supplement for medicine 60088 recombinant activated factor VII (Novo Seven) 2.4 mg use 1196.26 3064.  
* Supplement for medicine 60090 Alteplas 50 mg 274.16 use 3065.  
* Supplement for 60091 medicine Streptokināz (Streptokinas) (1 vial of 1.5 million units) in the 74.39 3066.  
* Supplement for 60092 drug Tirofiban 0.25 g/ml (1 bottle) (not used in conjunction with the manipulation, 06186 06185, 06193 06194 06195 06192,,,,,,, 06197 06196 06198 06199) 126.69 3067.  
* Kohleār implant implantation in 60093 children 0.00 3068.  
* Supplement for medicine 60094 VIII of coagulation factor apejoš activity (FEIB) about 500 international units use 267.10 3069.  
* Supplement for medicine 60095 VIII of coagulation factor apejoš activity (FEIB) about 1000 international units use 534.21 3070.  
60096 * bonus on drug Reteplas 10 U use 442.19 3071.  
60097 Patient whose treatment is paid from the reserve fund 0.00 3072.  
60098 service "addicts rehabilitation hospital" patients 0.00 3073.  
60099 Patient whose treatment in the payment of funds for priority action 0.00 3074.  
* Supplement for 60100 medicine patients infected with MRSA or karbapenēmrezistent. baumani-the charge is paid for each day of the bed during the course of therapy. Patients hospitalized with disaster Medical Center transfer payment is made for each of the days of 56.70 3075.  
* Supplement for medicine 60101 Tenecteplas 50 mg/10 ml (Metalys) use 795.31 3076.  
60102 * bonus on medicine Eptifibatid (2 mg/ml, 10 ml and 100 ml 0.75 mg/ml) 3077 87.77.  
* Supplement for medicine 60103 recombinant activated factor VII (Novo Seven) 1.2 mg use 631.97 3078.  
60105 accommodation costs, receive outpatient health care services that are paid from the social safety net strategy means (applied to persons of a certain 100% compensation, contributions and accompanying persons) 3079 9.40.  
* Coverage for 60106 one time stacionēšan surgery carried out surgical operations are paid from the social safety net strategy means (applied to persons of a certain 100% deposit refund), and the emergency medical service staff operations performed 30.00 3080.  
* 60107 accompanying persons at the location of the patient after medical indications: a child or patient rehabilitation institution 7.60 3081.  
patient treatment days 60110 site, except chronic haemodialysed services (one day) 3082 7.43.  
* Supplement for izgulējum 60111, including complex with osteomielīt and lasting healing, not skin, chronic soft tissue čū (problēmbrūč) treatment in society with Microsurgical limited atbīldib "Riga Eastern clinical University Hospital" (for one days) 35.68 3083.  
* Supplement for extra 60112 materials kardioķirurģisk operation of artificial circulation Paul stradins clinical University Hospital 3084 1140.83.  
* Premium 60116 renal transplant case on materials State society with limited liability "Paul stradins clinical University Hospital" 608.00 3085.  
preparation of the Patient 60200 kidney transplantation society with limited liability "Paul stradins clinical University Hospital" 0.00 3086.  
60201 * patients with Premium graft dysfunction, imūnsupresīv, the complications of therapy control, adjustment and functioning of the national society of transplant limited "Paul stradins clinical University Hospital" (for one days) 70.56 3087.  
the "iroangioloģij 60203. Functional neurological surgery "patients 0.00 3088.  
60207 service "site help Vascular Surgery" patients 0.00 3089.  
60208 service "Microsurgery in children" patients 0.00 3090.  
* Premium service 60211 "stationary help infants especially severe cases" patients (about one days) 28.17 3091.  
60212 * premium manipulation of drug one 60008 of chemotherapy during the procedure the national society with limited liability "children clinical University Hospital", a national society with limited liability "Paul stradins clinical University Hospital", a society with limited liability "the Riga Eastern clinical University Hospital" 82.47 3092.  
* Premium manipulation 60214 60008 on one drug of chemotherapy during the society with limited liability "Daugavpils regional hospital", a national society with limited liability "the seaside hospital" 58.76 3093.  
60216 *

Premium manipulation of drug one 60008 of chemotherapy during the procedure patients roonkoloģisk society with limited liability "the Riga Eastern clinical University Hospital" 40.18 3094.  
One judicial psychiatric 60220 inspection of the stationary State preparation in the society with limited liability "Psychiatry and the addiction of Riga Centre" the Court examiner's psychiatric department with security guards 0.00 3095.  
60250 specialist or family physician home visit to the patient that requires long-term artificial lung ventilation 9.54 3096.  
60251 treatment and patient care personal home visit to the patient that requires long-term artificial lung ventilation 9.31 3097.  
60252 artificial lung ventilation machines use a patient who requires long-term home artificial lung ventilation (for one day) 5.36 3098.  
60253 patient who required prolonged ventilation of the lung hospital conditions 0.00 3099.  
60256 r. Mantoux and read. Family doctor pay according to the tariff, but the manipulation of ftiziopulmonolog presented the service provided the statistical counting 0.16 3100.  
the Himērism analysis after 60257 allogeneic bone marrow or peripheral blood stem cell transplantation using real time PCR (real time PCR) 0.00 3101.  
60258 premium on mammography screening study mobile mammography study 4.81 3102.  
60259 Assistant (feldšer) or sisters in one patient carried out the first level of care health home care (according to chapter XII1 of these provisions), including care, which is paid from the social safety net strategy features. Payment shall be made no more than once a day. Hide with 60260 7.50 3103.  
60260 Assistant (feldšer) or sisters in one patient carried out the second level of care health home care (according to chapter XII1 of these provisions), including care, which is paid from the social safety net strategy features. Payment shall be made no more than once a day. Hide with 60259 11.47 3104.  
60262 vaccination against pandemic influenza A (H1N1) 0.00 3105.  
vaccination against hepatitis B in 60263 at-risk newborns 0.00 3106.  
60264 vaccination against hepatitis B vaccination 0.00 4 3107.  
60265 vaccination against hepatitis B vaccination 0.00 1.3108.  
60266 vaccination against tuberculosis in one dose of 0.00 3109.  
60267 vaccination against hepatitis B vaccination 3110 0.00 2.  
60268 vaccination against diphtheria vaccination 0.00 1 3111.  
vaccination against the leaden 60269 cramps 1. vaccination 0.00 3112.  
60270 vaccination against long cough vaccination 3113 0.00 1.  
60271 vaccination against polio vaccination 3114 0.00 1.  
60272 vaccination against Haemophilus influenza type b infection is vaccination 0.00 1.3115.  
vaccination against diphtheria 60273 2. vaccination 0.00 3116.  
vaccination against the numbness of 60274 seizures 2. vaccination 0.00 3117.  
vaccination against 60275 long cough vaccination 0.00 2 3118.  
60276 vaccination against polio vaccination 3119 0.00 2.  
60277 vaccination against Haemophilus influenza type b infection 2. vaccination of 0.00 3120.  
60278 vaccination against diphtheria vaccination 3121 0.00 3.  
vaccination against the numbness of 60279 seizures 3. vaccination 0.00 3122.  
60280 vaccination against long cough vaccination 3123 0.00 3.  
60281 vaccination against polio vaccination 3124 0.00 3.  
60282 vaccination against Haemophilus influenza type b infections 3. vaccination of 0.00 3125.  
60283 vaccination against hepatitis B vaccination 3126 0.00 3.  
60284 vaccination against measles vaccination 0.00 1.3127.  
60285 vaccination against rubella vaccination 0.00 1.3128.  
vaccination against epidemic of mumps 60286-1. vaccination 0.00 3129.  
vaccination against chickenpox 60287 one gave 0.00 3130.  
60288 vaccination against diphtheria vaccination 3131 0.00 4.  
vaccination against the leaden 60289 cramps 4. vaccination 0.00 3132.  
60290 vaccination against long cough vaccination 0.00 4.3133.  
60291 vaccination against polio vaccination 0.00 4.3134.  
vaccination against diphtheria 60292 5. vaccination 0.00 3135.  
vaccination against the leaden 60293 cramps 5. vaccination 0.00 3136.  
60294 vaccination against polio vaccination 0.00 3137.5.  
60295 vaccination against measles vaccination 3138 0.00 2.  
60296 vaccination against rubella vaccination 0.00 2.3139.  
vaccination against epidemic of mumps 60297-2. vaccination 0.00 3140.  
60307 vaccination against diphtheria vaccination 6.3141 0.00.  
60308 vaccination against cramps of the numbness 6. vaccination 0.00 3142.  
60309 vaccination against polio vaccination 6 0.00 3143.  
Booster vaccination against diphtheria 0.00 60316 3144.  
the booster to the numbness of 60317 cramps 0.00 3145.  
vaccination against the numbness of 60318 cramps (used by medical indications) 0.00 3146.  
vaccination against influenza 0.00 60319 3147.  
60320 vaccination against rabies (antirabisk vaccine) 0.00 3148.  
vaccination against tick encephalitis 60321 children vaccination 3149 0.00 1.  
60322 vaccination against tick encephalitis in children vaccination 0.00 3150 2.  
vaccination against tick encephalitis 60323 children vaccination 0.00 3.3151.  
60324 vaccination against tick encephalitis in children vaccination 0.00 4.3152.  
vaccination against rabies 60325 (antirābisk the Ig solution) 0.00 3153.  
60326 vaccination against pneumococcal infection in children with asplēnij of 0.00 3154.  
R-60327 monovalent vaccine against rubella 0.00 3155.  
60328 P-the epidemic of monovalent vaccine against mumps 0.00 3156.  
60329 pretērč encephalitis vaccination with the Ig solution 0.00 3157.  
60330 M – against measles monovalent vaccine 0.00 3158.  
vaccination against pneumococcal infection 60331-1. vaccination 0.00 3159.  
60332 vaccination against pneumococcal infection 2. vaccination 0.00 3160.  
60333 vaccination against pneumococcal infection 3. vaccination 0.00 3161.  
60334 vaccination against pneumococcal infection 4. vaccination 0.00 3162.  
60335 vaccination against human papilloma virus infection-3163 0.00 1. pot.  
60336 vaccination against human papilloma virus infection 2. vaccination 0.00 3164.  
60337 vaccination against human papilloma virus infection 3. vaccination 0.00 3165.  
vaccination against 60338 long cough 5. vaccination 0.00 3166.  
60339 vaccination against Haemophilus influenza type b infection 4. vaccination of 0.00 3167.  
diagnostic and therapeutic assistance 60400 hospital Hematology and onkohematoloģij in 0.00 3168.  
60401 service "rehabilitation after stroke unit" patients 0.00 3169.  
60404

Adult preventive inspections carried out by family doctors (in accordance with annex 5 of these rules). Pay for manipulation included family doctor kapitācij cash 0.00 3170.  
60405 adult preventive inspections carried out by the family doctor, when investigating patients with disease 0.00 3171.  
60406 accommodation costs, receive outpatient health care services that are paid from the social safety net strategy means (applied to persons of a certain contribution refund 50% of the patients and accompanying persons) 4.70 3172.  
60407 Coverage for one time in stacionēšan surgery carried out surgical operations are paid from the social safety net strategy means (applied to persons of a certain patient's contribution 50% compensation) 15.00 3173.  
patient visit 60408 asthma study 0.00 3174.  
60409 patient visit a psychologist's Office 0.00 3175.  
60410 patient visit diabetic foot care Office 0.00 3176.  
60411 patient visit stoma's 0.00 3177.  
60412 patient visit palliative care study 0.00 chemotherapy (manipulation 61000-61198) chemotherapy drugs schemes display statistical records according to the type of tumor.
Manipulation of each chemotherapy course is given only after completion of the course in accordance with the appropriate diagram (manipulation 61000-61264) description (this provision 22. point 6 of the annex), medical documentation indicating the chemotherapy schemes selection, specific course and completion of treatment of patients with chemotherapy and inpatient and day hospital and outpatient diagnosis and apply the appropriate schema must also be applied to activities of General pretinfekcij and granulocytes colony stimulating factors (manipulation 61265-61284). Depending on the particular course of volume used to indicate the number of manipulations on one unit.
No PO box
Manipulation of code manipulation name tariff 3178.  
61000 * head and neck malignant tumor chemotherapy (C00-C14). Diagram MTX 0.00 3179.  
61001 * head and neck malignant tumor chemotherapy (C00-C14). Scheme of CDDP 0.00 3180.  
61002 * head and neck malignant tumor chemotherapy (C00-C14). Scheme PF 0.00 3181.  
61003 * head and neck malignant tumor chemotherapy (C00-C14). Schema Cetux_1 0.00 3182.  
61004 * head and neck malignant tumor chemotherapy (C00-C14). Schema Cetux_2 0.00 3183.  
61005 * head and neck malignant tumor chemotherapy (C00-C14). Schema Docetaxel_1 0.00 3184.  
61006 * head and neck malignant tumor chemotherapy (C00-C14). Schema Docetaxel_2 0.00 3185.  
61007 * head and neck malignant tumor chemotherapy (C00-C14). Scheme TP 0.00 3186.  
the esophageal malignant 61008 tumour chemotherapy (C15). Schema CF_1 0.00 3187.  
61009 the esophageal malignant tumor chemotherapy (C15). Scheme PC 0.00 3188.  
61010 * esophageal malignant tumor chemotherapy (C15). Scheme CF_2 0.00 3189.  
61011 * esophageal malignant tumor chemotherapy (C15). Diagram CPU 0.00 3190.  
61012 * esophageal malignant tumor chemotherapy (C15). CI 0.00 3191 scheme.  
61013 * esophageal malignant tumor chemotherapy (C15). The CEF scheme 0.00 3192.  
61014 * esophageal malignant tumor chemotherapy (C15). Scheme of the OFL 0.00 3193.  
malignant tumour of the stomach 61015 chemotherapy (C16). Scheme of the EFC 0.00 3194.  
malignant tumour of the stomach 61016 chemotherapy (C16). The ELF scheme 0.00 3195.  
malignant tumour of the stomach 61017 chemotherapy (C16). Scheme DFC 0.00 3196.  
the slender casings 61018 malignant tumors (karcinoīd) chemotherapy (C17), as well as malignant tumor chemotherapy others and not accurately defined the digestive organs (C26) and chemotherapy for oral and digestive organ tumors with unclear or unknown natural (C513). INF-α 0.00 3197 scheme.  
the slender casings 61019 malignant tumors (adenokarcinom) chemotherapy (C17). Scheme FOLFOX 0.00 3198.  
the slender casings 61020 malignant tumors (adenokarcinom) chemotherapy (C17). Scheme of FOLFIR 0.00 3199.  
61021 the colon and rectum malignant tumor chemotherapy (C18-C20). Scheme FL 0.00 3200.  
61022 the colon and rectum malignant tumor chemotherapy (C18-C20). Scheme FOLFOX 0.00 3201.  
61023 the colon and rectum malignant tumor chemotherapy (C18-C20). To the 3202 0.00 FOLFIR scheme.  
61024 * colon and rectum malignant tumor chemotherapy (C18-C20). Schema Capecitabin 0.00 3203.  
61025 * colon and rectum malignant tumor chemotherapy (C18-C20). Scheme CapeOX 0.00 3204.  
61026 * colon and rectum malignant tumor chemotherapy (C18-C20). Scheme of Oxaliplatin 0.00 3205.  
61027 * colon and rectum malignant tumor chemotherapy (C18-C20). Scheme of Irinotecan 0.00 3206.  
61028 * colon and rectum malignant tumor chemotherapy (C18-C20). Scheme of Tegafur 0.00 3207.  
61029 * anus (anus) and the anus the Canal (Canalis anal) malignant tumor chemotherapy (C21). Scheme FM 0.00 3208.  
61030 * anus (anus) and the anus the Canal (Canalis anal) malignant tumor chemotherapy (C21). Scheme PF 0.00 3209.  
the liver and the intrahepātisk 61031 to examine malignant tumor chemotherapy (C22). DOXA 0.00 3210 scheme.  
the liver and the intrahepātisk 61032 to examine malignant tumor chemotherapy (C22). Scheme 5-FU/INF-α 0.00 3211.  
* intrahepātisk-61033 liver and malignant tumour chemotherapy examine (C22). INF-α of CDF schema 0.00 3212.  
malignant tumors of the gallbladder 61034 (not applicable) and other and specify the žultsceļ part of the malignant tumors (C24) chemotherapy. Scheme 5-FU 0.00 3213.  
malignant tumors of the gallbladder 61035 (not applicable) and other and specify the žultsceļ part of the malignant tumors (C24) chemotherapy. Diagram GEM/5-FU/LV 0.00 3214.  
malignant tumors of the gallbladder 61036 (not applicable) and other and specify the žultsceļ part of the malignant tumors (C24) chemotherapy. Diagram of Cape/Gem 0.00 3215.  
61037 * pancreatic malignant tumor chemotherapy (C25). Scheme 5-FU 0.00 3216.  
61038 * pancreatic malignant tumor chemotherapy (C25). Schema Gem_1 0.00 3217.  
61039 * pancreatic malignant tumor chemotherapy (C25). Schema Gem_2 0.00 3218.  
61040 *

Pancreatic malignant tumor chemotherapy (C25). Scheme/CDDP GEM 0.00 3219.  
61041 * pancreatic malignant tumor chemotherapy (C25). Diagram GE 0.00 3220.  
the nasal cavities 61042, middle ear, sinus, larynx (C30-C32) and middle ear, respiratory and chest organ tumor with uncertain or unknown natural (D38) malignant tumor chemotherapy. Schema Cetux_1 0.00 3221.  
the nasal cavities 61043, middle ear, sinus, larynx (C30-C32) and middle ear, respiratory and chest organ tumor with uncertain or unknown natural (D38) malignant tumor chemotherapy. Schema Cetux_2 0.00 3222.  
the nasal cavities 61044, middle ear, sinus, larynx (C30-C32), middle ear, respiratory and chest organ tumor with uncertain or unknown natural (D38), as well as other non-specified locale and respiratory sisstēm and thoracic cavity of malignant tumors of the organ (C39) chemotherapy. Scheme CF 0.00 3223.  
the nasal cavities 61045, middle ear, sinus, larynx (C30-C32), middle ear, respiratory and chest organ tumor with uncertain or unknown natural (D38), as well as other non-specified locale and respiratory sisstēm and thoracic cavity of malignant tumors of the organ (C39) chemotherapy. Scheme PC 0.00 3224.  
malignant tumors of the Trachea 61046 chemotherapy (C33). Scheme CF 0.00 3225.  
the bronchial and lung 61047 did not-small malignant tumour chemotherapy (C34). The CE scheme 0.00 3226.  
the bronchial and lung 61048 did not-small malignant tumour chemotherapy (C34). Diagram CV 0.00 3227.  
the bronchial and lung 61049 did not-small malignant tumour chemotherapy (C34). Diagram CPU 0.00 3228.  
the bronchial and lung 61050 did not-small malignant tumour chemotherapy (C34). Scheme/CDDP GEM 0.00 3229.  
the bronchial and lung 61051 did not-small malignant tumour chemotherapy (C34). Diagram of the CBDC/GEM 0.00 3230.  
the bronchial and lung 61052 did not-small malignant tumour chemotherapy (C34). Scheme/CDDP TAXI 0.00 3231.  
the bronchial and lung 61053 did not-small malignant tumour chemotherapy (C34). Scheme TP 0.00 3232.  
the bronchial and lung 61054 did not-small malignant tumour chemotherapy (C34). Diagram CD 0.00 3233.  
the bronchial and lung 61055 did not-small malignant tumour chemotherapy (C34). Scheme of Docetaxel 0.00 3234.  
the bronchial and lung 61056 did not-small malignant tumour chemotherapy (C34). Scheme of Erlotinib 0.00 3235.  
the bronchial and lung 61057-small malignant tumour chemotherapy (C34). Scheme PE 0.00 3236.  
the bronchial and lung 61058-small malignant tumour chemotherapy (C34). The CE scheme 0.00 3237.  
the bronchial and lung 61059-small malignant tumour chemotherapy (C34). Scheme VAC 0.00 3238.  
the bronchial and lung 61060-small malignant tumour chemotherapy (C34). Scheme TP a 0.00 3239.  
61061 * bronchial and lung malignant tumour chemotherapy-small (C34). Scheme TAX 0.00 3240.  
the Thymus gland of 61062 (tīmus) malignant tumor chemotherapy (C37). The CAC scheme 0.00 3241.  
the Thymus gland of 61063 (tīmus) malignant tumor chemotherapy (C37). Scheme PE 0.00 3242.  
the Thymus gland of 61064 (tīmus) malignant tumor chemotherapy (C37). Scheme IFF 0.00 3243.  
61065 * heart, mediastinum and pleura malignant tumor chemotherapy (C38). DOXA 0.00 3244 scheme.  
the bone and joint 61066 cartilage malignant tumor chemotherapy (C40-C41). The scheme AROUND 0.00 3245.  
61067 * bone and joint cartilage malignant tumor chemotherapy (C40-C41). Schema IE_1 0.00 3246.  
61068 * bone and joint cartilage malignant tumor chemotherapy (C40-C41).  Schema IE_2 0.00 3247.  
* malignant skin melanoma 61069 chemotherapy (C43). DTIC 0.00 3248 scheme.  
61070 other malignant skin tumor chemotherapy (C44). Scheme PF 0.00 3249.  
61071 * Mezoteliāl and soft tissue malignant tumor chemotherapy (C45-C49). DOXA 0.00 3250 scheme.  
61072 * Mezoteliāl and soft tissue malignant tumor chemotherapy (C45-C49). Scheme IFF 0.00 3251.  
61073 * Mezoteliāl and soft tissue malignant tumor chemotherapy (C45-C49). Diagram OH 0.00 3252.  
malignant tumour of breast 61074 an adjuvant chemotherapy in/in oadjuvant (C50). Schema CMF_2 0.00 3253.  
malignant tumour of breast 61075 an adjuvant chemotherapy in/in oadjuvant (C50). Schema CMF_1 0.00 3254.  
malignant tumour of breast 61076 an adjuvant chemotherapy in/in oadjuvant (C50). Scheme FACT 0.00 3255.  
malignant tumour of breast 61077 an adjuvant chemotherapy in/in oadjuvant (C50). Diagram EYE 0.00 3256.  
malignant tumour of breast 61078 an adjuvant chemotherapy in/in oadjuvant (C50). A-CMF_1-0.00 scheme 3257.  
malignant tumour of breast 61079 an adjuvant chemotherapy in/in oadjuvant (C50). Diagram A-CMF_1b 0.00 3258.  
malignant tumour of breast 61080 an adjuvant chemotherapy in/in oadjuvant (C50). Diagram ECU 0.00 3259.  
malignant tumour of breast 61081 an adjuvant chemotherapy in/in oadjuvant (C50). The CEF scheme 0.00 3260.  
malignant tumour of breast 61082 an adjuvant chemotherapy in/in oadjuvant (C50). Scheme-0.00 3261 T_1.  
malignant tumour of breast 61083 an adjuvant chemotherapy in/in oadjuvant (C50). Scheme-T_2 0.00 3262.  
61084 malignant tumors of the breast without adjuvant chemotherapy in/in oadjuvant (C50). Diagram AT 0.00 3263.  
malignant tumour of breast 61085 an adjuvant chemotherapy in/in oadjuvant (C50). Scheme of 0.00 Trast_1 3264.  
malignant tumour of breast 61086 an adjuvant chemotherapy in/in oadjuvant (C50). The scheme of Trast_2 0.00 3265.  
malignant tumour of breast 61087 an adjuvant chemotherapy in/in oadjuvant (C50). Diagram AT 0.00 3266.  
malignant tumour of breast 61088 an adjuvant chemotherapy in/in oadjuvant (C50). TC 0.00 3267 scheme.  
malignant tumour of breast 61089 an adjuvant chemotherapy in/in oadjuvant (C50). Diagram A-D-a CMF_1 0.00 3268.  
malignant tumour of breast 61090 an adjuvant chemotherapy in/in oadjuvant (C50). Schema (A)-(D)-CMF_1b 0.00 3269.  
malignant tumour of breast 61091 an adjuvant chemotherapy in/in oadjuvant (C50). Diagram of FEC-D_1 0.00 3270.  
malignant tumour of breast 61092 an adjuvant chemotherapy in/in oadjuvant (C50). Diagram of FEC-D_2 0.00 3271.  
malignant tumour of breast 61093 an adjuvant chemotherapy in/in oadjuvant (C50). Scheme DAC 0.00 3272.  
61094 * breast malignant tumor chemotherapy metastatisk (C50). Schema CMF_1 0.00 3273.  
malignant tumour of breast 61095 of metastatisk chemotherapy (C50). Schema CMF_2 0.00 3274.  
* 61096

Malignant tumour of breast metastatisk chemotherapy (C50). Scheme FACT 0.00 3275.  
malignant tumour of breast 61097-metastatisk chemotherapy (C50). DOXA 0.00 3276 scheme.  
61098 * breast malignant tumor chemotherapy metastatisk (C50). Diagram EYE 0.00 3277.  
61099 * evil metastatisk breast cancer chemotherapy (C50). Scheme EPI 0.00 3278.  
61100 * breast malignant tumor chemotherapy metastatisk (C50). Schema TAX_1 0.00 3279.  
61101 * breast malignant tumor chemotherapy metastatisk (C50). Schema TAX_2 0.00 3280.  
61102 * breast malignant tumor chemotherapy metastatisk (C50). Scheme NVB 0.00 3281.  
61103 * breast malignant tumor chemotherapy metastatisk (C50). Scheme/NVB 0.00 3282 Capeci.  
61104 * breast malignant tumor chemotherapy metastatisk (C50). Schema Capecitabin 0.00 3283.  
61105 * breast malignant tumor chemotherapy metastatisk (C50). Diagram of FEC 0.00 3284.  
61106 * breast malignant tumor chemotherapy metastatisk (C50). Diagram ECU 0.00 3285.  
61107 * breast malignant tumor chemotherapy metastatisk (C50). Diagram AT 0.00 3286.  
61108 * breast malignant tumor chemotherapy metastatisk (C50). Scheme ET 0.00 3287.  
malignant tumour of breast 61109 of metastatisk chemotherapy (C50). Scheme AD 0.00 3288.  
61110 * breast malignant tumor chemotherapy metastatisk (C50). Diagram DC 0.00 3289.  
61111 * breast malignant tumor chemotherapy metastatisk (C50). Schema ED 0.00 3290.  
61112 * breast malignant tumor chemotherapy metastatisk (C50). Schema Docetaxel_1 0.00 3291.  
61113 * breast malignant tumor chemotherapy metastatisk (C50). Schema Docetaxel_2 0.00 3292.  
61114 women external genital malignant tumor chemotherapy (C51). Scheme of CDDP 0.00 3293.  
61115 women external genital malignant tumor chemotherapy (C51). Scheme CF 0.00 3294.  
61116 women external genital malignant tumor chemotherapy (C51). Scheme of 0.00 3295 BLEU.  
the female external genitalia 61117 malignant tumor chemotherapy (C51). Scheme of Topotecan 0.00 3296.  
malignant tumor of the vagina 61118 chemotherapy (C52). Schema CDDP_1 0.00 3297.  
malignant tumor of the vagina 61119 chemotherapy (C52). Schema CDDP_2 0.00 3298.  
malignant tumor of the vagina 61120 chemotherapy (C52). CF 3299 0.00 scheme.  
61121 * cervical malignant tumor chemotherapy (C53). Schema CDDP_1 0.00 3300.  
61122 * cervical malignant tumor chemotherapy (C53). Schema CDDP_2 0.00 3301.  
61123 * cervical malignant tumor chemotherapy (C53). Scheme PF 0.00 3302.  
61124 * cervical malignant tumor chemotherapy (C53). Diagram of the CBDC 0.00 3303.  
61125 * cervical malignant tumor chemotherapy (C53). Scheme TP a 0.00 3304.  
61126 * cervical malignant tumor chemotherapy (C53). Scheme/TP the CDDP 0.00 3305.  
61127 * cervical malignant tumor chemotherapy (C53). Scheme/CDDP TAXI 0.00 3306.  
61128 * cervical malignant tumor chemotherapy (C53). Diagram CPU 0.00 3307.  
61129 * cervical malignant tumor chemotherapy (C53). Scheme/CDDP GEM 0.00 3308.  
61130 * cervical malignant tumor chemotherapy (C53). Scheme TAX 0.00 3309.  
* 61131 uterine malignant tumors of the body chemotherapy (C54). Scheme of CDDP 0.00 3310.  
61132 * uterine malignant tumors of the body chemotherapy (C54). Diagram of the CBDC 0.00 3311.  
the uterine body 61133 malignant tumor chemotherapy (C54). DOXA 0.00 3312 scheme.  
61134 * uterine malignant tumors of the body chemotherapy (C54). Diagram CD 0.00 3313.  
61135 * uterine malignant tumors of the body chemotherapy (C54). Scheme CDP 0.00 3314.  
61136 of uterine malignant tumors of the body chemotherapy (C54). Diagram CPU 0.00 3315.  
the uterine body 61137 malignant tumor chemotherapy (C54). 3316 0.00 TAX scheme.  
malignant tumour of the uterus 61138, part unspecified, chemotherapy (C55). Scheme CF 0.00 3317.  
malignant tumour of the uterus 61139, part unspecified, chemotherapy (C55). Diagram of IC 0.00 3318.  
malignant tumour of the uterus 61140, part unspecified, chemotherapy (C55). Diagram CPU 0.00 3319.  
* 61141 ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Scheme of CDDP 0.00 3320.  
61142 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Diagram of the CBDC 0.00 3321.  
61143 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Scheme of GSP-16 0.00 3322.  
61144 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Scheme PE 0.00 3323.  
61145 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Diagram CPU 0.00 3324.  
61146 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Scheme FL 0.00 3325.  
61147 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Scheme TP a 0.00 3326.  
61148 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Diagram CD 0.00 3327.  
61149 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Diagram of the CBDC/GEM 0.00 3328.  
61150 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Scheme/CDDP GEM 0.00 3329.  
61151 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Scheme of Docetaxel 0.00 3330.  

61152 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Schema TAX_1 0.00 3331.  
61153 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Schema TAX_2 0.00 3332.  
61154 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Scheme Etoposid 0.00 3333.  
61155 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Scheme Gemcitabin 0.00 3334.  
61156 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Scheme Ifosfamid 0.00 3335.  
61157 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. Diagram the BEPA 0.00 3336.  
61158 * ovarian and other specified female genital malignant tumors (C56 C57,), as well as female genital tumor with uncertain or unknown natural (D39) chemotherapy. The VIP scheme 0.00 3337.  
malignant tumour of the placental 61159 chemotherapy (C58). Scheme DAC 0.00 3338.  
malignant tumour of the placental 61160 chemotherapy (C58). Scheme ML 0.00 3339.  
malignant tumour of the placental 61161 chemotherapy (C58). Scheme EA 0.00 3340.  
malignant tumour of the placental 61162 chemotherapy (C58). Scheme-EMAS CO. 0.00 3341.  
malignant tumour of the placental 61163 chemotherapy (C58). Scheme PE/AMA 0.00 3342.  
malignant tumour of the penis 61164 chemotherapy (C60). Scheme CMV 0.00 3343.  
malignant tumour of the penis 61165 chemotherapy (C60). Scheme PF 0.00 3344.  
malignant tumour of the penis 61166 chemotherapy (C60). Scheme of the VBM 0.00 3345.  
malignant tumour of the prostate 61167 chemotherapy (C61). Scheme MP 0.00 3346.  
malignant tumour of the prostate 61168 chemotherapy (C61). Scheme DP 0.00 3347.  
malignant tumors of the Testicle 61169 (seminom) (C62), as well as other unspecified men and genital malignant tumor (C63) and male genital tumor with uncertain or unknown natural (D40) chemotherapy. Scheme PE 0.00 3348.  
malignant tumors of the Testicle 61170 (seminom) (C62), as well as other unspecified men and genital malignant tumor (C63) and male genital tumor with uncertain or unknown natural (D40) chemotherapy. Diagram the BEPA 0.00 3349.  
malignant tumors of the Testicle 61171 (seminom) (C62), as well as other unspecified men and genital malignant tumor (C63) and male genital tumor with uncertain or unknown natural (D40) chemotherapy. The VIP scheme 0.00 3350.  
malignant tumors of the Testicle 61172 (seminom) chemotherapy (C62). Diagram of the CBDC 0.00 3351.  
malignant tumors of the Testicle 61173 (seminom) chemotherapy (C62). Scheme PE 0.00 3352.  
malignant tumors of the Testicle 61174 (seminom) chemotherapy (C62). The VIP scheme 0.00 3353.  
malignant tumour of the kidney 61175 (C64), as well as other non-specified in urīnizvadorgān and malignant tumors (C68) and urīnizvadorgān tumor with uncertain or unknown natural (D41) chemotherapy. INF-α 0.00 3354 scheme.  
* Kidney 61176 bowls (C65), ureter (C66), bladder (C67) malignant tumor chemotherapy. Scheme CNAC 0.00 3355.  
61177 * kidney bowls (C65), ureter (C66), bladder (C67) malignant tumor chemotherapy. Scheme/CDDP GEM 0.00 3356.  
61178 * eye and eye for malignant tumor chemotherapy subsidiary bodies (C69). DTIC 0.00 3357 scheme.  
the eye and the eye 61179 subsidiary body of malignant tumor chemotherapy (C69). DOXA 0.00 3358 scheme.  
61180 * eye and eye for malignant tumor chemotherapy subsidiary bodies (C69). Scheme IFF 0.00 3359.  
the eye and the eye 61181 subsidiary body of malignant tumor chemotherapy (C69). Diagram OH 0.00 3360.  
61182 * brain casing (C70), brain (C71), spinal cord, cranial nerves and other central nervous system (C72), as well as the brain and the central nervous system with uncertain or unknown natural (D43) malignant tumor chemotherapy. Diagram PCV 0.00 3361.  
the brain shell 61183 (C70), brain (C71), spinal cord, cranial nerves and other central nervous system (C72), as well as the brain and the central nervous system with uncertain or unknown natural (D43) malignant tumor chemotherapy. Scheme of 3362 CCN 0.00.  
the brain shell 61184 (C70), brain (C71), spinal cord, cranial nerves and other central nervous system (C72), as well as the brain and the central nervous system with uncertain or unknown natural (D43) malignant tumor chemotherapy. Diagram of BCN 0.00 3363.  
the brain shell 61185 (C70), brain (C71), spinal cord, cranial nerves and other central nervous system (C72), as well as the brain and the central nervous system with uncertain or unknown natural (D43) malignant tumor chemotherapy. The scheme shall be 0.00 3364 Photos.  
the brain shell 61186 (C70), brain (C71), spinal cord, cranial nerves and other central nervous system (C72), as well as the brain and the central nervous system with uncertain or unknown natural (D43) malignant tumor chemotherapy. Schema Temz_1 0.00 3365.  
the brain shell 61187 (C70), brain (C71), spinal cord, cranial nerves and other central nervous system (C72), as well as the brain and the central nervous system with uncertain or unknown natural (D43) malignant tumor chemotherapy. Schema Temz_2 0.00 3366.  
malignant tumors of the thyroid 61188 chemotherapy (C73). DOXA 0.00 3367 scheme.  
malignant tumors of the thyroid 61189 chemotherapy (C73). Diagram EYE 0.00 3368.  
* adrenal cortical 61190 malignant tumor chemotherapy (C74). Scheme of ACEM 0.00 3369.  
61191 * malignant tumor of adrenal pith of chemotherapy (C74). Scheme CVD 0.00 3370.  
61192 other endocrine glands and related structures (highly differentiated tumor) malignant tumor chemotherapy (C75). Scheme Lanr 0.00 3371.  
61193 *

Other endocrine glands and related structures (highly differentiated tumor) malignant tumor chemotherapy (C75). Scheme 0.00 3372 Octr.  
61194 other endocrine glands and related structures (low-differentiated/non-differentiated tumor) (C75), as well as endocrine glands with unclear or unknown natural (D44) malignant tumor chemotherapy. Diagram ECU 0.00 3373.  
61195 other endocrine glands and related structures (low-differentiated/non-differentiated tumor) (C75), as well as endocrine glands with unclear or unknown natural (D44) malignant tumor chemotherapy. Scheme FDE 0.00 3374.  
61196 other endocrine glands and related structures (pancreatic endocrine tumours) malignant tumor chemotherapy (C75). Scheme 5-FU 0.00 3375.  
61197 other endocrine glands and related structures (pancreatic endocrine tumours) malignant tumor chemotherapy (C75). DOXA 0.00 3376 scheme.  
61198 and other inaccurate denote the locale (C76), secondary and unspecified lymph nodes (C77), secondary to respiratory and digestive organs (C78), secondary to other location (C79) malignant tumor, malignant tumours without indications of the (C80), localization of independent (primary) multiple malignant tumors (C97), as well as the other and unspecified locale tumor with uncertain or unknown natural (D48) chemotherapy. The CE scheme 0.00 3377.  
and other inaccurate 61199 designated locale (C76), secondary and unspecified lymph nodes (C77), secondary to respiratory and digestive organs (C78), secondary to other location (C79) malignant tumor, malignant tumours without indications of the (C80), localization of independent (primary) multiple malignant tumors (C97), as well as the other and unspecified locale tumor with uncertain or unknown natural (D48) chemotherapy. Diagram CPU 0.00 3378.  
61200 and other inaccurately labeled locale (C76), secondary and unspecified lymph nodes (C77), secondary to respiratory and digestive organs (C78), secondary to other location (C79) malignant tumor, malignant tumours without indications of the (C80), localization of independent (primary) multiple malignant tumors (C97), as well as the other and unspecified locale tumor with uncertain or unknown natural (D48) chemotherapy. Schema DOC 0.00 3379.  
the Hodgkins disease 61201 chemotherapy (C81). Schema ABVD_1 0.00 3380.  
the Hodgkins disease 61202 chemotherapy (C81). Schema ABVD_15 0.00 3381.  
the Hodgkins disease 61203 chemotherapy (C81). Scheme to 0.00 BEACOPP_s 3382.  
the Hodgkins disease 61204 chemotherapy (C81). Scheme of 0.00 3383 BEACOPP_p.  
the Hodgkins disease 61205 chemotherapy (C81). Dex-beam scheme 0.00 3384.  
the Hodgkins disease 61206 chemotherapy (C81). Schema ChIVPP 0.00 3385.  
the Hodgkins disease 61207 chemotherapy (C81). Schema VEPEMB 0.00 3386.  
* the non-Hodgkins Folikulār 61208 Lymphoma (C82), diffuse, of non-Hodgkins Lymphoma (C83), peripheral and cutaneous T cell Lymphoma (C84), other and non-Hodgkins Lymphoma specified (C85), malignant imūnproliferatīv disease (C 88), does not specify the lymphoid tissues, hematopoietic and related (C96), histiocitisk cell and mast cell with vague and unknown nature (D 29.2), lymphoid, hematopoetic and related tissue with unclear or unknown natural (D 29.6), as well as other lymphoid tissues, hematopoietic and related with unspecified or unknown nature not specified (D 29.8) malignant tumor chemotherapy. Scheme COP 0.00 3387.  
* Folikulār-61209 non-Hodgkins Lymphoma (C82), diffuse, of non-Hodgkins Lymphoma (C83), peripheral and cutaneous T cell Lymphoma (C84), other and non-Hodgkins Lymphoma specified (C85), malignant imūnproliferatīv disease (C 88), does not specify the lymphoid tissues, hematopoietic and related (C96), histiocitisk cell and mast cell with vague and unknown nature (D 29.2), lymphoid, hematopoetic and related tissue with unclear or unknown natural (D 29.6), as well as other lymphoid tissues, hematopoietic and related with unspecified or unknown nature not specified (D 29.8) malignant tumor chemotherapy. Schema CHOP_1 0.00 3388.  
* Folikulār-61210 non-Hodgkins Lymphoma (C82), diffuse, of non-Hodgkins Lymphoma (C83), peripheral and cutaneous T cell Lymphoma (C84), other and non-Hodgkins Lymphoma specified (C85), malignant imūnproliferatīv disease (C 88), does not specify the lymphoid tissues, hematopoietic and related (C96), histiocitisk cell and mast cell with vague and unknown nature (D 29.2), lymphoid, hematopoetic and related tissue with unclear or unknown natural (D 29.6), as well as other lymphoid tissues, hematopoietic and related with unspecified or unknown nature not specified (D 29.8) malignant tumor chemotherapy.  Schema CHOP_2 0.00 3389.  
* Folikulār-61211 non-Hodgkins Lymphoma (C82), diffuse, of non-Hodgkins Lymphoma (C83), peripheral and cutaneous T cell Lymphoma (C84), other and non-Hodgkins Lymphoma specified (C85), malignant imūnproliferatīv disease (C 88), does not specify the lymphoid tissues, hematopoietic and related (C96), histiocitisk cell and mast cell with vague and unknown nature (D 29.2), lymphoid, hematopoetic and related tissue with unclear or unknown natural (D 29.6), as well as other lymphoid tissues, hematopoietic and related with unspecified or unknown nature not specified (D 29.8) malignant tumor chemotherapy.  Scheme of R-CHOP 0.00 3390.  
* the non-Hodgkins Folikulār 61212 Lymphoma (C82), diffuse, of non-Hodgkins Lymphoma (C83), peripheral and cutaneous T cell Lymphoma (C84), other and non-Hodgkins Lymphoma specified (C85), malignant imūnproliferatīv disease (C 88), does not specify the lymphoid tissues, hematopoietic and related (C96), histiocitisk cell and mast cell with vague and unknown nature (D 29.2), lymphoid, hematopoetic and related tissue with unclear or unknown natural (D 29.6), as well as other lymphoid tissues, hematopoietic and related with unspecified or unknown nature not specified (D 29.8) malignant tumor chemotherapy. The CVP scheme 0.00 3391.  
* the non-Hodgkins Folikulār 61213 Lymphoma (C82), diffuse, of non-Hodgkins Lymphoma (C83), peripheral and cutaneous T cell Lymphoma (C84), other and non-Hodgkins Lymphoma specified (C85), malignant imūnproliferatīv disease (C 88), does not specify the lymphoid tissues, hematopoietic and related (C96), histiocitisk cell and mast cell with vague and unknown nature (D 29.2), lymphoid, hematopoetic and related tissue with unclear or unknown natural (D 29.6), as well as other lymphoid tissues, hematopoietic and related with unspecified or unknown nature not specified (D 29.8) malignant tumor chemotherapy.  Scheme FMD 0.00 3392.  
61214 *

Folikulār of non-Hodgkins Lymphoma (C82), diffuse, of non-Hodgkins Lymphoma (C83), peripheral and cutaneous T cell Lymphoma (C84), other and non-Hodgkins Lymphoma specified (C85), malignant imūnproliferatīv disease (C 88), does not specify the lymphoid tissues, hematopoietic and related (C96), histiocitisk cell and mast cell with vague and unknown nature (D 29.2), lymphoid, hematopoetic and related tissue with unclear or unknown natural (D 29.6), as well as other lymphoid tissues, hematopoietic and related with unspecified or unknown nature not specified (D 29.8) malignant tumor chemotherapy.  Fide 0.00 3393 scheme.  
* the non-Hodgkins Folikulār 61215 Lymphoma (C82), diffuse, of non-Hodgkins Lymphoma (C83), peripheral and cutaneous T cell Lymphoma (C84), other and non-Hodgkins Lymphoma specified (C85), malignant imūnproliferatīv disease (C 88), does not specify the lymphoid tissues, hematopoietic and related (C96), histiocitisk cell and mast cell with vague and unknown nature (D 29.2), lymphoid, hematopoetic and related tissue with unclear or unknown natural (D 29.6), as well as other lymphoid tissues, hematopoietic and related with unspecified or unknown nature not specified (D 29.8) malignant tumor chemotherapy.  Scheme FC 0.00 3394.  
* multiple myeloma 61216 and malignant plasma cell tumor (C90) chemotherapy. Scheme MP 0.00 3395.  
* multiple myeloma 61217 and malignant plasma cell tumor (C90) chemotherapy. Diagram CPU 0.00 3396.  
* multiple myeloma 61218 and malignant plasma cell tumor (C90) chemotherapy. Diagram wire 0.00 3397.  
* multiple myeloma 61219 and malignant plasma cell tumor (C90) chemotherapy. Diagram M-2 0.00 3398.  
* multiple myeloma 61220 and malignant plasma cell tumor (C90) chemotherapy. Scheme of Bortezomib 0.00 3399.  
* acute 61221 limfoblastoz (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. Scheme VCR 0.00 3400.  
* acute 61222 limfoblastoz (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. Diagram 6-MP 0.00 3401.  
* acute 61223-limfoblastoz (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. Schema ALL_SR_1 0.00 3402.  
* acute 61224 limfoblastoz (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. Schema ALL_SR_2 0.00 3403.  
* acute 61225 limfoblastoz (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. Schema ALL_AR_1 0.00 3404.  
* acute 61226 limfoblastoz (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. Schema ALL_AR_2 0.00 3405.  
* acute 61227 limfoblastoz (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. Schema ALL_AR_3 0.00 3406.  
* acute 61228 limfoblastoz (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. Schema ALL_AR_4 0.00 3407.  
61229 * acute limfoblastoz (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. Schema GMALL_1 0.00 3408.  
61230 * acute limfoblastoz (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. Schema GMALL_2 0.00 3409.  
* acute limfoblastoz-61231 (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. Schema GMALL_3 0.00 3410.  
* acute 61232 limfoblastoz (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. Schema ID-FLAG 0.00 3411.  
* acute 61233 limfoblastoz (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. The MAC scheme 0.00 3412.  
61234 * acute limfoblastoz (91.0, 91.3, C C C C C 56.9, 91.7, 91.9), does not specify the cell leukosis (acute) ((C) 95.0), sub-acute unspecified cell leukosis (95.2), other non-specified cell leukosis (95.7), as well as unspecified leucosis (C 95.9) chemotherapy. Scheme POMP 0.00 3413.  
61235 * chronic limfoleikoz (91.1, 91.2 C C) chemotherapy. Scheme FC 0.00 3414.  
61236 * chronic limfoleikoz (91.1, 91.2 C C) chemotherapy. Scheme FMD 0.00 3415.  
* chronic 61237 limfoleikoz (91.1, 91.2 C C) chemotherapy. Scheme COP 0.00 3416.  
61238 * chronic limfoleikoz (91.1, 91.2 C C) chemotherapy. Scheme CHOP 0.00 3417.  
61239 * chronic limfoleikoz (91.1, 91.2 C C) chemotherapy. The CVP scheme 0.00 3418.  
61240 * Hairy Cell leukosis (91.4) chemotherapy. Scheme pent 0.00 3419.  
the acute mieloleikoz of 61241 (C, C, C 92.2 92.3 92.0, 92.5, C C C 92.4, 92.9), acute monocitār leucosis (C, C, C, 93.2 93.0 93.7, C 58.3) and other specified leukosis (C, C, C 94.3 94.0 94.2, 94.4, C 94.5 C) chemotherapy. Scheme VCR 0.00 3420.  
61242 *

Acute mieloleikoz (C, C, C 92.2 92.3 92.0, 92.5, C C C 92.4, 92.9), acute monocitār leucosis (C, C, C, 93.2 93.0 93.7, C 58.3) and other specified leukosis (C, C, C 94.3 94.0 94.2, 94.4, C 94.5 C) chemotherapy. Diagram 6-MP 0.00 3421.  
* acute 61243 mieloleikoz (C, C, C 92.2 92.3 92.0, 92.5, C C C 92.4, 92.9), acute monocitār leucosis (C, C, C, 93.2 93.0 93.7, C 58.3) and other specified leukosis (C, C, C 94.3 94.0 94.2, 94.4, C 94.5 C) chemotherapy. Scheme with the DOXA/-C "3 + 7" 3422 0.00.  
61244 * acute mieloleikoz (C, C, C 92.2 92.3 92.0, 92.5, C C C 92.4, 92.9), acute monocitār leucosis (C, C, C, 93.2 93.0 93.7, C 58.3) and other specified leukosis (C, C, C 94.3 94.0 94.2, 94.4, C 94.5 C) chemotherapy. Scheme with the DOXA/-C "2 + 5" 0.00 3423.  
* acute 61245 mieloleikoz (C, C, C 92.2 92.3 92.0, 92.5, C C C 92.4, 92.9), acute monocitār leucosis (C, C, C, 93.2 93.0 93.7, C 58.3) and other specified leukosis (C, C, C 94.3 94.0 94.2, 94.4, C 94.5 C) chemotherapy. Scheme with-C 0.00 3424.  
61246 * acute mieloleikoz (C, C, C 92.2 92.3 92.0, 92.5, C C C 92.4, 92.9), acute monocitār leucosis (C, C, C, 93.2 93.0 93.7, C 58.3) and other specified leukosis (C, C, C 94.3 94.0 94.2, 94.4, C 94.5 C) chemotherapy. Schema ID-FLAG 0.00 3425.  
61247 * acute mieloleikoz (C, C, C 92.2 92.3 92.0, 92.5, C C C 92.4, 92.9), acute monocitār leucosis (C, C, C, 93.2 93.0 93.7, C 58.3) and other specified leukosis (C, C, C 94.3 94.0 94.2, 94.4, C 94.5 C) chemotherapy. The MAC scheme 0.00 3426.  
* acute 61248 mieloleikoz (C, C, C 92.2 92.3 92.0, 92.5, C C C 92.4, 92.9), acute monocitār leucosis (C, C, C, 93.2 93.0 93.7, C 58.3) and other specified leukosis (C, C, C 94.3 94.0 94.2, 94.4, C 94.5 C) chemotherapy. Scheme POMP 0.00 3427.  
* acute 61249 mieloleikoz (C, C, C 92.2 92.3 92.0, 92.5, C C C 92.4, 92.9), acute monocitār leucosis (C, C, C, 93.2 93.0 93.7, C 58.3) and other specified leukosis (C, C, C 94.3 94.0 94.2, 94.4, C 94.5 C) chemotherapy. Scheme Mae 0.00 3428.  
61250 * acute mieloleikoz (C, C, C 92.2 92.3 92.0, 92.5, C C C 92.4, 92.9), acute monocitār leucosis (C, C, C, 93.2 93.0 93.7, C 58.3) and other specified leukosis (C, C, C 94.3 94.0 94.2, 94.4, C 94.5 C) chemotherapy. The scheme THEN 0.00 3429.  
61251 * acute mieloleikoz (C, C, C 92.2 92.3 92.0, 92.5, C C C 92.4, 92.9), acute monocitār leucosis (C, C, C, 93.2 93.0 93.7, C 58.3) and other specified leukosis (C, C, C 94.3 94.0 94.2, 94.4, C 94.5 C) chemotherapy. Scheme DCE 0.00 3430.  
61252 * chronic mieloleikoz (57.2 C, C 92.7) and chronic non-specified cell leukosis (95.1) chemotherapy. Scheme INN 0.00 3431.  
61253 * chronic mieloleikoz (57.2 C, C 92.7) and chronic non-specified cell leukosis (95.1) chemotherapy. Scheme of IFN-α 0.00 3432.  
61254 * chronic mieloleikoz (57.2 C, C 92.7) and chronic non-specified cell leukosis (95.1) chemotherapy. Scheme with the DOXA/-C "2 + 5" 0.00 3433.  
* chronic 61255 mieloleikoz (57.2 C, C 92.7) and chronic non-specified cell leukosis (95.1) chemotherapy. Scheme with the DOXA/-C "3 + 7" 0.00 3434.  
* chronic 61256 mieloleikoz (57.2 C, C 92.7) and chronic non-specified cell leukosis (95.1) chemotherapy. Scheme with-C 0.00 3435.  
61257 * chronic mieloleikoz (57.2 C, C 92.7) and chronic non-specified cell leukosis (95.1) chemotherapy. Schema ID-3436 0.00 FLAG.  
* chronic 61258 eritrēmij (C 94.1), other specified leukosis (94.7), policitēmij (D45), chronic mieloproliferatīv disease (D 29.3) and essential (haemorrhagic) trombocitēmij ((D) 47.3) chemotherapy. Scheme INN 0.00 3437.  
61259 * chronic eritrēmij (C 94.1), other specified leukosis (94.7), policitēmij (D45), chronic mieloproliferatīv disease (D 29.3) and essential (haemorrhagic) trombocitēmij ((D) 47.3) chemotherapy. Scheme with-C 0.00 3438.  
61260 * chronic eritrēmij (C 94.1), other specified leukosis (94.7), policitēmij (D45), chronic mieloproliferatīv disease (D 29.3) and essential (haemorrhagic) trombocitēmij ((D) 47.3) chemotherapy. Diagram 6-MP 0.00 3439.  
* chronic monocitār leukemia 61261 (C 93.1), as well as the mielodisplastisk syndrome (D46) chemotherapy. Scheme with-C 0.00 3440.  
* chronic monocitār leukemia 61262 (C 93.1), as well as the mielodisplastisk syndrome (D46) chemotherapy. Diagram 6-MP 0.00 3441.  
* chronic monocitār leukemia 61263 (C 93.1), as well as the mielodisplastisk syndrome (D46) chemotherapy. DOXA 0.00 3442 scheme.  
* chronic monocitār leukemia 61264 (C 93.1), as well as the mielodisplastisk syndrome (D46) chemotherapy. Diagram DC 0.00 3443.  
61265 * Pretinfekcij feature of Piperacillin/Tazobactam for injection/infusion of 2000 mg/250 mg 0.00 3444.  
61266 * Pretinfekcij feature of Piperacillin/Tazobactam for injection/infusion of 4000 mg/mg 0.00 3445.  
61267 Pretinfekcij feature of the Meropenem injection/infusion of 0.00 mg 3446.  
* Pretinfekcij of 61268 Meropenem for injection/infusion of 1000mgs 0.00 3447.  
61269 * Pretinfekcij of Imipenem/Cilastatin for injection/infusion of 0.00 mg of 3448.  
the Pretinfekcij feature 61270 Amikacin injection/infusion of 0.00 mg of 3449.  
* Pretinfekcij of 61271 Amikacin injection/infusion of 1000mgs of 0.00 3450.  
61272 * Pretinfekcij feature for infusion of Ciprofloxacin injection/200 0.00 3451.  
61273 * Pretinfekcij feature of the Vancomycin injection/infusion 0.00 mg 3452.  
61274 * Pretinfekcij feature of Vancomycin injection/infusion of 1000mgs 0.00 3453.  
61275 * Pretinfekcij feature the use of Linezolid 600 mg oral 0.00 3454.  
61276 Pretinfekcij feature of the Amphotericin/infusion of 50 mg injection 0.00 3455.  
61277 * Pretinfekcij feature of Fluconazol injection/infusion of 200 3456 0.00.  
61278 * Pretinfekcij the use of oral Itraconazol 100 mg 0.00 3457.  
the Pretinfekcij feature 61279 Aciclovir for injection/infusion of 250 mg 0.00 3458.  
the granulocytes 61280 colony stimulating factor Filgrastim for injection/infusion, 12mg 0.00 0 3459.  
the granulocytes 61281 colony stimulating factor Filgrastim for injection/infusion, 30 mg 0 0.00 3460.  
the granulocytes 61282 colony stimulating factor Filgrastim for injection/infusion 48mg 0.00 0, 3461.  
the granulocytes 61283 colony stimulating factor for injection/infusion of Lenograstim 263mcg 0.00 3462.  
the granulocytes 61284 colony stimulating factor for injection/infusion of Pegfilgrastim 6mg 0.00 dental services tariff (manipulation 70001-77330)

70401-70415 manipulation, 70433, 70435 70429 70417-,-70025, 70456, 70201 70203-70254, 70301,,-, 70327 70340, 70304 70501-70510-70531, 70515, 70535-70555 include anesthesia costs, individual clinical situations allowed in addition to anesthesia, which should be based on the documentation, general outpatient manipulation costs not included, No anesthesia, p, k, manipulation of code manipulation name tariff 3463.  
70001 jobs for each visit that includes materials for single instruments, as well as the top three, the staffing of the preparatory work, the Orthodontist are presented at the diagnostic and treatment plan of 1.14 3464.  
70002, complete the patient first and history data collection, Payment is made once the patient on arrival at practice, handling costs are not included in the rentgendiagnostisk studies, presented at the Orthodontist in the diagnostic and treatment plan, the epidemiological project in cases where oral health center inspections show dental manipulations, pay for manipulation is done, if it is presented in the teeth higiēnist 2.57 3465.  
70003 was with the change detection, for manipulation is carried out if one patient presented more frequently than once in six months, pay for manipulation is done, if it is presented in the teeth higiēnist 1.30 3466.  
70005 dental hygiene index determination before professional dental hygiene, or periodontal disease treatment, pay for manipulation is carried out if one patient presented more frequently than twice a year, the Manipulation is also used oral health center dental higiēnist information screening cases 0.84 3467.  
70006 gum bleeding index determination before professional dental hygiene, or periodontal disease treatment, pay for manipulation is carried out if one patient presented more frequently than twice a year 0.53 3468.  
70007 periodontal index (CPITN) using the graduated pogveid probe, before professional dental hygiene, or periodontal disease treatment, pay for manipulation is carried out if one patient presented more frequently than twice a year, must be presented together with manipulation or 70006 1.96 3469 70005.  
70008 first complete periodontal examination, conducted by the periodontolog or specialist in one patient once a year 5.83 3470.  
70009 repeated periodontal examination, carried out periodontolog or a specialist, compared to the first results of the investigation of periodontal 3.89 3471.  
Picture or profile photos 70011, Orthodontist, presented at diagnostic and treatment plan of 0.94 3472.  
the vertical dimension of Occlusion 70012 assessment 1.21 3473.  
70013 wedge analysis, Orthodontist, presented at diagnostic and treatment plan of 1.30 3474.  
70014 teeth tooth vitality determination one of 0.39 3475.  
70016 specialist Orthodontist in the subspecialitāt consultation, presented at diagnostic and treatment plan of dialing 1.57 3476.  
70018-prosthetics and treatment planning in orthodontics, or by patient for clinical and radiographic examination, Orthodontist, presented at diagnostic and treatment plan of 1.20 3477.  
70023 puncture 1.36 3478.  
or a scrape cytology 70024 fingerprint investigation 0.68 3479.  
70025 biopsy 1.92 3480.  
microbiological examinations 70026, feed costs are not included in 0.64 3481.  
the patterns, wordless 70027 Orthodontist show at diagnostic and treatment plan of 1.19 3482.  
70028 Made the patterns, Orthodontist, presented at diagnostic and treatment plan of 1.24 3483.  
Orthodontic Orthodontist 70029-patterns, are presented at the diagnostic and treatment plan of 3484 1.13.  
70030 Patterns for measurements and analysis, presented at the Orthodontist diagnostic and treatment plan of 1.30 3485.  
Patterns of waxing 70031 diagnostic purposes (for sekstant) 3.86 3486.  
the fingerprint of the Orthodontist 70032 atliešan, presented at the diagnostic and treatment plan of 1.30 3487.  
70050 Periapikāl röntgen-one company, pay for manipulation is done, if it is presented once one visit 1.18 3488.  
70051 Periapikāl röntgen-each subsequent company 1.09 3489.  
Dental x-rays in a written 70052, Orthodontist, presented at diagnostic and treatment plan of 0.23 3490.  
Interproksimāl (BW) x-ray 70053-one company, pay for manipulation is done, if it is presented once one visit 1.01 3491.  
70054 Interproksimāl (BW) x-rays-each subsequent company 0.80 3492.  
70055 maxilla and mandibular panorama slāņuzņēmum (ortopantomogramm), Orthodontist, presented at diagnostic and treatment plan of 4.92 3493.  
70057 mandibular region of various x-ray 1.86 3494.  
70058 sinus x-ray images in one plane 1.86 3495.  
70059 cheek bone radiograph 1.86 3496.  
70061 digital cefalogrāfij (telerentgenogramm) 4.92 3497.  
Joint head of x-ray 70063 1.86 3498.  
x-rays of each tooth is 70071 rentgenkabinet in 1.42 3499.  
70101 hygiene instruction and motivation, oral care and prevention demonstrations and providing information for parents about the child's teeth, Orthodontist, presented at diagnostic and treatment plan of 1.51 3500.  
70103 tooth surface treatment by means of pretkaries-gel or foam applications may not be present together with manipulation or 0.60 3501 70105 70104.  
70104 Tooth surfaces with fluorlak around the mouth may show with manipulation or 70105 0.81 70103 3502.  
70105 Tooth surfaces with fluorprotektor around the mouth may show with manipulation or 70104 0.68 70103 3503.  
70108 teeth remove fever throughout the soft mouth may show with manipulation, 70110 70503 or 1.95 3504 70504.  
70109 tooth polishing throughout the mouth 1.89 3505.  
70110 tooth hard remove the pigment around the mouth may show with manipulation or 70504 4.86 3506 70108, 70503.  
70201 tooth kavitāt generation and temporary closures, carried out in cases where planned to make inlej or other prosthetic elements, as well as in the case of deep caries 2.94 3507.  
70202 one parapulpār pins or screws a channel forcing 1.06 3508.  
70203 milk teeth, amalgam, 1 surface

3509 3.43.  
70204 milk teeth, amalgam, 2 surface 4.34 3510.  
70205 milk teeth, amalgam, 3 surface 5.04 3511.  
70206 milk teeth, amalgam, 4 surface 5.89 3512.  
70207 milk teeth, glass jonomēr, 1 surface 3.65 3513.  
70208 milk teeth, glass jonomēr, 2 surface 4.81 3514.  
70211 milk teeth, kompomēr, 1 surface 3.83 3515.  
70212 milk teeth, kompomēr, 2 surface 5.08 3516.  
milk teeth, molar 70221, standard metal Crown 6.26 3517.  
70222 Amalgam, incisīv and premolār, 1 surface 4.04 3518.  
70223, premolār, Amalgam 2 surfaces 5.01 3519.  
70224 Amalgam, premolār, 3 surface 5.53 3520.  
70225 Amalgam, premolār, 4 surface 7.01 3521.  
70226 Amalgam, premolār, clinical Crown restoration 13.52 3522.  
70227 Amalgam, molar, 1 surface 4.18 3523.  
70228 Amalgam, molar, 3 surfaces 5.22 3524.  
70229 Amalgam, molar, 3 surfaces 5.72 3525.  
70230 Amalgam, molar, 4 and more surface 8.09 3526.  
70231 Amalgam, molar, clinical Crown restoration 14.98 3527.  
70232 glass jonomēr, incisīv, 1 surface 4.69 3528.  
70233 glass jonomēr, incisīv, 2 surface 5.57 3529.  
70234 glass, premolār jonomēr, 1 surface 4.69 3530.  
70235 glass jonomēr, molar, 1 surface 5.28 3531.  
Kompomēr, incisīv, 70236 1 surface 5.07 3532.  
70237 Kompomēr, incisīv, 2 surface 5.96 3533.  
70238 Kompomēr, premolār, 1 of 5.06 3534 surface.  
70239, Kompomēr, 1 molar surface 5.30 3535.  
70240 composite, incisīv, 1 surface using only the light of composite materials hardening 6.07 3536.  
70241 composite, incisīv, 2 surface using only the light-hardening materials 6.93 3537 composite.  
70242 composite, incisīv, 3 surface using only the light of composite materials hardening 8.63 3538.  
70243 composite, incisīv, 4 surface using only the light of composite materials hardening 9.76 3539.  
70244 composite, incisīv, 5 surface using only the light of composite materials hardening 11.61 3540.  
70301 milk teeth, the molar pulpotomij of vital 4.26 3541.  
70302 milk teeth, in the molar pulpotomij mortāl-first impressions, pulp devitalizācij, included in the cost of the temporary closure of the kavitāt 2.64 3542.  
70303 milk teeth, mortāl pulpotomij, the molar in the second session 2.42 3543.  
70304 milk teeth, pulpektomij the incisīv with a root canal treatment, the costs included in the temporary closure of the 5.25 kavitāt 3544.  
milk teeth 70305, pulpektomij incisīv, of the root canal filling, included in the cost of processing and temporary closure of the kavitāt 2.73 3545.  
70306, pulpektomij of milk teeth, molar root canal treatment 6.14 3546.  
70307 milk teeth, pulpektomij, the molar root canal filling 4.11 3547.  
70308 vital pulpotomij (apeksģenēz) the permanent teeth with not looking roots, after the part of the Crown pulp amputation using calcium preparations 4.65 3548.  
direct Pulp capping 70309 used to injuries in baby teeth, if the pulp opening is not more than 1 mm 4.38 3549.  
70310 pulpotomij children partial teeth with a roots-designed Horn removal of pulp injuries or accidentally open the case using the pulp, calcium preparations 4.65 3550.  
Apeksfiksācij-viensakn-70311 teeth with a roots-designed the first session 5.31 3551.  
70312-divsakņ Apeksfiksācij teeth with a roots-designed the first session 6.95 3552.  
Apeksfiksācij of trīssakņ teeth 70313 with design roots-first session 7.30 3553.  
Apeksfiksācij teeth with 70314 design roots with anatomical additional channel-first session 2.29 3554.  
Apeksfiksācij of the viensakn of the teeth 70315 with design roots-each subsequent session 3.94 3555.  
Apeksfiksācij of divsakņ teeth 70316 with design roots-each subsequent session 5.58 3556.  
Apeksfiksācij of trīssakņ teeth 70317 with design roots-each subsequent session 5.26 3557.  
Apeksfiksācij teeth with 70318 design roots with anatomical additional channel-each subsequent session 2.29 3558.  
pulpotomij's looking for vital 70319 premolār and molar as emergency assistance to the permanent pulpīt, if there is no time to make a pulpektomij 4.41 3559.  
pulpektomij of viensakn of acute 70320 teeth, as emergency assistance to the permanent pulpīt or pulp injury 5.35 3560.  
acute pulpektomij of the divsakņ of 70321 teeth, as emergency assistance to the permanent pulpīt or pulp injury 6.82 3561.  
acute pulpektomij of the trīssakņ of 70322 teeth, as emergency assistance to the permanent pulpīt or pulp injury 8.54 3562.  
acute pulpektomij 70323 teeth with anatomical additional channel, as emergency assistance to the permanent pulpīt or pulp injury 3563 2.29.  
70324 acute dead teeth and open drainage of viensakn teeth, as emergency assistance, do not live in the acute case of 5.35 3564 teeth.  
acute dead 70325 teeth open and drainage divsakņ teeth, as emergency assistance, do not live in the acute case of 6.98 3565 teeth.  
70326 acute dead teeth and open drainage trīssakņ teeth, as emergency assistance, do not live in the acute tooth case 7.96 3566.  
acute dead 70327 teeth open and teeth with anatomical supply additional channel, as emergency assistance, do not live in the acute case of 1.66 3567 teeth.  
70328 root canal treatment of tooth viensakn, Taken in one session, except in the case of withdrawal 3.72 3568 pus.  
70329 root canals of teeth for the default viensakn 2.90 3569.  
70330 root canal treatment of tooth divsakņ, Taken in one session, except in the case of withdrawal 4.70 3570 pus.  
70331 root canal filling teeth for 4.64 3571 divsakņ.  
70332 root canal treatment of tooth 7.42 3572 trīssakņ.  
70333 root canal filling of teeth to the 6.11 3573 trīssakņ.  
70334 root canal treatment tooth with anatomical additional channel 2.57 3574.  
70335 root canal filling teeth with anatomical additional channel 2.38 3575.  
the pārārstēšan of the root canal 70336 viensakn's teeth to 6.17 3576.  
70337 pārārstēšan of the divsakņ of the root canal tooth 7.17 to 3577.  
the pārārstēšan of the root canal 70338 trīssakņ teeth of 8.82 3578.  
70339 root canal teeth with anatomical pārārstēšan additional channels 3579 2.29.  
Endodontisk in the treated tooth 70340 Crown restoration before the imposition of the cofferdams 6.84 3580.  
Endodontisk to cure tooth 70341 opening through Crown 2.31 3581.  
70400 moving milk-teeth extraction

1.84 3582.  
Viensakn of tooth extraction 70401, including wounds finish 3.26 3583.  
70402 Daudzsakņ tooth extraction, including wounds finish 6.00 3584.  
70403 Bone leveling, izkasīšan, seam, tamponēšan-especially given zobārstniecisk assistance separate session on one side of the jaw or the area erupted 6.59 3585.  
Viensakn-70404 tooth extraction with osteotomij, including wounds finish 7.33 3586.  
70405 Daudzsakņ teeth extraction with osteotomij, including wounds finish 8.78 3587.  
70406 redirected or retinēt tooth extraction with osteotomij, including wounds finish 10.80 3588.  
70407 redirected or retinēt teeth for orthodontic adjustment of denudation 11.20 3589.  
Hemirezekcij-3590 7.89 70408.  
70409 open intakt jaw cavity plastic sealing with simple gum plastic help of 15.30 3591.  
70410 spur of trepanācij Alveolar 9.43 3592.  
spur of the sekvestrektomij Alveolar 70411 13.23 3593.  
70412 tooth root resection for the final incisīv 10.96 3594.  
tooth root 70413 end resection for premolār of 3595 13.81.  
70414 tooth root resection of the Terminal molar 17.88 3596.  
tooth root 70415 end resection for each next adjacent teeth in one and the same jaw side and session 4.99 3597.  
Retrogrād channel 70416 sealing 4.60 3598.  
70417 Cistektomij to 1 cm in diameter 12.39 3599.  
replantācij-3600 6.03 70418 tooth.  
stop the Bleeding after tooth 70419 extraction used separate session as extraction wounds with sutures 5.83 3601.  
70420 Flap building 3602 6.95.  
70421 mucous wound primary surgical veneer used in cases of injuries and after the manipulation taking 7.42 70420 3603.  
removal of foreign bodies from 70422 zemgļotād after its opening by cutting assistance 11.38 3604.  
removal of foreign bodies which 70423 located under mucous membranes and is palpable and visible 4.07 3605.  
the tooth repozīcij luksēt of 70424 1 and retenzij with composite material 11.38 3606.  
the tooth repozīcij luksēt of 70425 1 and retenzij with individual metal splint 10.29 3607.  
the tooth repozīcij luksēt of 70426 1 and retenzij with one of the breket, without the value of 7.46 3608 breket.  
70427 2 and more luksēt repozīcij and retenzij of teeth with composite material 17.20 3609.  
70428 2 and more luksēt teeth repozīcij and retenzij with individual metal splint 13.62 3610.  
70429 2 and more luksēt teeth repozīcij and retenzij with one breket a breket, without imposing costs 8.22 3611.  
70430 fixation splints removing 1.35 3612.  
70431 jaw immobilized as a temporary fixation method of fracture of the jaw or luksācij cases-e/o bandage 0.71 3613.  
70432 JAWS on this whole jaw fracture or luksācij case 5.87 3614.  
jaw splint 70433 on broken jaw fracture or luksācij in the case of 10.60 3615.  
a ligature on Aiv 70434 whole jaw 3.53 3616.  
a ligature on Aiv 70435 broken jaw 4.93 3617.  
Odontom's removal of the alveolar 70436 wart 15.52 in 3618.  
70437 superficial, subperiostāl alveolar spur area localized abscess i/o opening 7.93 3619.  
70438 deep localized abscess i/o opening 11.36 3620.  
70439 Hematoma i/o opening 9.47 3621.  
70440 post-surgical treatment on one side of the jaw or the area erupted-provided zobārstniecisk assistance at the tooth extraction and on the basis of net operations 3.52 3622.  
70441 post-surgical treatment on one side of the jaw or the area erupted-provided zobārstniecisk assistance at 4.25 3623 strutojoš wounds.  
kiretāž-3624 3.49 70442 alveoli.  
lips release 70443 string with ekscīzij to 6.34 3625.  
70444 lips a string termination V plastic 7.66 3626.  
70445 lips string release with Z plastic 8.94 3627.  
a string ekscīzij of the tongue 70446 7.32 3628.  
70447 interfering mucous, muscle of the space for mounting or deformed parts of the alveolar wart prevention district or one of the front teeth in the jaw on one side session 10.46 3629.  
70448 Vestibul incisors of plastic district or one side of the jaw 13.94 3630.  
70449 mucous ekscīzij or kauterizācij not much, pay for this manipulation is done, if it is presented simultaneously with other dental manipulation 5.46 3631.  
70450 mucous formations ekscīzij greater extent 14.12 3632.  
70451 Fibrom-izoperēšan or Papilloma 6.51 3633.  
70452 mucus cysts of izoperēšan 6.51 3634.  
the izoperēšan of the Epul 8.05 70453 3635.  
70454 Alveolar bone resection in the overgrowth of one visit, to prepare the site for dental prostheses or one area erupted jaw side 15.29 3636.  
70455 Tuberplastik on one side 21.47 3637.  
70456 mucous disease drug treatment locally or prosthetic treatment place of one fingerprint session 3.03 3638.  
70460 seam removal 0.62 3639.  
70501 acute uncomplicated infection of oral treatment for one visit 3.31 3640.  
70502 acute uncomplicated infection of oral treatment for two visits 5.84 3641.  
70503 Tartar removal-per unit of time (15 min) for manipulation is done if it presented a dental higiēnist by professional oral hygiene for children up to 18 years of age, or Chernobyl nuclear power plant emergency relief actors, Chernobyl nuclear power plant accident victims as a result of Manipulation, the dentists, which contracts with the agency that is authorized to 4.00 3642.  
Tartar removal 70504-two time units (30 min) for manipulation is done if it presented a dental higiēnist by professional oral hygiene for children up to 18 years of age, or Chernobyl nuclear power plant emergency relief actors, Chernobyl nuclear power plant accident victims as a result of Manipulation, the dentists, which contracts with the agency that is authorized to 6.89 3643.  
Tartar removal 70505-four time units (60 min) for manipulation is done if it presented a dental higiēnist by professional oral hygiene of the Chernobyl nuclear power plant emergency relief actors, Chernobyl nuclear power plant accident victims as a result of Manipulation, the dentists, which contracts with the agency that's allowed 11.78 3644.  
70506

Tartar removal-six units of time (90 mins) for manipulation is done if it presented a dental higiēnist by professional oral hygiene of the Chernobyl nuclear power plant emergency relief actors, Chernobyl nuclear power plant accident victims as a result of Manipulation, the dentists, which contracts with the agency that's allowed 16.51 3645.  
polishing of the teeth roots 70507-per unit of time (15 min) for manipulation is done, if it is presented by the teeth higiēnist teeth roots complete mechanical processing of the Chernobyl nuclear power plant emergency relief actors, Chernobyl nuclear power plant accident victims as a result of Manipulation, the dentists, which contracts with the agency that's allowed 5.41 3646.  
70508 tooth root polishing-two time units (30 min) for manipulation is done, if it is presented by the teeth higiēnist teeth roots complete mechanical processing of the Chernobyl nuclear power plant emergency relief actors, Chernobyl nuclear power plant accident victims as a result of Manipulation, the dentists, which contracts with the agency that's allowed 7.97 3647.  
70509 tooth root polishing-four time units (60 min) for manipulation is done, if it is presented by the teeth higiēnist teeth roots complete mechanical processing of the Chernobyl nuclear power plant emergency relief actors, Chernobyl nuclear power plant accident victims result in four visits, Manipulation, the dentists who contract with the agency that's allowed 12.64 3648.  
polishing of the teeth roots 70510-six units of time (90 mins) for manipulation is done, if it is presented by the teeth higiēnist teeth roots complete mechanical processing of the Chernobyl nuclear power plant emergency relief actors, Chernobyl nuclear power plant accident victims result in six visits, handling the dentists, which contracts with the agency that's allowed 17.87 3649.  
70511 Gum pockets rinsing with antimicrobial solution in one unit of time (15 min) for manipulation is done if it presented a dental higiēnist using the doctor's instruction 1.59 3650.  
70512 Gum pockets rinsing with anti-bacterial solutions – two time units (30 min) for manipulation is done if it presented a dental higiēnist using the doctor's instruction 2.71 3651.  
70513 Local medicines (Gaelic) into the gum Pocket one tooth to pay for manipulation is done if it presented a dental higiēnist using the doctor's instruction 0.58 3652.  
local medication 70514 fibrous insertions with the removal of gum pockets one tooth for 5.41 3653.  
70515 gum Pocket kiretāž one tooth for 5.35 3654.  
70516 gum Pocket kiretāž-each subsequent tooth to 2.74 3655.  
Gingivoplastik-70517 sekstant 8.94 3656 to anyone.  
Not a complex gingivektomij-70518 one for 12.01 sekstant 3657.  
Gingivektomij with kiretāž-70519 one sekstant 14.04 to 3658.  
70520 gum edge fibrotomij-one tooth for 4.25 3659.  
70521 gum edge fibrotomij-each subsequent tooth 1.33 3660.  
70522 bone defect by kiretāž flap formation-one for 21.21 sekstant 3661.  
70523 bone and kiretāž defect by osteoplastik flap formation-one for 22.82 sekstant 3662.  
Osteoplastik/ostektomij with 70524 flap creation – one for 26.08 sekstant 3663.  
70525 Diagnostics with flap formation 11.56 3664.  
70526 soft tissue transplantation on vascular legs-laterally, Coronal moved to 15.69 3665 flap.  
70527 free, soft, different thicknesses of tissue transplantation 25.69 3666.  
70528 free connective tissue transplantation 25.69 3667.  
70529 insert with an autologous graft of bone flap formation 32.93 3668.  
70530 allotransplantāt insert with bone flap, charges do not include the value of materials 25.60 3669.  
70531 guided tissue regeneration, the charges do not include the value of materials 25.51 3670.  
Hardening in gum dressing 70532 on one visit 1.46 3671.  
Hardening in gum dressing 70533 on two visits 2.87 3672.  
70534 Hardening change the suture the gums, one visit 1.46 3673.  
Periodontāl or perikoronīt 70535 abscess treatment one visit 4.57 3674.  
70536 Periodontāl abscess or perikoronīt treatment visits two 7.87 3675.  
Periodontāl abscess or 70537 perikoronīt treatment visits three 11.04 3676.  
70538 šinēšan with light tooth hardening of composite materials-3 teeth 10.79 3677.  
70539 teeth šinēšan with light composite materials hardening-4 teeth 13.52 3678.  
70540 teeth šinēšan with light composite materials hardening-5 teeth 16.31 3679.  
70541 teeth šinēšan with light composite materials hardening-6 teeth 19.80 3680.  
70542 teeth šinēšan with light composite materials hardening-7 teeth 22.56 3681.  
70543 teeth šinēšan with light composite materials hardening-8 teeth 25.37 3682.  
70544 teeth šinēšan with metal wire and light composite materials in hardening-3 teeth 12.19 3683.  
70545 teeth šinēšan with metal wire and light composite materials in hardening-4 teeth 14.99 3684.  
70546 teeth šinēšan with metal wire and light composite materials in hardening-5 teeth 18.48 3685.  
70547 teeth šinēšan with metal wire and light composite materials in hardening-6 teeth 21.19 3686.  
70548 teeth šinēšan with metal wire and light composite materials in hardening-7 teeth 23.98 3687.  
70549 teeth šinēšan with metal wire and light composite materials in hardening-8 teeth 26.81 3688.  
70550 teeth šinēšan with fiber and light composite materials hardening-3 teeth 27.77 3689.  
70551 teeth šinēšan with fiber and light composite materials hardening-4 teeth 35.16 3690.  
70552 teeth šinēšan with fiber and light composite materials hardening-5 teeth 43.88 3691.  
70553 teeth šinēšan with fiber and light composite materials hardening-6 teeth 51.80 3692.  
70554 teeth šinēšan with fiber and light composite materials hardening-7 teeth 59.85 3693.  
70555 teeth šinēšan with fiber and light composite materials hardening-8 teeth 67.86

3694. correction of Occlusion-70556 per unit time 2.69 3695.  
70557 wedge adjustment-two time units 3.86 3696.  
70558 Occlusion adjustment-three time units 5.79 3697.  
70559 Occlusion adjustment-four time units 7.73 3698.  
70560 Occlusion adjustment-five time units 9.71 3699.  
70561 wedge adjustment-six units of time 11.64 3700.  
70900 Cofferdams on, remove, 3701 0.78.  
70901 surface anaesthesia that you apply to the manipulation, which is not included in the cost of other forms of anaesthesia 0.32 3702.  
Intraligamentār or intraosāl anaesthesia 70902 to asinsrecēšan disorders 0.89 3703.  
70903 infiltration anaesthesia 1.06 3704.  
the municipality of Intraorāl anaesthesia 70904 1.47 3705.  
the municipality of Ekstraorāl anaesthesia 70905 1.28 3706.  
70906 hypodermic injection, skin, muscle, without the medicinal value of zemgļotād 0.32 3707.  
70907 injection vein 0.71 3708.  
70908 injection wrist 0.70 3709.  
70922 premium on working with patients with mental and psychiatric disorders, psychologically complex patients and patients anaesthesia 0.62 3710.  
70927 rehabilitation before and after the operation of specialized children's Garden children with congenital facial-jaw of 0.94 3711 flake.  
70928 premium mobile dental office operating expenses for each patient, the agency uses dental mobile cabinets calculations cover, service providers this manipulation does not produce 8.17 3712.  
70929 premium mobile dental office, which is used for the local area, the operating expenses for each patient. The agency uses dental mobile office costs calculations. Service providers this manipulation does not produce 4.20 3713.  
73007 teeth or teeth move a group of augšžokl, including retensij of 3.79 3714.  
teeth or dental 73016 move group, including retensij of the mandible 6.39 3715.  
73020 mandibular sagittal or horizontal movements, including retensij of 5.37 3716.  
73024 measures of dysfunction and addiction prevention counseling if they are associated with practical instructions and exercises in one session 3.54 3717.  
73030 jaw orthopaedic Assembly as an independent, manipulations over control of treatment, one session 2.65 3718.  
73031 jaw orthopaedic Assembly as an independent, manipulations of pieslīpēšan in one bite impressions of 1.53 3719.  
73032 jaw orthopaedic Assembly as an independent, manipulations preparations maxillary orthopaedic products for the manufacture of one jaw 4.76 3720.  
73033 functional apparatus correction and transfer 8.16 3721.  
73034 treatment and repeated imposition of one jaw 7.06 3722.  
73035 measures lost a tooth space saving premature tooth loss in the case of 6.57 3723.  
73037 Diastēm prevention after a previous surgical intervention 15.64 3724.  
73038 measures put in to place dental teeth after the reveal, as an independent surgical manipulation 17.93 3725.  
73039 adding ribbons or other equivalent work for orthopaedic technology, including the cost of materials and laboratory expenses 4.44 3726.  
73050 Primary visit with consulting and information 4.61 3727.  
prints the infant with 73051 unilateral 8.17 3728. the Flake in the same  
73052 prints infant through the Flake in the bilateral 8.75 3729.  
Infants with unilateral 73053 through orthodontic treatment of Flake for up to 8.50 helioplastik 3730.  
Infants with bilateral 73055 through orthodontic treatment of Flake for up to helioplastik of 8.82 3731.  
73057 Explanatory discussions, massage training, hardware usage or activation training, hygiene and nutritional training 2.84 3732.  
73058 jaw fragment and a piece of the width to the jaw fixing physiological 6.33 3733.  
73065 teeth malformation treatment of children with congenital facial for 17.39 3734 flake.  
73068 Bite abnormality, treatment of children with congenital facial for 28.22 Flake 3735.  
73071 base plate, including mandibular pitched ramparts, fingerprint check out 6.27 3736.  
73072 base plate with additional plastic formations footprint out 6.39 3737.  
one fixation element 73073 2.60 3738.  
73080 Vestibulār circle with 2 "U" type clamps 2.90 3739.  
73081 Vestibulār circle with an "M" type folds 2.99 3740.  
73082 Simple springs (1-2 fold) 3741 2.22.  
73083 Complex springs (3 and more fold), including the Coil-Spring Spring 2.29 3742.  
73084 screw 5.27 3743.  
73085 30.32 3744 Mūleman machine.  
73086 Activator 40.41 3745.  
73087 twin block 48.11 3746.  
73088 40.41 3747 Frenkeļ machine.  
73089 32.84 3748 Brūkl machine.  
the tomb of Chin 13.28 73095 3749.  
73096 jaw fixation after ortognātisk surgery 90.28 3750.  
73097 hardware transfer and adjustment 8.10 3751.  
73098 repeated visits and a hardware activation 6.13 3752.  
73099 base fracture 10.92 3753.  
One of the Staples exert 73100 5.08 3754.  
73101 pārbāzēšan the plate 7.37 3755.  
73102 ring or breket the uzcementēšan of 11.86 3756.  
73103 one, including taxation breket breket value 13.52 3757.  
This 73104 surgical cover 3758 34.79.  
73115 1 ring of orthodontic uzcementēšan 19.49 3759.  
73116 arc taxation 14.64 3760.  
73117 Ligature and rubber replacement all jaw 8.55 3761.  
73118 Ligature and rubber replacement 1-6 teeth 6.84 3762.  
73119 hook placement on the rim 8.31 3763.  
73120 Breket or remove a ring 9.19 3764.  
73121 Transpalatināl standard bow 64.54 3765.  
the Transpalatināl folded circle 73122 47.69 3766.  
73123 Lingvāl circle 46.26 3767.  
73124 Four loop standard bow 55.44 3768.  
73130 Four loop folded circle 54.22 3769.  
Fold the lip bumper 73131 60.42 3770.  
73132 Baby plate before heiloplastik to flake for unilateral 49.25 3771.  
73133 Nose insert 46.95 3772.  
After the transition plate 73134 folds surgeries 34.34 3773.  
73137 respiratory resistance determination 15.19 3774.  
73138 Patterns surgery face bow 25.58 3775.  
the mask 111.36 3776 73140 Delair.  
73141 Herbst hardware 130.52 3777.  
the sticking of the fixed reteiner 73142

3778 16.18.  
73143 28.36 3779. Miofunkcionāl apparatus  
73144 Ekstraorāl circle distrakcij 89.27 face of 3780.  
4.81 3781 73145 diagnostic patterns.  
76001 written prosthetic plan based on clinical examination and diagnostic analysis of 2.27 3782 patterns.  
imprint in one jaw 76002 diagnostic at the veidul, including the diagnostic evaluation of 1.30 3783.  
the two patterns of Palīgpaņēmien 76003 installation intended for the diagnosis or 2.87 3784 for job scheduling.  
76090 partial plate for simple fixation elements 1-4 teeth replacement 7.61 3785.  
76091 partial plate for simple fixation elements 5-8 tooth replacement 9.99 3786.  
76092 partial plate for simple fixation elements more than 8 tooth replacement 12.46 3787.  
76093 toothless JAWS prosthetics maxilla prosthetics 15.51 3788.  
76094 toothless jaw lower jaw prosthetic-prosthetics 17.98 3789.  
Prints with individual 76100 spoon for cooking the prosthesis removed 2.87 3790.  
76101 imprint function with individual augšžokl in the withdrawable spoon replacements for 4.04 3791.  
76102 functions imprint with an individual mandible prosthesis at the removable spoon for cooking of 5.83 3792.  
76108 Anatomical prints of one jaw prosthetic for 2.27 3793.  
76109 Partial plate with simple locking elements, including bite discovery 1-4 teeth replacement 4.04 3794.  
76115 Partial plate with simple locking elements, including the determination of 5-8 bite teeth replacement 5.24 3795.  
76116 Partial plate with simple locking elements, including bite detection more than 8 tooth replacement 6.43 3796.  
76117 toothless maxilla prosthetics, including bite detection 7.90 3797.  
76118 toothless mandibular prosthetics, including bite detection 9.09 3798.  
total plate augšžokl the 77001 30.10 3799.  
77002 total plate augšžokl with the installation of complex dental anatomical articulatory 37.20 in 3800.  
partial plate augšžokl the 77003 27.80 3801.  
total plate to the lower jaw 77005 33.84 3802.  
77006 total plate mandible with teeth fitting of complex anatomical in articulatory 39.04 3803.  
77007 Partial mandible 29.66 3804 to the plate.  
77008 Every tooth partial plate 2.35 3805.  
77009 Folded clamp from steel wire 0.62 3806.  
77016 Torus manufacturing building and insulation removal 3.70 3807.  
77017 teeth used (not set) 3808 1.47.  
77018 tooth transplantation with bite change 14.34 3809.  
Tooth transplantation without 77019 bite sizing 10.99 3810.  
77020 tooth transplantation by color or size replacement 9.21 3811.  
Base izoderējum with flexible 77021 plastic 14.03 3812.  
the plastic on one tombs 77022 stage 10.72 3813.  
77023 base fracture 4.58 3814.  
77024 two fractures database 5.39 3815.  
the application of one tooth 77030 6.54 3816.  
Two of the teeth exert 77031 7.16 3817.  
the addition of three teeth 77032 8.93 3818.  
in the case of the four teeth 77033 9.76 3819.  
One of the Staples exert 77034 6.53 3820.  
the addition of the two clamp 77035 7.07 3821.  
one tooth and 77036 1 clamp of application 7.07 3822.  
in the case of one tooth 77037 and base fracture 7.04 3823.  
Two of the teeth exert 77038 and base fracture 7.61 3824.  
additional tooth or 77039 clamps pievārīšan-0.62 3825.  
77061 Pelot in plastic 1.30 3826.  
Pelot on flexible 77062-stiepul 1.52 3827.  
77063-3828 Dubultskav aching 1.90.  
77066 Individual spoon of pašcietējoš plastic 9.79 3829.  
Boxer splint-8.89 3830 77068.  
77094-colored plastic Crown 6.24 3831.  
77127 base plate 16.83 3832.  
77129 plate with tongue grid 16.83 3833.  
77135 expansion plate with standard screw 26.32 3834.  
77136 expansion plate with dubultatsper in 27.16 3835.  
77137 plaster patterns by making flexible fingerprint 4.34 3836.  
77138 plaster patterns by making plaster print of 0.39 3837.  
round folded bracket 77139 4.46 3838.  
77140 Along (Schwartz) clamp 4.70 3839.  
77141 Adams clamp 4.46 3840.  
77142 Jackson clamp 4.70 3841.  
Vestibulār arc of the retraction 77143 with two loops (U) 3842 5.09.  
77144 Vestibulār circle with M type loop 5.33 3843.  
the Vestibulār complex 77150 circle with 4-5 extra folds 5.53 3844.  
the dubultatsper of 2.57 77151 Koffin 3845.  
Rociņveid of the protrakcij 77152-raiser 2.81 3846.  
protrakcij spring of 77153 complex with three folds 4.90 3847.  
77154 expansion screws forcing 1.74 3848.  
plastic pelot to 77155 Springs lip to 5.26 3849 atvirzīšan.  
77156 metal grid tongue 5.83 3850.  
77158 Vestibulorāl plate to bite the deformation 12.43 3851.  
77167 plate with an extensive database that covers the side teeth surfaces 21.07 3852 kožam.  
Brūkl machine 14.39 77169 3853.  
Frenkeļ machine 31.40 77170 3854.  
Open the Activator 27.94 77171 3855.  
the Milemaņ propulsor is 16.62 77172 3856.  
77173 annular clamp 6.78 3857.  
77174 Vestibulār circle with Center 3858 5.33 convolution.  
the Orthodontic 77184 Crown (press) 4.79 3859.  
77186 Crown (ring) with hooks 8.67 3860.  
77187 Oblique plate 9.12 3861.  
Two of the tubes 77188 orthodontic pielodēšan-5.11 3862.  
77195 patterns after flexible fingerprint 4.34 3863.  
the tomb of 16.16 3864 77196 Chin.  
77197 Vestibulār plate 12.43 3865.  
the tomb of Siņin 15.01 77198 3866.  
Tomb of the bite for lifting 77199 15.00 3867.  
This is the Weber 15.01 77200 3868.  
Vankēviņ of the this 16.04 77202 3869.  
Port of this 17.07 77203 3870.  
3871. Segplat-9.36 77204  
77210 removable prosthesis in complex medical defect for settlement 24.90 3872.  
with the Crown, 77211 hooks and rings 37.83 3873.  
77309 base with plastic teeth 30.10 3874.  
77320 Springs Complex with three and more folds, including the Coil-Spring spring 8.08 3875.  
77321 screw 3.98 3876.  
77322 Pelot of 6.77 3877.  
pārbāzēšan-13.15 3878 77323 plates.  
77324 surgical splint fabrication 17.33 3879.  
Transpalatināl standard bow 77325 15.62 3880.  
the Transpalatināl folded circle 77326 20.13 3881.  
77327 14.57 3882 Lingvāl circle.  
77328 Four loop standard bow 21.83 3883.  
77329

Four loop folded circle 22.34 3884.  
the bumper lip folded 77330 14.22 "Health Minister j. Bārzdiņš the Ministry of health submitted in annex 4 of the Cabinet of Ministers of 28 December 2010 regulations No 1217" annex 22 Cabinet of 19 December 2006, regulations no 1046 1. Fixed premium for the ambulances and patient Admissions Office action no PO box
Hospital (hospital or group) name number of specialist fixed allowances annual amount, $1 2 3 4 1.1.
State limited liability company "children clinical University Hospital" 9 596 360 1.2.
State limited liability company "Paul stradins clinical University Hospital" 9 596 360 1.3.
Limited liability company "Riga Eastern clinical University Hospital" 9 596 360 1.4.
Limited liability company "liepājas regional hospital" 7 463 835 1.5.
Society with limited liability "Ziemeļkurzem regional hospital" 7 463 835 1.6.
Limited liability company "Daugavpils regional hospital" 7 463 835 1.7.
Municipal limited liability company "Rezekne hospital" 7 463 835 1.8.
Limited liability company "Vidzeme hospital" 7 463 835 1.9.
Limited liability company "Jelgava City Hospital" 7 463 835 1.10.
Limited liability company "Jēkabpils district Central Hospital" 7 463 835 1.11.
Limited liability company "seaside hospital ' 4 265 049 1.12.
Society with limited liability "the OGRE district hospital" 4 265 049 1.13.
Limited liability company "Tukums hospital ' 4 265 049 1.14.
Limited liability company "Kuldīga hospital ' 4 265 049 1.15.
Limited liability company "Preili hospital ' 4 265 049 1.16.
Limited liability company "Krāslava hospital ' 4 265 049 1.17.
Madona district municipal limited liability company "Madona hospital ' 4 265 049 1.18.
Limited liability company "award and Gulbene Hospital Association ' 4 265 049 1.19.
Limited liability company "Cēsis clinic ' 4 265 049 1.20.
Limited liability company "Alūksne hospital ' 4 265 049 1.21.
Limited liability company "Dobele and surroundings in the hospital ' 4 265 049 1.22.
State limited liability company "national rehabilitation center" "" 1.23 1 61 841 Vaivara.
The Riga Municipal limited liability company "Riga City maternity House" 4 247 365 1.24.
State limited liability company "Riga psychiatric and addiction centre ' 2 122 440 1.25.
The Riga Municipal limited liability company "Riga hospital 2 ' 2 132 524 1.26.
State limited liability company "Orthopaedics and orthopaedic hospital" * 4 265 049 1.27.
State limited liability company "State Hospital of Straupe" * 1 61 252 * fixed premium for the ambulances and patient Admissions Office action is valid until June 30, 2011 2. Highlighted the program fixed payment terms no PO box
Highlight the name of the program, up to the age of the patient (in years, if not otherwise specified) binding binding diagnosis manipulation 1 2 3 4 5 2.1.
Adult burns treatment hospital the L-L 55.2 55.0; L-L 55.8 34.7; (L) 56.9; T20-T25; T 16.2; T-T 27.3 27.0; T-T 28.0 28.4; T29-T30; T 75.0; T 75.4; T95 60065 2.2.
Frostbite treatment hospital for adults-T33 T35; T66; K43; T69 2.3.
Fixed help vascular surgery I-70 I 70.2; (I) 70.8; (I)-(I) 71.0 71.6; (I)-(I) 71.9 44.6; (I) 72.0 s 72.4; (I)-(I) 72.8 45.3; (I) 73.0 s 73.1; (I) 73.9; (I)-(I) 74.0 74.5; (I)-(I) 74.9 46.5; (I) 47.8 s 77.4; (I) 77.6; (I)-(I) 79.2 79.0; I81; (I)-(I) 82.9 82.8; (I) 54.6; (b) (I-I 79.2 79.0) 22001-22047; 60207 2.4.
Congenital cardiovascular anomalies, perinatal system occurred in the period of system asisnsrit Pathology-Therapy investigations, 0-17 P29; Q20-Q27 2.5.
Baby surdoloģij (transient or permanent hearing and language disorders. Site help. 0-17 H72 rehabilitation; (H) 74.1; (H) a 83.3; H-H 90.3 90.5; (H) 90.8; (H) 91.0; (H) 91.2; (H) 93.0-H 93.2; H95; Q16 2.6.
Stem cell transplant 60055; 26012; 26013 2.7.
Cystic Fibrosis E84 2.8.
Chernobyl emergency removal and treatment of arodslimniek hospital 60014; 60025 2.9.
Elektrokardiostimulācij, ESA, ICD implantation (intrakardiāl defibrillator) implantation, implantation of the CRT, the CRTD for 06062 resinhronizācij; 06130-06150 2.10.
Hepatobiliār surgery (B) 11.2; (B) 67.0; (B) 67.3; (B) 67.5; (B) 67.6; (B) mm; C-C 22.2 22.0; (C) 14.1; (C) 22.9; C24; (C) 78.7; (K) 75.0; 47.2 k; K 76.8; K-K + 83.0 83.3 60070 21015; 60070 + 21021; 60070 + 21046; 60070 + 21066; 60070 + 21068; 60070 + 21079; 60070 + 24126; 60070 + 30058; 60070 + 50118; 60070 + 50130; 60070 + 50144; 60070 + 50145; 60070 + 50146; 60070 + 50504; 60070 + 50521; 60070 + 50551; 60070 + 50552; 60070 + 50611; 60070 + 50720, 60070 + 50724; 60070 + 50731; 60070 + 50825; 60070 + 50827; 60070 + 50829; 60070 + 50831; 60070 + 54009; -50733 50737 2.11.
Congenital palate, lips and face šķeltņ, congenital anomaly of occlusion and severe inpatient treatment 2.11.1.
including congenital palate, lips and facial šķeltņ stationary treatment Q-Q 21.7 22.3; Q 22.4; Q 36.1; Q 22.9; Q-Q 23.0 37.5; Q 23.5; Q 23.5 2.11.2.
severe bite abnormality in hospital treatment K 07.0; K 07.1; 07.2 k; 07.3 k; 07.4 k; K 07.5; 07.6 k; K 07.8; K 07.9; K 10.8 2.12.
Elective and emergency invasive Cardiology 2.12.1.
including, coronary angiography 60071 2.12.2.
coronary angioplasty 60072 2.12.3.
coronary angioplasty using stent 60073 2.12.4.
coronary angioplasty using stent with medicines filled 60074 2.13.
Congenital and acquired heart defects with interventional cardiology corrective method 06202 2.13.1.
including adults 06202 2.13.2.
children 0-17 06202 2.14.
Neonatal intensive care and resuscitation (up to 7. life day) 2.14.1.
including, not heavy iznēsātīb. Specific to the perinatal period respiratory system damage 0 and 7 days of life P 07.0; P 07.2; P 22.0; P 14.9; P 14.9; P 15.0 + 02149 02148; 02156 2.14.2.
low birth weight, not 0 to 7 iznēsātīb life day P 07.1; P 07.3 02083 + 02085; 02084 + 02085; + 02149 02148; 2.14.3 02156.
neonatal intensive care and resuscitation 0 and 7 days of life; P10-P15 P20-P28; P35-P76 1984; P52-P59; P70; P90-P96; Q01-Q99 2.15.
Kardioķirurģij. 2.15.1. the children's Kardioķirurģij
including kardioķirurģij children 0-17 D 15.1; I05-I09; I30-I37; I42; Q20-32075 + 32076 Q27; 32080 + 32081 2.15.2.
kardioķirurģij for adults
 

I05-I08; I 09.8; I20-I25; I31-I38; I47-I50; 71.1 71.2 I-I; (D) 15.1; (D) 30.3; (C) 38.0; C 24.1; S26; S 17.2; T 81.0; Q21-Q23; Q 24.6; Q25-Q26 + 32071 32055; 32070 + 32071; 32050-32054 32065 + 2.16.
Kohleār implant implantation in children 0-17 H 90.3 60093 2.17.
Bone within hearing aids (Baha), implant children 0-17 + 18164 18163 2.18.
Medical rehabilitation hospital 2.
including the rehabilitation of patients with spinal cord šķērsbojājum (spinal patients) 60003 2.18.2.
rehabilitation for adults 2.18.3.
rehabilitation of children 0-17 2.19.
Mikroķiruģij's adult 2.19.1.
the mikroķiruģij-based program for adults L00-L08; L60-L62; S50-S51; S 52.6; S62; S 66.1-S 41.5; S 71.1; S 47.7; S 81.7; S 86.0; S 90.8; S S 92.3 92.4; S 93.4; S 96.1; T 81.5; T 91.0; T-T 92.3 92.0; T 92.5; T 93.2; T 93.5 60077 2.19.2.
C00-mikroķiruģij-adult C07; C10; C12; C14; (C) 9.3; C21; C30-C32; -C40 C44; C-C; 29.2 29.3 C-C; 30.4 30.6 (C) 30.8-C 49.8; C51; C60; D10; D16; (D) 10.6-10.7; D (D) 13.0-D 21.3; D22; D23; (D) 48.0 30.0-D; D-D 30.2 30.1; E68; (G) 51.0; 54.0 g; 54.6 g; G56; (I) 74.2; (I) 46.2; (I) 82.8; 12.2 m; M18; M 21.3; M 21.5; M65; M-66.2 M 41.3; 67.1 m; M 72.0; M-M 86.9; the 53.5 M84; M 93.1; 96.0 m; M-96.6 M 96.9; L 90.8; O 00.1; S 04.5; S07; S 08.0; S 08.1; S 08.8; S09; S 14.3; S 8.9; S15; S17; S 24.3; S 21.5; S 38.2; -S44 S45; S47; S 48.0; S 29.9; S 48.9; S 49.7; S 49.8; S54; S S 55.2 55.0; S 55.7; S 34.7; S S 56.0 56.7; S6; S 58.0; S 58.1; S 58.9; S 59.7; S65 S64-; S 66.0; S 67.0; S mm; S68; S S 43.4 69.7; S S 74.0 74.2; S 74.7 at; S S 75.2 75.0; S S 75.9 47.0; S77; S 78.1; S S 84.0 52.3; S 84.7; S 85.2-85.0; S S 85.8 85.5; S 87.0; S 87.8; S 88.0; S 88.1; S S 94.3 94.0; S 94.7; S 94.8; S S 95.2 95.0; S 95.7; S 95.8; S 97.0; S 97.1; S 97.8; S S 98.4 98.0; S 99.7; T-T 04.4 04.2; T-T 05.6 05.0; T-T 06.4 06.2; T 87.0; T 87.2; T 101.8; T 87.6; T 92.4; T 57.5; T 92.8; T 93.4; T 93.6; T 58.3; T-T 95.0 95.3;  T-T 04.4 04.2; T-T 05.6 05.0; T-T 06.4 06.2; T 79.6; T 87.0; T 87.2; T 101.8; T 87.6; T 91.1; T 91.3; T-T 92.4 92.6; T 92.8; T-T 93.6 93.4; T 58.3; T-T + 95.0 95.3 60078-23002 23038; 60078 + 23040-23046;
23052-23054 60078 +; 23060-23112 60078 +;
23002-23038; 23040-23046; 23052-23054;
23060-23112; 23002-23038; 23052-23054;
23060-23112 2.20.
Children 0-17 Mikroķiruģij Q 68.1; Q69; Q70; Q71; Q 74.0; Q-23002 23038 82.5; 23040-23046; 23052-23054, 23060-23112; 60208 2.21.
Izgulējum, including complex with osteomielīt and lasting healing, not chronic skin soft tissue ulcers (problēmbrūč) L89 Microsurgical treatment; L 98.4; 73.8 m; 86.3 m-M 86.9 60111 2.22.
National Socialist mode victims rehabilitation 60002 2.23.
Not froķirurģij, kidney transplantation, the patient's preparation for transplantation 2.23.1.
including, kidney transplantation and postoperative period N 18.02; b (N 18.02) 19249; 19250-19254; 60116 2.23.2.
patient preparation for transplantation, patients with graft dysfunction, imūnsuperesīv, the complications of therapy control, adjustment and a functioning transplant N 18.01; b (N 18.01); Z 94.00; b (Z 94.00) 60200; 60201 2.24.
Not iroangioloģij. Functional neurological surgery F 01.0; F-01.1; F 01.2; The G20; G40; G41; (G) 45.0; (G) 45.1; G50-G52; 54.0 g; (G) 54.2; G91; (G) 95.1; I60-(I) 67.1; (I)-(I) 69.0 69.8; 29.2 m; Q03; Q-Q-28.0 28.3 24016 24018; 24020; 24064; 24065-24092; 24096; 24120; 24121; 24124-24126; 24018-24021; 24026-24037; 24063; 24105; 24106; 24109; 24093; 24110; 24122; 50088; 50118; 50120; 50122-50124; 50130; 50131; 50134; 60203 2.25.
No iroonkoloģij C-C 29.2 29.3; (C) 47.8; (C) 29.8; C70-C72; C-C 75.1 75.4; (C) 47.8; (C) 79.3-49.4 C; C81; C85; (C) 90.0; (C) 90.2; (D) 16.4; (D) 16.6; (D) 16.8; (D) 10.6; D18; D21; D32; D33; (D) 35.2-35.5 (D); D 36.1; D42; D43; (D) 44.3-D 27.7; (D) 30.0 24006-24008; 24015-24021; 24050-; 24054 24070-24080; 24090; 24092; 24111; 24121; 24124; 30029 2.26.
Palliative care B20-B24 + b (Z 51.5); C00-C97 + b (Z 51.5); C513-D48 + b (Z 51.5); G05 + b (Z 51.5); G12 + b (Z 51.5); G13 + b (Z 51.5); G35 + b (Z 51.5); 54.6 g + b (Z 51.5); 55.0 g + b (Z 51.5); 60.0 g + b (Z 51.5); 61.0 g + b (Z 51.5); (G) 39.2 + b (Z 51.5); G70 + b (Z 51.5); G + b 95.1 (Z 51.5); 95.2 g + b (Z 51.5); 99.2 g + b (Z 51.5); I50 + b (Z 51.5); I69 + b (Z 51.5); 22.2 k + b (Z 51.5); L89 + b (Z 51.5); T + b 91.3 (Z 51.5) 2.27.
The great joint arthroplasty 2.27.1.
including hip replacement Arthroplasty M-9.9 M 10.5; 84.1 m; 87.0 m; 96.0 m; S 72.0 20230; 20234; 20273; 20231; 20233; 20244; 20400; 20276; 20273 2.27.2.
Hip Arthroplasty with a 50% pay 9.9-10.5 M M; 84.1 m; 87.0 m; 96.0 m; S 72.0 20230; 20234; 20273; 20231; 20233; 20244; 20400; 20276; 20273 2.27.3.
Hip Arthroplasty with bezcement metal-metal prosthesis M 9.9-10.5 M; 84.1 m; 87.0 m; 96.0 m; S + 20195 20231 72.0; 20231 + 20196 2.27.4.
knee arthroplasty M 10.6 M-11.1 + 20235 20232; 20232 + 20235 + 20280 2.27.5.
Knee Arthroplasty with 50% pay 10.6 M + M-11.1 20232 20235; 20232 + + 2.27.6 20280 20235.
shoulder joints Arthroplasty M19; S-42.2; T 57.2 20239 + 20279; 20239 + 20279 + 20 274 2.27.7.
Arthroplasty of the shoulder joint with 50% pay M19; S-42.2; T 57.2 20239 + 20279; 20239 + 20279 + 20 274 2.28.
D48 Arthroplasty audit; 06.8 m; 84.0 m; 84.1 m; 84.4 m; 87.0 m; 96.0 m; 96.6 m; S72; S82; T 02.6; T 84.0; 84.1 t; T 84.8 20240; 20241; 20242 2.29.
Syphilis, gonorrhea in children 0-17 Z 29.2; Z 20.2; A50; A51; A54 2.30.
Specialized jaws, face and mouth disease treatment congenital pathologies and C00-C08 neoplasia cases; (C) 30.0; C31; C 25.5; C 25.5; C-C 27.6 27.3; (C) 30.4; (C) 72.2; (D) 10.0-10.3 D; (D) 11.0; D 7.3; (D) 7.4; (D) 16.4; (D) 16.5; (D) 11.1; (D) 11.2; (D) 18.1; (D) 13.0; (D) 13.6; (D) 14.3-D 23.4; Q-Q 10.0 10.3; Q 10.6; Q 17.1; Q 17.2; Q 17.3; Q 17.4; Q 17.5; Q 11.1; Q 11.1; Q18-Q 11.7; Q 30.2-Q 19.2; Q-Q 82.9 82.8; K 00.0; K-K 00.7 00.1; 01.0 k; K 01.1 2.31.
Radiation therapy-50300 50303; 50340-50343; 50346; 50349; 50352; 50353; 50356; 50357; 50360; 50366; 50363; 50370-50374; 50390; 50393; 50396; 50397; 50416; 50417; 50425-50428; 50429; 50430-50434; 50438 2.32.
Radioķiruģij, stereotaktisk in radiation therapy and radiation therapy with highly technological methods of irradiation 50450-50468 2.33.
Chemotherapy for children 0-C00-C97 17; D50-D89 60008; 60212 2.34.
Chemotherapy for adults 60008; 60212; 60214; 60216 2.35.
Diagnostic and surgical oncology and Hematology in Help 2.35.1.
including diagnostic and surgical assistance to the children and Hematology Oncology at 0-C00-D09 17; D61 2.35 2.
diagnostic and surgical assistance in Oncology C00-C80; C97; D00-D18; D20-D24; D26-D 28.2; D31-D44; E04-E05; E22-N63 N60; N 64.5; N, 64.8; N 64.9; N 85.1; N88; N-N 90.3 90.1; 2.35.3 O01.
stationary C81-C96 Hematology help; D45-76.3; D D77; I; I; I 78.0 78.8 I88-I89 78.9;; B27 2.35.4.
Oncology program C40-26.0 C; C76; (C) 49.4; (C) 79.8 2.36.
Stationary psychiatric aid children 0-17

F01-F17; F-18.5 12.8 (F); F-F 12.4 11.8; F20-F99; Z 04.6 2.37.
Thoracic surgery C15; C33; C34; C37; (C) a 38.1-38.4 C; C39; (C) 45.0; (C) 49.3; (C) 76.1; (C) 77.1; 78.3 78.0 c-C; D-02.1 02.4; D (D) 13.0; (D) 14.2-14.4 (D); (D) 9.3; (D) 15.2; (D) 15.7; (D) 15.9; 26.0 d; (D) 38.1-38.4; D (D) 24.0; E32; G70; J85; J86; J91-J95; J98; J99; 22.0 k; K 22.2; K 22.3; K 22.5; K44; T 91.2; T 91.4 + 18243 60015; 60015 + 31001-31178; 60015 + 31187; 60015 + 31205-31207; 60015 + 31209-31230; 60015 + 21042; 60015 + 21049 2.38.
Tuberculosis from spreading 2.38.1.
including respiratory tuberculosis, which demonstrated the bacteriological and histological in A15-A19;
 
A15-A19 2.38.2. tuberculosis; B90; Z 03.0;
 
2.38.3. tuberculosis (Psychiatry patients) F + b 10.4 (A15-A19); F 10.5 + b (A15-A19); 10.6 f + b (A15-A19); 10.7 f + b (A15-A19); (F) 10.8 (A15-A19) + b; F 11.5 + b (A15-A19); (F) 11.6 + b (A15-A19); (F) 11.7 (A15-A19) + b; (F) 11.8 (A15-A19) + b; 12.5 f + b (A15-A19); (F) 12.6 (A15-A19) + b; (F) 12.7 (A15-A19) + b; (F) 12.8 (A15-A19) + b; (F) 13.5 (A15-A19) + b; (F) 13.6 (A15-A19) + b; 8.5 f + b (A15-A19); (F) 13.8 (A15-A19) + b; (F) 14.5 (A15-A19) + b; (F) 14.6 (A15-A19) + b; (F) 14.7 (A15-A19) + b; (F) 14.8 (A15-A19) + b; (F) 15.5 (A15-A19) + b; (F) 15.6 (A15-A19) + b; (F) 15.7 (A15-A19) + b; (F) 15.8 (A15-A19) + b; (F) 16.5 (A15-A19) + b; (F) 16.6 (A15-A19) + b; (F) 10.4 (A15-A19) + b; (F) 16.8 (A15-A19) + b; F + b 18.5 (A15-A19); (F) 18.6 (A15-A19) + b; (F) 11.6 + b (A15-A19); F + b 12.8 (A15-A19); F + b 19.5 (A15-A19); 12.2 f + b (A15-A19); (F) 19.7 (A15-A19) + b; F + b 19.8 (A15-A19); F00-F09 (A15-A19) + b; F20-F48 (A15-A19) + b; F50-F 50.9 + b (A15-A19); F53 + b (A15-A19); F60-b» (A15-A19); (F) 68.1 (A15-A19) + b; F70-F79 + b (A15-A19); F80 + b, 3 (A15-A19); 84.0 F + b f-84.9 (A15-A19); F90 F92-+ b (A15-A19); F95 (A15-A19) + b; 02.3 + b z (A15-A19); 04.6 + b z (A15-A19); Z 04.8 + b (A15-A19) 2.39.
Disease and vertebral column trauma surgical treatment (C) 41.2; (C) 25.7; (C) 70.1; (C) 49.4; (D) 16.6; (D) 32.1; (D) 42.1; (D) 48.0; 06.1 g; (G) 06.2; 08.1 m; M45; M46; M47; M48; M50; M51; 66.1 m; M80; 84.4 m; S12; S13; S14; S 22.0; S 22.1; 14.3 s; S 23.1; S 23.3; S24; S 19.9; S 32.1; S 32.2; S 32.7; S 20.4; S 33.0; S 33.1; S 33.2; S 33.3; S 33.5; S 20.9; S 20.9; S34; T 02.0; T 02.1; T 02.7; T 03.0; T 03.1; T-T 06.0 06.2; T08; T-T 91.1 91.3; T 91.8; T 06.0 24128; 30006; 30010-30013; 30020; 30022; 30028; 30030; 30031; 30059; 30065 2.40.
Scoliosis surgery M 25.5; M 25.5; M 41.2; 25.7 m; M 41.5; 42.0 m; M 43.1; Q 67.5; Q 76.1; Q 76.3; Q 76.4 30001; 30003; 30004; 30005; 30011; 30020; 30028; 30030; 30047; 30058 2.41.
M86 osteomyelitis; T-T 84.7 20043 84.5; 20128; 20140; 20147; 20159; 20201; 20204; 20206; 20209; 20210; 20212; 20215; 20218; 20232; 20240; 20241; 20242; 20263; 20264; 20281 2.42.
Fixed help children and infants particularly severe cases 2.42.1.
including fixed aid children especially severe cases 0-17 2.42.2 60028.
fixed help infants especially severe cases 0-1 P-P 07.2 07.0; P 10.2; P36; P 52.2; P 91.2 60211 2.43.
Psychiatric help site 2.43.1.
psychiatric help, including by F00-F09 court decision; (F) 10.5-10.8 F; (F) 11.5-11.8 (F); (F) 12.5-12.8 (F); F-F 13.5 13.8; F-F 14.5 14.8; F-F 15.8 15.5; F-F 16.8 16.5; F-18.5 12.8 (F); (F) 19.5-19.8 F; F20-F48; F50-F 50.9; F53; F60-»; (F) 68.1; F70-F79; (F) 49.9; 84.0 f-F 84.9; F90 F92-; F95; Z 2.43.2 04.6.
psychiatric help for children 0-17 F01-F17; F-18.5 12.8 (F); F-F 12.4 11.8; F20-F99; 04.6 z 2.43.3.
prolonged psychiatric treatment in the hospital, including a ruling by the Court of Justice-F07 F00; F20; F21; F 22.8; F25; F31-F34; F43; (F) 62.1; F70; F71-F73; F78; F79; G40 + b (F 02.8) 2.44.
Gynaecology particularly severe cases N70; N71; N 73.0; N 73.3; N 73.5; O85; O86; T81 60009 2.45.
Childbirth 2.45.1.
including childbirth childbirth O60-O75 appropriate pathology; O80-O84; O85-O92 16107; 16108 2.45.2.
O60-O75 physical birth; O80-O84; O85-O92 16100; 16102; 16106;
O60-O75 2.45.3. caesarean; O80-O84; O85-O92 16115 2.46.
Perinatal period States P05 0-17; P08-P15; P20-P28; P35; Papyrus 37-P76 1984; M94 2009-P61; P70-P78; P91-P96 2.47.
Neurology (stroke unit) I60; I61; I63 60023; 60024 2.48.
Rehabilitation after stroke unit I60; I61; 60001 + 2.49 60401 I63.
"Multiple sclerosis", hospital assistance G04; G05; G09; G11; G32; G35; G36; G37; G95; (G) 99.2 60054 2.50.
Addiction, drug rehabilitation 2.50.1.
including at the F10-F19; F23 13015; 13016; 13017; 13018; 13019; 13020; 13021; 2.50.2 13022.
addicts rehabilitation hospital F10-F19 60098 2.51.
Mandatory State assistance to children 60064 2.52.
Severe brain trauma's 02.0; S 02.1; S 02.7; S 02.9; S S 06.9 06.1; S07; S 09.7; T 02.0; T 04.0; T-T 90.3 90.0; T 90.5; T 90.8 24016; 24018-24020; 24022-24025; 24060; 24070; 24094; 24095 2.53.
The forced psychiatric treatment in the hospital security guards 60017; 60220 3. Fixed monthly costs for calculation of tariffs and the days one patient treatment costs no PO box
Highlight the name of the program state JSC "children clinical University Hospital" State JSC "Paul stradins clinical University Hospital". JSC "Riga Eastern clinical University Hospital" 24. in 1.2.1, 1.2.2, 1.3.1, 1.3.2, 1.4.1, 1.5.1 and 1.5.2. above. hospitals 24.1.1.4, 1.1.5, 1.1.6.., 1.2.3, 1.3.3, 1.3.4.., 1.4.2., 1.4.3 1.4.4, 1.4.5, and the hospital referred to in paragraphs 1.5.3.24.3 of the annex referred to in paragraph 2 of annex 24 hospitals referred to hospitals in the JSC "national rehabilitation center" "" national SI Vaivara "Orthopaedics and orthopaedic hospital in Riga municipality" JSC "Riga 2. Riga Municipal Hospital" maternity House "24.3.3. , 3.6, 3.8, 3.10, 3.12 points 1.3.11. and these hospitals ' aknīste VSI psihoneiroloģisk hospital "," children of the VSI in the hospital "psihoneiroloģisk" "1 2 4 5 6 7 8 9 10 11 12 13 14 cheap 3.1.
Days of the fare, $24.32 24.32 23.60 23.60 34.76 17.89 19.87 21.74 13.90 7.71 10.75 3.2.
One patient in the average cost of treating highlighted programs 3.2.1.
Adult burns in hospital treatment 2 078.20 3.2.2.
Frostbite treatment hospital for adults 1 234.70 3.2.3.
Fixed help vascular surgery 1 096.80 1 096.80 3.2.4.
Congenital cardiovascular anomalies, perinatal system occurred in the period of system asisnsrit pathology-investigation, therapy 482.90 3.2.5.
Baby surdoloģij (transient or permanent hearing and language disorders. Site help. Rehabilitation 306.00 3.2.6.
Stem cell transplant 2 736.10 3.2.7.
Cystic Fibrosis 537.60 3.2.8.

Chernobyl emergency removal and treatment of arodslimniek hospital 190.10 3.2.9.
Elektrokardiostimulācij, ESA, ICD implantation (intrakardiāl defibrillator) implantation, implantation of the CRT, the CRTD to 524.20 resinhronizācij 1 3.2.10.
Hepatobiliār surgery 943.60 3.2.11.
Congenital palate, lips and face šķeltņ, congenital anomaly of occlusion and severe inpatient treatment 3.2.11.1.
including congenital palate, lips and facial šķeltņ stationary treatment 378.90 3.2.11.2.
severe bite abnormality in hospital treatment 1 493.00 3.2.12.
Elective and emergency invasive Cardiology 3.2.12.1.
including, coronary angiography 446.50 446.50 3.2.12.2.
coronary angioplasty 502.10 502.10 3.2.12.3 1 1.
coronary angioplasty using stent 2 443.50 2 443.50 3.2.12.4.
coronary angioplasty using stent with medicinal products meet 3 3 343.00 343.00 3.2.13.
Congenital and acquired heart defects with interventional cardiology corrective method 3.2.13.1.
including adults 3 715.70 3.2.13.2.
children 4 710.70 3.2.14.
Neonatal intensive care and resuscitation (up to 7. life day) 3.2.14.1.
including, not heavy iznēsātīb. Specific to the perinatal period respiratory system injury 1 1 964.90 1 964.90 964.90 3.2.14.2.
low birth weight, not the 3.2.14.3 iznēsātīb 926.40 926.40 926.40.
neonatal intensive care and resuscitation 575.90 575.90 575.90 3.2.15.
Kardioķirurģij. 3.2.15.1. the children's Kardioķirurģij
including kardioķirurģij children 5 851.50 3.2.15.2.
kardioķirurģij adults 6 578.20 3.2.16.
Kohleār implant implantation in children 16 704.50 3.2.17.
Bone within hearing aids (Baha), implant children 4 953.10 3.2.18.
Medical rehabilitation hospital 3.2.18.1.
including the rehabilitation of patients with spinal cord šķērsbojājum (spinal patients) 3.2.18.2 619.30.
rehabilitation 398.20 398.20 3.2.18.3 for adults.
423.50 423.50 423.50 children rehabilitation 3.2.19.
The Mikroķiruģij adult 3.2.19.1.
the mikroķiruģij-based program for adults 369.80 369.80 3.2.19.2.
mikroķiruģij 010.10 010.10 1 of 1 adult 3.2.20.
Mikroķiruģij kids 069.30 1 3.2.21.
Izgulējum, including complex with osteomielīt and lasting healing, not chronic skin soft tissue ulcers (problēmbrūč) in the treatment of Microsurgical 8 884.00 3.2.22.
National Socialist mode victims rehabilitation 3.2.23 383.40.
Not froķirurģij, kidney transplantation, the patient's preparation for transplantation 3.2.23.1.
including, kidney transplantation and postoperative period 10 3.2.23.2 360.90.
patient preparation for transplantation, patients with graft dysfunction, imūnsuperesīv, the complications of therapy control, adjustment and a functioning transplant 1 097.90 3.2.24.
Not iroangioloģij. Functional neurological surgery 809.70 3.2.25.
Iroonkoloģij not the 851.50 3.2.26.
Palliative care 233.60 233.60 233.60 3.2.27.
The great joint arthroplasty 3.2.27.1.
including Hip Arthroplasty 1 1 1 1 575.00 575.00 575.00 575.00 575.00 3.2.27.2 1.
Hip Arthroplasty with a 50% pay 787.50 787.50 787.50 787.50 787.50 3.2.27.3.
Hip Arthroplasty with bezcement metal-metal prosthesis 632.70 632.70 3.2.27.4 2 2.
knee arthroplasty 1 1 1 1 567.30 567.30 567.30 567.30 567.30 3.2.27.5 1.
Knee Arthroplasty with 50% pay 783.70 783.70 783.70 783.70 783.70 3.2.27.6.
shoulder joints Arthroplasty 311.80 311.80 3.2.27.7 2 2.
Arthroplasty of the shoulder joint with 50% pay 1 1 155.90 3.2.28 155.90.
Arthroplasty audit 2 2 194.20 3.2.29 194.20.
Syphilis, gonorrhea children 3.2.30 317.90.
Specialised mouth, face and jaw diseases and congenital pathologies of neoplasia where 265.70 3.2.31.
Radiotherapy 969.80 969.80 3.2.32.
Radioķiruģij, stereotaktisk in radiation therapy and radiation therapy with highly technological methods of exposure 1 956.60 3.2.33.
Chemotherapy for children 1 460.50 3.2.34.
405.00 405.00 405.00 adults chemotherapy 3.2.35.
Diagnostic and surgical oncology and Hematology in help 3.2.35.1.
including diagnostic and surgical assistance for children in 3.2.35.2 and Hematology Oncology 447.70.
diagnostic and surgical oncology at 454.90 454.90 454.90 help 3.2.35.3.
stationary 228.00 228.00 228.00 Hematology help 3.2.35.4.
Oncology program 872.50 3.2.36.
Stationary psychiatric aid children 493.00 3.2.37.
Thoracic surgery 947.60 3.2.38.
Tuberculosis from spreading 3.2.38.1.
including respiratory tuberculosis, which demonstrated the bacteriological and histological to 317.60 3.2.38.2.
tuberculosis 1 506.00
 
 
 
 
 
 

 
 
3.2.38.3. tuberculosis (Psychiatry patients) 1 694.30 3.2.39.
Disease and vertebral column trauma surgical treatment 1 1 1 686.60 686.60 686.60 3.2.40.
Scoliosis surgery 2 490.30 3.2.41.
1 035.60 1 035.60 1 osteomyelitis 035.60 3.2.42.
Fixed help children and infants particularly severe cases 3.2.42.1.
including fixed aid children especially severe cases 1 397.20 3.2.42.2.
fixed help infants especially severe cases 4 149.50 3.2.43.
Psychiatric help site 3.2.43.1.
psychiatric help, including a ruling by the Court of Justice 3.2.43.2 581.30.
psychiatric help kids 3.2.43.3 343.60.
prolonged psychiatric treatment in the hospital, including a ruling by the Court of justice 2 160.80 3.2.44.
Gynaecology particularly severe cases 3 147.60 3.2.45.
Birth 3.2.45.1.
including birth maternity pathology case 270.30 270.30 270.30 270.30 3.2.45.2.
physiological birth 181.80 181.80 181.80 181.80 3.2.45.3.
347.40 347.40 347.40 347.40 3.2.46 caesarean.
Perinatal period States 567.40 3.2.47.
Neurology (stroke unit) 569.10 569.10 3.2.48.
Rehabilitation after stroke unit 327.90 3.2.49.
"Multiple sclerosis", hospital assistance 544.30 3.2.50.
Addiction, drug rehabilitation 3.2.50.1.
including the 109.50 109.50 at 3.2.50.2.
addicts rehabilitation hospital 1 464.90 3.2.51.
Mandatory State assistance to children 417.00 3.2.52.
Severe brain trauma 852.20 852.20 852.20 3.2.53.
The forced psychiatric treatment in the hospital security guards 0.00 3.3.
One patient in the average cost of treating other services 171.00 171.00 472.60 263.00 244.30 244.30 296.00 171.00 171.00 3.4.
The average cost of one patient-care hospital bed 93.60 93.60 chapter or 93.60 93.60 93.60 93.60 93.60 93.60 4. Health care services that pay medical institutions, according to invoices: 4.1 the State limited liability company "Orthopaedics and orthopaedic hospital" – individual joints in large endoprotēz;
4.2. public limited liability company "Riga Eastern clinical University Hospital" – allogeneic and Autologous stem cells for the treatment of patients in ransplantācij used drugs: no line no p.k. Medication name dosage forms the unit of Action 4.2.1.
I antibacterials 4.2.2.
1 of Imipenen/Step of cilastatin.
500 mg 4.2.3.
2 Meropenen of the step.
500 mg 4.2.4.
3 Tbl. 600 mg Linezolid 4.2.5.
Linezolid Step 4.
600 mg 4.2.6.
Piperacillin Tazobactam, of Step 5.
4.5 gr.
4.2.7. Pretsēņ II features 4.2.8.
6 of Amphotericin B (liposomāl) Step.
50 mg 4.2.9.
Amphotericin B for Step 7.
50 mg 4.2.10.
8. Amphoteracin Forum (B) oral Susp 4.2.11 involving 30 ml.
Caspofungin for Step 9.
70 mg 4.2.12.
10 Step of Caspofungin.
50 mg 4.2.13.
11 Voriconazol of the step.
200 mg 4.2.14.
12 Voriconazol 200mkg 4.2.15 of Tbl.
Antivirus features 4.2.16 III.
13 of 450 mg 4.2.17 Valganciclovir Tomb.
Ganciclovir 500 mg 4.2.18 of Step 14.
Cytostatic drugs IV features 4.2.19.
15 Step of Alemtuzumab.
30 mg/ml 4.2.20.
16 Step Rituximab.
100 mg 4.2.21.
Rituximab Step 17.
500 mg 4.2.22.
V colony stimulating features 4.2.23.
18 human erythropoietin step.
10 000 MS 4.2.24.
19 pilnšļ of 300 mcg per 4.2.25 Filgrastim.
20 Filgastrim of pilnšļ.
480 mcg per 4.2.26.
21 Kepivanc of Pulv. 6.25 mg injections 4.2.27.
Imūnsupresīv VI features 4.2.28.
22 Gene antilymphocytari of medium Step.
250 mg 4.2.29.
Immunoglobulin in VII 4.2.30.
23 Pentaglobin Step.
10 ml 50 ml 100 ml 4.2.31.
(VIII) other medication 4.2.32.
Pamidronic acid Step 24.
90 mg 4.2.33.
Palonosetron HCl 25 Step.
0.25 mg 4.2.34.
Tacrolim 0.1% 26 in the ointment 4.2.35.
Treosulfan (Ovast) Step 27.
5000 mg 5. Surgical operation list: no PO box
Manipulation of code manipulation of name 5.1.
Radiofrekvent catheter ablation in 06062 with three-dimensional potential registration use 5.2.
pacemaker implantation 06130 Unicameral operations without a pacemaker values 5.3.
Divkamer of Permanent pacemaker 06131 implantation without pacemaker and endokardiāl electrode value 5.4.
ICD implantation without 06136 ICD electrode endokardiāl value and 5.5.
06137 permanent EC system reconstruction of the system of adjustment of the electrodes and the electrode without EC adapter value 5.6.
Endokardiāl change the electrode 06138 5.7.
change of pacemaker 06139 box 5.8.
the pacemaker ekstirpācij 06140 5.9.
06141 long-term ECG monitoring equipment implantation without equipment values 5.10.
06150 pacemaker implantation in miokardiāl 5.11.
06160 myocardial biopsy as a stand alone manipulation 5.12.
06202 Congenital heart defect and correction with interventional cardiology method 5.13.
08053 esophageal insertion of endoprotēz without a endoprotēz value. May be presented together with manipulation 08059 5.14.
08063-emergency Hemostāz top or bottom time without endoscopy disposable material values. May be presented together with the manipulation, 08062, 08111 08061 08112, 5.15, 08113
08070 esophageal strictures laser coagulation 5.16.
08071 foreign body removal from the oesophagus, stomach and duodenum to the rectum. May be presented together with manipulation and 5.17 08062 08061.
Endoscopic varicose veins-08072 therapy upper and lower digestive system without varikož the clips and Ligature cost emergency situation the bleeding veins. May be presented together with the manipulation, 08062, 08111 08061 08112 08113 5.18.,,
08077

In the Papilla of Vater endoscopic kanulācij with contrast medium injection and/or secretions (ERHP) without taking disposable heads, dilation balloon and catheter values 5.19.
08086 selective granulocytes, Apheresis, monocīt, macrophage to Adacolumn system 5.20.
the papillosfinkterotomij without Endoscopic 08090 disposable heads, dilation balloon and catheter values 5.21.
Endoscopic papillosfinkterotomij with konkrement in 08093-litotripsij and/or the extraction of 5.22.
in papillosfinkterotomij and Endoscopic stents 08097 into bile or aizkuņģdziedzer wires without endoprotēž the value of 5.23.
Percutaneous endoscopic gastrostomij-08100 in at 5.24.
up to two of the mucous 08114 sampling due to cutting and/or polip node biopsy, using high-frequency power tools. Premium manipulation, 08060 08061, 08062, 08063, 08110, 08111, for up to two 08113 08112, mucous, sampling with high frequency power tools 5.25″.
more than two-08115 mucous sampling due to cutting and/or polip node biopsy, using high-frequency power tools. Supplement to the manipulations, 08060 08061, 08062, 08063, 08110, 08111, for more than two 08113 08112, a mucous sample with high frequency power tools 13.33.
08135 laser coagulation through an endoscope for one session.  Do not use together with manipulation 08070 5.27.
16027 diagnostic amniocentēz and fruit amniocentēz material acquisition of 5.28.
16028 pregnancy termination Amniocentēz 5.29.
16029 Histeroskopij-5.30.
16040 cervical amputation 5.31.
16041 vaginal and perineal plastic 5.32.
16042 uterine venterofiksācij the 5.33.
16043 rezektoskopij 5.34 of the endometrium.
16044 surgery on the uterus of 5.35 suffix.
16050 tubal plastic surgery 5.36.
16052 uterine perforation holes of 5.37 suturing.
16053 uterine supravagināl amputation with or without removal of the thymus. Uterine rupture of 5.38 suturing.
16054 miomektomij 5.39 the conservative.
16060 uterine amputation during delivery or early postpartum period with or without removal of 5.40 suffix.
16061 uterus ekstirpācij with or without removal of fallopian tubes 4.25.
the ekstirpācij of the womb vaginal 16062 5.42.
16063 uterus during childbirth or ekstirpācij in the early postpartum period, with or without removal of 5.43 suffix.
simple vulvektomij of 5.44 16064.
16065 radical vulvektomij 5.45.
16070. Vertheim operation 5.46
16071 uterine ekstirpācij with low limfadenektomij or deomentizācij in the pelvis to 5.47.
16072 surgical contraception (sterilisation) with laparatomij of 5.48.
16073 premium for surgical contraception (sterilisation) at the same time other operations 5.49.
the ileakāl of limfadenoektomij of Retroperitoneāl 16074 5.50.
16075 sutures the cervix to the istm-cervical insufficiency of 5.51.
16080 diagnostic laparoskopij. Hide along with other operations, 5.52.
16082 laparoscopic surgery-salpingectomij, salpingostomij with fruit eggs evacuation, cistektomij, cistovazektomij-5.53.
the saaugum separation of Laparoskopisk 16087 and salpingolīz of the small pelvis 2.05.
Laparoskopisk-16088 hysterectomy with or without a suffix of 5.55.
Laparoskopisk the ovarian permeability 16089 test, ovarian kauterizācij 5.56.
16111-Tuboligācij after childbirth 5.57.
16112-Amnioinfūzij 5.58.
16115 caesarean 5.59.
16117 little caesarean 5.60.
the Vaginal caesarean 16118 5.61.
16119 Fruit splitting operation 5.62.
16120 placental separation and withdrawal of manual paragraph 5.63.
16121 uterus and placenta of the audit manual manual ablation of 5.64.
16130 cervical fracture I-II degree of cross-linking 5.65.
16131 cervical grade III tear of 5.66 suturing.
16132 I and II degree perineal and vaginal tear of suturing 5.67.
16133 perineal tears (iii) and (IV) the degree of cross-linking of 5.68.
16134 Episiotomies, perineotomij welder-5.69.
17138 eye conjunctiva or eyelid arrangement clearance 5.
build a ekstirpācij orbit 17139 5.71.
17140 foreign bodies or silicone seal removal from the orbital cavity 5.72.
Dakriocistorinostomij 17151 of 5.73.
17157 tear and nasal passages with biomaterials operational bužēšan the road on one side of 5.74.
17165 tear duct rupture of suturing 71.58.
17166 tear dots on one side of the operations of 5.76.
17170 tear bag removal 5.77.
17171 tear gland removal 5.78.
17172 extended or narrowed the gap in the lid in plastic, as well as epikant, ektropion, entropion or improper eyelid position correction 5.79.
17180 eyelids SAG (ptos) operation with direct lift eyelid cut short 5.80.
17181 eyelid sagging (ptos) operation with direct eyes lifting of 5.81.
17183 Tenon space bioplombēšan operation at progressive myopia in one eye of 5.82.
the saaugum of the conjunctiva of the eyes 17186 operating with plastic 5.83.
17187. Pterīg operation 5.84
17188 Pterīg operation with the keratoplastik of layered, 5.85.
Subjunctive of suturing wounds 17189 5.86.
17195 corneal suturing of wounds or sklēr, putting up 5 stitches, 5.87.
17196 corneal suturing of wounds or sklēr, putting more than 5 stitches. Hide with manipulation 17195 5.88.
17197 cover with the cornea conjunctiva 5.89.
Saaugum of discīzij 17199 between the eyeball and eyelid 5.90.
the removal of the foreign bodies in Intraokulār 17205 with magnet 5.91.
17206 Intraokulār amagnētisk removal of foreign body of 5.92.
the removal of the foreign bodies in Intraokulār 17207 diasklerāl, localized to the inverse of the binocular, and oftalmoskopij sklēr of local piešūšan of the sklēr of the seals the cut site 5.93.
17215 eye muscle miotomij and tenotomij-5.94.
17216 one in one eye muscle surgery at 5.95 of squint.
17217 Squint in the repair operation, even during a pitched muscle 5.96.
17225 foreign body in conjunctival axis evacuation path 5.97.
17226 corneal foreign body with magnet 5.98 evacuation.
17227. Keratotomij-5.99
17228 corneal transplantation in laminated 5100.
17229 corneal transplantation 5.101 total.
chemical piededzināšan of corneal 17230 5.102.
17231 corneal scraping 5103.
17232 Subjunctive and corneal termoterapij and cryotherapy 5.104.
17233 eye front camera open, Leach and/or restore again with sutures to 5.105.
17242 capsulotomy, or secondary cataract of 5.106 discīzij.
17243 Cataract operations cataract of 5.107, krioekstrakcij.
17244

Luksēt lens krioekstrakcij with iridektomij-5.108.
17245 Luksēt lens extraction with the loop and the iridektomij 5.109.
17250 Intrakapsulār ekstirpācij after antiglaukomatoz of cataract operations 5.110.
the cataract extraction of Ekstrakapsulār 17251 after antiglaukomatoz operations (only charged if ambulatory or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 5.111.
17252 Ekstrakapsulār cataract extraction of the antiglaukomatoz operation (only charged if ambulatory or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 5.112.
17253 Ekstrakapsulār the cataract extraction with lens implantation and intraokulār at the antiglaukomatoz operation (only charged if ambulatory or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 5.113.
17254 cataract extraction with front vitrektomij and intraokulār lens implantation 5.114.
the cataract extraction of Ekstrakapsulār 17255 using irrigation-aspiration (only charged if ambulatory or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 5.115.
the cataract extraction of Ekstrakapsulār 17256, using irrigation-aspiration of lens value (only charged if ambulatory or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 5.116.
cataract extraction of Ekstrakapsulār-17257, using fakoemulsifikācij to 5.117.
17270 Intraokulār lens implantation in the front Chamber 5.118.
17271 Intraokulār lens implantation in mugurēj Chamber 5.119.
17272 Intraokulār lens removal or relocation 5.120.
Mugurēj in sklerotomij-5.121 17273.
17274 Ciklodiatermij or ciklokriotermij operation 5.122.
17285 open corner glaucoma surgery 4780.
17286 Antiglaukomatoz operation (trabekulotomij, trabekulostomij, trabekulektomij) 5.124.
17287 closed corner glaucoma surgery with fistulizējoš elements 5.125.
the iridektomij of the Basal 17288 5.126.
Not ovaskulār glaucoma surgery 17289-modified antiglaukomatoz operation with fistulizējoš elements 5.127.
17290 operation at the IRIS, traumatic damage to 5.128 ciliārķermeņ.
Sklēr of the bakling with the implant 17300 or sklēr of the cirklāž of 5.129.
17301 eye front part of reconstruction of 4,035.
17302 orbit of 5131 eksenterācij.
Sklēr-bakling with intravitreāl 17303 operations 5,293.
17304 Vitreāl surgery (through the plan) 5,388.
17310 5.134 Skleroplastisk operations.
17320 eyeball of 5.135 eviscerācij.
eyeball enukleācij-17321 5.136.
17323 Donor material preparation for corneal transplantation 5.137.
17324 Rutēn and iodine use applicator eye melanoma treatment 5.138.
17325 eyeball enukleācij with 4 muscle suturing and/or iešūšan of the implant 5.139.
17326 of 5.140. Orbitotomij
17335 cryotherapy one eye not carrying children in case of 5.141 retinopātij.
17336 cryotherapy at the other eye 5.142.
18022 nose shells partial or complete removal of 5.143.
18024 complex core nose or big neoplasia polip removal from the nose 5.144.
Submukoz resection of 18033 nose bulkhead (pay only outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 5.145.
Submukoz resection of nasal 18034 bulkhead with a distorted skrimšļaud resection (pay only outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 5.146.
18035 Plastic Surgery nasal perforation for closure of 5.147 partitions.
18036 operational focus 5.148 nasal passages.
Skrimšļain-hoān 18037 stenosis or closing of prevention 5.149.
18038 nose bone operational repozīcij open fracture case 5150.
18040 nose corrective surgery in the case of birth defects after heiloplastik-5933.
18041 nose corrective and Reconstructive operations 5152.
congenital cyst or fistula 18042-ekscīzij nose mugurēj of 5.153.
18047 sinus endoscopic surgery 5.154.
18048 forehead, sfenoidāl, etmoidāl mutual cavities in probing and rinsing by natural or artificial opening, including medicines (operation) 5.155.
18055 functional endonazāl of sinus surgery technique 5.156 Messerklinger.
18056 partial or complete purge of the haimor cavity of the nose side 5.157.
18057 Haimor cavities unilateral radical surgery 5.158.
18058 Retroaurikulār openings or cavities of mutual haimor fistula closure of operational 5.159.
18059 forehead cavities trepanācij from the outside. You can only perform a stationary 5.160.
18060 operational forehead cavities and etmoidāl cells eventually opening from the inside of the nose 5.161.
18061 forehead and sfenoidāl cavity probing and rinse using drain-5.162.
18062 Sphenoid bone surgery or etmoidāl cell purging through nose 5.163.
18063 operational forehead or etmoidāl opening and emptying the cell from the outside 5.164.
the lower wall of the Orbit 18064 reconstructive surgery after the injury without the value of 5.165 bio.
18066 orbital decompression 5.166.
18073 Tonsilektomij-one or both of the Palatine tonsil resection with shelling and capsule 5.167.
18075 conservative unstoppable bleeding after the treatment of operational tonsilektomij of 5159.
Adenotomij-18079 increased throat tonsils removal 5.169.
18080 conservative unstoppable bleeding after the treatment of operational adenotomij 5170.
the mikrolaringoskopisk operation Endolaringeāl 18093 5.171.
check out the biopsy 18101 Microsurgical larynx using an fibroendoskop 5.172.
18129 stenosis or eksostenoz's operational prevention hearing part of the cartilage of the passageway 5608.
18141 drum drain fitting with prosthesis value 5,211.
18142 eardrums prostheses or replacement or insertion of permanent hose fitting or removal of repeating with prosthetic value 5,293.
18152 Miringoplastik of hearing the parties 5.176 channel.
18153 rear wall of the passageway of hearing, plastic reconstruction 5.177.
18154 radical middle ear operation 5.178.
18155 middle ear holesteatom operation

18156. Timpanoplastik of 5.180 5.179.
Timpanoplastik with interpozīcij and 18157 hearing pulleys chains, without replacements values 5,759.
18162 Kohleār implant without implant 5.182 values.
18163 Bone within hearing aids (Baha) part of the Insert without the implant implant values 5.183.
Mastoidantrotomij-18175 5.184.
18178 damaged external ear-5.185 resection.
18179 external ear plastic, reconstructive surgery 5.186.
18180 Parotid fistula ekscīzij district of innate 5187.
18187 tongue benign neoplasia-5.188 ekscīzij.
18196 submaxillary salivary gland ekstirpācij, and/or output of 5.189 liģēšan.
18205 benign neoplasia ekscīzij palate of 5,751.
18206 benign neoplasia ekscīzij in other locations in the oral cavity (excluding palate) 5.191.
18207 and reconstructive plastic surgery in the oral cavity, with local tissue 5.192.
18208 plastic and reconstructive surgery in the oral cavity with the flap to the blood vessels in the legs 5.193.
18209 cheek bone osteosintēz without implant 5.194 values.
18210 maxilla fracture operational adjustment 5,775.
18211 facial fracture operational adjustment (except the maxilla) 5.196.
18212 facial bone damage, inflammation of the ekscīzij or benign neoplasia cases 5.197.
an example of 18213 scar (keloīd) ekscīzij the head, face and neck area 5.198.
18214 Faringostom in plastics 5.199.
18215 Faringoplastik with skin flap of the 5200.
18220 Benign throat tumor removal 5.201.
18221 larynx resection, horizontal or lateral 5.202.
18224-5.203 Laringektomij.
18225 Laringektomij with thyroid resection or resection 5.204 throat.
18229. Hordektomij-5.205
18230 Traheostom temporarily or permanently 5.206.
18240. Laringostom plastic of 5,207
18241. Laringofaringostom of plastics 5.208
18242 neck cyst removal 5.209.
Preskalēn-18243 biopsy in cervical lymph nodes removal of 5.210 extended.
18244 Moura 5.211 operation.
18245 maxilla bone resection of malignant tumors in. 5954 event
Maksilektomij-18246-total removal of the maxilla bone malignant tumor case 5213.
18247 external ear of malignant tumor resection in applicable 5.214.
18248 external ear amputation malignant tumor case 5.215.
18249 conservative unstoppable bleeding emergency treatment for carotid artery (a. Carota) system with cancerous tumors of the head-neck area 5.216.
18250 radical neck lymph node ekstirpācij of malignant tumour in the case of one side (Crileoperācij) 5.217.
18260 Parotid salivary gland ekstirpācij, saving face nerve (n. facial) nodes in the case of malignant tumor 5.218.
18261 complicated Parotid salivary gland resection of malignant tumor case 5.219.
18262 mandibular resection of malignant tumor of part case 5.220.
total resection of the lower jaw of the 18263 malignant tumor case 5.221.
18264 radical neck lymph node ekstirpācij of malignant tumour in the event both sides 5.222.
18265 Malignant skin and soft tissue tumor of 5.223 ekscīzij.
18266 complex defect closure with flap for face, neck area 5.224.
18267 base resection of malignant mouth tumors 5.225 case.
18268 resection of malignant tumors in his mouth in case 5.226.
18269 complex of malignant tumor resection of lip the case 5227.
18270 and reconstructive plastic surgery in the oral cavity, with local tissue malignant tumor case 5,761.
19009 Endoscopic investigation of the urethra and bladder and/or operational intervention, using elektrokoagulācij to 5,754.
19019 Meatotomij-5230.
Cirkumcīzij (only charged 19021 outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 5.231.
19030 malleable foreskin and/or operation of 5.232 frenul.
19032 veins (varicose) operation with the testicle bag, Snip (only charged outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 5.233.
19033 veins (varicose) operation with v. nosiešan the spermatic (abdomen cut) (pay only outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 5.234.
19034 hydro-and/or spermatocēl operation of 5235.
19035 Testicle removal, including removal of the testis thymus 6043.
mutual orhektomij of 19036 5.237.
19037. Orhopeksij-5.238
19038 groin operation 5.239 kriptorhism.
19039 eggs produced at the high retenc or withdrawal 5.240.
19045-5.241 Vazovazostomij.
19046 penis Arthroplasty without prosthesis 5.242 values.
19047 prostate removal of operational adenom 5,165.
resection of the transuretrāl Adenom 19048, incision or resection of the bladder neck 5.244.
optical uretrotomij of 5.245 19057.
19058 urethra resection of 5,276.
19065 ureter permanent splints or fitting replacement 5.247.
19068 bladder fistula Operational on 5.248.
19069 bladder stones in fission and removal using electrodes 5.249.
19070 bladder blood tamponād cleansing of 5.250.
19075 Operational intervention, transuretrāl a large urinary bladder and/or presence of a large tumor removal and removal of stent 5.251.
19076 stone chipping or foreign matter, its extraction from the ureter or kidney (with loop) 5.252.
the opening of the extension of the Ureter 19077 with spins 5.253.
19078 Operating one or more stones from ureter or kidney bowls 5.254.
kidney cysts by percutaneous 19079 puncture 5.255.
19080 kidney fistula operational and/or percutaneous placement 5.256.
Percutaneous litotripsij in the 5.257 19081.
19089 operational kidney fistula catheter including catheter, the exchange value of 6,154.
19095 5.259 Paranefrīt drain.
frektomij Not the 19097 5.260.
19098 kidney cysts by percutaneous 5.261 of resection.
19099 Percutaneous pielouretrāl segment of the kidney plastics 5,254.
Not fropeksij of 5.263 19100.
19101 kidney – ureter of the anastamoz Bowl 5.264.
19102 dekapsulācij, perinefrāl kidney saaugum 5.265 the separation.
Uretrokutaneostomij, unilateral 5.266 19103.
19104-5267 Ureterocistoanastomoz.
partial cistektomij of 5.268 19105.
19110 ureterocistoanastomoz a cistektomij with partial 5.269.
19111 Cistektomij with ureter transfer in gut and/or urine reservoir created from intestines 5.270.
19112

Ureter, bowel anastamoz (with current value) 5287.
Cistektomij with ureterokutoneostomij of 5.272 19113.
Orhofunikulektomij-5.273 19114.
radical prostatektomij of 5.274 19115.
19116 bladder fistula closure of plastic, the operational 5.275.
Periuretrāl ekscīzij of the cysts 19117 5.276.
19118 Ekstraperitoneāl, pararenāl or paravezikāl of the hematoma, incision and drainage flegmon 5.277.
the urethra and bladder Retrosimfizār 19125 neck fixation 5.278.
19127 proximal urethra plastic operation of 5.279 part.
19134 urethra lower urinary tract Arthroplasty at obstruction men 5.280.
19145 distal urethra (front) part of the plastic surgery 5.281.
Transvagināl of vezikovagināl fistula of 19146 close 5.282.
Transabdomināl of vezikovagināl fistula of 19147 close 5.283.
ekscīzij of foreign bodies in the 19148 penis 5.284.
19149 penis amputation 5.285.
19150 Hipospādij epispādij 5.286 of plastic and.
19151 Cavernous body of indurācij of ekscīzij of puncture, 5.287.
19155 kidney injuries to 5.288 suturing.
19156 suturing the bladder to injuries with transabdomināl 5.289 approach.
19157 suturing the bladder to injuries with transvezikāl 5.290 approach.
Prostate and testis biopsy 19158 with disposable needles 5.291 values.
19160. Emaskulācij of 5,292
19170 groin limfadenektomij, unilateral 5.293.
Retroperitoneāl-limfadenektomij-5219 19171.
19172 Ureter of 5295 suturing.
19173 Ureterorenoskopij (with current value) 5.296.
19174 Ureterorenoskopij with litoekstrakcij of the loop (the loop value) 5.297.
contact Ureterorenoskopij with litotripsij 19175 (with current value) 5.298.
19177 operational removal of stones from bladder 5.299.
Kidney resection of 19185 5300.
19186. Adrenalektomij of 5.301
in the 5.302. litotripsij Extracorporeal 19187
19195 diagnostic laparoskopij. Hide together with other operations 5.303.
Laparoskopisk-adrenalektomij-19196 5.304.
Laparoskopisk testikulār of the 19197 vein of 5.305 liģēšan.
the transperitoneāl of limfadenektomij of Laparoskopisk 19198 t.sk. testicular tumor cases 5.306.
19199 Ekstraperitoneāl laparoskopisk of the ekstirpācij of the t.sk of the lymph nodes of the pelvis. Prostate Tumor cases 5.307.
Laparoskopisk-ureterolitotomij-5.308 19200.
19201 Laparoskopisk bladder neck fixation (stress adjustment of inkontinenc) with 5309.
Laparoskopisk frektomij not a 5310 19202.
the asistēt hand laparoskopij 19203 (at Uro tract operations) 5.311.
19204 hand of 5,311 frektomij not asistēt.
check out Donornier's 5,316 19250.
19251. Donornier preparation of 5.314
19252 kidney transplantation 5315.
19270 chronic hemodialīz (not included in the erythropoietin and iron preparation costs), 5.316.
19275 acute hemodialīz (not included in the erythropoietin and iron preparation costs) 5.317.
or Haemofiltration and hemodiafiltrācij of 19276 (not included in the erythropoietin and iron preparation costs) 5.318.
Hemodialīz 19277 after transplant (not included in the cost of erythropoietin and iron preparations) 5.319.
19278 acute automated peritoneāl in dialysis session 5.320.
19280 dialysis catheter implantation in Peritoneāl with the value of the catheter 5.321.
19300 slow continuous or haemofiltration (SCUF) one day without dialysis catheter 5.322 values.
19302 continuous venovenoz or haemofiltration (CVVH) in one day without dialysis catheter 5.323 values.
19304 continuous venovenoz hemodialīz (CVVHD) in one day without dialysis catheter 5.324 values.
continuous venovenoz hemodiafiltrācij in the 19305 (CVVHDF) per day without dialysis catheter values 5325.
19307 continuous high flow venovenoz dialysis (CVVHFD) for one day without dialysis catheter 5.326 values.
19309 continuous venovenoz plasma filtration and adsorption (CPF) for one day without dialysis catheter values 5.327.
20085 finger bone ekscīzij, resection of tumors, injuries or other ailments. Finger ekskohleācij and plastics 5.328.
20087 big joint "Z" plastics to 5.329 contractures.
20108 Ahill tendons weld 5.330.
20128 Bone or cartilage material for transplantation or free sampling of 5.331 osteonekrektomij.
osteotomij of the pelvic bone 20130 5.332.
20139 hands, feet or jaw joint operational reponēšan the 5.333 wrench.
20140 mežģījum of large joints loose the 5.334 repozīcij.
20141 clavicle end of mežģījum the knees loose or repozīcij of 5.335.
20145 shoulder joint stabilising operation 5.336.
20146 joint ligaments, suturing of the plastic arms and legs, hands, fingers, feet and jaw joints 5.337.
20147 sleeping deep foreign body from soft tissue, bones with surgery (also controlled by the Rtg) 5.338.
20155 hand or toe joint resection (artrodēz) 5.339.
20159 bone tumor or cavity of 5.340 ekskohleācij.
20161 Osteotomij for large barrel bones (without fixation) 5.341.
20200 of remedial osteotomij small stobrkaul, "Z" type osteotomij I metatarsāl the bone 5.342.
20202 big barrel bone osteosintēz with rod (without implants values) 5.343.
20204 internal fixation of bone removal from large barrel bones 5,739.
20206 Reparatīv operations at the long barrel of pseidoartroz bones and/or bone transport, extension of the limbs, Hahutov operation (without the value of the implant) 5.345.
the great stobrkaul of osteosintēz 20208 with plate (without implants values) 5.346.
the great stobrkaul of osteosintēz 20214 with screws (without implants values) 5.347.
20215 big barrel bone resection, pelvic bone, a bone tumor resection and plastic (without implants values) 5.348.
20217 feet and hands finger joints of 5.349 artrotomij.
20218 big joints, meniskektomij artrotomij and/or other wrist structure removal (links, and other foreign bodies), joint taxation of rinsing system of 5,350.
Sinovijektomij of knee joint of 20219 5.351.
20220 big joints artrodēz (without fixation) 5.352.
20222 fingers and toes, hands and feet of 5.353 artroplastik.
20224 forearm bone osteosintez-5.354 one.
20225 bone cane heads osteosintēz (without the value of the implant) 5.355.
20226 Olecranon osteosintēz (without the value of the implant) 5.356.
20227 proximal end of humerus with osteosintēz plate (without implants values) 5,328.
the upper arm bone in proximal 20228 final osteosintēz with wires and/or astringent loop (without implants values) 5.358.
20229

Clavicle plate blade OS with the OS with the plate (without the value of the implant) 5359.
20230 a total Hip Arthroplasty with cementējam of endoprotēz (without dentures) 5.360.
20231 Hip Arthroplasty with bezcement a endoprotēz (without dentures) 5.361.
20232 knee arthroplasty (without dentures) 5.362.
20236 Femurokapitāl Arthroplasty of the hip joint (without dentures) 5.363.
20239 shoulder joints Arthroplasty (without dentures) 5.364.
20240 Cementējam of hip joint implantation of the audit endoprotēz (without dentures) 5.365.
20241 Bezcement the hip joint audit of endoprotēz implantation (without dentures) 5.366.
20242 knee endoprotēz audits for operation (without dentures) 5.367.
20245 upper arm bone of a distal metaepifīz osteosintēz (without the value of the implant) 5.368.
20246 forearm distal bone of osteosintēz metaepifīz (without the value of the implant) 5.369.
20247 roller bone osteosintēz (without the value of the implant) 5.370.
20248 heel bone fracture osteosintēz (without the value of the implant) 5.371.
20249 hands and feet finger eksartikulācij or amputation, amputation of trunk handle 5.372.
20251 upper or lower limb amputation, eksartikulācij, amputation of trunk processing, audit (per limb) 5,739.
the large joints eksartikulācij-20253 5.374.
20257 Acetabul and/or pelvic bone osteosintēz (without implants) 5.375.
20258 Symphysis-osteosintēz (without the value of the implant) 5.376.
20259 Femur fracture with transtrohanter osteosintēz wires (not the value of the implant) 5.377.
20260 Femur neck with kanulēt screws osteosintēz (without the value of the implant), 5.378.
20261 thighbone fracture with dynamic hip osteosintēz screw-plate or dynamic kondiļ screw-plate (DHS or DC) (without the value of the implant) 5,768.
20262 thigh bone trohanter zone osteosintēz with screw (without implants values) 5.380.
20263 big barrel of diafīz bones osteosintēz with plate (without implants values) 5.381.
20264 big barrel bone osteosintēz with the block bar (without implants values) 5397.
20265 Osteosintēz with angle plate (without implants values) 5.383.
the knees of 20266 osteosintēz (without the value of the implant) 5.384.
20267 a proximal end a large lielkaul of osteosintēz (without the value of the implant) 5.385.
Tībij of the metaepifīz of distal 20268 OS (no implant values) 5.386.
20269 little big bone osteosintēz with the plate (without the value of the implant) 5.387.
20270 ankle fracture osteosintēz (without the value of the implant) 5.388.
20271 tipping osteosintēz Trīspotīš (without the value of the implant) 5392.
20276 evaluations of hybrid type hip joint arthroplasty of 5,255.
20281 Arthroscopy (knee, elbow, ankle joint) 5397.
20282 Artroskopisk shoulder joint stabilising subakromiāl decompression or surgery (pay only outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 5392.
20284 Artroskopisk shoulder rotator tendons of the 5.393 suturing.
20285 Artroskopisk the knee cross link reconstruction (without the interference screw value) 5.394.
20288 Arthroscopy (shoulder, hip) 5.395.
20290 Artroskopisk the knee meniscus suturing the 5.396.
20291 Artroskopisk of knee cartilage defect of 5.397 mozaikplastik.
20292 Artroskopisk the knee bone osteosintēz (without implants) 5397.
20293 a Artroskopisk knee sinovijektomij of 5,399 per person.
Not krotomij and not krektomij 20303 at 5-10% burn face, hands or feet, also deep soft tissue necrosis off injuries and trauma consequences of 5,400.
Not krotomij and not krektomij 20304 at 11-30% burns in the surface, also deep soft tissue necrosis off injuries and trauma consequences 5431.
20305 krotomij and Not krektomij at the burns over 30% of the surface, also burn deep soft tissue necrosis off injuries and trauma consequences 5.402.
20306 Autodetermoplastik at 5-10% of the surface of the 5.403 burns.
20307 Autodetermoplastik at 11-30% Burns surface 5.404.
20308 Autodetermoplastik at Burns over 30% 5.405.
20309 Reconstructive operations after Burns 5.406.
the process of laparotomij-21017 5.407.
21018 conventional 5.408 of an appendectomy.
21019 Intraabdomināl bleeding prevention 5.409.
21020 Saaugum realignment. Stand alone operation. Hide together with other operations 5410.
21021 Intraabdomināl biopsy or abscess opening 5.411.
21022 milk gland resection of 5.412 sectoral.
21023 deep perforation of the organ of the cross-linking 5.413.
21024 conventional herniorafij (pay, if carried out in hospital outpatient or day, in all cases, the 24-hour inpatient only stuck in hernia and in cases where the patient is not possible contraindications to carry the day in the hospital. Children up to 8 years of age pay the 24-hour fixed in all cases) 5.414.
21026 5.415 Postoperatīv hernia plastics.
21027 liver biopsy 5.416.
Gastroenteroanastomoz, enteroenteroanastomoz-5.417 21040.
resection of the intestine 5.418 21041.
21042 Gastrotomij, gastrostomij, enterotomij, enterostomij, kolostomij, stoma closing 5.419.
21043 Distal gastric resection or ekscīzij's 5.420.
21044 the 5.421 Vagotomij.
21045 conventional holecistektomij with the path audit 5.422 bile.
Biliodigestīv of anastamoz of 5.423 21046.
21047 Radical mastectomy 5.424.
21048 Lean operation 5.425.
21049 aperture operation with the laparatomij approach of 5.426.
a total of gastrektomij, 21050 proximal gastric resection-5.427.
Transduodenāl 21051 operation to the duoden major 5.428 papill.
21060 pancreatic drenējoš operations; krektomij not the 5.429.
21061 adrenal surgery 5.430.
21062 rectal resection or ekstirpācij-5431.
a Total of kolektomij 5.432 21063.
' recto ' of resection with 21064 Sigma anal discharge channel 5.433.
21065-limfadenektomij Intraabdomināl or the great collector radical limfadenektomij (intraabdomināl, armpits and groin collectors) 5.434.
21066 repeated or reconstructive surgery of abdominal, obstetric fistula surgery 5435.
21067 thyroid and epitēlijķermenīš operations, deep cyst formation and localized surgery neck 5.436.
21068 liver resection, pancreatic resection of 5,707.
21069 formations of 5.438 Retroperitoneāl ekstripācij.
21082

Repeating the operation due to the bleeding operation zone during post-operative 5.439.
21100 diagnostic laparoskopij. Hide together with other operations 5.440.
Laparoskopisk-holecistektomij-21101 6235.
Laparoskopisk of an appendectomy was 5.442 21102.
a total of ekstraperitoneāl hernia 21103 plastics (TEC) (pay only outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 5.443.
21104 Transabdomināl of preperitoneāl hernia (TAPPU) (plastic pay only outpatient or day hospital. 24-hour hospital pay in cases where the patient is not possible contraindications do day hospital) 5.444.
Laparoskopisk of postoperative hernias 21105 plastics 5.445.
Laparoskopisk-adrenalektomij-21106 5.446.
Laparoskopisk of the fundoplikācij 5.447 21107.
Laparoskopisk of kardiomiotomij of 5.448 21108.
21110 Laparoskopisk hemikolektomij on the right side of 5.449.
21111 a Laparoskopisk left hemikolektomij, Sigma resection resection of 5.450, front.
Laparoskopisk splenektomij of the 5.451 21112.
21113 asistēt-hand laparoskopij-intestinal operations 5.452.
21114 manually asistēt the right hemikolektomij, intestinal resection the 5.453.
21115 asistēt's hand left, hemikolektomij Sigma resection resection of 5.454, front.
21130 Saaugum realignment (laparoskopisk operation). Hide together with other operations 5.455.
21190 operations at the proktoloģisk conditions with perineal approach 5.456.
21192 operations at the proktoloģisk conditions with the abdominal approach. Hide together with manipulation and 21064, 21065 5.457 21063.
22001 thoracic aortic surgery reconstructive 5.458.
thoracic aortic arc 22002 branch reconstructive surgery (intratorakāl) 5.459.
22003 breast aortic arc branch reconstructive surgery (ekstratorakāl) 5.460.
22004 upper limb arterial reconstructive surgery 5.461.
22005 abdominal aortic reconstructive operations on okluzējoš diseases 5.462.
22006 abdominal aortic visceral branches of the reconstructive operations 5.463.
22007 abdominal aortic aneurysm of reconstructive operations at 5.464.
22008 abdominal aortic aneurysm reconstructive operation to tear, detachment 5.465.
22009 pelvic arterial shunt replacement surgery, reconstructive surgery 5.466.
22010 pelvic arterial reconstructive operations of 5.467 endarterektomij.
22015 femur artery reconstructive operations 5.468.
22016 Raise and lower arterial reconstructive surgery 5.469.
the vascular šuntējoš Ekstraanatomisk 22017 operations brahiocefāl of blood vessels 5,470.
the vascular šuntējoš Ekstraanatomisk 22018 operations lower limbs 5.471.
the vessel with the audit periarteriāl 22019-simpatektomij-5.472.
part of the thoracic simpatektomij 22020 5.473.
22021-5505 simpatektomij belt parts.
22022 vein Surgery Reconstructive congenital and acquired illness cases 5.475.
22023 varicose vein operations are extended in cases of complications of 5.476.
congenital abnormality of blood vessel 22024 operations 5973.
Operation of the trunk 22025 vascular cases 5.478 embolisms.
22031 acute aortic bypass operations, the hollow vein damage cases 6074.
22032 acute vascular reconstructive surgery one blood vessel damage 5.480.
22034 Arteriovenoz fistula creation 5,717.
22035 Arteriovenoz create 5.482 shunt.
22062 the perforant veins of Endoscopic subfasciāl for klipēšan of 5.483.
23002 peripheral nerve, primary or secondary seam 5.484.
23003 peripheral nerve autoplastik. Primary operation 5866.
23004 peripheral nerve autoplastik. Graft 5.486 sampling.
23005 two peripheral nervous autoplastik interfascikulār the nerve, or plastic. Operation-5772.
23006 two peripheral nervous autoplastik. Graft 5.488 sampling.
23007 ear of 5.489 replantācij.
23008 scalp-5.490 replantācij.
Microsurgical technique of irolīz Not 23009 in 5.491.
irinom of the ekscīzij Not 23010 5,742.
Intraneirāl irolīz not in 5.493 23015.
23016 vein graft extraction technique of Microsurgical 5.494.
23017 large soft tissue defect with Microsurgical vaskularizēt plastic skin, subcutaneous an autologous graft. Operation of 5.495.
23018 large soft tissue defect with Microsurgical vaskularizēt plastic skin, subcutaneous graft (TDL, skapulār, ingvināl, deltoid muscle, with tram, serratus anterior). Sampling and skin graft closure defects (ads) 5728.
23019 medium to large soft tissue defect with Microsurgical plastic skin, subcutaneous an autologous graft. Operation of 5.497.
23020 medium to large soft tissue defect with Microsurgical plastic skin, subcutaneous an autologous graft (radial, ulnār, arm, arm medial lateral, mugurēj in the starpkaul artery, the deltoid, the dorsal fasciokutān ped). Sampling, skin graft the defect closure 5.498.
23021 small soft tissue defect with Microsurgical plastic skin, subcutaneous an autologous graft. 5.499 primary operation.
23022 small soft tissue defect with Microsurgical plastic skin, subcutaneous an autologous graft (digital artery flap, Thenar flap, the venous flap to 3 cm2). Sampling, skin graft the defect closure 5,500.
23023 barrel bone defects or pseidartroz plastic vaskularizēt of Microsurgical with an autologous graft of bone (bone, gut fibul fragments). Primary operation 5.501.
23024 barrel bone defects or pseidartroz plastic vaskularizēt of Microsurgical with an autologous graft of bone (bone, gut fibul fragments). Graft taking fault closure 5.502.
23025 hands, I or another finger using Microsurgical reconstruction of the foot finger II, II-III finger pad or Morrison. Primary operation 5.503.
23030 hands, I or another finger using Microsurgical reconstruction of the foot finger II, II-III finger pad or Morrison. Graft taking fault closure (ADP) 5.504.
23031 Muscle failure replace with free Microsurgical muscle graft. Primary operation 5.505.
23032 Muscle failure replace with free Microsurgical muscle graft. Graft taking fault closure 5.506.
23033 damage of the brachial Plexi full secondary Microsurgical plastics with an autologous graft of sural nerves. Operation-5090.
23034 "tenderloin" flap autotransplantācij of acute trauma case. Primary operation 5.508.
23035

"Tenderloin" flap autotransplantācij of acute trauma case. Amputāt processing, structure identification 5.509.
23036 radial, temporal, TDL flap rotation (medium, large) 5510.
23037 local, local or rotate the flap (flap-pārkrustot, V-Y flap, small) 6245.
Limfovenoz of the anastomoz at the primary 23038 or secondary lymph reflux condition (not less than 6) 5,928.
Microsurgical treatment of Impotence 23039 (Dick revaskularizācij) 5.513.
Sēklvad of the caurejamīb recovery 23040-vazostomij, vazoepididimo of 5.514.
23045 tubal mechanical tightness Microsurgical technique in reconstruction-salpingolīz and salpingoneostomij of 5.515.
Microsurgical technique of 23046 Salpingostomij 5.516.
23047 breast reconstruction following mastectomy, tissue, use espander espander 5.517 without values.
23048 breast reconstruction following mastectomy, using free miokutān flap (TDL, tram) 5.518.
23049 breast reconstruction following mastectomy, using a rotated miokutān flap (TDL, tram) 5519.
23050 reduction mamoplastik (medical indications) 5520.
23051 breast pea 5.521 create.
23052 Distortionary scars correction. Operation of 5.522.
23053 fault with full thickness skin graft or plānināt to a 10 cm $5.523.
23054 fault with full thickness skin graft or plānināt up to 100 cm2 5.524.
23056 breast reconstruction following mastectomy, flap closure, sampling and fault 5.525.
23060 small bone graft (distal end of radium, tibij, not vaskularizēt) 5.526.
23061 large bone graft (bowel bone, the thigh bone, not vaskularizēt) 5.527.
23062 a large flap of the separation operation 5.528 stands.
23063 small and medium flap stand isolation operation 5,774.
23064 root operation 5530.
23065 finger scars Z, V-Y plastics 5.531.
23066 big joint scar correction with Z, V-Y plastic help to contractures 5,714.
23068 Tendon sheath stenosis surgery with a sample cut 5.533.
23069 Tendovagināl radical operation (tendosinovialektomij) with the bone and tendon resection 5.534.
23070 deep existing tumor ekstripācij Palm and forearm with nerves and blood vessels release 5.535 amalgamated.
23075 Sindaktilij in reconstructive surgery 5.536.
Dubultveidojum-23076 coming out from izoperēšan, finger joints, including the side links for reconstruction, including service manipulation 23075 5.537.
23077 legs feet and hands the wrong bone, tendons and ligaments formations operation (congenital deformities) 5.538.
23079 Binder preparation and suturing of tendons, including processing of fresh wounds 5.539.
23080 Tightening, shortening, extension or plastic cutting tendons, fascia or muscle (reconstruction) 5.540.
23081 tendons, miolīz tenolīz» 5.541.
23083 tendon transposition 5.542.
23084 Free tendon graft sampling 7614.
23091 a Contracture surgery with Dipitrēn not irovaskulār the release of the amalgamated 5544.
Karpāltuneļ or tarzāltuneļ syndrome 23092 operation with neural decompression (also another tunnel syndrome surgeries) 10,395.
23093 links primary weld and/or joints of the arm and suturing the bag my toe, hands and feet and jaw joints 6,654.
23094 wire fixation of small bone in his hand or foot in the open in cases of damage to 5.547.
23096 hand or toe joint resection (artrodēz) 5.548.
23097 finger prostheses or artificial joint operational putting path 5.549.
23098 Osteotomij and/or resection of the small wrist bones 5341.
23099 Artrotomij (capsulotomy) feet or hands finger joints 5.551.
23105 Divetap sinew plastic I phase (operation) 5.552.
23106 hands and feet finger amputation eksartikulācij or stem processing 5.553.
23108 tendon fixation 5.554 transosāl.
23109 annular ligament plastics 1 finger 6274.
23110 finger joints of tenodēz 5,701.
23111 finger Z, V-Y fresh plastic trauma case 5.557.
23112 Vascular Microsurgical technique in seam 5.558.
in the case of injuries Laminektomij 24004 (without the hard brain membrane opening) 5.559.
24005 Laminektomij injuries (with hard brain membrane opening) 5.560.
Laminektomij of the ekstradurāl of spinal 24006 tumor or epidurīt for evacuation of 5.561.
Laminektomij of the intradurāl of spinal 24007 tumor or epidurīt for evacuation of 5.562.
Laminektomij-the intramedulār of 24008 spinal tumor 5.563 evacuation.
24015 spinal tumor reoperācij (no laminektomij) 5.564.
24016 Trefinācij (single hole) 5.565.
24017 Trefinācij by 5.566 stereotaktisk operations.
Osteoplastisk of trepanācij of 5.567 24018.
Osteoklastisk-trepanācij-10011 24019.
24020 skull pit of 5.569 mugurēj trepanācij.
Bifrontāl-trepanācij-24021 6235.
chronic subdurāl hematoma of 24022 evacuation 5.571.
acute hematoma of 24023 evacuation 5.572 subdurāl.
24024 Epidurāl evacuation of hematoma 5.573.
24025 Windage and intracerebral hematoma of the focus of evacuation 5.574.
spontaneous intracerebral hematoma of 24026 evacuation with the cerebrotomij 6081.
24035 internal carotid arteries suprafenoidāl part of klipācij aneurysm 5.576.
24036 Bazilār arteries aneurysm was 5.577 klipācij.
24037 other cerebral artery aneurysm klipācij (manipulation, 24035 24036, 24037) (without clip) 5.578.
Infiltratīv of the supratentoriāl tumor 24050 evacuation 5.579.
Infiltratīv of the subtentoriāl tumor 24051 evacuation 5.580.
supratentoriāl of tumor 24052 designated evacuation 5,722.
subtentoriāl of tumor 24053 designated evacuation 5.582.
pituitary adenom 24054 transkraniāl evacuation of 5.583.
Skull and brain injuries 24060 wounds finish 5.584.
24061 skull brain abscess evacuation (no trepanācij value) 5.585.
24062 operations parasitic brain disease (without trepanācij values) 5.586.
24063 Intrakraniāl-arteriovenoz-ekstirpācij-5.587 malformations.
24064 brain decompression of cranial nerves mugurēj down 5.588.
24065 brain operation at the temporal epilepsy (manipulation 24022-24064) (no trepanācij value) 6,081.
24070 Ventrikulostomij-5.590.
24071 Ventrikuloatriostomij (without the equipment value šuntējoš) 5.591.
24072 Ventrikuloperitoneostomij (without the equipment value šuntējoš) 5.592.
24080 Ventricle shunt revision 5.593.
24090

Brain stereotaksisk operations (no trefinācij value) 5,727.
24092 spinal cord operations 5.595 stereotaksisk.
Ekstraintrakraniāl of the construction of the anastamoz 24093 5.596.
24094 skull defect plastic (no plastic material cost) 5.597.
24095 Skull Base bone defect of plastics (without plastic material cost) 6,674.
24096 operations congenital CNS diseases 5.599.
operation of purulent epidurīt 24097 for decontamination of 5,600.
24098 spinal cord and/or nerve roots audit with plastic 5.601.
24099 peripheral nerve of Microsurgical suturing technique 5.602.
24105 cerebral vascular ekstrakraniāl parts deformation correction 5.603.
carotid artery bifurcation of 24106 endarterektomij of 5.604.
is neurosurgical operation 24109 Endovazāl (translumināl for angioplasty, occlusion, dilation, selective intraarteriāl of Pharmacotherapy without special catheterization Kit) 5.605.
of the pituitary adenom 24111 transfenoidāl ekstirpācij of 5,709.
Not the ventrikulostomij of the likvor iroendoskopisk 24120 circulation reconstruction 5.607.
24121 Intraventrikulār thing ekstirpācij with an iroendoskop of 5608.
24122 intracerebral hemorrhage of Various genesis of the endoscopic stereotaktisk evacuation of 5.609.
24123 iroendoskopisk of mesothelioma is Not nerve roots decompression 5610.
24124 iroendoskopisk Not brain biopsy 5.611.
24127 nerve and muscle biopsy at the neuromuscular dystrophy of 5.612.
24128 Vertebroplastij to one vertebroplastij Kit 5.613.
25005 (HS) Hemosorbcij (1operācij) 5.614.
25008 Plazmaferēz (PA) with the centrifuge manual mode (one operation) 5.615.
25009 Citaferēz with the centrifuge manual 5.616.
25010 detoxification and imūnmodulēšan complex (AUV, AL, AM) 5.617.
Plazmosorbcij (PS) 5.618 25014.
25016 Antibacterial therapy with treated erythrocytes (ATA) 5.619.
25018 colon dialysis (RZSD) sorption 5.620.
25020 Plazmaferēz is 5.621.
25021 Hemoperfūzij with carbon absorbent 5.622.
25022 healing plazmaferēz with auto blood separator (2 hours) 5.623.
25023 Plazmosorbcij with carbon sorbent and automatic blood separator 5.624.
26001 peripheral blood stem cell collection unit 1 of Apheresis procedure the patient (for one day) 5.625.
27002, miogēn Miotomij of nature in the case of the crooked neck 5626.
27003 soft tissue and bone operations sastrutojum children aged 5,754.
27004 leg or hand-reconstructive surgery for children congenital or acquired defects of distortion, and contracture cases 5,701.
Piloromiotomij by Ramšted-27005 Šēd of 5.629.
27006-Klitoroplastik 5630.
small omfolocēl of plastics 27007 without alloplastik-5501.
27008 belly front wall plastic newborn period with alloplastik (allotransplantāt values) 5.632.
27009 chest front wall plastic 5.633.
27010 diaphragm hernias plastic newborn 5.634.
27011 chest front wall plastic-Pect-Bar modifications with the feeding value of the implant Pect 5.635.
27015 esophageal and gastric intestinal tract congenital caurejamīb of newborn surgery not 5.636.
Artēzij operations 27016 newborns 5.637.
27017 Gill circle of operational treatment of 5.638 derivatives.
27018 vaginas plastic case atrēzij 5.639.
Proktoplastik anorektāl abnormalities of 27019 case 5640.
27020 congenital CNS pathologies in children aged 5.641 operation.
a rare congenital anomalies 27021 correction newborn 5.642.
Reconstructive Surgery of the foot 27022 congenital and acquired defects and deformity cases with tendons, muscles, joints the capsule tissue and/or redistribution of 5.643 transposition.
27023 Reconstructive operations for hip, knee, wrist or elbow joints in the area, including the tendon and muscle pāršķelšan, extension or transposition, capsulotomy, or free with osteotomij and osteosintēz, preventing child cerebral stroke effects 5644.
27024 Reconstructive operations of the long barrel of the child bone phony joints, tumors, shortening, deformity including osteosintēz, osteotomij and t.sk. with external fixation method with or without bone graft (without external fixation apparatus) 5.645.
27025 hip joint reconstructive surgery for children congenital and acquired defects and deformities (congenital dysplasia and wrench, the upper head aseptic necrosis, juvenīl epifiziolīz, distrofisk of the coxa may), including the osteotomij and osteosintēz of 5.646 and/or.
27030 Parenhimatozo organs tillage operations in children traumatic damage to 5.647.
27032 operation Hiršpung in the event of sickness with circular mechanical bowel seamstress, including seamstress 5.648 values.
major omfalocēl or gastrošīz 27034-plastic without graft values 5.649.
bone cyst of the Solitaire 27037 treatment with rinsing method children 5650.
sakrokokcigeāl of congenital 27038 teratogenic ekstripācij neoplasia of the tail vertebrae bone resection 5,945.
27039 deep venous or lymphatic malformations of the ekstripācij or surgical correction 5.652.
27040 Ureterocistoneostomij with the lower third of the ureter modulated 5.653.
27041 bladder neck bladder of plastic at the Microsurgical technique 5.654 ekstrofij.
27042 Hipospādij and/or epispādij in the plastic arts for children in 5.655. Microsurgical technique
28001 tongue string release with Z plastic or free skin transplantation children 5.656.
28003-osteotomij of the plastic Nose 5.657.
28004-plastic osteotomij of the nose with the nasal septum correction 5658.
partial Operation 28005 upper lip Flake's case, 5,659.
28006 operation through unilateral lip Flake's case 5660.
28007 operation through mutual lips Flake's case, 5.661.
28008 soft palate closure of Flake (phase 1) 5.662.
28009 hard palate closure of Flake (phase 2) 5.663.
Through the palate 28010 closure of one Flake stage 5.664.
28015 palate surgery-velofaringoplastik-Flake 5,699.
28016 palate surgery-Flake at velofaringouvuāl in faringoplastik condition 5.666.
28017 palate surgery-vestibuloplastik flake or defect limits the closing of 5680.
28018 Vestibuloplastik with free skin graft with residual defect closure 5.668.
28019 Vestibuloplastik with free skin transplantation without defect limits the closing of 5.669.
fault osteoplastik of maxilla 28020 5,699.
28021

The adjustment for congenital lip flake, with local tissue 5,694.
28022 adjustment after congenital lip flake, with flap from 5.672 remote areas.
28023 adjustment for congenital nasal cartilage flake, without entering the 5,581.
28024 adjustment for hereditary flake, nose with cartilage entering 5.674.
28025 hereditary Correction after the mouth and nose, flake, without entering the 5.675 cartilage.
28026 adjustment for congenital lip flake, and nose with cartilage entering 5.676.
28030 palate closure defect diameter up to 0.5 cm 5.677.
28031 palate closure defect diameter and 1 cm 5.678.
28032 palate closure defect diameter larger than 1 cm 5.679.
28033 Faringoplastik after the palate of 5.680 flake.
28034 palate closure defect with flap from 5.681 mouth.
28035 palate defects after the conclusion of the bilateral palate closure of 5.682 flake.
28036 maxilla osteotomij by Le-Fort type 1 5.683.
28037 mandibular osteotomij with i/o access to the mandibular branch district 5684.
28038 mandibular osteotomij with i/o access to the mandibular body District 5.685.
28039 mandibular osteotomij with i/o access to the mental area 5.686.
28040 mandibular osteotomij with e/o approach to mandibular branch district of 5.687.
mandibular osteotomij by 28041 e/o approach the mandibular body District 5.688.
28042 mandibular osteotomij with e/o approach the mental area 5.689.
29005 soft tissue injury secondary to finish off through skalpēt of wounds with foreign matter (operations room) 5.690.
29006 More soft tissue damage to the primary finish (over 3 cm in length), complex wounds (damaged) (operations room) 5.691.
sleeping in the deep foreign body 29009 removal of soft tissues or bones with surgery (surgery Hall), 5.692.
29015 mandibular reinforcements in case of an old luksācij (operation) 5.693.
29016 nose repozīcij with disabilities (operation) 5,700.
the Zygomatic orbital complex 29019 damage operational repozīcij of the cheek bone 5.695.
29020 Zygomatic orbital complex the deterioration of his osteosintēz is 5.696.
the Zygomatic orbital complex 29021 failure, orbital base plastics 5.697.
29022 cheek bone through the repozīcij sinus, 5.698 operation.
29023 nasal bone repozīcij with the operation of the bulkhead 5.699.
29025 Repozīcij and retensij in several places to the mandible, lower jaw broken by rock fracture or fractures with bone tissue defects 5700.
transfokāl osteosintēz of the mandibular 29031 with wire in the event of unilateral 5.701.
transfokāl in osteosintēz-29032 mandibular wire in several places with broken jaw 5.702.
29033 mandibular fragment ekstrafokāl of osteosintēz of distrakcij of compression 5.703.
29034 mandibular repozīcij and ekstrafokāl fixation with Kiršner wire (operating room) 5.704.
29035 mandibular osteosintēz with metal Ligature unilaterally in the event of 5.705.
29036 mandibular osteosintēz with metal plate with e/o approach in the event of unilateral 5.706.
29037 osteosintēz with metal lower jaw plate with i/o access in the event of unilateral 5.707.
29038 maxilla after Adams 5.708 osteosintēz.
29039 maxilla with osteosintēz i/o access with ligatures or metal plate 5.709.
29040 Perimandibulār Ligature taxation (operation) 5.710.
Joint heads of 29045 removal at complicated fractures 5,919.
29046 Joint head, repozīcij fixation at 5.712 fractures.
29047 facial bone osteosintēz through Coronal incision 5.713.
29048 joints pathology surgical treatment (osteotomij, plastic arts) at mežģījum for chronic 5.714.
29049 joints pathology surgical treatment (osteotomij, plastic arts) at 5.715 ankiloz rooms.
29050 Orthopaedic and plastic surgery of spontaneous breakage in case of osteomielīt or the jaw resection in applicable 5.716.
29070 Pseidoartroz or broken bone surgery, associated with the bone sutures 5.717 taxation.
29071 Pseidoartroz broken bone or surgery related to bone, sanaglošan Assembly or the transplant of bone implantation 5.718.
29080 Osteotomij after we deployed fracture 5.719.
stopping Bleeding with 29083 vascular liģēšan, a. communis, by a. carota carota the extern the 5.720.
stopping Bleeding with 29084 vascular liģēšan, a., a. the superficial temporal facial by 5.721.
29097 in one place broken jaw – šinēšan (broken jaw to hurt and not) and the tooth extraction of fracture gaps (operating room) 5722.
29098 in one place broken jaw – šinēšan (broken jaw to hurt and not) and the extraction of a tooth fracture and intraorāl in Kiršner in ekstrafokāl fixed with wire (operating room) 5.723.
29099 two and several places for broken jaw šinēšan (broken and jaw to hurt not) (operating room) 5.724.
29100 two and several places for broken jaw šinēšan (broken and jaw and teeth to hurt not the extraction of fracture gaps) (surgery), 5.725.
29101 two and several places for broken jaw šinēšan (broken and jaw and teeth to hurt not the extraction of fracture and intraorāl in Kiršner in ekstrafokāl fixed with wire) (the Theatre) 5.726.
29113 jaw of 5.727 sekvestroektomij.
Antrotomij-29114 5,728.
Antrotomij with oroantrāl fistula in 29115 closure diameter up to 1.0 cm 5.729.
Antrotomij with oroantrāl fistula of 29116 closure diameter over 1 cm (with dubultlēver) 5730.
with the flap of Antrotomij 29117 vestibul of or and hard palate 5.731.
29118 open jaw cavity plastic sealing with simple gum plastic help 5,677.
jawbone trepanācij-29119 5.733.
Fisurāl ekstirpācij of the cysts 29128 5435.
ekstirpācij of Radikulār cysts 29129 without root end resection in diameter to 2 cm 5.735.
ekstirpācij of Radikulār cysts 29130 without root end resection in diameter over 2 cm 5.736.
the Radikulār cysts ekstirpācij 29131 with viensakņ teeth end resection 5.737.
29133 of cysts ekstirpācij Radikulār with molar dangling from it after resection of root 5.738.
ekstirpācij of Radikulār cysts 29135 with tooth root resection with end-sealing viensakņ retrogrād teeth and molar dangling from it of 5.739.
29140 Cistektomij (cyst of the diameter over 2 cm) and fill the cavity with bone autotransplāt the 5.740.
29141 Cistektomij (cyst of the diameter over 2 cm) and fill the holes with artificial materials 5.741.
29142

Cistektomij (cyst of the diameter over 2 cm) and fill the holes with the maxilla and the lower jaw of immobilization 5.742.
Cistotomij at the folikulār and 29143 radikulār of cyst of 5.743.
29146 submaxillary salivary gland of 5.744 ekstirpācij.
29147 intra oral salivary gland fistula operation 5.745.
29148 Extra oral salivary fistula closure 5.746.
29149 intra oral salivary gland of the siekalakmen withdrawal from the output of 5.747.
29150 intra oral salivary gland removal from the siekalakmen gland 5.748.
29151 Parotid salivary gland ekstirpācij, subtotāl or the total resection, salivary gland cysts ekstirpācij, including regional lymphatic system, saving face nerve (n. facial) branches 5.749.
29155 Vanah operation 5750.
iralģij-surgical treatment Not 29157 method-not irekserēz-5.751.
Non surgical treatment iralģij 29158 method-open the decompression 5.752.
29159 of surgical treatment iralģij Not method-Canal decompression 5.753.
29165 nerve injury in the case of weld intrafascikulār (shell, seam to fascikul) 5.754.
29166 nerve injury in the case of the epineirāl seam (nerve skin seam) 5.755.
29168 Odontom and osteom removal of 5.756.
limfangiom of ekstirpācij Hemangiom and 29169 the 5.757.
29171 placed deep formations cut (neck cyst, cyst of dermoīd) 5,742.
29172 maxilla or lower jaw-alveolar processes parts of 5.759 nokalšan.
29173 maxilla or mandibular resection of part of one of the parties of 6646.
29174 maxilla or mandibular resection of part of one party with the radical regional lymphatic system removal 5.761.
the entire maxilla 29175 or mandibular resection of 5.762.
29180 mandibular branch of 5.763 osteotomij.
29181 tongue part or full of tongue resection of 5.764.
29188 Alveolar bone resection spur, to prepare the site for dental prostheses erupted or one area on the side of the jaw (self help in one session) 5.765.
29189 oral base or plastic of incisors district vestibul or one side of the jaw 5999.
29190 plastic on one side of the Tuber 5.767.
29196 tongue string release with Z plastic 5.768.
29197 tongue string release with free skin transplantation 5.769.
29198 nose plastic-osteotomij-5770.
29199-plastic osteotomij of the nose with the nasal septum correction 5.771.
29200 Zygomatic orbital complex of deformation-based plastic, orbital corrections 5.772.
29204 scars cut with local tissue plastic from adjacent topographic zones 5.773.
29205 soft tissue defect by substitution with adjacent tissue 5.774.
29206 soft tissue defect with tissue substitution of 5.775 remote areas.
29207 soft tissue defect of the facial area with the replacement flap for vascular legs 5.776.
29208 soft tissue defect in the substitution of other parts of the body 5.777.
29209 scar cut using a free skin plastic 5.778 method.
one part 29224, or frontal area of 5.779 kortikotomij.
29225 facial mimic muscles paralysis surgical correction of intraorāl in miotomij-5.780.
29226 facial mimic muscles paralysis surgical correction, skin and subcutaneous ekscīzij of 5.781.
29227 facial mimic muscles paralysis surgical correction-mioplastik with m. Masseter 5.782.
29228 facial mimic muscles paralysis surgical correction-mioplastik with a temporal 5.783 m..
29229 facial mimic muscles paralysis surgical correction – Microsurgical nerve reconstruction 5784.
29230 facial mimic muscles paralysis surgical correction-blephororrhaphi's 5.785.
29235 sampling: Bone Graft material (anterior, superior to the iliac Crista, cortical lamina) 5.786.
29236 Graft sampling-rib 5.787.
29237 Graft-free sampling skin 5.788.
29238 Expander pot 5.789.
29239 Expander is removed, and plastic with the stretched tissue 5.790.
29240 Kontūrplastik facial area with car, all the artificial transplant 6,089.
single tooth implant 29257 forcing 5.792.
29258 one tooth implant with augšžokl antrotomij of Pan sinus preparation 5.793.
30001 spine scoliosis operation without implant 5.794 values.
Spinal fixation 30006 injuries etc. spine instability where 5.795.
spinal canal decompression 30010 spondilodēz with stabilization (Olb) 5.796.
the vertebral column fixation with 30011 laminektomij, with/without keel of 5.797 nokalšan Urban.
thoracic vertebral column 30012-belt parts fixation without laminektomij-5.798.
the vertebral column fixation with laminektomij 30013, spinal cord, radikulolīz, with/without keel nokalšan of Urban Microsurgical technique 5.799.
the front of the vertebral column 30020 spondilodēz thoracic and/or lumbar part of the 5800.
the vertebral column of her neck 30022 mugurēj fixation in 5.801.
the tail bone resection of 30027 5.802.
Hello stamping apparatus 30028 5.803.
the removal of the vertebral column tumors 30029 5.804.
30030 Implant removal of spinal 5.805.
Izgulējum of plastic 5.806 30031.
30059 Hemifasetektomij, hemilaminektomij diskektomij or epineirāl with the redistribution of radikulolīz connective tissue, nerve roots, spinal cord decompression and intra/extra durāl a tumor removal, reoperācij after diskektomij of Microsurgical technique 5.807.
of the thoracic vertebral column 30065 torakoskopisk operations 5.808.
31002 pleural drain taxation with rib resection 5.809.
31003 intercostal artery of 5.810 nošūšan.
31005 Mediastinal drainage 5.811.
Mugurēj drainage of Mediastinal 31006 with rib resection 6000.
31007 diagnostic purposes Torakotomij, including tissue sampling, and torakotomij with heart massage 5.813.
Bronchial arteries liģēšan-31008 5.814.
31009 breast lymphatic damage to cladding the 5815 run.
Bronhotomij a foreign body or tumor 31010 removal 5.816.
Pneimotomij-31015 5,963.
31016 lungs evacuation 5.818 foreign bodies.
31017 lung injury nošūšan 5819.
31018 bronchial rupture of nošūšan lobe of 5.820.
the main bronchial rupture 31019 nošūšan of 5.821.
31020 trachea bifurcation of trachea rupture of nošūšan of 5,822.
31021 main and other bronchial rupture of plastic reconstruction of 6,132.
31022 foreign body removal from the breast Wall 5.824.
31023 breast wall structure ekstirpācij. Torakotomij-5825.
31024 breast wall plastic 5.826.
Rib resection of 5.827 31030.
31031 two or more rib resection of 5.828.
31032 breast wall ekstenzij on 5.829.
31033 breast bone fracture fixation 5.830.

31034 one or more ribs in the case of a fracture fixation 5.831.
Torakoplastik-31035 5.832.
marginal resection of the lung 31036 5.833.
31037 Two or more atypical of resection of segment 5.834.
31038 typical lung resection of segment of 5.835.
31039 two or more pulmonary resection of segment of the typical 5.836.
Lobektomij-31045 5.837.
31046 Lobektomij with mediastinal lymph node ekstirpācij of 5.838.
Lobektomij with circular 31047 main bronchial resection of 5.839.
31048 Lobektomij with the main bronchial wedge resection 5.840.
Lobektomij to the main bronchi 31049 circular vessel and marginal resection 5.841.
31050 Lobektomij with blood vessels and the circular main bronchial resection 5.842.
31051 Lobektomij with marginal resection of vessel 5.843.
Lobektomij and segmentār resection in 31052-5,844.
31053 Lobektomij with pericardial resection 5.845.
Bilobektomij of 5.846 31054.
31055 Bilobektomij and vascular resection of 5.847.
31056 Pneimonektomij was 5.848.
pneimonektomij-31057 extended resection of pericardial lymphatic node ekstripācij of Mediastinal 5.849.
31058 Pneimonektomij with marginal vein resection 5850.
31065 pleural scarification 5.851.
31066 pleural space realignment 5.852 saaugum.
31067 blood clots escape from the pleural space 5.853.
Retorakotomij and hemostāz-31068 5854.
Pleirektomij of 5.855 31069.
31070 Pleirektomij and marginal resection of the lung 5.856.
Pleirolobektomij of 5.857 31071.
Pleirobilobektomij-31072 5.858.
Pleiropneimonektomij-31073 5.859.
Pneimonlobektomij with orifice and 31074 breast wall block resection 5860.
31080 Trahe (bronchial)-esophageal fistula in ekstirpācij of 5.861.
31081 Trahe (bronchial) – esophageal fistula ekstirpācij and lobektomij of the 5.862.
31082 tracheal resection with circular thoracic approach 5.863.
resection of trachea bifurcation of 31083 stands at 5864.
31084 tracheal resection with circular neck 5.865 approach.
31085 wedge resection of trachea with thoracic approach 5.866.
31086 wedge resection of the trachea in the neck approach 5893.
31087 tracheal resection with sternotomij circular cut of 6,192.
31088 Retorakotomij, bronchial fistula-nošūšan-5.869.
31095 Transsternāl and/or transperikardiāl of the nošūšan of bronchial fistula-5870.
Retrosternāl of the ekstirpācij of the Struma 31096 with cervical approach 5.871.
31097 Mediastinoskopij with mediastinal lymph node biopsy-5872.
build ekstirpācij of Mediastinal 31098 5.873.
31099 Mediastinal formations ekstirpācij and lung resection of tissue of 5874.
diaphragm resection of the 31105 5.875.
nošūšan-diaphragm 5.876 31106.
31107 Old traumatic injury of diaphragm of 5.877 nošūšan.
31108 diaphragm rupture of spleen nošūšan and ekstirpācij and stomach-bowel resection of 5.878.
31115-Mediastinal tumor Sternotomij ekstirpācij of 5.879.
31116 Sternotomij-Butterfly ekstirpācij the gland 5,880.
Sternotomij with traheotomij of 5.881 31117.
the trunkulār of vagotomij of Transtorakāl 31118 5.882.
Torakotomij and ezofagomiotomij-5.883 31119.
31125 esophageal resection of divertikul with thoracic approach 5.884.
31126 esophageal leiomiom of ekstirpācij of 5.885.
31127 esophageal tear nošūšan with thoracic approach 5.886.
31128 esophageal resection of the divertikul and the nošūšan to the fracture neck of 5.887 approach.
31129 esophageal of 5.888 ekstirpācij.
31130 esophageal stent implantation of the stent-free values 5889.
31137 esophageal ekstirpācij with following esophageal-gastric or esophageal anastamoz-intestinal anastamoz the creation of 12,800 sample ad.
31138 esophageal bypass anastamoz of creation with stomach 5.891.
the esophageal Antesternāl 31139 anastamoz» 5.892.
Torakoskopij with biopsy 5.893 31145.
31146 Torakoskopisk breast tumor ekstirpācij wall-5894.
Torakoskopisk blood clot 31147 evacuation 5895.
Torakoskopisk of pericardial divertikuļ 31148-cysts resection of 5.896.
Torakoskopisk-31149 marginal resection of lung tissue was 5.897.
Torakoskopisk-pleirektomij-31150 5908.
Torakoskopisk of Mediastinal tumor 31151 and bronhogēn ekstirpācij of 6,166 of cysts.
Videoskopisk-the divertikuļ of Cenker 31152 resection with cassette value 5,900.
31153 Torakoskopisk esophagus mobilization 6,163.
31175 breast wall biopsy 5.902.
31230 trachea and bronchial balondilatācij by entering the stent with disposable balloon 5.903.
32050 myocardial revaskularizācij, aortokoronār, mamarokoronār, repeating the shunt (redo) surgery myocardial revaskularizācij, a heart tumor surgery, plastic surgery, valvular heart removal of foreign bodies in the artificial circulation (the national society with limited liability "Paul stradins clinical University Hospital") 6,191.
32051 Operation with a mechanical heart connection (Novocor) system (without system values) artificial circulation (the national society with limited liability "Paul stradins clinical University Hospital") 5.905.
32052 thoracic aorta (aneurysm rupture) operation of artificial circulation artificial circulation (the national society with limited liability "Paul stradins clinical University Hospital") 5.906.
32053 valvular replacement, repeat (redo) heart valve adjustment (prosthetics) artificial circulation (the national society with limited liability "Paul stradins clinical University Hospital") 5.907.
32054 myocardial revaskularizācij (aortokoronār the shunt) with valve replacement of artificial circulation (the national society with limited liability "Paul stradins clinical University Hospital") 5.908.
32055 myocardial revaskularizācij (mamarokoronār the shunt) (not used in conjunction with manipulation 32065) artificial circulation (the national society with limited liability "Paul stradins clinical University Hospital") 5.909.
32070 heart surgery without artificial circulatory-torakotomij, closed komisurotomij, Mediastinal tumor surgery, congenital heart ailments adjustment, chest or heart trauma, surgery, resternotomij of pericardial 5.910.
32075 complex congenital sirdskaiš adjustment the artificial circulation, valve replacement, valve plastic surgery, heart surgery, tumor (redo) surgery society with limited liability "children clinical University Hospital" 5.911.
32080 heart surgery without artificial circulatory-torakotomij, Mediastinal tumor surgery, congenital heart disease, the adjustment of the chest or heart trauma, pericardial surgery society with limited liability "children clinical University Hospital" 5.912.
50118

Intraarteriāl of embolizācij or direct trombolīz, using mikrokatetr to 5.913.
50119 hollow vein filter implantation 5.914.
the translumināl Percutaneous angioplasty 50120, stentēšan the 5.915.
Arteriovenoz of the embolizācij malformations 50123 head and spinal brain 5463.
50131 cerebral aneurysm using mikrokater of embolizācij 6,172.
the transhepatisk was to examine 50145 Percutaneous drainage (with disposable bile and pancreatic drain Kit) 5.918.
the transhepatisk was to examine 50146 Percutaneous dilation 5.919.
50720 USA controls a puncture aspiration biopsy or by tumor localization labelling 5920.
50721 puncture biopsy in USA Endokavitāl controlled 5.921.
50722 USA controls a "core" biopsy (without biopsy needles and devices) 5.922.
50724 Fluid collection (abscess, cyst, hematoma) percutaneous drainage without a drain Kit 5.923 values.
coronary angioplasty stent 60072 without the implantation site and day hospital 5.924.
coronary angioplasty with stent 60073 the implantation site and day hospital 5.925.
60074 coronary angioplasty using stent grafts by medicine filled (DES) and the date fixed in the stationary 6. From the State budget funds pay chemotherapy schemes for malignant tumors list 6.1. Oncology chemotherapy schemes no PO box
Manipulation code Medication, medication scheme ATC code Gave a course of one ERA PP C00-C14 6.1.1. Lips, mouth and throat malignant tumors 6.1.1.1. MTX L01BA01 60mg/61000 Methotrexat m2 of i/v day 1 7 days 6.1.1.2. Iii L01XA01 75mg of Cisplatin/CDDP 61001 m2 day 1 i/v 7 days (A) (I). L01XA01 of 6.1.1.3 61002 Cisplatin 100 mg/m2, PF, i/v day 1 (A) (I) of the 28 days of 1000mgs/m2 L01BC02 Fluorouracil i/v 1-5 days for 28 days and Cetux 61003 6.1.1.4. 1 400 mg/m2 of Cetuximab L01XC06 i v day 1, then use the following scheme Cetux_2 7 days 6.1.1.5. Iii Cetux_2 of L01XC06 only on Cetuximab 61004 schema: Cetux_1 250 mg/m2 day 1 of 7 days (iii) 6.1.1.6. Docetaxel_1 of L01CD02 40mg Docetaxel 61005/m2 day 1 i/v 7 days 6.1.1.7. Iii Docetaxel_2 L01CD02 100 mg of Docetaxel 61006/m2 day 1 i/v 21 day 6.1.1.8. Iii L01XA01 75mg of Cisplatin/61007 TP m2 i/v day 1 of A 21-day
I L01CD02 75mg/m2 Docetaxel for i/v day 1 21 day 6.1.2. C15 esophageal malignant tumor 6.1.2.1. CF_1 L01XA01 75mg of Cisplatin 61008/m2 day 1 i/v 28 days (A) (I) of Fluorouracil 1000mgs/m2 i/v L01BC02 1-4 days for 28 days of Paclitaxel 6.1.2.2. PC L01CD01 60mg 61009/m2 i/v 1, 8, 15, 22 days 28 days I 75mg/m2 of Cisplatin L01XA01 i v day 1 28 days A L01XA01 of CF_2 6.1.2.3. Cisplatin 80 mg/61010 m2 I/v day 1 day 21 (A) (I) of Fluorouracil 1000mgs/m2 i/v L01BC02 1-4 day 21 day 6.1.2.4. CPU of 600 mg L01XA02 61011 Carboplatin (AUC 5) i/v 1 day 21 days of 150 g/m2 Paclitaxel II L01CD01 i v day 1 21 day L01XA01 of Cisplatin 6.1.2.5.61012 CII 30 mg/m2 i/v 1., 8., 21 days 21 days A L01XX19 65mg of Irinotecan/m2 I i/v 1. 8. day 21 days 6.1.2.6.61013 CEF V L01XA01 60mg/m2 of Cisplatin i/v day 1 day 21 (A) (I) 50 mg/m2 of Epirubicin L01DB03 i v day 1 21 day L01BC02, 200 g/m2 of Fluorouracil i/v 1-21 of 21 days of the day of L01XA03 Oxaliplatin 6.1.2.7.61014 OFL 85mg/m2 day 1 i/v 14 days of Fluorouracil L01BC02 2600mg II V/m2 day 1 i/v 14 days Leucovorin (Calcio in folinat) V03AF03 200/m2 i/v 1. 2. the day 14 days 6.1.3 C16 gastric malignant tumor 6.1.3.1. EFC of Epirubicin 50 mg L01DB03 61015/m2 day 1 i/v 21 day of the V I 60mg/m2 Cisplatin L01XA01 i v day 1 of A 21-day of 200 mg/m2 L01BC02 Fluorouracil i/v 1-21 day 21 day 6.1.3.2.61016 ELF Leucovorin (Ac, folinat) V03AF03 300mg/m2 i/v 1.-3. day 28 days of L01CB01 120mg/m2 Etoposid II i/v 1.-3. day 28 days L01BC02 mg/m2 of Fluorouracil V i/ 1. v-day 3 28 days of Docetaxel 6.1.3.3. L01CD02 75mg 61017 DFC/m2 day 1 i/v 21 days I 60mg/m2 of Cisplatin L01XA01 i v day 1 of A 21-day L01BC02 750mg/m2 of Fluorouracil i/v 1-5 day 21 day 6.1.4. Slender casings C17 malignant tumor (karcinoīd), malignant tumor C26 General and not precise defined the digestive organs, C513 oral and digestive organ tumor with uncertain or unknown nature 6.1.4.1. INF-α 61018 Interferon alpha L03AB0 10x106 IU of s/c
 
 
6.1.5. Iii C17 in Thin intestine malignant tumors (adenokarcinom). L01XA03 Oxaliplatin 6.1.5.1 61019 FOLFOX of i/v 85mg/m2 day 1 of 14 days of Fluorouracil 400 mg/g II L01BC02 m2 bolus 1., 2., and 600 mg/m2 day 19 h 1., 2. infusion day 14 day Leucovorin (Calcio in folinat) V03AF03 200/m2 i/v 1., 2. date 14 days FOLFIR in Irinotecan 6.1.5.2. for L01XX19 180mg 61020/m2 day 1 i/v 14 days of Fluorouracil 400 mg L01BC02 III/m2 bolus day 1 and 2400mg/m2 infusion of 46h
14 days Leucovorin (Calcio in folinat) V03AF03 400 mg/m2 day 1 i/v 14 days 6.1.6. C18 colon malignant tumor, C19 Sigmveid and rectal cancer connection, C20 rectum malignant tumor sections 6.1.6.1. FL L01BC02 425mg of Fluorouracil 61021/m2 i/v 1-5 days for 28 days (iii) Leucovorin (Liege, folinat) V03AF03 20mg/m2 i/v 1-5 day 28 days of L01XA03 6.1.6.2.85mg Oxaliplatin 61022 FOLFOX/m2 day 1 i/v 14 days of Fluorouracil 400 mg/g (II) L01BC02 m2 bolus, 600 mg/m2 infusion of 1.35 m, 2. day 14 day Leucovorin (Calcio in folinat) V03AF03 200/m2 i/v 1, 2 day 14 days FOLFIR in Irinotecan 61023 6.1.6.3. L01XX19 of 180mg/m2 day 1 i/v 14 days of Fluorouracil L01BC02 3000mg II V/m2 infusion of 46h day 1 Leucovorin 14 days (Liege, folinat) V03AF03 200/m2 day 1 i/v 14 days Capecitabin Capecitabin of L01BC06 61024 6.1.6.4.1250mg/m 2 p/o 2 times a day 1-14. date 21 days III 6.1.6.5.61025
130mg/m2 of Oxaliplatin CapeOX L01XA03 i v day 1 II of the 21 day Capecitabin L01BC06 1250mg g/m2 p/o 2 times a day 1-14. date 21 days L01XA03 of Oxaliplatin 6.1.6.6.130mg Oxaliplatin 61026/m2 day 1 i/v 21 V 6.1.6.7. date II L01XX19 350mg of Irinotecan/Irinotecan 61027 m2 i/v day 1 21 day V II. L01BC03 of Tegafur Tegafur 6.1.6.8 61028 30 mg/kg p/o 1.-28. the day 35 days 6.1.7. C21 anus (anus) and the anus the Canal (Canalis anal) malignant tumor of Fluorouracil 6.1.7.1. L01BC02 750mg/61029 FM m2 i/v 1-5 days or 28 days 1000mgs/m2 i/III (v) 1-4 days for 28 days of Mitomycin L01DC03 15mg/m2 day 1 i/v 28 days of L01XA01 6.1.7.2. PF Cisplatin 100 mg 61030/m2 day 2 i/v 28 days (A) (I) of Fluorouracil 1000mgs/m2 i/v L01BC02 1-5 day 28 days 6.1.8. Liver and intrahepātisk the C22 to examine malignant tumor 61031 DOXA 6.1.8.1.

75mg/m2 of Doxorubicin L01DB01 i v day 1 g II 21-day 5-FU/61032 6.1.8.2. INF-L01BC02 200 mg/m2 of Fluorouracil α i/v 1-21 days 28 days of Interferon alpha III L03AB0 4x106 IU's/c 1-3 day 28 days 6.1.8.3. INF-α of Cisplatin 61033 CDF L01XA01 20mg/m2 i/v 1.-4. day 21 days (A) (I) of Doxorubicin L01DB01 40mg/m2 day 1 i/v 21 days of Fluorouracil 400 mg/m2 V L01BC02 i v day 1-4 21 days
 
Interferon alpha L03AB0 5x106 IU of i/v 1.-4. day 21 day 6.1.9 not applicable gallbladder cancer, C24 and clarify Other parts of žultsceļ malignant tumor (holangiokarcinom)-FU_1 of Fluorouracil 6.1.9.1.61034 5 mg/m2 i/v L01BC02 1-5 days for 28 days (iii) 6.1.9.2.
61035 GEM/5-FU/LV L01BC05 1000mgs/m2 of Gemcitabin i/v 1, 8, 15 days for 28 days (iii) L01BC02 of Fluorouracil 600 mg/m2 i/v 1, 8, 15 day 28 days Leucovorin (Ac, folinat) V03AF03 20mg/m2 i/v 1, 8, 15 day 28 days 6.1.9.3.61036/Gem of Cape Capecitabin L01BC06 1250mg/m2 p/o 2 times a day 1-14. date 21 days of Gemcitabin 1000mgs/L01BC05 III i/v 1 m2. 8. day 21 day 6.1.10. C25 pancreatic malignant tumor 6.1.10.1.-FU_2 of L01BC02 425mg 61037 5 Fluorouracil/m2 i/v 1.-3. day 14 day 6.1.10.2. III Gem_1 L01BC05 400 mg of Gemcitabin 61038/m2 day 1 i/v 7 days a 6.1.10.3 III Gem_2 L01BC05 1000mgs of Gemcitabin 61039./m2 i/v 1, 8, 15 day 28 days 6.1.10.4 III./L01XA01 CDDP 61040 Cisplatin 25 mg/m2 of the GEM i/v 1. 15. day 21 days (A) (I) (i) of L01BC05/m2 Gemcitabin 1000mgs/1 v, 15 day 21 day 6.1.10.5. L01XE03 100 mg of Erlotinib 61041 GE day p/o 28 days of Gemcitabin III 1000mgs/m2 i/v L01BC05 1, 8, 15 day 28 days 6.1.11. C30 nose cavity and middle ear malignant tumor, C31 sinus malignant tumor of Larynx Cancer, C32, D38 middle ear, respiratory and chest organ tumor with uncertain or unknown nature 6.1.11.1 Cetux_1 L01XC06 400 mg of Cetuximab 61042./i/m2 v day 1, then use the following scheme Cetux_2 7 days 6.1.11.2 III. Cetux_2 of L01XC06 only on Cetuximab 61043 schema: Cetux_1 250 mg/m2 day 1 7 days a 6.1.11.3 III. L01XA01 of Cisplatin 100 mg/61044 CF m2 i/v day 1 day 21 (A) (I) of Fluorouracil/m2 i/v L01BC02 1000mgs 1-5 day 21 day 6.1.11.4. L01XA01 75mg of Cisplatin 61045 PC i/g/m2 day 1 of A 21-day of 175mg/m2 Paclitaxel I L01CD01 i v day 1 21 6.1.12. C33 day tracheal malignant tumor 6.1.12.1. L01XA01 of Cisplatin 100 mg/61046 CF m2 i/v day 1 day 21 (A) (I) of Fluorouracil/m2 i/v L01BC02 1000mgs 1-5 day 21 day 6.1.13. Bronchial and lung C34 malignant tumor (non-small lung cancer) 6.1.13.1. L01XA01 of Cisplatin 80 mg/61047 CE m2 day 1 i/v 28 days (A) (I) of 100 mg/m2 Etoposid L01CB01 i/v 1.-3. day 28 days V 6.1.13.2. L01XA00 of Cisplatin 80 mg/61048 CV m2 i/v day 1
28 days I L01CA04 30 mg/m2 of Vinorelbin i/v, 8.1 day 28 days 6.1.13.3 L01XA02 300mg of Carboplatin 61049 CP./m2 day 1 i/v 21 days L01CD01, 200 g/m2 of Paclitaxel II i/v day 1 21 day 6.1.13.4./L01XA01 CDDP 61050 80 mg/m2 of Cisplatin GEM, i/v day 1 day 21 (A) (I) of 1000mgs/m2 L01BC05 Gemcitabin i/v 1. 8. day 21 day 6.1.13.5./GEM of Carboplatin 61051 CBDC L01XA02 300mg/m2 day 1 i/v 21 days of Gemcitabin 1000mgs/L01BC05 II V m2 i/v 1, 8 day 21 day 6.1.13.6./L01XA01 CDDP 61052 80 mg/m2 of Cisplatin TAXI i/v day 1 day 21 (A) (I) of 200 mg/m2 Paclitaxel L01CD01 i v day 1 21 day 6.1.13.7. L01XA01 75mg/TP Cisplatin 61053 m2 of i/v day 1 day 21 (A) (I) of 75mg/m2 Docetaxel L01CD02 i v day 1
21 days 6.1.13.8 CD L01XA02 300mg of Carboplatin 61054./m2 day 1 i/v 21 days of L01CD02 75mg g/m2 Docetaxel II i/v day 1 21 day 6.1.13.9. L01CD02 75mg of Docetaxel 61055 Docetaxel/m2 day 1 i/v 21 day 6.1.13.10 III. L01XE03 of Erlotinib 150 61056 Erlotinib day p/o III 6.1.14. Bronchial and lung C34 malignant tumor (cancer of the lung-small) 6.1.14.1.60mg/L01XA01 of Cisplatin 61057 PE m2 i/v day 1 day 21 (A) (I) of L01CB01 120mg/m2 Etoposid I/g 1-3 day 21 day V 6.1.14.2. L01XA02 300mg/CE of Carboplatin 61058 m2 day 1 i/v 28 days of L01CB01 120mg g/m2 Etoposid II i/v 1.-3. day 28 days V 6.1.14.3. L01DB01 of Doxorubicin 50 mg/61059 VAC i/v m2 day 1 of a 21-day Cyclophosphamid 1000mgs/V I i v L01AA01/m2 day 1 of a 21-day V/A L01CA02 of 2 mg Vincristin i/v day 1 day 21 6.1.14.4. L01XX16 of the Topotecan 61060 TP 1, 5 mg/m2 i/v 1-5 day 21 day 6.1.14.5 III. L01CD01 175mg/Paclitaxel 61061 TAX for m2 i/v day 1 21 day III of the Thymus gland 6.1.15. C37 (thymus) malignant tumor 6.1.15.1.50 mg/L01XA01 of Cisplatin 61062 CAC m2 i/v day 1 of A 21-day of Doxorubicin 50 mg/m2 I L01DB01 i v day 1 in 21 days of L01AA01 mg/m2 Cyclophosphamid V i/v day 1 day 21 V 6.1.15.2. L01XA01 60mg of Cisplatin 61063 PE i/g/m2 day 1 of A 21-day I Etoposid
L01CB01 120mg/m2 i/v 1-3 day 21 day V 6.1.15.3. L01AA06 of 1500 mg/61064 IFF Ifosfamid m2 i/v 1-5 day 21 day 6.1.16. II C38 V heart, mediastinum and pleura malignant tumors 6.1.16.1. L01DB01 75mg of Doxorubicin 61065 DOXA/m2 day 1 i/v 21 days (iii) 6.1.17. Other and unspecified C39 locale of the respiratory system and the organs of the thoracic cavity malignant tumors 6.1.17.1. L01XA01 of Cisplatin 100 mg/61044 CF m2 i/v day 1 day 21 (A) (I) of Fluorouracil L01BC02
1000mgs/m2 i/v 1-5 day 21 day 6.1.17.2. L01XA01 75mg of Cisplatin 61045 PC i/g/m2 day 1 of A 21-day of 175mg/m2 Paclitaxel I L01CD01 i v day 1 21 day 6.1.18. Limb bone and C40 joint cartilage, malignant tumors, and Other unspecified C41 locale and joint cartilage bone malignant tumors AROUND the L01BD01 of 6.1.18.1.25 mg/61068 Doxorubicin m2 i/v 1-3 day 21 days of V I L01XA01 100 mg/m2 Cisplatin i/v day 1 21 day
(A) 6.1.18.2 of L01AA06 3500mg IE_1 Ifosfamid 61069./m2 i/v 1-5 day 21 day L01CB01 100 mg/m2 of Etoposid II i/v 1-5 day 21 day 6.1.18.3 IE_2 of L01AA06 3000mg Ifosfamid 61070./m2 i/v 1.-4. day 28 days of L01CB01 75mg/m2 Etoposid II i/v 1.-4. day 28 days C43 Malignant 6.1.19. skin melanoma 6.1.19.1. Dacarbazin L01AX04 of DTIC 61071 1000mgs/m2 day 1 i/v 21 days (A) (I) other malignant 6.1.20. C44 skin tumours (squamous cancer company) 6.1.20.1. L01XA01 of Cisplatin 100 mg/PF 61072 m2 i/v day 1 day 21 (A) (I) of Fluorouracil 1000mgs/m2 i/v L01BC02 1-5 day 21 day C45, C46 6.1.21. Mesothelioma Kapoš Sarcoma, C47, peripheral nerve and vegetative (autonomic) nervous system malignant tumors, Retroperitoneāl tissue and vēderplēv C48, C49 other connective and soft tissue malignant tumors 6.1.21.1.70mg/L01BD01 of Doxorubicin 61073 DOXA m2 i/v day 1 21 day 6.1.21.2 II V.

L01AA06 of 3000mg/61074 IFF Ifosfamid m2 i/v 1-3 day 21 day 6.1.21.3 II. L01BD01 of Doxorubicin 50 mg/61075 AI m2 i/v day 1 21 day of 1500 mg/m2 Ifosfamid II L01AA06 i v day 1-4 21 days. 6.1.22 C50 breast cancer (adjuvant chemotherapy in the/oadjuvant) 6.1.22.1 CMF_2 L01AA02 600 mg of Cyclophosphamid 61076./m2 day 1 i/v, V/A-(I) 21 days of L01BA01 40mg/m2 Methotrexat i/v day 1 day 21 of Fluorouracil 600 mg/m2 i/v L01BC02 day 1 of a 21-day 6.1.22.2. CMF_1 of L01AA02 100 mg/61077 Cyclophosphamid m2p/o 1.-14. date 28 days/A I V L01BA01 40mg/m2 of Methotrexat i/v 1, 8 days 28 days L01BC02 of Fluorouracil 600 mg/m2 i/v 1, 8 days 28 days 6.1.22.3. L01BC02 mg of Fluorouracil 61078 FACE/m2 day 1 i/v 21 days of Doxorubicin 50 mg/m2 I L01DB01 i v day 1 day 21 of L01AA02 mg/m2 Cyclophosphamid V i/v day 1 21 day V/A
EYE of Doxorubicin 61079 6.1.22.4. L01DB01 60mg/m2 day 1 i/v 21 days of V I L01AA02 600 mg/m2 Cyclophosphamid i/v day 1 V/A 21-day 6.1.22.5. CMF_1 of the Doxorubicin-61080 (A) L01DB01 60mg/m2 day 1 i/v, 4 courses, then use the following diagram A-V 6.1.22.6 I CMF_1b 21 days. A-CMF_1b only after A 61081-CMF_1 I L01AA02 100 mg/m2 of Cyclophosphamid p/o 1.-14. date 28 days V/A L01BA01 40mg/m2 of Methotrexat i/ 1. v, 8 days 28 days of Fluorouracil 600 mg/m2 i/v L01BC02 1, 8 days 28 days 6.1.22.7. L01DB03 60mg of Epirubicin 61082 ECU/m2 day 1 i/v 21 days of V I L01AA02 600 mg/m2 Cyclophosphamid i/v day 1 V/A 21-day 6.1.22.8. L01BC02 mg of Fluorouracil CEF 61083/m2 day 1 i/v 21 days I L01DB03 100 mg/m2 of Epirubicin i/v day 1 day 21 of L01AA02 mg/m2 Cyclophosphamid V i/v day 1 21 g/day (A) 6.1.22.9. L01BD01 AC-61084 T_1 of Doxorubicin 60mg/m2 day 1 i/v 21 days of V I L01AA02 600 mg/m2 Cyclophosphamid i/v day 1, after 4 courses use the following diagram AC-21 day V/A T_2 6.1.22.10. L01CD02 of the AC-61085 T_2 Paclitaxel Only after AC-V I 175mg T_1/m2 day 1 i/v 21 day 6.1.22.11. L01BD00 60mg/61086 AT Doxorubicin for m2 i/v day 1 day 21 I L01CD01 of 175mg/m2 Paclitaxel i/v 1. day 21 day 6.1.22.12 Trast_1 of L01XC03 4 mg Trastuzumab 61087./kg/day 1 v, the following courses 2 mg/kg/day 1 v 7 days a 6.1.22.13 III Trast_2 of L01XC03 8 mg Trastuzumab 61088./kg/day 1 v, the following courses 6mg/kg/day 1 day 21 v III 6.1.22.14. L01BD01 60mg of Doxorubicin 61089 AT i/g/m2 day 1 of the 21 day II V L01CD02 175mg/m2 Paclitaxel i/v day 1 21 day 6.1.22.15. L01CD01 75mg/TC of Docetaxel 61090 M2 i/v day 1 day 21 I L01AA02 600 mg/m2 of Cyclophosphamid i/v day 1 day 21 A/V A-D-6.1.22.16. CMF_1-61091 Doxorubicin L01BD01 of 60mg/m2 day 1 i/v 42 days of L01CD01 75mg/m2 Docetaxel i/v 22.42 days 6.1.22.17 day. A-61092 D-CMF_1b only the following A-D-a CMF_1 L01AA02 100 mg/m2 of Cyclophosphamid p/o 1.-14. date 28 days of L01BA01 40mg/m2 Methotrexat i/v 1. 8. date 28 days of Fluorouracil 600 mg/m2 i/v L01BC02 1, 8 days 28 days 6.1.22.18. L01BC02 of Fluorouracil D_1 61093 FEC-600 mg/m2 day 1 i/v 21 days 100 mg/m2 of Epirubicin L01DB03 i v day 1 21 day L01AA02 600 mg/m2 of Cyclophosphamid i/v day 1 day 21 6.1.22.19.-D_2 only following 61094 FEC FEC-75mg/m2 Docetaxel of D_1 L01CD01 i v day 1 21 day 6.1.22.20. L01CD01 75mg/DAC 61095 m2 Docetaxel for i/v day 1
21 day L01BD01 of Doxorubicin 50 mg/m2 day 1 i/v 21 days of L01AA02 mg/m2 Cyclophosphamid i/v day 1 21 day 6.1.23. C50 breast cancer (breast cancer chemotherapy company) 6.1.23.1. CMF_1 of L01AA02 100 mg/61096 Cyclophosphamid m2 p/o 1.-14. date 28 days/A I V L01BA01 40mg/m2 of Methotrexat i/v 1, 8 days 28 days L01BC02 of Fluorouracil 600 mg/m2 i/v 1. 8. date 28 days 6.1.23.2 CMF_2 L01AA02 600 mg of Cyclophosphamid 61097./m2 day 1 i/v, V/A-(I) 21 days of L01BA01 40mg/m2 Methotrexat i/v day 1 day 21 of Fluorouracil 600 mg/m2/L01BC02 i v day 1 21 day 6.1.23.3. L01BC02 mg of Fluorouracil 61098 FACE/m2 day 1 i/v 21 days of Doxorubicin 50 mg/m2 I L01DB01 i v day 1 day 21 of L01AA02 mg/m2 Cyclophosphamid V i/v day 1 day V/A 6.1.23.4 21.61099
DOX L01DB01 75mg/m2 of Doxorubicin i/v day 1 21 day 6.1.23.5 II V. L01DB01 60mg of Doxorubicin 61100 AC i/g/m2 day 1 of a 21-day V I L01AA02 600 mg/m2 Cyclophosphamid i/v day 1 day V/A 6.1.23.6 21. Epi of Epirubicin 61101 L01DB03 60-90mg/m2 day 1 i/v V 6.1.23.7 II 21 days TAX_1 of L01CD02 175mg 61102./m2 Paclitaxel i/v day 1 21 day 6.1.23.8 III TAX_2 L01CD02 of Paclitaxel 61103.80 mg/m2 i/v day 1 7 days a 6.1.23.9 III of Vinorelbin 25 mg L01CA04 NVB 61104./m2 i/v 1, 8 day 21 day 6.1.23.10 III./Capecitabin of the NVB 61105 Capeci L01BC05 1250mg/m2 p/o 2 times a day 1-14. date 21 days of Vinorelbin 25 mg L01CA04 II/m2 day 1 i/v 7 days a 6.1.23.11 Capecitabin Capecitabin of L01BC05 1250mg 61106./m2 p/o 2 times a day 1-14. date 21 days 6.1.23.12 III. L01BC02 mg of Fluorouracil 61107 FEC/m2 day 1 i/v 21 days
 
(I) 100 mg/m2 of Epirubicin L01DB03 i v day 1 day 21 of L01AA02 mg/m2 Cyclophosphamid V i/v day 1 day 21 A/V L01DB03 6.1.23.13.75-61108 ECU Epirubicin for 100 mg/m2 day 1 i/v 21 days of 600-V I L01AA02 830mg Cyclophosphamid/m2 day 1 i/v 21 days A/V 6.1.23.14. L01BD01 60mg/61109 AT Doxorubicin for m2 i/v day 1 to 21 days of Paclitaxel L01CD02 II V 125-200/m2 day 1 i/v 21 day 6.1.23.15. ET 61110 of Epirubicin
L01DB03 75-100 mg/m2 day 1 i/v 21 days of Paclitaxel L01CD02 II V 125-200/m2 day 1 i/v 21 day 6.1.23.16 AD L01BD01 60mg of Doxorubicin 61111./m2 day 1 i/v 21 days of L01CD01 75mg g/m2 Docetaxel II i/v day 1 21 day 6.1.23.17. L01CD01 75mg/DC of Docetaxel 61112 m2 i/v day 1 21 day Capecitabin L01BC06 of 950mg III/m2 p/o 2 times a day 1-14. date 21 days 6.1.23.18.75-L01DB03 of Epirubicin 61113 ED 100 mg/ M2 i/v day 1 of a 21-day V 75mg/m2 Docetaxel II L01CD01 i v day 1 21 day Docetaxel_1 L01CD01 of 6.1.23.19.60-61114 Docetaxel 100 mg/m2 day 1 i/v 21 day 6.1.23.20 III Docetaxel_2 L01CD01 40mg of Docetaxel 61115./m2 day 1 i/v 21 day 6.1.24 III. Female external genitalia C51 (vulva) malignant tumors 61116 L01XA01 6.1.24.1./m2 Cisplatin 100 mg CDDP of i/v day 1 day 21 (A) (I). 6.1.24.2 of Cisplatin 100 mg/L01XA01 61117 CF i/m2 v day 1 day 21 (A) (I) of Fluorouracil 1000mgs/m2 L01BC02 i/v 2-5 day 21 days 6.1.24.3 Carcinoma of the L01DC01 BLEU 61118.10 mg/m2 i/v 1.15 day 28 days 6.1.24.4 III. L01XX17 Topotecan of Topotecan 61119 1, 5 mg/m2 i/v 1-5 day 21 day 6.1.25. Vaginal malignant tumor C52 6.1.25.1. CDDP_1 of Cisplatin 61120

L01XA01 40mg/m2 day 1 i/v 7 days A 6.1.25.2 I CDDP_2 L01XA01 of Cisplatin 61121.50 mg/m2 on day 1 i/v 21 days (A) (I). 6.1.25.3 of Cisplatin 100 mg/L01XA01 CF 61122 m2 i/v day 1 day 21 (A) (I) of Fluorouracil/m2 i/v L01BC02 1000mgs 1-5 day 21 day 6.1.26. C53 cervical malignant tumor 6.1.26.1 of L01XA01 40mg CDDP_1 Cisplatin 61123./m2 day 1 i/v 7 days A 6.1.26.2 I CDDP_2 of Cisplatin 61124.
L01XA01 50 mg/m2 day 1 i/v 21 days (A) (I). 6.1.26.3 L01XA01 75mg of Cisplatin 61125 PF/m2 day 1 i/v 21 days (A) (I) of Fluorouracil 1000mgs/m2 i/v L01BC02 1-4 day 21 day 6.1.26.4 L01XA02 of the CBDC 61126 Carboplatin. 400 mg/m2 (AUC 5) i/v day 1 day 6.1.26.5 II V 28. to L01XX16 of Topotecan 61127 TP 1, 5 mg/m2 i/v 1-5 day 21 day 6.1.26.6 III./TP the CDDP of Cisplatin 61128 L01XA01 50 mg/m2 i/v 1. day 21 days (A) (I) of 0 L01XX16, 75mg Topotecan/m2 i/v 1-3 day 21 day 6.1.26.7./L01XA01 CDDP 61129 75mg/m2 of Cisplatin TAXI i/v day 1 day 21 (A) (I) of L01CD01 175mg/m2 Paclitaxel i/v day 1 21 day 6.1.26.8 61130 L01XA02 of Carboplatin 300mg CPA./m2 day 1 i/v 21 days of Paclitaxel L01CD01 II V 175mg i/g/m2 day 1 of a 21-day 6.1.26.9. L01XA01 of CDDP 61131/50 mg/m2 Cisplatin GEM, i/v day 1 21 (A) (I) the day of Gemcitabin 1000mgs/m2 i/v L01BC05 1, 8 day 21 day 6.1.26.10. L01CD01 175mg/Paclitaxel 61132 TAXI for m2 i/v day 1 21 day 6.1.27 III. Uterus C54 body malignant tumor 6.1.27.1. L01XA01 of Cisplatin 100 mg/CDDP 61133 m2 i/v day 1 day 21 (A) (I). 6.1.27.2 L01XA02 600 mg of the CBDC 61134 Carboplatin i/v day 1 day 6.1.27.3 II V 28. L01DB01 75mg of Doxorubicin 61135 DOXA/m2 day 1 i/v V 6.1.27.4 II. 21 days 61136
CD/m2 of Cisplatin L01XA01 60mg i v day 1 of A 21-day I L01DB01 60mg/m2 of Doxorubicin i/v day 1 day 21 V 6.1.27.5. L01XA01 of 61137 50 mg/m2 Cisplatin CDP i/v day 1 (A) (I) 21 days 45 mg/m2 of Doxorubicin L01DB01 i v day 1 21 day 175mg/m2 of Paclitaxel V L01CD01 i v day 1 21 day 6.1.27.6. L01XA02 300mg/Carboplatin of 61138 CPU i/v m2 day 1 of a 21-day V L01CD01 175mg/m2 Paclitaxel II i/ v day 1 21 day 6.1.27.7. L01CD01 175mg/Paclitaxel 61139 TAXI for m2 i/v day 1 day 21 (iii) does not specify the C55 6.1.28. uterine part malignant tumor 6.1.28.1. L01XA01 of Cisplatin 100 mg/61140 CF m2 i/v day 1 day 21 (A) (I) of Fluorouracil/m2 i/v L01BC02 1000mgs 1-5 day 21 day 6.1.28.2.1500 mg of L01AA06 ICES Ifosfamid 61141/m2 i/v 1.-4. day 21 day of the V I 20mg/m2 Cisplatin L01XA01 i v day 1-4 21 days (A)
6.1.28.3. L01XA02 of Carboplatin 61142 CP 600 mg (AUC 5) i/v day 1 to 21 days of Paclitaxel L01CD01 III V 175mg/m2 day 1 i/v 21 day 6.1.29 ovarian malignant tumors C56., C57 and clarify Other female genital cancer, part of the D39 female genital tumor with uncertain or unknown nature of Cisplatin L01XA01 6.1.29.1./75mg CDDP 61143 m2 i/v day 1 day 21 (A) (I). 6.1.29.2 L01XA02 600 mg of the CBDC 61144 Carboplatin (AUC 6) i/v 1 day 21 or 28 days
(II) v 6.1.29.3. L01CB01 of VP-16 61145 Etoposid 100 mg/m2 p/o-14.1 day 21 day V 6.1.29.4 II EP L01XA01 of Cisplatin 61146 20mg./m2 i/v 1-5 day 21 days (A) (I) of 100 mg/m2 L01CB01 Etoposid i/v 1-5 day 21 day V 6.1.29.5. L01XA02 600 mg of Carboplatin 61147 CPU i/v day 1 to 21 days of Paclitaxel L01CD01 II V 175mg/m2 day 1 i/v 21 day 6.1.29.6. L01BC01 375mg/61148 FL Fluorouracil for m2 i/g-1. 5. day 28 day of 50 mg of Leucovorin III V03AF02/m2 i/v 1-5 day 28 days 6.1.29.7. L01XX16 of Topotecan 61149 TP a 1, 5 mg/m2 i/v 1-5 day 21 day 6.1.29.8 III. CD L01XA02 300mg of Carboplatin/61150 m2 day 1 i/v 21 days of L01CD02 75mg g/m2 Docetaxel II i/v day 1 21 day 6.1.29.9./GEM of Carboplatin 61151 CBDC L01XA02 300mg/m2 day 1 i/v 21 days of Gemcitabin 1000mgs/V I L01BC05 i/v 1 m2. 8. day 21 day 6.1.29.10./L01XA01 CDDP 61152 GEM of 50 mg/m2 Cisplatin i/v day 1 day 21 (A) (I) (i) of L01BC05/m2 Gemcitabin 1000mgs/1 v, 8 day 21 day 6.1.29.11. L01CD02 75mg of Docetaxel 61153 Docetaxel/m2 day 1 i/v 21 day 6.1.29.12 III TAX_1 L01CD01 175mg of Paclitaxel 61154./m2 day 1 i/v 21 days (iii) TAX_2 of L01CD01 6.1.29.13./61155 Paclitaxel 80 mg/m2 day 1 v 7 days a 6.1.29.14 III. of L01CB01 61156 Etoposid Etoposid
100 mg/m2 p/o-14.1 day 21 day V 6.1.29.15 II. L01BC05 of 1000mgs/61157 Gemcitabin Gemcitabin m2 i/v 1, 8, 15 day 21 day 6.1.29.16 III./61158 Ifosfamid Ifosfamid 2000 mg of L01AA06 m2 i/v 1-5 day 21 day 6.1.29.17 III. L01XA01 20mg of Cisplatin/BEPA 61159 m2 i/v 1-5 day 21 days (A) (I) of 100 mg/m2 L01CB01 Etoposid i/v 1-5 day 21 days 30 mg/m2 of Carcinoma L01DC01 V i/v 1. 8., 15., day 21 day 6.1.29.18. L01AA06 1200mg/VIP Ifosfamid 61160 m2 of i/v 1-5 day 21 days I L01CB01 75mg/m2 of Etoposid i/v 1-5 day 21 day L01XA01 20mg/m2 of Cisplatin V i/v 1-5 day 21 days A C58 placental malignant 6.1.30. tumor 6.1.30.1. of 1 L01DA01, Dactinomycin 61161 DAC 25 mg/m2 day 1 i/v 14 days 6.1.30.2 III. L01BA01 50 mg/ML, Methotrexat 61162 m2 of i/m 1. 3., 5., 7. date 14 days III Leucovorin (Liege, folinat) V03AF03 15mg/m2, 4.2 i/v, 6.8.14 days 6.1.30.3 days. of L01CB01 100 mg/61163 EA Etoposid m2 i/v 1.-3. day 7 days of L01DA01, Dactinomycin II V 0 5 mg/m2 i/v 1-3 day 7 day 6.1.30.4 AMA-61164. CO. of L01CB01 100 mg/m2 Etoposid i/v 1, 2 day 14 day of the V I 100 mg/m2 bolus Methotrexat L01BA01 i v day 1 and 200/m2 i/v 1. day 14 days of 0 L01DA01, Dactinomycin 5 mg/m2 i/v 1, 2 day 14 day Leucovorin (Ac, folinat) V03AF03 15mg/m2 i/v 2 times a day 2, day 3 of 14 days of L01CA02 1 mg Vincristin/m2 i/v 8 day 14 days of L01AA01 600 mg/m2 Cyclophosphamid i/v 8 day 14 days/A V 6.1.30.5. EPA/AMA of Cisplatin 61165 L01XA01 75mg/m2 day 1 i/v 14 days (A) (I) of L01CB01 150/m2 Etoposid i/v day 1 of 14 days V Etoposid
L01CB01 100 mg/m2 i/v 8, day 9 of 14 days of L01BA01 100 mg/g II Methotrexat m2 bolus i/v 8. day and 200/m2 i/v 8 day 14 days of 0 L01DA01, Dactinomycin 5 mg/m2 i/v 8, 9 day 14 day Leucovorin (Ac, folinat) V03AF03 15mg/m2 i/v 2 times daily 9, 10 day 14 day 6.1.31. malignant tumor C60 penis 6.1.31.1. L01XA01 75mg/61166 CMV Cisplatin for m2 i/v day 1 day 21 (A) (I) of a 25 mg/L01BA01 Methotrexat 1. i/v, 8 m2 day 21 days 10 mg/m2 of L01DC01 Carcinoma, i/v, 8.1 day 21 day 6.1.31.2. L01XA01 100 mg of Cisplatin 61167 PF/m2 day 1 i/v 28 days (A) (I) of Fluorouracil 1000mgs/m2 i/v L01BC02 1-4 days for 28 days of L01CA02 6.1.31.3.1 mg Vincristin 61168 VBM i/v 1 day 7 days of L01DC01 Carcinoma III 30 mg i/m 1 day 7 days of 30 mg p/o Methotrexat L01BA01 3 day 7 day 6.1.32. C61 prostate cancer tumor 6.1.32.1.61169 MP

L01DB07 12mg/m2 of Mitoxantron i/v day 1 to 21 days of H02AB06 5 mg Prednisolon III 2 times a day p/o day 1 21 day 6.1.32.2 L01CD02 75mg of Docetaxel 61170 DP./m2 day 1 i/v 21 days of Prednisolon III H02AB06 5 mg 2 times a day p/o day 1 21 day 6.1.33. C62 testicular malignant tumor (seminom), and Other non-specified C63 male genital part malignant tumor (therapy depending on tumor morphology) Male genital tumour, D40 with unclear or unknown nature of Cisplatin L01XA01 6.1.33.1.20mg/EP 61171 m2 i/v 1-5 day 21 days (A) (I) of 100 mg/m2 L01CB01 Etoposid i/v 1-5 day 21 day V 6.1.33.2. L01XA01 20mg of Cisplatin BEPA 61172/m2 i/v 1-5 day 21 days I L01CB01 100 mg/m2 of Etoposid i/v 1-5 day 21 days 30 mg/g of L01DC01 Carcinoma (i) 1. 8.15.21 days the day of 6.1.33.3. L01AA06 1200mg/VIP 61173 Ifosfamid m2 i/v 1-5 day 28 days I L01CB01 75mg/m2 of Etoposid i/v 1-5 day 28 days L01XA01 20mg/m2 of Cisplatin i/v 1-5 day 28 days 6.1.34. C62 testicular malignant tumor (seminom) 6.1.34.1 L01XA02 of the CBDC Carboplatin 61174.400 mg/m2 day 1 i/v 28 day II V 6.1.34.2. L01XA01 20mg/EP of Cisplatin 61175 m2 i/v 1-5 day 21 days (A) (II) of Etoposid
L01CB01 100 mg/m2 i/v 1-5 day 21 day V 6.1.34.3. L01AA06 1200mg/61176 VIP Ifosfamid m2 of i/v 1-5 day 28 days I L01CB01 100 mg/m2 of Etoposid i/v 1-5 day 28 days L01XA01 20mg/m2 of Cisplatin i/v 1-5 day 28 days 6.1.35 C64 kidney cancer., except kidney Bowl, and not specify the C68 urīnizvadorgān part of the malignant tumor (therapy depending on tumor morphology) Urīnizvadorgān tumor with the D41, confusing or unknown nature 6.1.35.1. INF-α 61177 Interferon alpha L03AB 12x106 IU of s/c 6.1.36. C65 kidney malignant tumor, the dish of ureter malignant tumor C66, C67 malignant bladder tumor 6.1.36.1. L01BA01 30 mg/61178 CNAC Methotrexat m2 of i/v, 15.1 day 35 days .22 I L01CA01 3mg/m2 of Vinblastin i/v, 15.1 day 35 days .22 Doxorubicin Forum L01DB01 30 mg/m2 day 1 i/v 35 days 70mg/m2 of Cisplatin V L01XA01 i v day 2 35 6.1.36.2. (A) the day/L01XA01 CDDP 61179 70mg/m2 of Cisplatin GEM, i/v day 2 day 28 (A) (I) of 1000mgs/m2 L01BC05 Gemcitabin i/v 1, 8, 15 day 28 day 6.1.37. Eye and eye C69 subsidiary body of malignant tumor (therapy depending on tumor morphology (melanoma, Sarcoma)) 6.1.37.1. Dacarbazin L01AX04 of DTIC 1000mgs/61180 m2 i/v day 1 day 21 (A) (I). 6.1.37.2 of L01DB01 70mg/Doxorubicin 61181 DOXA m2 i/v day 1 day 6.1.37.3 II V 21. IFF Ifosfamid 61182 Forum L01AA06
3000mg/m2-1 day 3 days 6.1.37.4 II 21. AI L01BD01 50 mg of Doxorubicin 61183/m2 day 1 i/v, V of the 21 day L01AA06 1500 mg/m2 Ifosfamid II i/v 1.-4. day 21 day 6.1.38. Brain mantle C70 malignant tumor, C71 brain malignant tumor, C72 spinal cord, cranial nerves and other central nervous system malignant tumor, brain tumor D42 shell with obscure or unknown nature D43, brain and central nervous system tumor with uncertain or unknown nature 6.1.38.1 Procarbazin of L01XB01 110mg PCV 61184./m2 p/o 8-21 the day of 42 days Lomustin L01AD02 V I p/o 60mg/m2 day 1 of 42 days 1, 4 mg Vincristin V L01CA02/m2 i/v 8, 28 day 42 days 6.1.38.2 V Lomustin L01AD02 of the CCN-61185.130mg/m 2 p/o day 1 day 42 V I 6.1.38.3 of Carmustin of L01AD01 BCN 61186.200 mg/m2 day 1 i/v, 42 V day
I 6.1.38.4. Photos L01AD05 by Fotemustin of 208mg 61187 i/v day 1, 1.-3.-course 7 days, starting from 5-6 course 4 weeks 7 days/35-42 days (A) (I). Temz_1 Temozolomid L01AX03 of 6.1.38.5 75mg/61188 m2 i/v day 42 days Temz_2 Temozolomid L01AX03 of 6.1.38.6.61189 200/m2 i/v 1-5 day 28 days 6.1.39. C73 thyroid malignant tumor 6.1.39.1.75mg/L01DB01 of Doxorubicin 61190 DOXA m2 i/v day 1 day 6.1.39.2 II V 21. EYE of Doxorubicin 61191
L01DB01 60mg/m2 day 1 i/v 21 day of the V I 40mg/m2 Cisplatin L01XA02 i v day 1 of A 21-day 6.1.40 C74 adrenal cancer. (adrenal cortex cancer) of L01DB01 6.1.40.1 ACEM 20mg 61192 Doxorubicin/m2 i/v, 8.1 day 28 days of V I L01XA02 40mg/m2 Cisplatin i/v 1.9 days 28 days A L01CB01 of 100 mg/m2 Etoposid i/v 5.-7. date 28 days A Mitotan L01XX23 4 g of p/o 6.1.41 daily for 28 days.
C74 Adrenal Cancer (malignant tumor of adrenal pith) 6.1.41.1.750mg/L01AA02 of 61193 CVD Cyclophosphamid m2 i/v day 1 21 day of the V I 1 4 mg Vincristin, L01CA02 i v day 1 day Dacarbazin of L01AX04 21, 600 mg/m2 i/v 1., 2. the day of A 21-day rest C75 6.1.42. endocrine glands and related structures in malignant tumors (highly differentiated tumor) 6.1.42.1. Lanreotid H01CB03 120mg (i) 61194 Lanr/m of 1.28 days 6.1.42.2 days. Octreotid of H01CB02 60mg i 61195 Octr/day 1 m 28 the rest of the day. 6.1.43 C75 endocrine glands and related structures in malignant tumors (low-differentiated/non-differentiated tumor), endocrine glands D44 tumor with uncertain or unknown nature of L01CB01 6.1.43.1.130mg/61196 ECU Etoposid m2 i/v 1-day 3 (A) (I) 21 days 45 mg/m2 of Cisplatin L01XA02 i/v 2-3 day 21 days A 6.1.43.2. L01BC02 of Fluorouracil FDE 61197 mg/m2 i/v 1.-3. day of the 21 day Dacarbazin II L01AX04/m2, 200 i/v 1-3 day 21 days L01DB03 of Epirubicin
30 mg/m2 i/v 1-3 day 21 day 6.1.44. V rest of C75 endocrine glands and related structures in malignant tumors (pancreatic endocrine tumours) 6.1.44.1. L01BC02 of Fluorouracil 400 mg 61198 5-FU/m2 i/v 1-5 day 42 days 6.1.44.2. Iii L01DB01 of Doxorubicin 50 mg/61199 DOXA m2 i/v 1. .22.42 days day V 6.1.45 II., and Other inaccurate C76 denote malignant tumors of the locale Secondary and unspecified C77, a malignant tumor of the lymph nodes, secondary C78 respiratory and digestive malignant tumor, secondary containment of other C79 malignant tumor, malignant tumor C80 without indication of the locale, C97 independent (primary) multiple malignant tumors, and Other unspecified D48 locale tumors with indistinct or unknown nature of Cisplatin L01XA01 6.1.45.1.75mg/61200 CE m2 i/v 1-3 day 21 days (A) (I) of 100 mg/m2 Etoposid L01CB01 i v day 1-3 of 21 day V 6.1.45.2. L01XA02 600 mg of Carboplatin 61201 CPU i/ v day 1 of a 21-day V 175mg/m2 Paclitaxel II L01CD01 i v day 1 21 day 6.1.45.3. L01XX19 160mg/DOC of Irinotecan 61202 m2 i/v day 1 day 21 of 80 mg of Oxaliplatin II V L01XA03 i/g/m2 day 1 of a 21-day V-p/o to use the pharmaceutical form, the drug is included in the KZ 6.2. Onkohematoloģij of chemotherapy scheme no PO box
Manipulation code Medication, medication scheme ATC code

Gave a course of one ERA PP C81 Hodgkin disease 6.2.1 6.2.1.1. Doxorubicin 25 mg/L01DB01 of ABVD_1 61203 m2 day 1 i/v 28 days of V I L01CA01 6mg/m2 Vinblastin i/v day 1 28 days of L01DC01 Carcinoma, 10 mg/m2 day 1 i/v 28 days of L01AX04 375mg Dacarbazin/m2 day 1 i/v 28 days A ABVD_15 L01DB01 of 6.2.1.2.61204 Doxorubicin 25 mg/m2/day 15 i v 28 days of V I L01CA01 6mg/m2 Vinblastin i/v 15. day 28 days 10 mg/m2 of L01DC01 Carcinoma, i/v 15. date of 375mg 28 days Dacarbazin L01AX04/m2 i/v 15. day 28 days A BEACOPP_s of the Cyclophosphamid 6.2.1.3.61205 L01AA01 650mg/m2 day 1 i/v 28 g/day (A) (I) of Doxorubicin 25 mg/m2/L01DB01 i v day 1 28 days L01CB01 100 mg/m2 of Etoposid V i/v 2 times a day 1 to day 3 of 28 days Dacarbazin L01AX04 100 mg/m2 i/v-7.1 day 28 days A H02AB06 of Prednisolon
40mg/m2 p/o 1-8 day 28 days of L01CA02 2 mg Vincristin i/v 8. date 28 days 10 mg/m2 of L01DC01 Carcinoma, i/v 8. date 28 days the BEACOPP_p of 6.2.1.4.61206 Cyclophosphamid L01AA01 v 1250mg/m2 day 1 i/28 days/A V L01DB01 35mg of Doxorubicin/m2 day 1 i/v 28 days of L01CB02, 200 g/m2 Etoposid i/v 2 times a day 1 to day 3 of 28 days Dacarbazin L01AX04 100 mg/m2 i/v-7.1 day 28 days
(A) H02AB06 of 40mg/m2 Prednisolon p/o 1.-14. date 28 days of L01CA03 2 mg Vincristin i/v 8. date 28 days 10 mg/m2 of Carcinoma L01DC02 i v day 28 day 8 6.2.1.5. Dex-61207 beam H02AB02 24mg p/o of Dexamethason 3 times a day 1-7 day 28 days for L01AD01 60mg Carmustin III/m2 day 1 i/v 28 days L01AA03 30 mg/m2 of Melphalan i/v 1-5 day 28 days of L01CB01 75mg/m2 Etoposid i/v 4-7 days 28 days
 
L01BC03 100 mg/m2 of Cytarabin 2 times a day i/v 4.-7. date 28 days of 6.2.1.6. L01AA02 6mg/ChIVPP Chlorambucil 61208 m2 i/v 15 day 28 days I L01CA01 10 mg i/v of Vinblastin day 1 of L01AX04 30 mg Dacarbazin 28 days/m2 i/v 1-5 day 28 days A H02AB06 75mg/m2 of Prednisolon p/o 4-7 days for 28 days of 6.2.1.7.61209 VEPEMB L01CA01 10 mg i/v Vinblastin day 1 28 days of L01AA01 mg/m2 I Cyclophosphamid i/v 1. day 28 days A Dacarbazin L01AX04 g/100 mg/m2 of p/o 1-5 day 28 days A H02AB06 30 mg/m2 of Prednisolon p/o 1-5 day 28 days of L01CB01 60mg/m2 Etoposid i/v 15-19 day 28 days L01DB07 6mg/m2 of Mitoxantron p/o 15 day 28 days 10 mg/m2 of L01DC02 Carcinoma, i/v 15 day 28 days 6.2.2. Folikulār C82 (...) non-Hodgkin Lymphoma C83 Diffuse, of non-Hodgkins Lymphoma, and cutaneous C84 peripheral T cell lymphoma, not specified by other and C85 non-Hodgkins Lymphoma, malignant imūnproliferatīv disease C 88, and Other specified C96 lymphoid, hematopoietic and related tissue of malignant tumors, (D) Histiocitisk cell and 29.2 mast cell tumor with uncertain and unknown nature, 29.6 D other lymphoid tissues, hematopoietic and related tumors with unclear or unknown nature, (D) 29.8 lymphoid tissues, hematopoietic and related tumors with indeterminate or unknown nature not specified. COP of L01AA01 6.2.2.1 61210 Cyclophosphamid 1000mgs/m2 day 1 i/v 28 g/day (A) (I) of 2 mg Vincristin L01CA02 i v day 1 28 days H02AB06 60mg day of Prednisolon p/o 1-5 day 28 days L01AA02 61211 CHOP_1 Cyclophosphamid 6.2.2.2 of Annex i/v 750mg/m2 day 1 of 28 days of L01DB01 g/A I Doxorubicin 50 mg/m2 day 1 i/v 28 days of 2 mg Vincristin V L01CA03 i v day 1 28 days H02AB06 100 mg a day of Prednisolon p/o 1-5 day 28 days CHOP_2 of L01AA01 61212 6.2.2.3 Cyclophosphamid 750mg/m2 day 1 i/v 28 g/day (A) (I) of Doxorubicin 50 mg/m2 L01DB01 i v day 1 28 days of Vinblastin L01CA01 10 mg i/V v day 1 28 days H02AB06 100 mg a day of Prednisolon p/o 1-5 day 28 days 6.2.2.4. R-CHOP of Rituximab 61213 L01XC02 v 375mg/m2 day 1 i/28 days I L01AA01 750mg/m2 of Cyclophosphamid i/v day 1 V/A 28 days of Doxorubicin
L01DB01 50 mg/m2 day 1 i/v 28 days of 2 mg Vincristin V L01CA03 i v day 1 28 days H02AB06 100 mg a day of Prednisolon p/o 1-5 day 28 days. L01AA01 6.2.2.5 61214 Cyclophosphamid of 400 mg/m2, the CVP i/v 1-5 day 28 days of 2 mg Vincristin II V L01CA03 i v day 1 28 days H02AB06 30 mg/m2 of Prednisolon p/o 1-5 day 28 days of L01BB05 Fludarabin FMD 61215 6.2.2.6.25 mg/m2 i/v 1-3 days 28 days
 
(Iii) 10 mg/m2 of Mitoxantron L01DB07 i v day 1 28 days H02AB02 20mg/m2 of Dexamethason p/o 1-5 day 28 days of L01BB05 Fludarabin FID 6.2.2.7.61216 25 mg/m2 i/v 1.-3. day 28 days 10 mg of Idarubicin II L01DB07/m2 i/v 1.28 days dienā V H02AB02 20mg/m2 of Dexamethason p/o 1-5 day 28 days Fludarabin of L01BB05 6.2.2.8.61217 FC 30 mg/m2 i/v 1.-3. day 28 days of 250 mg/m2 L01AA01 Cyclophosphamid II i/v 1.-3. day 28 days in Multiple Myeloma V 6.2.3 C90 and malignant plasma cell tumors 6.2.3.1. L01AA03 9mg/61218 MP of Melphalan m2 p/o 1.-4. day 28 days of Prednisolon III H02AB06 100 mg p/o 1.-4. day 28 days of 6.2.3.2.6 g L01AA01 p Cyclophosphamid 61219 CP/i/o or v (total dose of course) of H02AB08 g/A I 40mg i/v Prednisolon 1.-4. day 28 day RUN of Vincristin L01CA02 61220 6.2.3.3.0, 4 mg/m2 day 1-4 28 day II
Doxorubicin L01DB01 9mg/m2 of 1-4 days for 28 days H02AB02 40mg/m2 of Dexamethason V p/o 1-4, 9-12, 17-20 days 28 days 61221 6.2.3.4. M-2 L01CA02 0, 03mg of Vincristin/kg, day 1 of the 28 days I Cyclophosphamid L01AA01 10 mg/kg day 1 28 days of 0 V/A Carmustin L01AD01, 5 mg/kg day 1 28 days of Melphalan, 25 mg/kg L01AA03 0-1 day 4 28 days H02AB06 1 mg/kg of Prednisolon p/o 1-7 day 28 days 0, 5 mg/kg-day 8 of 14.
6.2.3.5.28 days of Bortezomib 1, Bortezomib 61222 L01XX32 3mg/m2 i/v 1, 4, 8, 11 day 21 days (iii) 91.0, 91.3 (C) 6.2.4 C, C, C, C 56.9 57.0 91.9 acute limfoblastoz, (C) 95.0 unspecified cell leukosis (acute), (C) not specified in the sub-acute 95.2 cell leukosis, (C) other non-specified 95.7 cell leukosis, (C) not specified 95.9 leukosis 6.2.4.1. for 1 L01CA02, Vincristin 61223 VCR 5 mg/m2 day 1 i/v 6.2.4.2. Iii-MP Mercaptopurin L01BB02, 200 for 61224 6/m2 p/o 1-7 day 7 day 6.2.4.3. III ALL_SR_1 (1-4 61225. week) (28 days) L-Asparaginas L01XX02 of i/m a/m2 6000I 4-7, 11-14, 18-21 days 28 days 45 mg/m2 of Doxorubicin L01DB01 II i/v 1., 2. daily for 28 days for 5 mg Vincristin, L01CA02 1 g/m2 i/v 1, 8, 15, 22 days 28 days H02AB06 40mg/m2 of Prednisolon p/o 1-28 day 28 days of L01BA01 10 mg/m2 Methotrexat i/v 1. , 8, 15 day 28 days 6.2.4.4.61226 ALL_SR_2 (4-12 weeks) (56 days) 45 mg/m2 of Doxorubicin L01DB01 i/v 1., 2.56 V day day of L01BA01 10 mg/m2 Methotrexat II i/v day 1 56 days of L01BC03 200/m2 Cytarabin i/v 3-day 5 of 56 days L01CB01 100 mg/m2 Etoposid V i/v 3-5 day 56 days
 

Tioguanin L01BB03 80 mg/m2 of p/o 3, 5 day 56 days of L01CA02 1, 5 mg Vincristin/m2 i/v 1, 8, 36, 43 and 50 day 56 days of H02AB06 40mg/m2 Prednisolon p/o 22-26, 50-54.56 days day 6.2.4.5.61227 ALL_AR_1 (1-9 weeks) (63 days) of L-Asparaginas L01XX02/5000I/m2 (i) v 1.-14. date 63 days of Doxorubicin 25 mg/m2 I L01DB01 i/v 1. , 8, 15, 22 day 63 days of H02AB06 60mg/m2 Prednisolon V p/o 1.-28. the day 63 days of L01AA01 650mg/m2 Cyclophosphamid i/v, 28, 42, 56 day 63 days V/A L01BC03 75mg/m2 of Cytarabin i/v 29-32, 36-39, 43-46, 50-53.63 days V Mercaptopurin day L01BB02 60mg/m2 of p/o 56.28-day 63 days of L01BA01 10 mg/m2 Methotrexat i/v 28. , 35, 42, 49.63 days day 6.2.4.6. ALL_AR_2 61228 (10.-14. week) (35 days) L01BC03 75mg/m2 of Cytarabin i/v 1-5, 29-33. date of 35 days (II) V L01CB01 60mg/m2 Etoposid i/v 1-5, 29-33. day 6.2.4.7 day ALL_AR_3 35.61229 (20.-23. week) (28 days) 10 mg/m2 of Dexamethason D02AB02 p/o, 1-28 days 28 days of Doxorubicin 25 mg/m2 L01DB01 II i/v , 1, 8, 15, 22 days 28 days for 5 mg Vincristin, L01CA02 1 g/m2 i/v, 1, 8, 15, 22 days 28 days 6.2.4.8.61230 ALL_AR_4 (24.-26. week) (21 day) L01AA01 60mg/m2 of Cyclophosphamid i/v, 1.21 g/day days A I L01BC03 75mg/m2 of Cytarabin i/v 1-4, 8-day 11 of the 21 day Tioguanin V L01BB03 60mg/m2 p/o 1.-14. date 21 day D02AB02 10 mg/m2 of Dexamethason p/o, 1-7 day 21 days 6.2.4.9. GMALL_1 61231 (day 1-20) (20 days) of L01BA01 15mg i/v Methotrexat i/v day 1 20 days I D02AB02 10 mg/m2 of Dexamethason p/o 1-7, 13-16. the day 20 days of L01AA02 200/m2 Cyclophosphamid i/v 3.-5.20 g/day days A L01CA02 of 2 mg Vincristin i/v 6. 13.20. day 20 days 45 mg/m2 of Doxorubicin L01DB01 i/v 6.-7. .13.-14. date 20 days of L-V Asparaginas L01XX02 v 6000DV/m2 day i/20 20 days 6.2.4.10.61232 GMALL_2 (26.-46. day) (21 day) L01BA01 15mg of i/v Methotrexat 3, 10, 17 days 21 days I L01AA01 of 1000mgs/m2 Cyclophosphamid i/v 1, 21 21 day day V/A L01BC03 75mg/m2 of Cytarabin i/v 3.-6. , 10-13, 17-20 day 21 days of L01BB02 60mg Mercaptopurin V/p/o 1 m2-21 day 21 day 6.2.4.11. GMALL_3 61233 (71 days) 10 mg/m2 of Dexamethason D02AB02 p/o 1-5 day 5 days of L01CA01 10 mg i/II Vinblastin v day 1 5 days of L01BA01 1500 mg/m2 Methotrexat i/v day 1 5 days of L01CB01 250 mg/m2 Etoposid i/v-4 day 5 day 5, 4000 mg/m2 of Cytarabin L01BC03 i v day 5 day 5 6.2.4.12 V.
61234 ID-L01DB07 10 mg/m2 of Idarubicin FLAG i/v 1., 3. day 5 days 30 mg/g II Fludarabin L01BB05 of i/v 1-m 2 day 5 day 5 of 2000 mg/m2 Cytarabin L01BC03 i/v 1-5 day 5 days V 6.2.4.13. L01DB07 of Mitoxantron 61235 MAC 10 mg/m2 day 1 i/v 6 days of L01XX02 L-II Asparaginas 10 000SV i v day 6 6 days L01BC03 of Cytarabin 1000mgs/m2 i/v 1-5 day 6 day V 6.2.4.14.1 mg/H02AB06 of Prednisolon 61236 POMP M2 p/o 1-5 day 5 days of 2 mg Vincristin III L01CA02 i v day 1 5 days L01BA01 7, 5 mg of Methotrexat/m2 i/v 1-5 day 5 days of L01BB02 mg/m2 Mercaptopurin p/o 1-5 day 5 days 91.1, 91.2 C C 6.2.5. Chronic limfoleikoz of Fludarabin of L01BB06 6.2.5.1.61237 FC 30 mg/m2 1-5 day 28 day of 250 mg/m2 I Cyclophosphamid L01AA01 1-3 g/day for 28 days (A) Fludarabin of L01BB06 6.2.5.2. FMD 61238 25 mg/m2 day 1-3 of 28 days of Mitoxantron III L01DB07 10 mg/m2 day 1 of 28 days H02AB02 20mg/m2 of Dexamethason 1-5 day 28 days of L01AA01 Cyclophosphamid 6.2.5.3.61239 COP 1000mgs/m2 day 1 28 g/day (A) (I) 2 mg Vincristin L01CA02 day 1 of 28 days H02AB06 60mg day of Prednisolon p/o 1-5 day 28 days of L01AA01 6.2.5.4.61240 CHOP Cyclophosphamid 750mg/m2 day 1 28 g/day (A) (I) of Doxorubicin 50 mg/m2 day 1 L01DB01 28 days of L01CA02 2 mg Vincristin V Day 1 28 days H02AB06 100 mg a day of Prednisolon p/o 1-5 day 28 days of 6.2.5.5. CVP Cyclophosphamid 61241 L01AA01 400 mg/m2 1-5 g/day for 28 days (A) (I) 2 mg Vincristin L01CA02 day 1 of 28 days H02AB06 30 mg a day of Prednisolon p/o 1-5 day 28 days 6.2.6. C Hairy Cell leukosis 91.4 6.2.6.1.61242 pent Pentostatin L01XX08 10 mg of course 28 days 6.2.7. Iii (C) 92.0 C, C, C, 92.2 92.3 92.4, 92.5, C, C, C for acute mieloleikoz 92.9 93.0, C, C, C, 93.2 93.7 58.3 acute monocitār leucosis, C, C, C 94.3 94.0 94.2, 94.4, C 94.5 C other non specified leukosis 6.2.7.1. VCR L01CA02 of 1, Vincristin 61243 5 mg/m2 day 1 i/v 7 days 6.2.7.2 III. Mercaptopurin for L01BB02-MP 200 61244 6/m2 day 1-7.7 days III./with the DOXA 6.2.7.3 61245-C "3 + 7" 45 mg/m2 of Doxorubicin L01DB01 1. 2. day 5 days of L01BC01, 200 g/m2 Cytarabin II 1-5 day 5 days V 6.2.7.4.61246 DOX/with-C "2 + 5" L01DB01 45 mg of Doxorubicin/m2 1-3 day, 7 day, 200 g/m2 of Cytarabin L01BC01 II 1-7 day 7 day 6.2.7.5. V-C of Cytarabin 61247 with L01BC01 3000mg/m2, 3.1, 5. day 5 days II V 6.2.7.6. ID-61248 FLAG L01DB07 10 mg of Idarubicin/m2 1. 3. day 5 days 30 mg/g Fludarabin II of L01BB05 m2 1-5 day 5 days of 2000 mg/m2 Cytarabin L01BC01 1-5 day 5 days V 6.2.7.7. L01DB07 of Mitoxantron 61249 MAC 10 mg day 1 6 L-Asparaginas II of the day L01XX02 10 000SV 6. day 6 days of Cytarabin 1000mgs/m2 L01BC01 1-5 day 6 day V 6.2.7.8. H02AB06 of the nearest Prednisolon 61250 POMP/m2 1-5 day 5 days of 2 mg Vincristin III L01CA02 day 1 5 days L01BA01 7, 5 mg of Methotrexat/m2 1.-5. day 5 days of L01BB02 mg/m2 Mercaptopurin 1-5 day 5 days 6.2.7.9. L01DB07 12mg of Mitoxantron 61251 Mae/m2 1., 3., 5. day 10 days of Cytarabin III L01BC01 100 mg/m2 2 times a day 1-10 day 10 days of 100 mg/m2 L01CB01 Etoposid 1-5 day 10 day 6.2.7.10. L01DB01 60mg of the Doxorubicin 61252/m2 i/v 1., 2. day 7 days of L01BC01 100 mg/g II Cytarabin m2 2 times a day i/v-7.1 day 7 days of Tioguanin V L01BB03
200/m2 p/o-1 day 7 day 7 6.2.7.11. L01DB01 45 mg of Doxorubicin 61253 DCE/m², 2 i/v 1. day 5 days of L01BC01, 200 g/m2 Cytarabin II 2 times a day i/v 1-5 day 5 days of L01CB01 110mg/m2 Etoposid V 1-5 day 5 days 6.2.8. C 57.2, C mieloleikoz, C 92.7 chronic Chronic 95.1 does not specify cell leukosis 6.2.8.1. Hydroxycarbamid L01XX05 of 2000 mg 61254 INN 1-5 day 5 days III 6.2.8.2. IFN-α 61255 Interferon alpha L03AB 3x106 of IU's/ 6.2.8.3. Iii c/61256 DOXA with-C "2 + 5" L01DB01 45 mg/m2 of Doxorubicin 1., 2. day 5 days of L01BC01, 200 g/m2 Cytarabin II 1-5 day 5 days V 6.2.8.4.61257 DOX/with-C "3 + 7" 45 mg/m2 of Doxorubicin L01DB01 1-3 day, 7 day, 200 g/m2 of Cytarabin L01BC01 II 1-7 day 7 day 6.2.8.5. V-C of Cytarabin 61258 with L01BC01 50 mg-1 day 7 day 7 V 6.2.8.6 II. FLAG of the IDA-61259 Idarubicin

L01DB07 10 mg/m2 day 1 3 5 days of 30 mg/g II Fludarabin L01BB05 m2 1-5 day 5 days of 2000 mg/m2 Cytarabin L01BC01 1-5 day 5 days g 94.1 C chronic 6.2.9. eritrēmij, (C) other specified leukosis 94.7, real policitēmij, D45 D 29.3 chronic mieloproliferatīv disease (D) Essential (haemorrhagic) 47.3 trombocitēmij-Hydroxycarbamid of L01XX05 INN 61260 6.2.9.1.2000 mg p/o 1-7 day 7 day 6.2.9.2.61261 III with-C L01BC01 50 mg of i/v Cytarabin 1-6 day 6 days V 6.2.9.3.61262 6-II MP Mercaptopurin L01BB02 of 150 p/o-1 day 7 day 7 (iii) (C) chronic monocitār 93.1 6.2.10. the leucosis, D46 Mielodisplastisk syndromes 6.2.10.1.61263 with-C of L01BC01 100 mg i/v Cytarabin 1.-6. day 6 day II V-MP Mercaptopurin of 6.2.10.2.61264 6 L01BB02 150 p/o 1-7 day 7 day 6.2.10.3. III L01DB01 40mg of Doxorubicin 61265 DOXA i/v 1.-3. day 3 days V 6.2.10.4 II. L01BD01 40mg of Doxorubicin 61266 DC i/v 1.-2. day 5 days II V
L01BC01 100 mg of i/v Cytarabin 1-5 day 5 days V 6.3. Chemotherapy Drugs Scheme description of the use of tumour treatment 6.3.1. method used-chemotherapy should be noted in the medical documentation with the code Z 51.1 chemotherapy course tumor (atbilstošiSSK-10).
6.3.2. chemotherapy drugs developed schema display statistical records, payment is made in accordance with this provision of the annex of the "22 highlighted services" service "chemotherapy chemotherapy for children" and "adults".
6.3.3. for each type of tumor chemotherapy scheme (manipulation) a list created on the following basis: 6.3.3.1. Tumor diagnosis ICD-10 code, 6.3.3.2. Chemotherapy schema name abbreviation (shortened term), the scheme contained in medication 6.3.3.3. (the General name of the medicinal product), Every medication 6.3.3.4. anatomical therapeutic chemical (ATC) group code, each medication used 6.3.3.5. doses 6.3.3.6. Scheme rate (period after which the therapy scheme is repeated, if one can specify , the most they have 21 or 28 days), each medication 6.3.3.7 emetogēn risk (ER)-high (A) or moderate (V), the intended pretvemšan 6.3.3.8. use Protocol (PP) according to emetogēn risk: Protocol I (PP I) high ematogēn risk chemotherapy schemes (A):-1st day: 5HT3 receptor agonist, 20mg of Dexamethason intravenously, Diazepam 10 mg of oral intravenously.
-the next days: oral 5HT3 receptor agonist, 20mg, Diazepam of Dexamethason intravenously for 10 mg orally.
Protocol II (PPA II) medium-risk ematogēn chemotherapy schemes (V):-oral 5HT3 receptor agonist, 12mg, Diazepam of Dexamethason intravenously for 10 mg orally.
Protocol III (PP III) moderate or low risk of ematogēn chemotherapy schemes:-of intravenous 12mg, Dexamethason Metoclopramid Forum 40mg 4 times a day orally.
6.3.4. Whereas Interferon monotherapy of (diagnosis, C64, C C17 carcinoid 57.2, 92.7, C C 95.1) subcutaneous injection (s/c) uses a different mode, the patient can get both stationary and stationary and ambulatory day, therefore, is marked by one of the procedure for entering Interferon (1 day).
6.3.5. The following diagram use case is indicated in the order of use: 6.3.5.1. C00-C14 at diagnoses and C30-Cetux_1 and Cetux_2 of the scheme, the C32 6.3.5.2. adjuvant therapy at diagnosis C50 diagram A-CMF_1 and A-CMF_1b, at diagnosis C50 6.3.5.3. adjuvant therapy schemes-T_1 and T_2 6.3.5.4. AC-, at diagnosis, adjuvant therapy in the scheme of the C50 A-D-A-D-CMF_1 and CMF_1b, at diagnosis C50 6.3.5.5 adjuvant therapy schemes-D_1-D_2 and FEC FEC. 6.3.6. appropriate diagnosis and the applicable schema must also the General steps used pretinfekcij and granulocytes colony stimulating factors (manipulation 61265-61284). Depending on the particular course of volume used to indicate the number of manipulations on one unit.
6.3.7. the manipulation of these stationary points working oncologist-ķīmijterapeit or: hematología 6.3.7.1. public limited liability company "Riga Eastern clinical University Hospital", State company 6.3.7.2 limited "Paul stradins clinical University Hospital", State company 6.3.7.3 limited "seaside hospital" 6.3.7.4. Limited liability company "Daugavpils regional hospital".
6.3.8. Manipulation of each chemotherapy course is given only after you complete the course in accordance with the description of the scheme, medical documentation indicating the chemotherapy scheme picker (manipulation 61000-61266), course completion, and treating patients with chemotherapy and inpatient and day hospital and outpatient. "
Health Minister j. Bārzdiņš the Ministry of health submitted version of annex 5 of the Cabinet of Ministers of 28 December 2010 regulations No 1217 annex 26. Cabinet of Ministers of 19 December 2006, regulations no 1046 overview of workers ' compensation, the actual average average salary and average monthly salary in the period: six months, year _____ ____ ____ ____ section/medical establishment _____ _____ _____ _____ _____ _____ telephone, fax _____ _____ _____ _____ _____ _____ no PO box
Medical and other personnel Working in the normal working hours within the remuneration including remuneration monthly salary allowances and bonuses reward individuals to legal relations regulatory basis for the employer's national insurance-definition of social payments, social benefits and ingoffsetbya rapid rise-sācij employer's social insurance State – the definition of mandatory contributions employers ' social benefits, ingoffsetbya rapid rise-sācij and other employer payments social benefits -sācij and ingoffsetbya rapid rise, other payments the employer's expenditure on health, life and accident insurance-definition of national budgetary resources 1 2 3 4 5 6 = 6 + 10 = 7 + 8 + 9 = 7 8 9 10 11 12 13 + 11 + 12 = 14 13 14 1 doctors an average of kopā1 per 2 treatments and patient care personnel kopā2 average per 3 treatment and patient care support staff average kopā3 per 4 sanitary together average per 5 Administration total average per 6
Other staff kopā4
 











 

on average, one set together on average per 1) doctors, dentists and functional specialists (physiotherapists, audiologopēd, nutritional specialists, ergoterapeit, reitterapeit, technical podiatrists) with vocational higher education and academic education;
2) people with treatment 1 and 2 level professional higher education, vocational secondary education or vocational training (physician assistants (paramedics), nurses, midwives, dental technicians, biomedical technician, dental assistant, dental higiēnist, the functional specialist assistants (physiotherapist, Assistant ergoterapeit Assistant), reitterapeit Assistant, dental nurses);
3 nursing assistants);
4) other personnel that is not listed in the above positions.
The head of the authority signature, printed name Chief Accountant (Economist) signature, printed name, "Health Minister j. Bārzdiņš the Ministry of health submitted version of annex 6 of the Cabinet of Ministers of 28 December 2010 regulations No 1217" 27. Annex a Cabinet of 19 December 2006, regulations no 1046 overview of funds for medical treatment institutions in the reporting period (six months) __ _____ _____ _____ _____ _____ _____ the medical establishment/chapter ____ ____ ____ ____ ____ ____ ____ ____ ____ ___ phone, fax _____ _____ _____ _____ _____ _____ _____ _____ _____ _____ (b. c.) lines of code type of expenditure from the State budget to help the hospital from the State budget to help the Hospital (outpatient expenditure together with the doctor who funding, if the medical establishment is darbadevēj) total budget from the State medical institution of the EU funds (the structural funds of the EU, EEA and Norway financial instrument, Transitional facility, etc.)
Total hospital's funds (budget; paid services, and other resources), cash flow (cash) actual expenditure cash flow (cash) actual expenditure cash flow (cash) actual expenditure cash flow (cash) actual expenditure cash flow (cash) actual expenditure 1 2 3 4 5 6 7 = 3 + 5 = 8 4 + 6 9 10 11 12 1000 1100 Remuneration, the remuneration, including 1110: doctors, dentists, and specialists in the functional treatments and patient care 1120 persons and functional specialist assistants, including: Assistant 1121 (paramedics), midwives, biomedical technician in 1122, dental nurse sisters 1123-1130 not mentioned above other treatments and patient care support (nursing assistants, etc.)
 
 
 
 
 
 
 
 
 
 

1140 the remaining staff, including: 1141 1142 administration personnel associated with the provision of catering, 1143 other (orderlies, janitors, etc.)
 
 
 
 
 
 
 
 
 
 

Premium 1200 1150 State employers ' compulsory social insurance contributions, social benefits and compensation 1210 State social security payments 1220 employer social benefits, compensation and other payments 2000 2100 goods and services missions and services travel services domestic mission 2110 and 2120 foreign travel missions 2200 2210 postal services, telephone and other communications services postal services 2212 2213 2214 pay telephone services Internet services other telecommunication services 2219 2220 expenditure on utilities costs for 2221 heating costs 2222 water and sewage costs for electricity 2229 2223 expenditure on other utilities 2230 institutions administrative expenses and the institution's operating expenditure administrative expenditure and 2231 public relations, courses and workshops on a contractual basis outside 2232 expert expenses 2233 expenditure on transport services 2234 legislation provided for employer health costs to workers 2236 Bank Commission 2239 other services administrative expenditure of the authority and to the Authority's activities to the provision of related services 2240 repairs and maintenance services of the institutions (except buildings, structures and roads for overhaul) 2241 buildings, structures and premises repair 2242 vehicle maintenance and repair equipment, inventory and 2243 hardware repair, technical service 2244 buildings, structures and premises maintenance 2245 vehicles compulsory third party insurance premiums 2247 real and movable property insurance 2249 general repairs and maintenance services of the institutions 2250 information technology services information system maintenance 2251 2252
Information system license lease expenses 2259 other information technology services 2260 and 2261 rent Building rent, room rental and rental vehicle hire 2262 2263 2264 land rental equipment and rental of equipment and rent the rest of the rent 2270 2269 other services
 

 
 
 
 
 
 
 
 
 

2300 items, materials, energy, commodities, Office supplies and equipment, which are not listed in the code 5000 2310 office supplies and equipment office supplies 2311 2312 2313 Spectērp equipment for the fuel and energy 2320-2321 fuel fuel remaining 2329 2322-2330 energy materials and raw materials for medicine, 2340 palīgražošan chemicals, laboratory supplies, medical devices, medical instruments, laboratory animals and their maintenance medications, chemicals, 2341 laboratory goods 2343 2344 blood buying medical instruments , laboratory animals and their maintenance routine repairs and 2350 institutional maintenance materials 2360 maintenance persons 2361 Soft inventory 2362 kitchen equipment, Cookware and tableware 2363 catering expenses other goods 2390 2400 periodicals acquisition costs 2500 tax payments tax payments 2510 2515 natural resources tax payments 2518 business risk duty 2519 taxes and other fees paid 4000 4100 interest expense interest payable to foreign and international financial institutions 4200 interest payments to domestic credit institutions 4300 other interest payments 4310
Interest payments the Treasury 4340 interest on loans from the municipal budget.
 
 
 
 
 
 
 
 
 
 

fixed capital formation-5000 x x x x x 5100 intangible assets x x x x x x x x x 5200 assets x 5220 technological equipment and machinery (laboratory and medical equipment) x x x x x x x other fixed assets 5230 x x x 5250 overhaul and reconstruction of x x x x x 6 000 depreciation x x x x x 6 100 depreciation intangible investment x x x x x x x 6 200 x fixed asset depreciation
 
x x 6 210 fixed asset depreciation (without the cost of administration and catering) x x x x x 6 220 administrative part of fixed assets depreciation x x x x x 6 230 fixed asset depreciation, related to food security x x x x x statement of revenue (in dollars) revenues in cash flow actual total revenue including: 1. The State budget: 1.1. hospital care including: 1.1.1 stationary service pay 1.1.2. starpslimnīc settlement services 1.1.3. instruments received from other health care institutions 1.1.4. patient contribution for but categories 1.2. outpatient care, including: 1.2.1. outpatient service pay UR1.2.2.sa taking resources from other health care institutions 1.2.3. patient contribution for but categories 2. Paid Services (medical services), URt.sk.
 
 
 






from insurance companies 3. installment of patients but not categories: 3.1.-hospital care, including: direct payment 3.1.1 3.1.2. third parties charge 3.2. outpatient care, including: 3.2.1 3.2.2. direct payment to third-party charges 4. Patient coverage 5. other revenues: 6. Other operating income not related to medical services means investments 7 7.1 7.2 the national budget funds from the EU funds. 7.3. other sources 8. Municipalities (specify targets) statement referred to in paragraph 6, the other operating revenue (which not related to medical services) certificate for other operating expenses (not related to medical services) type of Revenues actual income expenditure type expenditure authority actually Manager ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ signature, printed name Chief Accountant (Economist) _____ _____ _____ _____ _____ _____ _____ _____ _____ the signature, printed name Note: 1. the document property "signature" does not fill in, if the electronic document was made according to the design of the electronic documents regulations; 2. the type of expenditure which cannot be directly attributed to the outpatient or inpatient, outpatient and inpatient section of separation is determined by proprcionāl revenue. "
Health Minister j. Bārzdiņš the Ministry of health submitted version of the annex 7 of the Cabinet of Ministers of 28 December 2010 regulations No 1217 "29. Annex to the Cabinet on 19 December 2006, regulations no 1046 overview of the number of the employed and loads of treatment institutions reporting period: 6 months, year _____ _____ _____ _____ _____ _____ _____ _____ _____ _____ _____ chapter/medical establishment ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ _____ telephone, fax ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ ____ ___ indicators lines of code the number of employees the average number of Assignments during the period total average medical institution t.sk. hospital health care t.sk. outpatient health care t.sk. doctors surgeries

Total medical institution t.sk. hospital health care t.sk. outpatient health care t.sk. doctors surgeries in total including funds from the national budget total funded from State budget total funded from State budget total funded from State budget total funded from State budget total funded from State budget total funded from State budget total funded from the State budget funded 1 2 3 4 5 6 7 8 9 10 11 12 13 14
15 16 17 18 total, including: 100 doctors, dentists and functional specialists in the medical and patient care 110 persons and functional specialist assistants: Assistant 120 (paramedics), midwives, dental technicians, biomedical technician to 121, dental nurses, dental teeth higiēnist 122 123 assistants, functional specialist assistants reitterapeit assistants, 124-125 not mentioned above other treatments and patient care support: the nursing assistants other staff 130 140 141 personnel administration associated with the provision of catering to others 142 (orderlies, janitors, etc.)
143 institutions shall sign, printed name Chief Accountant (Economist) signature, printed name Note: document properties does not fill in the "signature" If the electronic document was made according to the design of the electronic documents regulations the requirements set out in the "Health Minister j. Bārzdiņš